,index,trialid,source_register,date_registration,date_enrollement,retrospective_registration,normed_spon_names,recruitment_status,phase,study_type,countries,public_title,study_category,intervention,intervention_list,target_enrollment,web_address,cross_registrations
0,0,NCT04246242,ClinicalTrials.gov,2020-01-27,2020-01-25,True,Xiangya Hospital of Central South University,Not Recruiting,Phase 4,Interventional,No Country Given,A Randomized Multicenter Controlled Clinical Trial of Arbidol in Patients With 2019 Novel Coronavirus (2019-nCoV),Drug,Umifenovir,Umifenovir,500,https://clinicaltrials.gov/show/NCT04246242,None
1,1,NCT04252885,ClinicalTrials.gov,2020-01-30,2020-01-28,True,Guangzhou 8th People's Hospital,Recruiting,Phase 4,Interventional,China,The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection,Drug,Lopinavir/ritonavir vs. umifenovir,Lopinavir/ritonavir; Umifenovir,125,https://clinicaltrials.gov/show/NCT04252885,None
2,4,NCT04260594,ClinicalTrials.gov,2020-02-06,2020-02-07,False,Jieming QU,Not Recruiting,Phase 4,Interventional,No Country Given,Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus,Drug,Umifenovir,Umifenovir,380,https://clinicaltrials.gov/show/NCT04260594,None
3,5,NCT04261426,ClinicalTrials.gov,2020-02-06,2020-02-10,False,Peking Union Medical College Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia,ATMP,Immunoglobulin,Immunoglobulin,80,https://clinicaltrials.gov/show/NCT04261426,None
4,6,NCT04261907,ClinicalTrials.gov,2020-02-06,2020-02-07,False,The First Affiliated Hospital of Zhejiang University,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection,Drug,SC09 + ritonavir vs. lopinavir/ritonavir,ASC09; lopinavir/ritonavir,160,https://clinicaltrials.gov/show/NCT04261907,None
5,9,ChiCTR2000029947,ChiCTR,2020-02-16,2020-03-01,False,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A Randomized Controlled Trial for Qingyi No. 4 Compound in the treatment of Convalescence Patients of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=49599,None
6,10,ChiCTR2000029941,ChiCTR,2020-02-16,2020-03-01,False,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for Traditional Chinese Medicine in the treatment for Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=49596,None
7,11,ChiCTR2000029939,ChiCTR,2020-02-16,2020-02-10,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,"A Single-blind, Randomized, Controlled Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19)",Drug,Chloroquine,Chloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49612,None
8,12,ChiCTR2000029935,ChiCTR,2020-02-16,2020-02-06,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,A Single-arm Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19),Drug,Chloroquine,Chloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49607,None
9,18,ChiCTR2000029869,ChiCTR,2020-02-15,2020-02-10,True,Huangshi Hospital of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, controlled trial for integrated Chinese and western medicine in the treatment of ordinary novel coronavirus pneumonia (COVID-19) based on the ' Internal and External Relieving -Truncated Torsion' strategy",Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=49486,None
10,19,ChiCTR2000029867,ChiCTR,2020-02-15,2020-02-15,False,"Beijing You'an Hospital, Capital Medical University",Recruiting,Phase 4,Interventional,China,"The efficacy and safety of carrimycin treatment in patients with novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial",Drug,Carrimycin vs. lopinavir/ritonavir,Carrimycin; lopinavir; ritonavir,520,http://www.chictr.org.cn/showproj.aspx?proj=49514,None
11,20,ChiCTR2000029855,ChiCTR,2020-02-15,2020-02-15,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,"A randomized, open and controlled clinical trial for traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,180,http://www.chictr.org.cn/showproj.aspx?proj=49543,None
12,21,ChiCTR2000029853,ChiCTR,2020-02-15,2020-02-16,False,People's Hospital of Guangshan County,Recruiting,Not Applicable,Interventional,China,"A randomized, open-label, controlled clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,Azvudine,20,http://www.chictr.org.cn/showproj.aspx?proj=49532,None
13,22,ChiCTR2000029850,ChiCTR,2020-02-15,2020-02-15,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,Study on convalescent plasma treatment for severe patients with novel coronavirus pneumonia (COVID-19),ATMP,Plasma,Plasma,20,http://www.chictr.org.cn/showproj.aspx?proj=49533,None
14,23,ChiCTR2000029849,ChiCTR,2020-02-15,2020-02-01,True,The First Affiliated Hospital of Zhengzhou University,Recruiting,Not Applicable,Interventional,China,Application of Regulating Intestinal Flora in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),ATMP,Intestinal microbiome,Intestinal microbiome,60,http://www.chictr.org.cn/showproj.aspx?proj=49530,None
15,25,ChiCTR2000029822,ChiCTR,2020-02-14,2020-02-07,True,Nanjing Second Hospital,Recruiting,Not Applicable,Interventional,No Country Given,A randomized controlled trial for honeysuckle decoction in the treatment of patients with novel coronavirus (COVID-19) infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,110,http://www.chictr.org.cn/showproj.aspx?proj=49502,None
16,26,ChiCTR2000029821,ChiCTR,2020-02-14,2020-02-14,False,Deyang Integrated Traditional Chinese and Western Medicine Hospital,Not Recruiting,Not Applicable,Prevention,China,Based on Delphi Method to Preliminarily Construct a Recommended Protocol for the Prevention of Novel Coronavirus Pneumonia (COVID-19) in Deyang Area by Using Chinese Medicine Technology and its Clinical Application Evaluation,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=49306,None
17,27,ChiCTR2000029819,ChiCTR,2020-02-14,2020-02-11,True,"Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University",Recruiting,Phase 4,Interventional,China,Ba-Bao-Dan in the adjuvant therapy of novel coronavirus pneumonia (COVID-19) patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://www.chictr.org.cn/showproj.aspx?proj=49490,None
18,29,ChiCTR2000029814,ChiCTR,2020-02-14,2020-02-14,False,Children's Hospital of Fudan University,Recruiting,Not Applicable,Interventional,China,Clinical Trial for Integrated Chinese and Western Medicine in the Treatment of Children with Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,30,http://www.chictr.org.cn/showproj.aspx?proj=49387,None
19,30,ChiCTR2000029813,ChiCTR,2020-02-14,2020-02-14,False,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Interventional,China,Clinical Trial for Tanreqing Capsules in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,72,http://www.chictr.org.cn/showproj.aspx?proj=49425,None
20,31,ChiCTR2000029811,ChiCTR,2020-02-14,2020-02-20,False,"Guangzhou reborn health management consultation co., LTD",Not Recruiting,Not Applicable,Interventional,No Country Given,Clinical Study for Anti-aging Active Freeze-dried Powder Granules in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=49355,None
21,33,ChiCTR2000029806,ChiCTR,2020-02-14,2020-02-12,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Interventional,China,Immunomodulatory Therapy for Severe Novel Coronavirus Pneumonia (COVID-19),Drug,PD1 vs. thymosin,PD1; Thymosin,120,http://www.chictr.org.cn/showproj.aspx?proj=49161,None
22,36,ChiCTR2000029790,ChiCTR,2020-02-13,2020-02-17,False,Shanghai Pulmonary Hospital,Recruiting,Not Applicable,Interventional,China,Clinical study for the integration of traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=49453,None
23,37,ChiCTR2000029789,ChiCTR,2020-02-13,2020-02-15,False,The First Affiliated Hospital of He'nan University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Randomized controlled trial for TCM syndrome differentiation treatment impacting quality of life of post-discharge patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=49348,None
24,38,ChiCTR2000029788,ChiCTR,2020-02-13,2020-03-01,False,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Traditional Chinese medicine cooperative therapy for patients with novel coronavirus pneumonia (COVID-19): a randomized controlled trial,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=49452,None
25,41,ChiCTR2000029778,ChiCTR,2020-02-13,2020-02-14,False,Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Clinical Study for Traditional Chinese Medicine Combined With Western Medicine in Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,600,http://www.chictr.org.cn/showproj.aspx?proj=49422,None
26,42,ChiCTR2000029777,ChiCTR,2020-02-13,2020-02-05,True,Huangshi Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, controlled trial for integrated chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19) based on the 'Truncated Torsion' strategy",Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,160,http://www.chictr.org.cn/showproj.aspx?proj=49380,None
27,43,ChiCTR2000029776,ChiCTR,2020-02-13,2020-02-11,True,The First Affiliated Hospital of Wenzhou Medical University,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Polyinosinic-Polycytidylic Acid Injection in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Polyinosinic-polycytidylic acid,Polyinosinic-polycytidylic acid,40,http://www.chictr.org.cn/showproj.aspx?proj=49342,None
28,44,ChiCTR2000029769,ChiCTR,2020-02-13,2020-02-15,False,Enze Hospital of Taizhou Enze Medical Center (Group),Not Recruiting,Not Applicable,Interventional,China,Babaodan Capsule used for the adjuvant treatment of severe novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.chictr.org.cn/showproj.aspx?proj=49415,None
29,45,ChiCTR2000029768,ChiCTR,2020-02-13,2020-02-12,True,Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,"A randomized, open, controlled trial for diammonium glycyrrhizinate enteric-coated capsules combined with vitamin C tablets in the treatment of common novel coronavirus pneumonia (COVID-19) in the basic of clinical standard antiviral treatment to evaluate the safety and efficiency",Drug,Diammonium glycyrrhizinate + Vitamin C,Diammonium glycyrrhizinate; Vitamin C,60,http://www.chictr.org.cn/showproj.aspx?proj=49131,None
30,46,ChiCTR2000029765,ChiCTR,2020-02-13,2020-02-10,True,The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital),Recruiting,Phase 4,Interventional,China,"A multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19)",Drug,Tocilizumab,Tocilizumab,188,http://www.chictr.org.cn/showproj.aspx?proj=49409,None
31,48,ChiCTR2000029763,ChiCTR,2020-02-12,2020-02-13,False,China Academy of Chinese Medical Sciences; Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,"The efficacy of traditional chinese medicine on Novel Coronavirus Pneumonia (COVID-19) patients treated in square cabin hospital: a prospective, randomized controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,408,http://www.chictr.org.cn/showproj.aspx?proj=49408,None
32,50,ChiCTR2000029756,ChiCTR,2020-02-12,2020-02-15,False,Renmin Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,Clinical study of nebulized Xiyanping injection in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,238,http://www.chictr.org.cn/showproj.aspx?proj=49222,None
33,53,ChiCTR2000029747,ChiCTR,2020-02-11,2020-02-11,False,The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Effect evaluation and prognosis of Chinese medicine based on Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=49287,None
34,54,ChiCTR2000029742,ChiCTR,2020-02-11,2020-02-10,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A randomized, parallel controlled trial for the efficacy and safety of Sodium Aescinate Injection in the treatment of patients with pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,90,http://www.chictr.org.cn/showproj.aspx?proj=49297,None
35,55,ChiCTR2000029741,ChiCTR,2020-02-11,2020-02-12,False,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Phase 4,Interventional,China,"Efficacy of Chloroquine and Lopinavir/ Ritonavir in mild/general novel coronavirus (CoVID-19) infections: a prospective, open-label, multicenter randomized controlled clinical study",Drug,Lopinavir/ritonavir vs. chloroquine,Lopinavir/ritonavir; Chloroquine,112,http://www.chictr.org.cn/showproj.aspx?proj=49263,None
36,56,ChiCTR2000029739,ChiCTR,2020-02-11,2020-02-12,False,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Interventional,China,"A Multicenter, Randomized, Parallel Controlled Clinical Study of Hydrogen-Oxygen Nebulizer to Improve the Symptoms of Patients With Novel Coronavirus Pneumonia (COVID-19)",Drug,Hydrogen + Oxygen vs Oxygen,Hydrogen; Oxygen,440,http://www.chictr.org.cn/showproj.aspx?proj=49283,None
37,61,ChiCTR2000029656,ChiCTR,2020-02-09,2020-02-14,False,Wuhan Pulmonary Hosptial,Not Recruiting,Not Applicable,Interventional,China,"A randomized, open-label study to evaluate the efficacy and safety of low-dose corticosteroids in hospitalized patients with novel coronavirus pneumonia (COVID-19)",Drug,Corticosteroids,Methylprednisolone,100,http://www.chictr.org.cn/showproj.aspx?proj=49086,None
38,62,ChiCTR2000029639,ChiCTR,2020-02-08,2020-02-10,False,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Interventional,China,"Study for Mental health and psychological status of doctors, nurses and patients in novel coronavirus pneumonia (COVID-19) designated hospital and effect of interventions",Other (psych),No Intervention,No Intervention,192,http://www.chictr.org.cn/showproj.aspx?proj=49187,None
39,64,ChiCTR2000029636,ChiCTR,2020-02-08,2020-02-09,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,Efficacy and safety of aerosol inhalation of vMIP in the treatment of novel coronavirus pneumonia (COVID-19): a single arm clinical trial,ATMP,Vaccine,Vaccine,40,http://www.chictr.org.cn/showproj.aspx?proj=49215,None
40,69,ChiCTR2000029621,ChiCTR,2020-02-07,2020-02-07,False,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Recruiting,Phase 4,Interventional,China,Clinical study of arbidol hydrochloride tablets in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Umifenovir,Umifenovir,380,http://www.chictr.org.cn/showproj.aspx?proj=49165,None
41,70,ChiCTR2000029609,ChiCTR,2020-02-06,2020-02-10,False,The Fifth Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Phase 4,Interventional,China,"A prospective, open-label, multiple-center study for the efficacy of chloroquine phosphate in patients with novel coronavirus pneumonia (COVID-19)",Drug,Chloroquine vs. lopinavir/ritonavir,Chloroquine; lopinavir; ritonavir,205,http://www.chictr.org.cn/showproj.aspx?proj=49145,None
42,71,ChiCTR2000029606,ChiCTR,2020-02-07,2020-01-25,True,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,Clinical Study for Human Menstrual Blood-Derived Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),ATMP,Cells (stem cells),Cells (stem cells),63,http://www.chictr.org.cn/showproj.aspx?proj=49146,None
43,72,ChiCTR2000029603,ChiCTR,2020-02-06,2020-02-06,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,"A Randomized, Open-Label, Multi-Centre Clinical Trial Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Confirmed Cases of Novel Coronavirus Pneumonia (COVID-19)",Drug,ASCO9 + Ritonavir vs. Lopinavir/ritonavir,ASC09; Ritonavir; Lopinavir/ritonavir,160,http://www.chictr.org.cn/showproj.aspx?proj=49075,None
44,73,ChiCTR2000029602,ChiCTR,2020-02-06,2020-02-01,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Clinical study for community based prevention and control strategy of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population,Clinical Presentation (Epidemiology),No Intervention,No Intervention,600,http://www.chictr.org.cn/showproj.aspx?proj=48985,None
45,74,ChiCTR2000029601,ChiCTR,2020-02-06,2020-02-01,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Community based prevention and control for Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=48988,None
46,75,ChiCTR2000029600,ChiCTR,2020-02-06,2020-01-30,True,The Third People's Hospital of Shenzhen,Recruiting,Not Applicable,Interventional,China,Clinical study for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Favipiravir + interferon alpha vs. interferon alpha + Lopinavir/ritonavir + interferon alpha vs. interferon alpha,Favipiravir; interferon alpha; Lopinavir/ritonavir,90,http://www.chictr.org.cn/showproj.aspx?proj=49042,None
47,76,ChiCTR2000029578,ChiCTR,2020-02-05,2020-02-06,False,Zhejiang Chinese Medical University,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19): a perspective, sing-arm trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,1000,http://www.chictr.org.cn/showproj.aspx?proj=49080,None
48,77,ChiCTR2000029572,ChiCTR,2020-02-05,2020-02-05,False,Xiangyang First People's Hospital,Recruiting,Not Applicable,Interventional,China,Safety and efficacy of umbilical cord blood mononuclear cells in the treatment of severe and critically novel coronavirus pneumonia(COVID-19): a randomized controlled clinical trial,ATMP,Cells (mononuclear),Cells (mononuclear),30,http://www.chictr.org.cn/showproj.aspx?proj=41760,None
49,78,ChiCTR2000029569,ChiCTR,2020-02-04,2020-02-05,False,Xiangyang First People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Safety and efficacy of umbilical cord blood mononuclear cells conditioned medium in the treatment of severe and critically novel coronavirus pneumonia (COVID-19): a randomized controlled trial,ATMP,Cells (mononuclear),Cells (mononuclear),30,http://www.chictr.org.cn/showproj.aspx?proj=49062,None
50,79,ChiCTR2000029559,ChiCTR,2020-02-04,2020-01-31,True,Renmin Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,Therapeutic effect of hydroxychloroquine on novel coronavirus pneumonia (COVID-19),Drug,Hydroxychloroquine,Hydroxychloroquine,300,http://www.chictr.org.cn/showproj.aspx?proj=48880,None
51,80,ChiCTR2000029558,ChiCTR,2020-02-04,2020-01-29,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Recommendations of Integrated Traditional Chinese and Western Medicine for Diagnosis and Treatment of Novel Coronavirus Pneumonia (COVID-19) in Sichuan Province,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=48792,None
52,81,ChiCTR2000029548,ChiCTR,2020-02-04,2020-02-04,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Interventional,China,"Randomized, open-label, controlled trial for evaluating of the efficacy and safety of Baloxavir Marboxil, Favipiravir, and Lopinavir-Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19) patients",Drug,Baloxavir + Marboxil vs. Favipiravir vs. Lopinavir/ritonavir,Baloxavir; Marboxil; Favipiravir; Lopinavir/ritonavir,30,http://www.chictr.org.cn/showproj.aspx?proj=49015,None
53,82,ChiCTR2000029544,ChiCTR,2020-02-03,2020-02-04,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Interventional,China,"A randomized controlled trial for the efficacy and safety of Baloxavir Marboxil, Favipiravir tablets in novel coronavirus pneumonia (COVID-19) patients who are still positive on virus detection under the current antiviral therapy",Drug,Baloxavir + Marboxil vs. Favipiravir,Baloxavir; Marboxil; Favipiravir,30,http://www.chictr.org.cn/showproj.aspx?proj=49013,None
54,83,ChiCTR2000029542,ChiCTR,2020-02-03,2020-02-03,False,Sun Yat sen Memorial Hospital of Sun Yat sen University,Recruiting,Phase 4,Interventional,China,Study for the efficacy of chloroquine in patients with novel coronavirus pneumonia (COVID-19),Drug,Chloroquine,Chloroquine,20,http://www.chictr.org.cn/showproj.aspx?proj=48968,None
55,84,ChiCTR2000029541,ChiCTR,2020-02-03,2020-02-10,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A randomised, open, controlled trial for darunavir/cobicistat or Lopinavir/ritonavir combined with thymosin a1 in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Darunavir + Cobicistat vs. Lopinavir/ritonavir,Darunavir; Cobicistat; Lopinavir/ritonavir,100,http://www.chictr.org.cn/showproj.aspx?proj=48992,None
56,85,ChiCTR2000029539,ChiCTR,2020-02-03,2020-02-04,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,"A randomized, open-label study to evaluate the efficacy and safety of Lopinavir-Ritonavir in patients with mild novel coronavirus pneumonia (COVID-19)",Drug,Lopinavir/ritonavir,Lopinavir; Ritonavir,328,http://www.chictr.org.cn/showproj.aspx?proj=48991,None
57,86,ChiCTR2000029518,ChiCTR,2020-02-03,2020-02-04,False,Zhejiang Chinese Medical University,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19): a perspective, double-blind, placebo, randomised controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,140,http://www.chictr.org.cn/showproj.aspx?proj=48860,None
58,87,ChiCTR2000029517,ChiCTR,2020-02-03,2020-02-04,False,Zhejiang Chinese Medical University,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for suspected novel coronavirus pneumonia (COVID-19): a perspective, double-blind, placebo, randomised controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=48861,None
59,88,ChiCTR2000029495,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine, Psychological Intervention and Investigation of Mental Health for Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period",Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,90,http://www.chictr.org.cn/showproj.aspx?proj=48971,None
60,89,ChiCTR2000029493,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine for Pulmonary Fibrosis, Pulmonary Function and Quality of Life in Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period: a Randomized Controlled Trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=48931,None
61,90,ChiCTR2000029487,ChiCTR,2020-02-02,2020-02-10,False,Wuhan Hospital of Integrated Traditional Chinese and Western Medicine,Not Recruiting,Not Applicable,Prevention,China,Clinical Study for Gu-Biao Jie-Du-Ling in Preventing of Novel Coronavirus Pneumonia (COVID-19) in Children,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=48965,None
62,91,ChiCTR2000029468,ChiCTR,2020-02-02,2020-02-01,True,"Institute of Emergency Medicine and Disaster Medicine Sichuan People's Hospital, Sichuan Academy of Medical Sciences",Not Recruiting,Not Applicable,Interventional,China,A real-world  study for lopinavir/ritonavir (LPV/r) and emtritabine (FTC) / Tenofovir alafenamide Fumarate tablets (TAF) regimen in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Lopinavir/ritonavir + emtricitabine + tenofovir vs. lopinavir/ritonavir,Lopinavir/ritonavir; Emtricitabine; Tenofovir,120,http://www.chictr.org.cn/showproj.aspx?proj=48919,None
63,93,ChiCTR2000029461,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,A Randomized Controlled Trial for Integrated Traditional Chinese Medicine and Western Medicine in the Treatment of Common Type Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=48927,None
64,94,ChiCTR2000029460,ChiCTR,2020-02-02,2020-02-02,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,The effect of shadowboxing for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period,Other (exercise),Exercise,Exercise,100,http://www.chictr.org.cn/showproj.aspx?proj=48930,None
65,95,ChiCTR2000029459,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,The effect of pulmonary rehabilitation for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,100,http://www.chictr.org.cn/showproj.aspx?proj=48929,None
66,96,ChiCTR2000029439,ChiCTR,2020-02-01,2020-02-02,False,Beijing Hospital of Traditional Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Not Applicable,Interventional,China,Combination of traditional Chinese medicine and western medicine in the treatment of common type novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=48904,None
67,97,ChiCTR2000029438,ChiCTR,2020-02-01,2020-02-04,False,Beijing Hospital of Traditional Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Phase 4,Interventional,China,A randomized controlled trial of integrated TCM and Western Medicine in the treatment of severe novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=48911,None
68,99,ChiCTR2000029436,ChiCTR,2020-02-01,2020-02-01,False,The First Hospital of He'nan University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A single arm study for evaluation of integrated traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=48884,None
69,100,ChiCTR2000029435,ChiCTR,2020-02-01,2020-02-01,False,Wuhan First Hospital,Not Recruiting,Not Applicable,Interventional,China,Randomized controlled trial for traditional Chinese medicine in the prevention of novel coronavirus pneumonia (COVID-19) in high risk population,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=48827,None
70,101,ChiCTR2000029432,ChiCTR,2020-02-01,2020-02-01,False,The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,A Real World Study for the Efficacy and Safety of Large Dose Tanreqing Injection in the Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,72,http://www.chictr.org.cn/showproj.aspx?proj=48881,None
71,102,ChiCTR2000029431,ChiCTR,2020-02-01,2020-01-29,True,Affiliated Zhongshan Hospital of Dalian University,Recruiting,Not Applicable,Interventional,China,Clinical study for the remedy of M1 macrophages target in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,45,http://www.chictr.org.cn/showproj.aspx?proj=48907,None
72,104,ChiCTR2000029418,ChiCTR,2020-01-30,2020-02-03,False,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Chinese Herbal medicine for Severe nevel coronavirus pneumonia (COVID-19): a Randomized Controlled Trial,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,42,http://www.chictr.org.cn/showproj.aspx?proj=48886,None
73,105,ChiCTR2000029400,ChiCTR,2020-01-29,2020-01-29,False,China Academy of Chinese Medical Sciences,Recruiting,Not Applicable,Interventional,China,Clinical Controlled Trial for Traditional Chinese Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=48824,None
74,106,ChiCTR2000029381,ChiCTR,2020-01-27,2020-01-24,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Phase 4,Interventional,China,A prospective comparative study for Xue-Bi-Jing injection in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=48768,None
75,107,NCT04268537,ClinicalTrials.gov,2020-02-08,2020-02-10,False,"Southeast University, China",Not Recruiting,Phase 2,Interventional,No Country Given,Immunoregulatory Therapy for 2019-nCoV,Drug,PD1 vs. thymosin,PD1; Thymosin,120,https://clinicaltrials.gov/show/NCT04268537,None
76,108,ChiCTR2000030188,ChiCTR,2020-02-24,2020-02-15,True,Guangdong Provincial Hospital of Chinese Medicine - Zhuhai Hospital,Recruiting,Not Applicable,Interventional,China,Clinical Study on Syndrome Differentiation of TCM in Treating Severe and Critical novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=50025,None
77,110,ChiCTR2000030179,ChiCTR,2020-02-24,2020-02-24,False,The First Affiliated Hospital of Nanchang University,Recruiting,Not Applicable,Interventional,China,Experimental study of novel coronavirus pneumonia rehabilitation plasma therapy severe novel coronavirus pneumonia (COVID-19),ATMP,Plasma,Plasma,100,http://www.chictr.org.cn/showproj.aspx?proj=50059,None
78,111,ChiCTR2000030173,ChiCTR,2020-02-24,2020-02-17,True,"Hunan yuanpin Cell Biotechnology Co., Ltd",Not Recruiting,Not Applicable,Interventional,China,Key techniques of umbilical cord mesenchymal stem cells for the treatment of novel coronavirus pneumonia (COVID-19) and clinical application demonstration,ATMP,Cells (mesenchymal),Cells (mesenchymal),60,http://www.chictr.org.cn/showproj.aspx?proj=49229,None
79,112,ChiCTR2000030170,ChiCTR,2020-02-24,2020-02-15,True,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Interventional,China,Study for safety and efficacy of Jakotinib hydrochloride tablets in the treatment severe and acute exacerbation patients of novel coronavirus pneumonia (COVID-19),Drug,Jakotinib,Jakotinib,16,http://www.chictr.org.cn/showproj.aspx?proj=50017,None
80,113,ChiCTR2000030167,ChiCTR,2020-02-24,2020-03-02,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,Clinical Trial for Recombinant Human Interleukin-2 in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Interleukin-2,Interleukin-2,80,http://www.chictr.org.cn/showproj.aspx?proj=49567,None
81,114,ChiCTR2000030166,ChiCTR,2020-02-24,2020-02-25,False,The Fifth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,"Randomized, parallel control, open trial for Qing-Wen Bai-Du-Yin combined with antiviral therapy in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,http://www.chictr.org.cn/showproj.aspx?proj=49696,None
82,115,ChiCTR2000030165,ChiCTR,2020-02-24,2020-02-24,False,Tianjin University,Recruiting,Not Applicable,Interventional,China,Clinical study for ozonated autohemotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Ozone,Ozone,60,http://www.chictr.org.cn/showproj.aspx?proj=49947,None
83,117,ChiCTR2000030138,ChiCTR,2020-02-24,2020-02-24,False,Chinese PLA General Hospital,Not Recruiting,Phase 2,Interventional,China,Clinical Trial for Human Mesenchymal Stem Cells in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),60,http://www.chictr.org.cn/showproj.aspx?proj=50004,None
84,119,ChiCTR2000030136,ChiCTR,2020-02-24,2020-02-24,False,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Interventional,China,Humanistic Care in Patients With Novel Coronavirus Pneumonia (COVID-19),Other,Humanistic Care,Humanistic Care,130,http://www.chictr.org.cn/showproj.aspx?proj=50005,None
85,120,ChiCTR2000030118,ChiCTR,2020-02-23,2020-02-24,False,Shenzhen National Medicine Inheritance Medical Research Institute co. LTD,Not Recruiting,Not Applicable,Interventional,China,A clinical study for ''Huo-Shen'' particles in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=49594,None
86,121,ChiCTR2000030117,ChiCTR,2020-02-23,2020-02-15,True,Shanghai Public Health Clinical Center,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, parallel controlled trial for the evaluation of the effectiveness and safety of Xiyanping injection in the treatment of common type novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,348,http://www.chictr.org.cn/showproj.aspx?proj=49762,None
87,122,ChiCTR2000030116,ChiCTR,2020-02-23,2020-02-01,True,The First Affiliated Hospital of Nanchang University,Recruiting,Not Applicable,Interventional,China,Safety and effectiveness of human umbilical cord mesenchymal stem cells in the treatment of acute respiratory distress syndrome of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),16,http://www.chictr.org.cn/showproj.aspx?proj=49901,None
88,124,ChiCTR2000030113,ChiCTR,2020-02-23,2020-02-22,True,The Third People's Hospital of Shenzhen,Recruiting,Not Applicable,Interventional,No Country Given,Randomized controlled trial for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19) with poorly responsive ritonavir/ritonavir,Drug,Favipiravir vs. ritonavir,Favipiravir,30,http://www.chictr.org.cn/showproj.aspx?proj=49988,None
89,125,ChiCTR2000030102,ChiCTR,2020-02-23,2020-02-24,False,Tianjin Huanhu Hospital,Recruiting,Not Applicable,Interventional,China,A multicenter randomized controlled trial for ozone autohemotherapy in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Ozone,Ozone,180,http://www.chictr.org.cn/showproj.aspx?proj=49747,None
90,128,ChiCTR2000030093,ChiCTR,2020-02-23,2020-03-01,False,The Second Hospital of Shanxi Medical University,Not Recruiting,Not Applicable,Interventional,China,Study for application of simplified cognitive-behavioral therapy for related emergency psychological stress reaction of medical providers working in the position of treatment and control of novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,Psychological,60,http://www.chictr.org.cn/showproj.aspx?proj=49932,None
91,130,ChiCTR2000030090,ChiCTR,2020-02-22,2020-02-22,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,A Prospective Randomized Controlled Trial for Home Exercise Prescription Intervention During Epidemic of Novel Coronary Pneumonia (COVID-19) in College Students,Other (exercise),Exercise,Exercise,400,http://www.chictr.org.cn/showproj.aspx?proj=49910,None
92,131,ChiCTR2000030089,ChiCTR,2020-02-22,2020-02-28,False,Shanghai Changzheng Hospital,Not Recruiting,Phase 4,Interventional,China,A clinical study for the efficacy and safety of Adalimumab Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19),Drug,Adalimumab,Adalimumab,60,http://www.chictr.org.cn/showproj.aspx?proj=49889,None
93,132,ChiCTR2000030088,ChiCTR,2020-02-22,2020-03-01,False,The Sixth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,Umbilical cord Wharton's Jelly derived mesenchymal stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),40,http://www.chictr.org.cn/showproj.aspx?proj=49902,None
94,135,ChiCTR2000030084,ChiCTR,2020-02-22,2020-02-24,False,The First Hospital of Shanxi Medical University,Recruiting,Not Applicable,Interventional,China,A multicenter study for efficacy of intelligent psychosomatic adjustment system intervention in the treatment of novel coronavirus pneumonia (COVID-19) patients with mild to moderate anxiety and depression,Other (psych),Psychological,Psychological,180,http://www.chictr.org.cn/showproj.aspx?proj=49952,None
95,136,ChiCTR2000030058,ChiCTR,2020-02-22,2020-03-10,False,Renmin Hospital of Wuhan University,Not Recruiting,Phase 3,Interventional,China,"A multicenter, randomized, double-blind, controlled clinical trial for leflunomide in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Leflunomide,Leflunomide,200,http://www.chictr.org.cn/showproj.aspx?proj=49831,None
96,138,ChiCTR2000030054,ChiCTR,2020-02-22,2020-02-22,False,Zhongshan Hospital Affiliated to Xiamen University,Not Recruiting,Not Applicable,Interventional,China,"A prospective, open label, randomized, control trial for chloroquine or hydroxychloroquine in patients with mild and common novel coronavirus pulmonary (COVIP-19)",Drug,Chloroquine + Hydroxychloroquine,Chloroquine; Hydroxychloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49869,None
97,139,ChiCTR2000030046,ChiCTR,2020-02-21,2020-02-07,True,"The First People's Hospital of Jiangxia District, Wuhan (Union Jiangnan Hospital)",Recruiting,Not Applicable,Interventional,China,A single arm trial to evaluate the efficacy and safety of anti-2019-nCoV inactivated convalescent plasma in the treatment of novel coronavirus pneumonia patient (COVID-19),ATMP,Plasma,Plasma,10,http://www.chictr.org.cn/showproj.aspx?proj=49861,None
98,140,ChiCTR2000030043,ChiCTR,2020-02-21,2020-02-21,False,Peking University Third Hospital,Not Recruiting,Phase 4,Interventional,China,"Shen-Fu injection in the treatment of severe novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=49866,None
99,141,ChiCTR2000030041,ChiCTR,2020-02-21,2020-02-25,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A single-arm, single-center clinical trial for Azivudine tablets in the treatment of adult novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,Azvudine,40,http://www.chictr.org.cn/showproj.aspx?proj=49891,None
100,142,ChiCTR2000030039,ChiCTR,2020-02-21,2020-05-31,False,Affiliated Hospital of Xuzhou Medical University,Recruiting,Not Applicable,Interventional,China,Clinical study for infusing convalescent plasma to treat patients with new coronavirus pneumonia (COVID-19),ATMP,Plasma,Plasma,90,http://www.chictr.org.cn/showproj.aspx?proj=49544,None
101,143,ChiCTR2000030034,ChiCTR,2020-02-21,2020-02-07,True,Tongde Hospital of Zhejiang Province,Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19): a multicentre, randomized controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,132,http://www.chictr.org.cn/showproj.aspx?proj=49647,None
102,144,ChiCTR2000030033,ChiCTR,2020-02-21,2020-02-24,False,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,A study for the intervention of Xiangxue antiviral oral solution and Wu-Zhi-Fang-Guan-Fang on close contacts of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,828,http://www.chictr.org.cn/showproj.aspx?proj=49703,None
103,147,ChiCTR2000030029,ChiCTR,2020-02-21,2020-02-20,True,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Interventional,China,A multi-center study on the efficacy and safety of suramin sodium in adult patients with novel coronavirus pneumonia (COVID-19),Drug,Suramin,Suramin,20,http://www.chictr.org.cn/showproj.aspx?proj=49824,None
104,148,ChiCTR2000030027,ChiCTR,2020-02-20,2020-02-20,False,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Traditional Chinese medicine cooperative therapy for patients with Novel coronavirus pneumonia (COVID-19) and its effect on spermatogenesis: a randomized controlled trial,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=49852,None
105,150,ChiCTR2000030020,ChiCTR,2020-02-20,2020-02-06,True,"Second Hospital of University of South China, Hengyang",Recruiting,Not Applicable,Interventional,China,The clinical application and basic research related to mesenchymal stem cells to treat novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://www.chictr.org.cn/showproj.aspx?proj=49812,None
106,153,ChiCTR2000030016,ChiCTR,2020-02-19,2020-02-04,True,Guangxi Medical University,Recruiting,Phase 4,Interventional,China,Basic and clinical study of inhalation of inactivated mycobacterium vaccine in the treatment of Novel coronavirus pneumonia (COVID-19),ATMP,Vaccine,Vaccine,60,http://www.chictr.org.cn/showproj.aspx?proj=49799,None
107,155,ChiCTR2000030012,ChiCTR,2020-02-19,2020-02-19,False,"The First People's Hospital of Chenzhou, Institute of Translational Medicine,University of South China",Not Recruiting,Not Applicable,Interventional,China,Development of anti-2019-nCoV therapeutic antibody from the recovered novel coronavirus pneumonia patients (COVID-19),ATMP,Antibody,Antibody,20,http://www.chictr.org.cn/showproj.aspx?proj=49718,None
108,156,ChiCTR2000030010,ChiCTR,2020-02-19,2020-02-19,False,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, parallel-controlled, trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia patients (COVID-19)",ATMP,Plasma,Plasma,100,http://www.chictr.org.cn/showproj.aspx?proj=49777,None
109,158,ChiCTR2000030007,ChiCTR,2020-02-19,2020-02-03,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Multicenter randomized controlled trial for rhG-CSF in the treatment of novel coronavirus pneumonia (COVID-19),Drug,G-CSF,G-CSF,200,http://www.chictr.org.cn/showproj.aspx?proj=49619,None
110,159,ChiCTR2000030006,ChiCTR,2020-02-19,2020-02-19,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the efficacy of ozonated autohemotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Ozone,Ozone,60,http://www.chictr.org.cn/showproj.aspx?proj=49737,None
111,161,ChiCTR2000030003,ChiCTR,2020-02-19,2020-02-19,False,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Optimization Protocal of Integrated Traditional Chinese and Western Medicine in the Treatment for Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,480,http://www.chictr.org.cn/showproj.aspx?proj=49770,None
112,162,ChiCTR2000030002,ChiCTR,2020-02-19,2020-02-15,True,The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital),Recruiting,Phase 4,Interventional,China,Clinical study of novel NLRP Inflammasome inhibitor (Tranilast) in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Tranilast,Tranilast,60,http://www.chictr.org.cn/showproj.aspx?proj=49738,None
113,163,ChiCTR2000030001,ChiCTR,2020-02-19,2020-02-15,True,Health commission of Heilongjiang province,Recruiting,Phase 3,Interventional,China,"The efficacy and safety of Triazavirin for 2019 novel coronary pneumonia (COVID-19): a multicenter, randomized, double blinded, placebo-controlled trial",Drug,Triazavirin,Triazavirin,240,http://www.chictr.org.cn/showproj.aspx?proj=49723,None
114,164,ChiCTR2000030000,ChiCTR,2020-02-19,2020-02-16,True,The Ninth Hospital of Nanchang,Recruiting,Phase 4,Interventional,China,"An open, controlled clinical trial for evaluation of ganovo combined with ritonavir and integrated traditional Chinese and Western medicine in the treatment of novel coronavirus infection (COVID-19)",Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,50,http://www.chictr.org.cn/showproj.aspx?proj=49748,None
115,165,ChiCTR2000029999,ChiCTR,2020-02-19,2020-02-20,False,Shanghai 10th People's Hospital,Not Recruiting,Not Applicable,Interventional,China,A clinical study for probiotics in the regulation of intestinal function and microflora structure of novel coronavirus pneumonia (COVID-19),Supplement,Probiotics,Probiotics,60,http://www.chictr.org.cn/showproj.aspx?proj=49717,None
116,166,ChiCTR2000029996,ChiCTR,2020-02-20,2020-02-20,False,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Phase 2,Interventional,China,"A randomized, open-label, controlled trial for the efficacy and safety of Farpiravir Tablets in the treatment of patients with novel coronavirus pneumonia (COVID-19)",Drug,Favipiravir,Favipiravir,60,http://www.chictr.org.cn/showproj.aspx?proj=49510,None
117,168,ChiCTR2000029994,ChiCTR,2020-02-18,2020-02-19,False,Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Liu-Zi-Jue Qigong and Acupressure Therapy for Pulmonary Function and Quality of Life in Patient with Severe novel coronavirus pneumonia (COVID-19): A Randomized Controlled Trial,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=49309,None
118,169,ChiCTR2000029992,ChiCTR,2020-02-18,2020-02-17,True,Zhongshan Hospital Affiliated to Xiamen University,Not Recruiting,Phase 4,Interventional,China,"A prospective, randomized, open label, controlled trial for chloroquine and hydroxychloroquine in patients with severe novel coronavirus pneumonia (COVID-19)",Drug,Chloroquine + Hydroxychloroquine,Chloroquine; Hydroxychloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49574,None
119,170,ChiCTR2000029990,ChiCTR,2020-02-18,2020-01-30,True,"Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences",Recruiting,Phase 1/Phase 2,Interventional,China,Clinical trials of mesenchymal stem cells for the treatment of pneumonitis caused by novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),120,http://www.chictr.org.cn/showproj.aspx?proj=49674,None
120,171,ChiCTR2000029989,ChiCTR,2020-02-18,2020-02-20,False,Chinese PLA General Hospital,Not Recruiting,Phase 4,Interventional,China,A randomized controlled Trial for therapeutic efficacy of Recombinant Human Interferon alpha 1b Eye Drops in the treatment of elderly with novel coronavirus pneumonia (COVID-19),Drug,Interferon alfa,Interferon alfa,300,http://www.chictr.org.cn/showproj.aspx?proj=49720,None
121,172,ChiCTR2000029988,ChiCTR,2020-02-18,2020-02-13,True,Zhongnan Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,Clinical Study of Chloroquine Phosphate in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),Drug,Chloroquine,Chloroquine,80,http://www.chictr.org.cn/showproj.aspx?proj=49218,None
122,175,ChiCTR2000029978,ChiCTR,2020-02-18,2020-02-21,False,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Not Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the efficacy of Dao-Yin in the prevention and controlling novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,186,http://www.chictr.org.cn/showproj.aspx?proj=49702,None
123,176,ChiCTR2000029974,ChiCTR,2020-02-18,2020-02-09,True,"Qingdao East Sea Pharmaceutical Co., Ltd.",Recruiting,Not Applicable,Interventional,China,"A prospective, multicenter, open-label, randomized, parallel-controlled trial for probiotics to evaluate efficacy and safety in patients infected with 2019 novel coronavirus pneumonia (COVID-19)",Supplement,Probiotics,Probiotics,300,http://www.chictr.org.cn/showproj.aspx?proj=49321,None
124,177,ChiCTR2000029972,ChiCTR,2020-02-17,2020-02-17,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the Efficacy of Ultra Short Wave Electrotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),Other (physical),Ultra short wave electrotherapy,Ultra short wave electrotherapy,40,http://www.chictr.org.cn/showproj.aspx?proj=49664,None
125,178,ChiCTR2000029960,ChiCTR,2020-02-17,2020-02-28,False,The First Affiliated Hospital of Hu'nan University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Comparative study for integrate Chinese and conventional medicine the the treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=49639,None
126,180,ChiCTR2000029956,ChiCTR,2020-02-17,2020-02-18,False,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Chinese Medicine Promotes Rehabilitation Recommendations after 2019 Novel Coronavirus Infection (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=49618,None
127,181,ChiCTR2000029954,ChiCTR,2020-02-17,2020-04-30,False,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Phase 4,Interventional,China,"Efficacy and safety of honeysuckle oral liquid in the treatment of novel coronavirus pneumonia (COVID-19): a multicenter, randomized, controlled, open clinical trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=49402,None
128,184,ChiCTR2000029851,ChiCTR,2020-02-15,2020-02-19,False,"Zhongshan Hospital, Fudan University",Recruiting,Phase 4,Interventional,China,"A multicenter, randomized controlled trial for the efficacy and safety of Alpha lipoic acid (iv) in the treatment of patients of severe novel coronavirus pneumonia (COVID-19)",Supplement,Alpha lipoic acid,Alpha lipoic acid,68,http://www.chictr.org.cn/showproj.aspx?proj=49534,None
129,185,ChiCTR2000029803,ChiCTR,2020-02-14,2020-02-20,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A prospective, randomized, open-label, controlled clinical study to evaluate the preventive effect of hydroxychloroquine on close contacts after exposure to the Novel Coronavirus Pneumonia (COVID-19)",Drug,Hydroxychloroquine vs. Umeprevir,Hydroxychloroquine; Umeprevir,320,http://www.chictr.org.cn/showproj.aspx?proj=49428,None
130,186,ChiCTR2000029781,ChiCTR,2020-02-13,2020-02-14,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open and controlled trial for the efficacy and safety of Kang-Bing-Du granules in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,160,http://www.chictr.org.cn/showproj.aspx?proj=49138,None
131,187,ChiCTR2000029780,ChiCTR,2020-02-13,2020-02-14,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, controlled trial for the efficacy and safety of Shen-Qi Fu-Zheng injection in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,160,http://www.chictr.org.cn/showproj.aspx?proj=49220,None
132,188,ChiCTR2000029740,ChiCTR,2020-02-11,2020-02-11,False,The First Hospital of Peking University,Recruiting,Phase 4,Interventional,China,Efficacy of therapeutic effects of hydroxycholoroquine in novel coronavirus pneumonia (COVID-19) patients(randomized open-label control clinical trial),Drug,Hydroxychloroquine,Hydroxychloroquine,78,http://www.chictr.org.cn/showproj.aspx?proj=49317,None
133,190,NCT04273529,ClinicalTrials.gov,2020-02-14,2020-02-20,False,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Phase 2,Interventional,No Country Given,The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia,Drug,Thalidomide,Thalidomide,100,https://clinicaltrials.gov/show/NCT04273529,None
134,191,NCT04273581,ClinicalTrials.gov,2020-02-14,2020-02-18,False,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Phase 2,Interventional,No Country Given,The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19,Drug,Thalidomide + Corticosteroids,Thalidomide; Methylprednisolone,40,https://clinicaltrials.gov/show/NCT04273581,None
135,192,NCT04275245,ClinicalTrials.gov,2020-02-06,2020-02-03,True,Tang-Du Hospital,Recruiting,Phase 1/Phase 2,Interventional,China,Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia,Drug,Mepolizumab,Mepolizumab,20,https://clinicaltrials.gov/show/NCT04275245,None
136,194,NCT04279197,ClinicalTrials.gov,2020-02-15,2020-02-15,False,ShuGuang Hospital,Recruiting,Phase 2,Interventional,China,Treatment of Pulmonary Fibrosis Due to 2019-nCoV Pneumonia With Fuzheng Huayu,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,136,https://clinicaltrials.gov/show/NCT04279197,None
137,198,NCT04280588,ClinicalTrials.gov,2020-02-20,2020-02-22,False,The First Affiliated Hospital of Fujian Medical University,Recruiting,Phase 2,Interventional,China,Fingolimod in COVID-19,Drug,Fingolimod,Fingolimod,30,https://clinicaltrials.gov/show/NCT04280588,None
138,199,ChiCTR2000030442,ChiCTR,2020-03-02,2020-03-05,False,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Interventional,No Country Given,"Combination of Tocilizumab, IVIG and CRRT in severe patients with novel coronavirus pneumonia (COVID-19)",Drug (+ ATMP + Other (renal)),Tocilizumab + immunoglobulin + renal replacement therapy,Tocilizumab; Immunoglobulin; Renal replacement therapy,100,http://www.chictr.org.cn/showproj.aspx?proj=50380,None
139,200,ChiCTR2000030433,ChiCTR,2020-03-01,2020-03-01,False,The First Affiliated Hospital of Fujian Medical University,Not Recruiting,Phase 1,Interventional,China,Application of Rehabilitation and Lung Eight-segment Exercise in Home Rehabilitation of Survivors from novel coronavirus pneumonia (COVID-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,80,http://www.chictr.org.cn/showproj.aspx?proj=50273,None
140,201,ChiCTR2000030432,ChiCTR,2020-03-01,2020-03-02,False,The First Affiliated Hospital of Fujian Medical University,Not Recruiting,Not Applicable,Interventional,China,Application of rehabilitation and Lung eight-segment exercise in front-line nurses in the prevention of novel coronavirus pneumonia (COVID-19) epidemic,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,80,http://www.chictr.org.cn/showproj.aspx?proj=50268,None
141,202,ChiCTR2000030424,ChiCTR,2020-03-01,2020-03-02,False,Henan Provincial People's Hospital,Not Recruiting,Not Applicable,Interventional,China,"A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,Azvudine,30,http://www.chictr.org.cn/showproj.aspx?proj=50174,None
142,203,ChiCTR2000030420,ChiCTR,2020-03-01,2020-03-01,False,"Institute of Integrative Medicine of Dalian Medical University, Dalian, China",Not Recruiting,Not Applicable,Interventional,China,A Clinical Trial Study for the Influence of TCM Psychotherapy on Negative Emotion of Patients with Novel Coronavirus Pneumonia (COVID-19) Based on Network Platform,Other (psych),Psychological,Psychological,60,http://www.chictr.org.cn/showproj.aspx?proj=50286,None
143,204,ChiCTR2000030418,ChiCTR,2020-03-01,2020-03-01,False,The First Affiliated Hospital of Fujian Medical University,Recruiting,Not Applicable,Interventional,China,Application of rehabilitation lung exercise eight-segment exercise in patients with novel coronavirus pneumonia (COVID-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,80,http://www.chictr.org.cn/showproj.aspx?proj=50341,None
144,205,ChiCTR2000030398,ChiCTR,2020-03-01,2020-02-27,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, placebo-controlled trial for evaluation of  the efficacy and safety of bismuth potassium citrate capsules in the treatment of patients with novel coronavirus pneumonia (COVID-19).",Drug,Bismuth potassium citrate,Bismuth potassium citrate,340,http://www.chictr.org.cn/showproj.aspx?proj=50173,None
145,210,ChiCTR2000030386,ChiCTR,2020-02-18,2020-03-01,False,Hunan University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Study for moxibustion in the preventing of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,1000,http://www.chictr.org.cn/showproj.aspx?proj=50323,None
146,214,ChiCTR2000030333,ChiCTR,2020-02-28,2020-03-04,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,"A randomized, open-label controlled trial for the efficacy and safety of Pirfenidone in patients with severe and critical novel coronavirus pneumonia (COVID-19)",Drug,Pirfenidone,Pirfenidone,292,http://www.chictr.org.cn/showproj.aspx?proj=48801,None
147,217,ChiCTR2000030324,ChiCTR,2020-02-28,2020-02-28,False,"Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",Not Recruiting,Not Applicable,Interventional,China,Traditional Chinese Medicine 'Zang-Fu Point-pressing' massage for children with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,40,http://www.chictr.org.cn/showproj.aspx?proj=50231,None
148,219,ChiCTR2000030317,ChiCTR,2020-02-28,2020-03-01,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,Clinical study for a new type of Gastroscope isolation mask for preventing and controlling the novel coronavirus pneumonia (COVID-19) Epidemic period,Other (physical),Gastroscope mask,Gastroscope mask,300,http://www.chictr.org.cn/showproj.aspx?proj=50247,None
149,221,ChiCTR2000030314,ChiCTR,2020-02-28,2020-02-28,False,"Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",Not Recruiting,Not Applicable,Interventional,No Country Given,Traditional Chinese medicine Ma-Xing-Shi-Gan-Tang and Sheng-Jiang-San in the treatment of children with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.chictr.org.cn/showproj.aspx?proj=50248,None
150,226,ChiCTR2000030265,ChiCTR,2020-02-26,2020-02-24,True,The First Affiliated Hospital of Harbin Medical University,Not Recruiting,Not Applicable,Interventional,China,Study for continuous renal replacement therapy with adsorption filter in the treatment of the novel coronavirus pneumonia (COVID-19),Other (renal),Renal replacement therapy,Renal replacement therapy,30,http://www.chictr.org.cn/showproj.aspx?proj=49691,None
151,229,ChiCTR2000030261,ChiCTR,2020-02-26,2020-03-01,False,Wuxi Fifth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,A study for the key technology of mesenchymal stem cells exosomes atomization in the treatment of novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),26,http://www.chictr.org.cn/showproj.aspx?proj=49963,None
152,230,ChiCTR2000030260,ChiCTR,2020-02-26,2020-02-27,False,"Ganzi Hospital of West China Hospital, Sichuan University",Not Recruiting,Not Applicable,Interventional,China,Clinical study for individualized nutritional assessment and supportive treatment of novel coronavirus pneumonia (COVID-19) patients in Tibetan Plateau,Other (nutrition),Nutrition,Nutrition,20,http://www.chictr.org.cn/showproj.aspx?proj=50130,None
153,231,ChiCTR2000030259,ChiCTR,2020-02-26,2020-02-22,True,Shanghai Changzheng Hospital,Recruiting,Not Applicable,Interventional,China,"Evaluation Danorevir sodium tablets combined with ritonavir in the treatment of novel coronavirus pneumonia (COVID-19): a randomized, open and controlled trial",Drug,Danoprevir + Ritonavir,Danoprevir; Ritonavir,60,http://www.chictr.org.cn/showproj.aspx?proj=49918,None
154,232,ChiCTR2000030258,ChiCTR,2020-02-26,2020-02-21,True,The Fourth Affiliated Hospital of Harbin Medical University,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, controlled trial for efficacy and safety of hydrogen inhalation in the treatment of novel coronavirus pneumonia (COVID-19) patients",Drug,Hydrogen,Hydrogen,60,http://www.chictr.org.cn/showproj.aspx?proj=49887,None
155,234,ChiCTR2000030255,ChiCTR,2020-02-26,2020-03-01,False,Shanghai University of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of Jing-Yin Granule in the treatment of novel coronavirus pneumonia (COVID-19) wind-heat syndrome,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=50089,None
156,237,ChiCTR2000030225,ChiCTR,2020-02-26,2020-02-22,True,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Not Recruiting,Not Applicable,Interventional,China,Clinical Reseach of Acupuncture in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,186,http://www.chictr.org.cn/showproj.aspx?proj=49945,None
157,240,ChiCTR2000030219,ChiCTR,2020-02-25,2020-01-21,True,The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Study for evaluation of integrated traditional Chinese and Western Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=50110,None
158,241,ChiCTR2000030218,ChiCTR,2020-02-25,2020-01-22,True,The Fifth People's Hospital of Ganzhou,Recruiting,Not Applicable,Interventional,China,Study of Pinavir / Ritonavir Tablets (Trade Name: Kelizhi) Combined with Xiyanping Injection for Novel Coronavirus Pneumonia (COVID-19),Drug,Lopinavir/ritonavir (+ Tradtional Medicine),Lopinavir; Ritonavir; Traditional Medicine,80,http://www.chictr.org.cn/showproj.aspx?proj=50115,None
159,242,ChiCTR2000030215,ChiCTR,2020-02-25,2020-02-26,False,"The First Affiliated Hospital of Nanchang University, Ten layers pulse Research Institute of traditional Chinese medicine, Nanchang University",Not Recruiting,Not Applicable,Interventional,China,Study for the efficacy of Kangguan No. 1-3 prescription in the treatment of novel coronavirus pneumonia (COVID19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=50107,None
160,243,ChiCTR2000030196,ChiCTR,2020-02-25,2020-02-20,True,Central South Hospital of Wuhan University,Not Recruiting,Phase 2,Interventional,China,"A multicenter, single arm, open label trial for the efficacy and safety of CMAB806 in the treatment of cytokine release syndrome of novel coronavirus pneumonia (COVID-19)",Drug,Tocilizumab,Tocilizumab,60,http://www.chictr.org.cn/showproj.aspx?proj=49883,None
161,245,ChiCTR2000030091,ChiCTR,2020-02-23,2020-02-22,True,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,A prospective randomized controlled trial for the home exercise prescription intervention in nursing students during epidemic of novel coronary pneumonia (COVID-19),Other (exercise),Exercise,Exercise,200,http://www.chictr.org.cn/showproj.aspx?proj=49914,None
162,247,ChiCTR2000030022,ChiCTR,2020-02-20,2020-02-22,False,The First Affiliated Hospital of Anhui Medical University,Not Recruiting,Phase 4,Interventional,China,"A parallel, randomized controlled clinical trial for the efficacy and safety of Pediatric Huatanzhike granules (containing ipecacuanha tincture) in the treatment of mild and moderate novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=49797,None
163,248,ChiCTR2000030013,ChiCTR,2020-02-19,2020-02-20,False,Chinese PLA General Hospital,Not Recruiting,Phase 4,Interventional,China,A prospective clinical study for recombinant human interferon alpha 1b spray in the prevention of novel coronavirus (COVID-19) infection in highly exposed medical staffs.,Drug,Interferon alfa,Interferon alfa,450,http://www.chictr.org.cn/showproj.aspx?proj=49796,None
164,249,ChiCTR2000029991,ChiCTR,2020-02-18,2020-02-18,False,The First Affiliated Hospital of Nanchang University,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, controlled trial for the safety and efficiency of Kesuting syrup and Keqing capsule in the treatment of mild and moderate novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,72,http://www.chictr.org.cn/showproj.aspx?proj=49666,None
165,250,ChiCTR2000029975,ChiCTR,2020-02-18,2020-02-24,False,The First Hospital of Jilin University,Not Recruiting,Phase 4,Interventional,China,Single arm study for exploration of chloroquine phosphate aerosol inhalation in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Chloroquine,Chloroquine,10,http://www.chictr.org.cn/showproj.aspx?proj=49592,None
166,253,ChiCTR2000029899,ChiCTR,2020-02-16,2020-02-17,False,Peking University Third Hospital,Recruiting,Phase 4,Interventional,China,"Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Mild and Commen Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-label, Parallel, Controlled Trial",Drug,Hydroxychloroquine vs. Chloroquine,Chloroquine; Hydroxychloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49536,None
167,254,ChiCTR2000029898,ChiCTR,2020-02-16,2020-02-17,False,Peking University Third Hospital,Recruiting,Phase 4,Interventional,China,"Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Severe Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-Label, Parallel, Controlled Trial",Drug,Hydroxychloroquine vs. Chloroquine,Chloroquine; Hydroxychloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49482,None
168,260,ChiCTR2000029755,ChiCTR,2020-02-12,2020-02-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A randomized, open, parallel-controlled clinical trial on the efficacy and safety of Jingyebaidu granules in treating novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=49301,None
169,262,ChiCTR2000029387,ChiCTR,2020-01-29,2020-01-25,True,Chongqing Public Health Medical Center,Recruiting,Not Applicable,Interventional,China,"Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha and ribavirin plus lopinavir/ritonavir plus interferon-alphain in patients with mild to moderate novel coronavirus pneumonia",Drug,"Ribavirin + Interferon alfa
vs. lopinavir/ritonavir + interferon alfa
vs. ribavirin + interferon alfa vs. lopinavir/ritonavir",Ribavirin; Interferon alpha; Lopinavir; Ritonavir,108,http://www.chictr.org.cn/showproj.aspx?proj=48782,None
170,263,ChiCTR2000029386,ChiCTR,2020-01-29,2020-01-29,False,Chongqing Public Health Medical Center,Recruiting,Not Applicable,Interventional,China,Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: a randomized controlled trial,Drug,Corticosteroids,Methylprednisolone,48,http://www.chictr.org.cn/showproj.aspx?proj=48777,None
171,264,NCT04276987,ClinicalTrials.gov,2020-02-16,2020-02-15,True,Ruijin Hospital,Not Recruiting,Phase 1,Interventional,No Country Given,A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04276987,None
172,265,NCT04281693,ClinicalTrials.gov,2020-02-20,2020-02-01,True,Affiliated Hospital to Academy of Military Medical Sciences,Not Recruiting,Not Applicable,Interventional,China,A New Screening Strategy for 2019 Novel Coronavirus Infection,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,230,https://clinicaltrials.gov/show/NCT04281693,None
173,266,NCT04282902,ClinicalTrials.gov,2020-02-10,2020-02-04,True,Huilan Zhang,Recruiting,Phase 3,Interventional,China,A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection,Drug,Pirfenidone,Pirfenidone,294,https://clinicaltrials.gov/show/NCT04282902,None
174,268,NCT04286503,ClinicalTrials.gov,2020-02-25,2020-02-23,True,"Beijing You'an Hospital, Capital Medical University",Not Recruiting,Phase 4,Interventional,No Country Given,The Clinical Study of Carrimycin on Treatment Patients With COVID-19,Drug,Carrimycin vs. lopinavir/ritonavir or Umifenovir or chloroquine,Carrimycin; lopinavir; ritonavir; Umifenovir; chloroquine,520,https://clinicaltrials.gov/show/NCT04286503,None
175,269,ChiCTR2000030627,ChiCTR,2020-03-08,2020-02-01,True,The First Affiliated Hospital of Zhengzhou University,Recruiting,Not Applicable,Interventional,China,Study for using the healed novel coronavirus pneumonia (COVID-19) patients plasma in the treatment of severe critical cases,ATMP,Plasma,Plasma,30,http://www.chictr.org.cn/showproj.aspx?proj=50727,None
176,273,ChiCTR2000030578,ChiCTR,2020-03-08,2020-03-07,True,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical Prediction and Intervention of Pulmonary Function Impairment in Patients with Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,40,http://www.chictr.org.cn/showproj.aspx?proj=50690,None
177,284,ChiCTR2000030540,ChiCTR,2020-03-06,2020-03-08,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,China,Research for the mechanism of improvement of novel coronavirus pneumonia (COVID-19) patients' pulmonary exudation by continuous renal replacement therapy,Other (renal),Renal replacement therapy,Renal replacement therapy,152,http://www.chictr.org.cn/showproj.aspx?proj=50658,None
178,285,ChiCTR2000030535,ChiCTR,2020-03-06,2020-02-20,True,Wuhan Red Cross Hospital,Recruiting,Phase 4,Interventional,China,Multi-Center Clinical Study on the Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19) by Ebastine,Drug,Ebastine + Interferon alpha + Lopinavir vs. Interferon alpha + Lopinavir,Ebastine; interferon alpha; lopinavir,100,http://www.chictr.org.cn/showproj.aspx?proj=49790,None
179,286,ChiCTR2000030522,ChiCTR,2020-03-06,2020-03-09,False,Affiliated Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Efficacy and safety of Ma-Xing-Gan-Shi decoction in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=44213,None
180,287,ChiCTR2000030518,ChiCTR,2020-03-05,2020-02-29,True,The Second Affiliated Hospital of Wenzhou Medical University,Recruiting,Not Applicable,Interventional,China,"Zedoary Turmeric Oil for Injection in the treatment of Novel Coronavirus Pneumonia (COVID-19): a randomized, open, controlled trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=50586,None
181,288,ChiCTR2000030503,ChiCTR,2020-03-05,2020-01-20,True,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,Extracorporeal blood purification therapy using Li's Artifical Liver System for patients with severe novel coronavirus pneumonia (COVID19) patient,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=49632,None
182,292,ChiCTR2000030490,ChiCTR,2020-03-04,2020-02-01,True,Huo-Shen-Shan Hospital,Recruiting,Not Applicable,Interventional,No Country Given,To evaluate the efficacy and safety of diammonium glycyrrhizinate enteric-coated capsules combined with hydrogen-rich water in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Diammonium glycyrrhizinate + Hydrogen,Diammonium glycyrrhizinate; Hydrogen,100,http://www.chictr.org.cn/showproj.aspx?proj=50487,None
183,294,ChiCTR2000030487,ChiCTR,2020-03-04,2020-03-04,False,The First Affiliated Hospital of He'nan University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,Azvudine,10,http://www.chictr.org.cn/showproj.aspx?proj=50507,None
184,296,ChiCTR2000030484,ChiCTR,2020-03-03,2020-02-02,True,Hubei Shiyan Taihe hospital,Not Recruiting,Not Applicable,Interventional,China,HUMSCs and Exosomes Treating Patients with Lung Injury following Novel Coronavirus Pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),90,http://www.chictr.org.cn/showproj.aspx?proj=50263,None
185,298,ChiCTR2000030481,ChiCTR,2020-03-03,2020-03-01,True,Zhongnan Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,The clinical value of corticosteroid therapy timing in the treatment of novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial,Drug,Corticosteroids,Corticosteroids,200,http://www.chictr.org.cn/showproj.aspx?proj=50453,None
186,299,ChiCTR2000030480,ChiCTR,2020-03-03,2020-03-03,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"Randomized, open, blank controlled trial for the efficacy and safety of recombinant human interferon alpha 1beta in the treatment of Wuhan patients with novel coronavirus pneumonia (COVID-19)",Drug,Interferon alfa,Interferon alfa,328,http://www.chictr.org.cn/showproj.aspx?proj=50470,None
187,300,ChiCTR2000030479,ChiCTR,2020-03-03,2020-02-26,True,"Affiliated Hospital of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine",Not Recruiting,Not Applicable,Interventional,China,Study for the Effectiveness and Safety of Yi-Qi Hua-shi Jie-Du-Fang in the Treatment of the Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50450,None
188,301,ChiCTR2000030477,ChiCTR,2020-03-03,2020-03-04,False,Chinese Academy of Medical Sciences Peking Union Medical College Hospital,Not Recruiting,Not Applicable,Interventional,China,oXiris Membrane in Treating Critically Ill Hospitalized Adult Patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,19,http://www.chictr.org.cn/showproj.aspx?proj=50458,None
189,302,ChiCTR2000030475,ChiCTR,2020-03-03,2020-03-04,False,Chinese Academy of Medical Sciences Peking Union Medical College Hospital,Not Recruiting,Not Applicable,Interventional,China,Cytosorb in Treating Critically Ill Hospitalized Adult Patients with novel coronavirus pneumonia (COVID-19),Other (physical),Blood purification,Blood purification,19,http://www.chictr.org.cn/showproj.aspx?proj=50452,None
190,303,ChiCTR2000030472,ChiCTR,2020-03-03,2020-02-25,True,Shenyang Sixth People's Hospital,Recruiting,Not Applicable,Interventional,China,An open and controlled clinical study to evaluate the efficacy and safety of Ganovo combined with ritonavir in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,20,http://www.chictr.org.cn/showproj.aspx?proj=49753,None
191,304,ChiCTR2000030471,ChiCTR,2020-03-02,2020-03-02,False,Maoming People's Hospital,Recruiting,Phase 4,Interventional,China,Efficacy and safety of lipoic acid injection in reducing the risk of progression in common patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,394,http://www.chictr.org.cn/showproj.aspx?proj=50421,None
192,305,ChiCTR2000030469,ChiCTR,2020-03-02,2020-02-27,True,Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,A randomized parallel controlled trial for LIUSHENWAN in Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,96,http://www.chictr.org.cn/showproj.aspx?proj=50082,None
193,307,ChiCTR2000030467,ChiCTR,2020-03-02,2020-03-01,True,"Dalian Medical University, Dalian, China.",Not Recruiting,Not Applicable,Interventional,China,A Randomized  Controlled Trial  for the Influence of TCM Psychotherapy on Negative Emotion of Patients with Novel Coronavirus Pneumonia (COVID-19) Based on Network Platform,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=50378,None
194,316,ChiCTR2000029993,ChiCTR,2020-02-18,2020-02-20,False,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Interventional,China,A pilot study for Integrated Chinese and Western Medicine in the treatment of non-critical novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,40,http://www.chictr.org.cn/showproj.aspx?proj=49435,None
195,318,ChiCTR2000029757,ChiCTR,2020-02-12,2020-02-14,False,China-Japan Friendship Hospital,Recruiting,Not Applicable,Interventional,China,Convalescent plasma for the treatment of severe and critical novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial,ATMP,Plasma,Plasma,200,http://www.chictr.org.cn/showproj.aspx?proj=49081,None
196,319,ChiCTR2000029580,ChiCTR,2020-02-05,2020-01-31,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,"Severe novel coronavirus pneumonia (COVID-19) patients treated with ruxolitinib in combination with mesenchymal stem cells: a prospective, single blind, randomized controlled clinical trial",Drug (+ ATMP),Ruxolimab + Cells (mesenchymal),Ruxolimab; Cells (mesenchymal),70,http://www.chictr.org.cn/showproj.aspx?proj=49088,None
197,321,ChiCTR2000029550,ChiCTR,2020-02-04,2020-01-29,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Recommendations for Diagnosis and Treatment of Influenza Patients in the Hospital of Chengdu University of Traditional Chinese Medicine Under the Raging of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=48775,None
198,322,ChiCTR2000029549,ChiCTR,2020-02-04,2020-02-03,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Recommendations of Integrated Traditional Chinese and Western Medicine for Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=49014,None
199,323,ChiCTR2000029308,ChiCTR,2020-01-23,2020-01-10,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Interventional,China,"A randomized, controlled open-label trial to evaluate the efficacy and safety of lopinavir-ritonavir in hospitalized patients with novel coronavirus pneumonia (COVID-19)",Drug,Lopinavir/ritonavir,lopinavir/ritonavir,160,http://www.chictr.org.cn/showproj.aspx?proj=48684,None
200,326,NCT04293887,ClinicalTrials.gov,2020-02-15,2020-03-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Phase 1,Interventional,No Country Given,Efficacy and Safety of IFN-a2 in the Treatment of Novel Coronavirus Patients,Drug,Interferon alfa,Interferon alfa,328,https://clinicaltrials.gov/show/NCT04293887,None
201,327,NCT04295551,ClinicalTrials.gov,2020-03-03,2020-03-14,False,Jiangxi Qingfeng Pharmaceutical Co. Ltd.,Not Recruiting,Not Applicable,Interventional,No Country Given,Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,https://clinicaltrials.gov/show/NCT04295551,None
202,328,NCT04296643,ClinicalTrials.gov,2020-03-03,2020-04-01,False,McMaster University,Not Recruiting,Not Applicable,Interventional,No Country Given,Medical Masks vs N95 Respirators for COVID-19,Other (device),Masks,Masks,576,https://clinicaltrials.gov/show/NCT04296643,None
203,334,ChiCTR2000030897,ChiCTR,2020-03-16,2020-02-10,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,Evaluation of the effect of taking Newgen beta-gluten probiotic composite powder to nutrition intervention of patients with novel coronavirus pneumonia (COVID-19),Supplement,Probiotics,Probiotics,20,http://www.chictr.org.cn/showproj.aspx?proj=50462,None
204,335,ChiCTR2000030896,ChiCTR,2020-03-16,2020-02-06,True,Zhengzhou People's Hospital,Recruiting,Not Applicable,Interventional,China,Clinical Application and Theoretical Discussion of Fu-Zheng Qing-Fei Thought in Treating Non-Critical Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,24,http://www.chictr.org.cn/showproj.aspx?proj=51028,None
205,338,ChiCTR2000030892,ChiCTR,2020-03-16,2020-03-06,True,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Pirfenidone in the Treatment of Severe Post-Novel Coronavirus Pneumonia (COVID-19) Fibrosis: a prospective exploratory experimental medical study,Drug,Pirfenidone,Pirfenidone,40,http://www.chictr.org.cn/showproj.aspx?proj=51118,None
206,342,ChiCTR2000030864,ChiCTR,2020-03-16,2020-02-01,True,Xiangyang First People's Hospital,Recruiting,Not Applicable,Interventional,China,Traditional Chinese Medicine for novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,50,http://www.chictr.org.cn/showproj.aspx?proj=50662,None
207,351,ChiCTR2000030855,ChiCTR,2020-03-16,2020-02-01,True,Third Affiliated Hospital of Zunyi Medical University,Not Recruiting,Phase 1,Interventional,No Country Given,Study for the effect of external diaphragmatic pacing assisted invasive ventilation and weaning in patients with severe novel coronavirus pneumonia (COVID-19),Other (physical),Mechanical ventilation,Mechanical ventilation,200,http://www.chictr.org.cn/showproj.aspx?proj=51090,None
208,353,ChiCTR2000030853,ChiCTR,2020-03-16,2020-02-01,True,Third Affiliated Hospital of Zunyi Medical University,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluation of the protective effect of dexmedetomidine on patients with severe novel coronavirus pneumonia (COVID-19),Drug,Dexmedetomidine,Dexmedetomidine,200,http://www.chictr.org.cn/showproj.aspx?proj=51081,None
209,356,ChiCTR2000030849,ChiCTR,2020-03-15,2020-03-16,False,Zhengzhou People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Investigation on psychological status of novel coronavirus pneumonia (COVID-19) rehabilitation patients in Zhengzhou City and research on coping strategies,Other (psych),No Intervention,No Intervention,81,http://www.chictr.org.cn/showproj.aspx?proj=51086,None
210,357,ChiCTR2000030841,ChiCTR,2020-03-15,2020-02-17,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,Exploratory study for Immunoglobulin From Cured COVID-19 Patients in the Treatment of Acute Severe novel coronavirus pneuvirus (COVID-19),ATMP,Immunoglobulin,Immunoglobulin,10,http://www.chictr.org.cn/showproj.aspx?proj=51072,None
211,360,ChiCTR2000030836,ChiCTR,2020-03-15,2020-02-01,True,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,Novel coronavirus pneumonia (COVID-19) combined with Chinese and Western medicine based on ''Internal and External Relieving -Truncated Torsion'' strategy,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=51054,None
212,361,ChiCTR2000030835,ChiCTR,2020-03-15,2020-02-14,True,The First Affiliated Hospital of Xinxiang Medical University,Recruiting,Not Applicable,Interventional,China,Clinical study for the efficacy of Mesenchymal stem cells (MSC) in the treatment of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://www.chictr.org.cn/showproj.aspx?proj=51050,None
213,364,ChiCTR2000030832,ChiCTR,2020-03-15,2020-03-16,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,No Country Given,Study for the pathogenesis and effective intervention of mood disorders caused by the novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,Psychological,800,http://www.chictr.org.cn/showproj.aspx?proj=51044,None
214,372,ChiCTR2000030810,ChiCTR,2020-03-15,2020-02-23,True,Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Recruiting,Phase 1,Interventional,China,Clinical observation and evaluation of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in Hubei 672 Orthopaedics Hospital of Integrated Chinese&Western Medicine,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50986,None
215,377,ChiCTR2000030804,ChiCTR,2020-03-15,2020-02-01,True,Maoming People's Hospital,Recruiting,Phase 4,Interventional,China,Exocarpium Citri Grandis Relieves Symptoms of Novel Coronavirus Pneunomia (COVID-19): a Randomized Controlled Clinical Trial,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,128,http://www.chictr.org.cn/showproj.aspx?proj=51018,None
216,389,ChiCTR2000030779,ChiCTR,2020-03-14,2020-03-16,False,Shanghai Changzheng Hospital,Recruiting,Phase 4,Interventional,China,A clinical trial for Ulinastatin Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50973,None
217,391,ChiCTR2000030773,ChiCTR,2020-03-14,2020-02-12,True,Huashan Hospital; Fudan Universtiy,Recruiting,Not Applicable,Interventional,China,Application of blood purification in the treatment of novel coronavirus pneumonia (COVID-19),Other (physical),Blood purification,Blood purification,20,http://www.chictr.org.cn/showproj.aspx?proj=50934,None
218,396,ChiCTR2000030761,ChiCTR,2020-03-13,2020-05-31,False,"Renji Hospital, Shanghai Jiaotong University School of Medicine",Not Recruiting,Not Applicable,Interventional,China,Continuous renal replacement therapy (CRRT) alleviating inflammatory response in severe patients with novel coronavirus pneumonia (COVID-19) associated with renal injury: A Prospective study,Other (renal),Renal replacement therapy,Renal replacement therapy,20,http://www.chictr.org.cn/showproj.aspx?proj=50956,None
219,398,ChiCTR2000030759,ChiCTR,2020-03-13,2020-02-15,True,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Study for the therapeutic effect and mechanism of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,70,http://www.chictr.org.cn/showproj.aspx?proj=49284,None
220,406,ChiCTR2000030751,ChiCTR,2020-03-13,2020-01-25,True,Affiliated Hospital of Inner Mongolia University for the Nationalities,Not Recruiting,Not Applicable,Interventional,China,Clinical Research for Traditional Mongolian Medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=50941,None
221,408,ChiCTR2000030744,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Interventional,China,Clinical Application of ECMO(or Ultra-Protective Lung Mechanical Ventilation) in the Treatment of Patients with ARDS due to novel Coronavirus Pneumonia (COVID-19),Drug,Oxygen,Oxygen,30,http://www.chictr.org.cn/showproj.aspx?proj=50910,None
222,415,ChiCTR2000030720,ChiCTR,2020-03-11,2020-03-01,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Prognosis Investigation and Intervention Study on Patients with novel coronavirus pneumonia (COVID-19) in recovery period Based on Community Health Management,Prognosis,No Intervention,No Intervention,120,http://www.chictr.org.cn/showproj.aspx?proj=50793,None
223,417,ChiCTR2000030718,ChiCTR,2020-03-11,2020-02-12,True,Zhongnan Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,Randomized controlled trial for Chloroquine Phosphate in the Treatment of novel coronavirus pneumonia (COVID-19),Drug,Chloroquine,Chloroquine,80,http://www.chictr.org.cn/showproj.aspx?proj=50843,None
224,423,ChiCTR2000030703,ChiCTR,2020-03-10,2020-03-10,False,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Interventional,China,"A randomized, blinded, controlled, multicenter clinical trial to evaluate the efficacy and safety of Ixekizumab combined with conventional antiviral drugs in patients with novel coronavirus pneumonia (COVID-19)",Drug,"Ixekizumab + up to three of interferon-alfa, lopinavir/ritonavir, chloroquine, ribavirin, umifenovir",Ixekizumab; Interferon alpha; Lopinavir; Ritonavir; Chloroquine; Ribavirin; Umifenovir,40,http://www.chictr.org.cn/showproj.aspx?proj=50251,None
225,424,ChiCTR2000030702,ChiCTR,2020-03-10,2020-02-15,True,China-Japan Friendship Hospital,Recruiting,Not Applicable,Interventional,China,Plasma of the convalescent in the treatment of novel coronavirus pneumonia (COVID-19) common patient: a prospective clinical trial,ATMP,Plasma,Plasma,50,http://www.chictr.org.cn/showproj.aspx?proj=50537,None
226,425,ChiCTR2000030701,ChiCTR,2020-03-10,2020-03-10,False,The Third People's Hospital of Shenzhen,Not Recruiting,Not Applicable,Interventional,China,"A randomized, parallel controlled open-label trial for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in the treatment of adult patients with novel coronavirus pneumonia (COVID-19)",Drug,Heparin,Heparin,60,http://www.chictr.org.cn/showproj.aspx?proj=50795,None
227,426,ChiCTR2000030700,ChiCTR,2020-03-10,2020-03-09,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,China,Study for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in treatment of novel coronavirus pneumonia (COVID-19) adult common patients,Drug,Heparin,Heparin,60,http://www.chictr.org.cn/showproj.aspx?proj=50786,None
228,432,ChiCTR2000030681,ChiCTR,2020-03-09,2020-03-16,False,Liaocheng People's Hospital,Not Recruiting,Not Applicable,Interventional,China,An anaesthesia procedure and extubation strategy for reducing patient agitation and cough after extubation that can be used to prevent the spread of Novel Coronavirus Pneumonia (COVID-19) and other infectious viruses in the operating Room,Other (physical),Extubation,Extubation,240,http://www.chictr.org.cn/showproj.aspx?proj=50763,None
229,437,ChiCTR2000030580,ChiCTR,2020-03-08,2020-02-01,True,Shanghai General Hospital,Recruiting,Phase 4,Interventional,China,Efficacy and safety of tozumab combined with adamumab(Qletli) in severe and critical patients with novel coronavirus pneumonia (COVID-19),Drug,Adamumab,Adamumab,60,http://www.chictr.org.cn/showproj.aspx?proj=50693,None
230,439,ChiCTR2000030545,ChiCTR,2020-03-06,2020-02-04,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Phase 4,Interventional,China,"Efficacy and safety of honeysuckle oral liquid in the treatment of novel coronavirus pneumonia (COVID-19): a multicenter, randomized, controlled, open clinical trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=50126,None
231,444,ChiCTR2000030476,ChiCTR,2020-03-03,2020-03-03,False,"Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine",Recruiting,Not Applicable,Interventional,China,Study for meditation assists for the rehabilitation of patients with novel coronaviruse pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=50455,None
232,447,ChiCTR2000030388,ChiCTR,2020-03-01,2020-02-18,True,Jingzhou First People's Hospital,Recruiting,Not Applicable,Interventional,China,Efficacy and safety of Xue-Bi-Jing injection in the treatment of severe cases of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=50306,None
233,452,ChiCTR2000030187,ChiCTR,2020-02-24,2020-02-25,False,Jingzhou First People's Hospital,Recruiting,Not Applicable,Interventional,China,Clinical study for Lopinavir and Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Lopinavir/ritonavir,lopinavir/ritonavir,60,http://www.chictr.org.cn/showproj.aspx?proj=50057,None
234,472,NCT04264533,ClinicalTrials.gov,2020-02-04,2020-02-14,False,ZhiYong Peng,Recruiting,Phase 2,Interventional,China,Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia,Drug,Vitamin C,Vitamin C,140,https://clinicaltrials.gov/show/NCT04264533,None
235,474,NCT04299724,ClinicalTrials.gov,2020-03-05,2020-02-15,True,Shenzhen Geno-Immune Medical Institute,Recruiting,Phase 1,Interventional,China,Safety and Immunity of Covid-19 aAPC Vaccine,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04299724,None
236,475,NCT04302519,ClinicalTrials.gov,2020-02-27,2020-03-05,False,"CAR-T (Shanghai) Biotechnology Co., Ltd.",Not Recruiting,Phase 1,Interventional,No Country Given,Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells,ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://clinicaltrials.gov/show/NCT04302519,None
237,481,ChiCTR2000031139,ChiCTR,2020-03-22,2020-03-20,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Interventional,China,Safety and Effectiveness of Human embryonic stem cell-derived M cells (CAStem) for Pulmonary Fibrosis Correlated with novel coronavirus pneumonia (COVID-19),ATMP,Cells (stem cells),Cells (stem cells),20,http://www.chictr.org.cn/showproj.aspx?proj=51404,None
238,482,ChiCTR2000031138,ChiCTR,2020-03-22,2020-02-26,True,"The Third Xiangya Hospital, Central South University",Recruiting,Not Applicable,Interventional,China,Prospective exploratory clinical research on the efficacy and safety of pirfenidone capsules in the treatment of severe novel coronavirus pneumonia (COVID-19),Drug,Pirfenidone,Pirfenidone,40,http://www.chictr.org.cn/showproj.aspx?proj=51416,None
239,485,ChiCTR2000031090,ChiCTR,2020-03-22,2020-03-23,False,Ningbo Kangning Hospital,Not Recruiting,Not Applicable,Interventional,China,Psychological Support for Diagnosed Patients with novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,Psychological,60,http://www.chictr.org.cn/showproj.aspx?proj=51148,None
240,486,ChiCTR2000031089,ChiCTR,2020-03-22,2020-03-13,True,Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,A medical records based study for Tou-Jie-Qu-Wen Granules in the Treatment of mild and moderate patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=51136,None
241,488,ChiCTR2000031023,ChiCTR,2020-03-21,2020-03-16,True,Hu'nan Cancer Hospital,Recruiting,Not Applicable,Interventional,China,Perioperative immune prediction and intervention of tumor patients undergoing surgery during the novel coronavirus pneumonia (COVID-19) outbreak period,Prognosis,No Intervention,No Intervention,320,http://www.chictr.org.cn/showproj.aspx?proj=50984,None
242,490,ChiCTR2000030996,ChiCTR,2020-03-20,2020-03-18,True,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Recruiting,Not Applicable,Interventional,China,Effect of Auricular point pressing on insomnia of novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial.,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=51349,None
243,493,ChiCTR2000030989,ChiCTR,2020-03-20,2020-03-20,False,Beijing Normal University,Not Recruiting,Not Applicable,Interventional,China,Internet based Solution Focused Brief Therapy treating adolescent anxiety under the novel coronavirus pneumonia (COVID-19) outbreak: A randomized controlled trial,Other (psych),Psychological,Psychological,76,http://www.chictr.org.cn/showproj.aspx?proj=51331,None
244,501,ChiCTR2000030946,ChiCTR,2020-03-19,2020-02-10,True,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Phase 4,Interventional,China,Effects of different VTE prevention methods on the prognosis of hospitalized patients with novel coronavirus pneumonia (COVID-19),Drug,Heparin,Heparin,120,http://www.chictr.org.cn/showproj.aspx?proj=51265,None
245,502,ChiCTR2000030944,ChiCTR,2020-03-18,2020-09-01,False,The Second Affiliated Hospital of Nanchang University,Not Recruiting,Phase 1,Interventional,China,Clinical study of human NK cells and MSCs transplantation for severe novel coronavirus pneumonia (COVID-19),ATMP,"Cells, (mesenchymal/NK)",Cells (mesenchymal); Cells (NK),20,http://www.chictr.org.cn/showproj.aspx?proj=50199,None
246,506,ChiCTR2000030939,ChiCTR,2020-03-18,2020-03-16,True,PLA General Hospital,Recruiting,Not Applicable,Interventional,China,Preliminary evaluation of the safety and efficacy of oral LL-37 antiviral peptide (CAS001) in the treatment of novel coronavirus pneumonia (COVID-19),ATMP,Gene-derived protein,Gene-derived protein,10,http://www.chictr.org.cn/showproj.aspx?proj=51059,None
247,508,ChiCTR2000030933,ChiCTR,2020-03-18,2020-03-31,False,The First Affiliated Hospital of Nanchang University,Not Recruiting,Not Applicable,Interventional,China,Effectiveness of ''Liu-Zi-Jue'' combined with respiratory muscle training for respiratory function in novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,108,http://www.chictr.org.cn/showproj.aspx?proj=51184,None
248,511,ChiCTR2000030929,ChiCTR,2020-03-17,2020-03-17,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, parallel-controlled trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia (COVID-19)",ATMP,Plasma,Plasma,60,http://www.chictr.org.cn/showproj.aspx?proj=50696,None
249,512,ChiCTR2000030922,ChiCTR,2020-03-17,2020-02-26,True,Foshan First People's Hospital,Recruiting,Not Applicable,Interventional,China,"Prospective, open-label, controlled, multicenter cohort study of long-acting interferon plus ribavirin in patients with novel coronavirus pneumonia (COVID-19)",Drug,Interferon + Ribavirin vs. Umifenovir + Ribavirin,Interferon; Ribavirin; Umifenovir,30,http://www.chictr.org.cn/showproj.aspx?proj=51141,None
250,513,ChiCTR2000030920,ChiCTR,2020-03-17,2020-02-20,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,"Evaluation of the effect of taking tricholoma matsutake, cannabis sativa capsule and dendrobium candidum to nutrition intervention of patients with novel coronavirus pneumonia (COVID-19) during convalescence.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50476,None
251,515,ChiCTR2000030906,ChiCTR,2020-03-17,2020-03-10,True,Jiangsu Provincial Center for Disease Control and Prevention,Recruiting,Phase 1,Prevention,China,A phase I clinical trial for recombinant novel coronavirus (2019-COV) vaccine (adenoviral vector),ATMP,Adenovirus vector,Adenovirus vector,108,http://www.chictr.org.cn/showproj.aspx?proj=51154,None
252,518,ChiCTR2000030539,ChiCTR,2020-03-06,2020-03-06,False,Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Study for clinical oral characteristics of patients with novel coronavirus pneumonia (COVID-19) and Effect of 3% hydrogen peroxide gargle on the Intraoral novel coronavirus,Drug,Hydrogen peroxide,Hydrogen peroxide,40,http://www.chictr.org.cn/showproj.aspx?proj=50660,None
253,520,ChiCTR2000030254,ChiCTR,2020-02-26,2020-02-20,True,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"the Efficacy and Safety of Favipiravir for novel coronavirusinfected pneumonia: A multicenter, randomized, open, positive, parallel-controlled clinical study",Drug,Favipiravir vs. Umifenovir,Favipiravir; Umifenovir,240,http://www.chictr.org.cn/showproj.aspx?proj=50137,None
254,525,ChiCTR2000029868,ChiCTR,2020-02-15,2020-02-11,True,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Phase 4,Interventional,China,"Hydroxychloroquine treating novel coronavirus pneumonia (COVID-19): a randomized controlled, open label, multicenter trial",Drug,Hydroxychloroquine,Hydroxychloroquine,360,http://www.chictr.org.cn/showproj.aspx?proj=49524,None
255,527,ChiCTR2000029658,ChiCTR,2020-02-09,2020-02-10,False,Central Theater General Hospital of PLA,No Status Given,Not Applicable,Interventional,China,Nasal high-fow preoxygenation assisted fibre-optic bronchoscope intubation in patients with critical novel coronavirus pneumonia (COVID-19),Other (physical),Mechanical ventilation,Mechanical ventilation,60,http://www.chictr.org.cn/showproj.aspx?proj=49074,None
256,528,ChiCTR2000029573,ChiCTR,2020-02-05,2020-02-06,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, controlled clinical study to evaluate the efficacy and safety of recombinant cytokine gene-derived protein injection in combination with standard therapy in patients with novel coronavirus infection",ATMP,Gene-derived protein,Gene-derived protein,480,http://www.chictr.org.cn/showproj.aspx?proj=49065,None
257,529,ChiCTR2000029496,ChiCTR,2020-02-03,2020-01-29,True,The First Hospital of Changsha; The Second Xiangya Hospital of Central South University,Recruiting,Phase 4,Interventional,China,"A randomized, open label, parallel controlled trial of evaluating the efficacy of recombinant cytokine gene-derived protein injection for clearing novel coronavirus in patients with novel coronavirus pneumonia (COVID-19)",ATMP,Gene-derived protein,Gene-derived protein,90,http://www.chictr.org.cn/showproj.aspx?proj=48809,None
258,530,EUCTR2020-000890-25-FR,EU Clinical Trials Register,2020-03-10,2020-03-05,True,Fondation Mditerrane Infection (FMI) - IHU Mditerrane Infection,Authorised,Phase 3,Interventional,France,Hydroxychloroquine as a treatment for coronavirus disease COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,25,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000890-25,None
259,532,NCT04251767,ClinicalTrials.gov,2020-01-30,2020-02-05,False,The Second Hospital of Nanjing Medical University,Not Recruiting,Not Applicable,Interventional,China,Washed Microbiota Transplantation for Patients With 2019-nCoV Infection,ATMP,Intestinal microbiome,Intestinal microbiome,0,https://clinicaltrials.gov/show/NCT04251767,None
260,533,NCT04254874,ClinicalTrials.gov,2020-02-02,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia",Drug,Interferon + Umifenovir vs. Umifenovir,Interferon; Umifenovir,100,https://clinicaltrials.gov/show/NCT04254874,None
261,534,NCT04255017,ClinicalTrials.gov,2020-02-02,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia",Drug,Umeprevir vs. Oseltamivir vs. lopinavir/ritonavir,Umeprevir; Oseltamivir; Lopinavir/ritonavir,400,https://clinicaltrials.gov/show/NCT04255017,None
262,535,NCT04261270,ClinicalTrials.gov,2020-02-04,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 3,Interventional,China,"A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia",Drug,ASCO9F + Ritonavir vs. Ritonavir + Oseltamivir vs. Oseltamivir,ASCO9F; Ritonavir; Oseltamivir,60,https://clinicaltrials.gov/show/NCT04261270,None
263,536,NCT04263402,ClinicalTrials.gov,2020-02-02,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia,Drug,Corticosteroids,Methylprednisolone,100,https://clinicaltrials.gov/show/NCT04263402,None
264,537,NCT04264858,ClinicalTrials.gov,2020-02-08,2020-03-17,False,"Wuhan Union Hospital, China",Not Recruiting,Not Applicable,Interventional,China,Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients,ATMP,Immunoglobulin,Immunoglobulin,10,https://clinicaltrials.gov/show/NCT04264858,None
265,539,NCT04276896,ClinicalTrials.gov,2020-02-17,2020-03-24,False,Shenzhen Geno-Immune Medical Institute,Recruiting,Phase 1/Phase 2,Interventional,China,Immunity and Safety of Covid-19 Synthetic Minigene Vaccine,ATMP,Vaccine,Vaccine,100,https://clinicaltrials.gov/show/NCT04276896,None
266,541,NCT04287686,ClinicalTrials.gov,2020-02-21,2020-02-01,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,Drug,ACE enzyme,ACE enzyme,0,https://clinicaltrials.gov/show/NCT04287686,None
267,542,NCT04291053,ClinicalTrials.gov,2020-02-27,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,550,https://clinicaltrials.gov/show/NCT04291053,None
268,544,NCT04293692,ClinicalTrials.gov,2020-02-24,2020-02-24,False,Puren Hospital Affiliated to Wuhan University of Science and Technology,Not Recruiting,Not Applicable,Interventional,China,Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus,ATMP,Cells (mesenchymal),Cells (mesenchymal),0,https://clinicaltrials.gov/show/NCT04293692,None
269,545,NCT04304313,ClinicalTrials.gov,2020-02-14,2020-02-09,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 3,Interventional,China,A Pilot Study of Sildenafil in COVID-19,Drug,Sildenafil,Sildenafil,10,https://clinicaltrials.gov/show/NCT04304313,None
270,548,NCT04308317,ClinicalTrials.gov,2020-03-04,2020-03-05,False,Henan Provincial People's Hospital,Recruiting,Phase 4,Interventional,China,Tetrandrine Tablets Used in the Treatment of COVID-19,Drug,Tetrandrine,Tetrandrine,60,https://clinicaltrials.gov/show/NCT04308317,None
271,551,NCT04313322,ClinicalTrials.gov,2020-03-15,2020-03-16,False,Stem Cells Arabia,Recruiting,Phase 1,Interventional,Jordan,Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells,ATMP,Cells (mesenchymal),Cells (mesenchymal),5,https://clinicaltrials.gov/show/NCT04313322,None
272,555,NCT04316728,ClinicalTrials.gov,2020-03-14,2020-03-01,True,"Centro Studi Internazionali, Italy",Not Recruiting,Not Applicable,Interventional,Italy,Clinical Performance of the VivaDiag  COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04316728,None
273,566,ChiCTR2000031328,ChiCTR,2020-03-27,2020-03-13,True,The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,The protective effect of sleep psychology and music therapy of novel coronavirus pneumonia (COVID-19) mild and moderate type patients,Other,Sleep aids,Sleep aids,60,http://www.chictr.org.cn/showproj.aspx?proj=51425,None
274,568,ChiCTR2000031319,ChiCTR,2020-03-27,2020-04-01,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe novel coronavirus pneumonia (COVID-19) patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://www.chictr.org.cn/showproj.aspx?proj=51647,None
275,572,ChiCTR2000031272,ChiCTR,2020-03-26,2020-02-18,True,China European International Business School (CEIBS),Not Recruiting,Not Applicable,Interventional,China,The effectiveness of mindfulness intervention in improving people's psychological and physical well-being during novel coronavirus pneumonia (COVID-19) outbreak,Other (psych),Psychological,Psychological,110,http://www.chictr.org.cn/showproj.aspx?proj=51455,None
276,573,ChiCTR2000031271,ChiCTR,2020-03-26,2020-04-01,False,The Third Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Not Applicable,Interventional,China,Metabolic abnormalities and rearrangement reversal treatment of patient with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,80,http://www.chictr.org.cn/showproj.aspx?proj=51194,None
277,581,ChiCTR2000031204,ChiCTR,2020-03-24,2020-01-30,True,"Beijing You'an Hospital, Capital Medical University",Recruiting,Phase 2,Interventional,China,"A multicenter, single-blind, randomized controlled clinical trial for chloroquine phosphate in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Chloroquine,Chloroquine,300,http://www.chictr.org.cn/showproj.aspx?proj=49420,None
278,582,ChiCTR2000031203,ChiCTR,2020-03-24,2020-03-16,True,Zhengzhou People's Hospital,Recruiting,Not Applicable,Interventional,China,Study for the effect of Moxibustion Guidance and Intervention based on internet for the discharged patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,28,http://www.chictr.org.cn/showproj.aspx?proj=51030,None
279,584,ChiCTR2000031196,ChiCTR,2020-03-23,2020-01-10,True,The Fifth Medical Center of PLA General Hospital,Recruiting,Not Applicable,Interventional,China,Efficacy and optimization of antiviral therapy for novel coronavirus pneumonia (COVID-19) patients,Drug,Lopinavir/ritonavir + Interferon,Lopinavir/ritonavir; Interferon,90,http://www.chictr.org.cn/showproj.aspx?proj=51112,None
280,587,ChiCTR2000030988,ChiCTR,2020-03-20,2020-03-23,False,Guangdong Provincial Hospital of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A RCT for Hua-Shi Bai-Du granules in patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,204,http://www.chictr.org.cn/showproj.aspx?proj=51317,None
281,589,ChiCTR2000030940,ChiCTR,2020-03-18,2020-02-01,True,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Study for ''Bai-Du Duan Fang'' application on the acupoint in the treatment of general type novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,76,http://www.chictr.org.cn/showproj.aspx?proj=51061,None
282,591,ChiCTR2000030937,ChiCTR,2020-03-18,2020-03-19,False,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, controlled trial for Gu-Shen Ding-Chuan-Wan in the treatment of patients with novel coronavirus pneumonia (COVID-19) at recovery phase with Fei-Pi-Qi-Xu Zhen",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,144,http://www.chictr.org.cn/showproj.aspx?proj=51240,None
283,592,ChiCTR2000030936,ChiCTR,2020-03-18,2020-03-10,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,A real-world study for the Chinese medicines ''Xinguan 2'' and ''Xinguan 3'' in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,2840,http://www.chictr.org.cn/showproj.aspx?proj=51100,None
284,593,ChiCTR2000030923,ChiCTR,2020-03-17,2020-02-15,True,Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,The treatment and diagnosis plan of integrated traditional Chinese and Western medicine for novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=51139,None
285,595,ChiCTR2000030704,ChiCTR,2020-03-10,2020-02-10,True,The First People's Hospital of Jiangxia District,No Status Given,Phase 4,Interventional,China,Observation Of Clinical Efficacy And Safety Of Bufonis Venenum Injection In The Treatment Of Severe Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://www.chictr.org.cn/showproj.aspx?proj=50778,None
286,597,ChiCTR2000030288,ChiCTR,2020-02-27,2020-02-27,False,China Academy of Chinese Medical Sciences,Recruiting,Not Applicable,Interventional,China,Efficacy of Traditional Chinese Medicine in the Treatment of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,204,http://www.chictr.org.cn/showproj.aspx?proj=50202,None
287,599,ChiCTR2000030198,ChiCTR,2020-02-25,2020-02-24,True,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,Clinical research of pulmonary rehabilitation in survivors due to severe or critial novel coronavirus pneumonia (COVID-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,60,http://www.chictr.org.cn/showproj.aspx?proj=50066,None
288,600,ChiCTR2000030028,ChiCTR,2020-02-20,2020-02-24,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,Clinical comparative study of PD-1 mAb in the treatment of severe and critical patients with novel coronavirus pneumonia (COVID-19),Drug,PD1,PD1,40,http://www.chictr.org.cn/showproj.aspx?proj=49840,None
289,602,EUCTR2020-000919-69-NL,EU Clinical Trials Register,2020-03-17,2020-03-17,False,UMC Utrecht,Authorised,Phase 4,Interventional,Netherlands,Reducing health care workers absenteeism in Coronavirus 2019 pandemic nu enhancement of the immune system through vaccination with Bacillus Calmette-Gurin,ATMP,Vaccine,Vaccine,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000919-69,None
290,604,NCT04290871,ClinicalTrials.gov,2020-02-27,2020-03-23,False,Xijing Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.,Drug,Nitric oxide,Nitric oxide,0,https://clinicaltrials.gov/show/NCT04290871,None
291,605,NCT04305106,ClinicalTrials.gov,2020-03-09,2020-03-17,False,Qilu Hospital of Shandong University,Recruiting,Not Applicable,Interventional,China,Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT,Drug,Bevacizumab,Bevacizumab,140,https://clinicaltrials.gov/show/NCT04305106,None
292,608,NCT04319900,ClinicalTrials.gov,2020-03-20,2020-03-05,False,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Phase 2/Phase 3,Interventional,China,Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia,Drug,Chloroquine + Favipiravir vs. Favipiravir,Chloroquine; favipiravir,150,https://clinicaltrials.gov/show/NCT04319900,ChiCTR2000030987
293,609,NCT04322344,ClinicalTrials.gov,2020-03-23,2020-03-23,False,University of Catanzaro,Recruiting,Phase 2/Phase 3,Interventional,Italy,Escin in Patients With Covid-19 Infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,https://clinicaltrials.gov/show/NCT04322344,None
294,611,NCT04323332,ClinicalTrials.gov,2020-03-08,2020-03-01,True,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Not Recruiting,Phase 3,Interventional,China,Traditional Chinese Medicine for Severe COVID-19,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,50,https://clinicaltrials.gov/show/NCT04323332,None
295,612,NCT04323514,ClinicalTrials.gov,2020-03-18,2020-03-13,True,University of Palermo,Recruiting,Not Applicable,Interventional,Italy,Use of Ascorbic Acid in Patients With COVID 19,Drug,Vitamin C,Vitamin C,500,https://clinicaltrials.gov/show/NCT04323514,None
296,613,NCT04323631,ClinicalTrials.gov,2020-03-25,2020-03-01,True,Rambam Health Care Campus,Not Recruiting,Phase 1,Interventional,No Country Given,Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death,Drug,Hydroxychloroquine,Hydroxychloroquine,1116,https://clinicaltrials.gov/show/NCT04323631,None
297,615,NCT04324996,ClinicalTrials.gov,2020-03-25,2020-03-21,True,Chongqing Public Health Medical Center,Recruiting,Phase 1/Phase 2,Interventional,China,A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19,ATMP,Cells (NK),Cells (NK),90,https://clinicaltrials.gov/show/NCT04324996,None
298,620,ISRCTN14966673,ISRCTN,2020-03-18,2020-03-20,False,University Hospital Southampton NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,Does point-of-care testing for coronavirus in hospital improve patient care compared to laboratory testing?,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,http://isrctn.com/ISRCTN14966673,None
299,621,ChiCTR2000031639,ChiCTR,2020-04-05,2020-03-27,True,Peking University Sixth Hospital,Not Recruiting,Not Applicable,Interventional,China,Effects of a single session internet-delivered cognitive behavioral therapy for Acute Insomnia during the pandemic of novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,Psychological,192,http://www.chictr.org.cn/showproj.aspx?proj=51119,None
300,622,ChiCTR2000031630,ChiCTR,2020-04-05,2020-02-17,True,Guangzhou Eighth People's Hospital,Recruiting,Not Applicable,Interventional,China,Clinical study for Celebrex in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Celecoxib,Celecoxib,60,http://www.chictr.org.cn/showproj.aspx?proj=50474,None
301,626,ChiCTR2000031540,ChiCTR,2020-04-03,2020-02-05,True,Affiliated Hospital of Zunyi Medical University,Recruiting,Phase 1,Interventional,China,Study for clinical effect of rehabilitation nursing program for patients with novel coronavirus pneumonia (COVID-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,100,http://www.chictr.org.cn/showproj.aspx?proj=51684,None
302,630,ChiCTR2000031503,ChiCTR,2020-04-03,2020-04-01,True,Shanghai Sixth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Application of non-invasive multichannel cardiopulmonary monitoring cloud management platform in patients with Novel Coronavirus Pneumonia (COVID-19),Other (device),Cardiopulmonary monitoring,Cardiopulmonary monitoring,100,http://www.chictr.org.cn/showproj.aspx?proj=51911,None
303,631,ChiCTR2000031501,ChiCTR,2020-04-02,2020-03-17,True,Eastern Theater General Hospital,Not Recruiting,Not Applicable,Interventional,China,"The efficacy  of convalescent plasma in patients with critical novel coronavirus pneumonia (COVID-19): a pragmatic, prospective cohort study",ATMP,Plasma,Plasma,20,http://www.chictr.org.cn/showproj.aspx?proj=50254,None
304,634,ChiCTR2000031494,ChiCTR,2020-04-02,2020-02-01,True,Huangshi Hospital of Traditional Chinese Medicine,Recruiting,Phase 1,Interventional,China,Clinical study for stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),36,http://www.chictr.org.cn/showproj.aspx?proj=51904,None
305,636,ChiCTR2000031454,ChiCTR,2020-04-01,2020-01-25,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Interventional,China,Clinical study for prevention and treatment of digestive tract lesions caused by novel coronavirus pneumonia (COVID-19),Drug,Rabeprazole + chloroquine vs. lopinavir + rabeprazole,Rabeprazole; chloroquine; lopinavir; rabeprazole,56,http://www.chictr.org.cn/showproj.aspx?proj=51693,None
306,637,ChiCTR2000031453,ChiCTR,2020-04-01,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Phase 4,Interventional,China,"Efficacy and safety of Nintedanib esilate soft capsules in the treatment of pulmonary fibrosis in healed moderate to severe patients of novel coronavirus pneumonia (COVID-19): a single-center, randomized, placebo-controlled trial",Drug,Nintedanib,Nintedanib,80,http://www.chictr.org.cn/showproj.aspx?proj=51859,None
307,641,ChiCTR2000031430,ChiCTR,2020-03-31,2020-03-20,True,The Fifth Medical Center of PLA General Hospital,Recruiting,Phase 2,Interventional,China,Clinical study of human umbilical cord mesenchymal stem cells in the treatment of novel coronavirus pneumonia (COVID-19) induced pulmonary fibrosis,ATMP,Cells (mesenchymal),Cells (mesenchymal),200,http://www.chictr.org.cn/showproj.aspx?proj=49254,None
308,647,EUCTR2020-001271-33-FR,EU Clinical Trials Register,2020-03-24,2020-03-31,False,CHU Angers,Authorised,Phase 3,Interventional,France,HYCOVID - Hydroxychloroquine versus placebo chez les patients ayant une infection COVID-19  risque daggravation secondaire : tude prospective multicentrique randomise en double aveugle,Drug,Hydroxychloroquine,Hydroxychloroquine,1300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001271-33,None
309,648,EUCTR2020-001281-11-FR,EU Clinical Trials Register,2020-03-26,2020-03-30,False,CHU de Saint Etienne,Authorised,Phase 4,Interventional,France,Evaluation of the concentration/viral effect relationship of hydroxychloroquine in COVID-19 patients in the intensive care unit..,Drug,Hydroxychloroquine,Hydroxychloroquine,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001281-11,None
310,649,EUCTR2020-001236-10-NL,EU Clinical Trials Register,2020-03-31,2020-03-31,False,UMC Amsterdam,Authorised,Phase 2,Interventional,Netherlands,Countering Lung Damage in COVID-19 infection: the CounterCovid Study,Drug,Imatinib,Imatinib,304,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001236-10,None
311,650,EUCTR2020-001010-38-NO,EU Clinical Trials Register,2020-03-16,2020-03-23,False,Akershus University Hospital,Authorised,Phase 4,Interventional,Norway,NORWEGIAN CORONAVIRUS DISEASE 2019 [NO-COVID-19] STUDY: A TRIAL TO EVALUATE THE ANTIVIRAL EFFECT OF CHLOROQUINE IN ADULT PATIENTS WITH SARS-COV-2 INFECTION,Drug,Hydroxychloroquine,Hydroxychloroquine,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001010-38,None
312,653,NCT04275414,ClinicalTrials.gov,2020-02-14,2020-02-15,False,Qilu Hospital of Shandong University,Recruiting,Phase 2/Phase 3,Interventional,"China, Italy",Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia,Drug,Bevacizumab,Bevacizumab,20,https://clinicaltrials.gov/show/NCT04275414,None
313,654,NCT04298060,ClinicalTrials.gov,2020-02-28,2020-04-01,False,"Ansun Biopharma, Inc.",Not Recruiting,Phase 2,Interventional,China,DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19),Drug,DAS181,DAS181,280,https://clinicaltrials.gov/show/NCT04298060,None
314,655,NCT04320238,ClinicalTrials.gov,2020-03-21,2020-01-21,True,Shanghai Jiaotong University,Recruiting,Phase 3,Interventional,China,Experimental Trial of rhIFNa Nasal Drops to Prevent 2019-nCOV in Medical Staff,Drug,Interferon Alpha vs. Interferon Alpha + Thymosin Alpha,Interferon alpha; Thymosin alpha,2944,https://clinicaltrials.gov/show/NCT04320238,None
315,659,NCT04324528,ClinicalTrials.gov,2020-03-25,2020-03-27,True,Dr. Alexander Supady,Recruiting,Not Applicable,Interventional,Germany,Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,Drug,Oxygen,Oxygen,30,https://clinicaltrials.gov/show/NCT04324528,DRKS00021300
316,660,NCT04325867,ClinicalTrials.gov,2020-03-21,2020-03-31,False,Professor Adrian Covic,Recruiting,Not Applicable,Interventional,Romania,Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19,Other,Other,Other,200,https://clinicaltrials.gov/show/NCT04325867,None
317,661,NCT04326036,ClinicalTrials.gov,2020-03-26,2020-03-25,True,Healeon Medical Inc,Recruiting,Phase 1,Interventional,United States,Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection,ATMP,Stromal Vascular Fraction,Stromal Vascular Fraction,10,https://clinicaltrials.gov/show/NCT04326036,None
318,662,NCT04326075,ClinicalTrials.gov,2020-03-26,2020-04-06,False,Mario Negri Institute for Pharmacological Research,Not Recruiting,Not Applicable,Interventional,No Country Given,Early CPAP in COVID Patients With Respiratory Failure.,Other (physical),Mechanical ventilation,Mechanical ventilation,900,https://clinicaltrials.gov/show/NCT04326075,None
319,663,NCT04326452,ClinicalTrials.gov,2020-03-25,2020-03-27,False,TMC HealthCare,Recruiting,Not Applicable,Interventional,United States,Treating COVID-19 With a Bidirectional Oxygenation Valve,Other (device),Bidirectional Oxygenation Valve,Bidirectional Oxygenation Valve,15,https://clinicaltrials.gov/show/NCT04326452,None
320,665,NCT04327349,ClinicalTrials.gov,2020-03-24,2020-03-28,True,Mazandaran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04327349,IRCT20181104041551N1
321,667,NCT04328272,ClinicalTrials.gov,2020-03-25,2020-03-28,False,Dr. Umar Farooq,Not Recruiting,Phase 3,Interventional,Pakistan,Effectiveness of Hydroxychloroquine in Covid-19 Patients,Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,75,https://clinicaltrials.gov/show/NCT04328272,None
322,671,NCT04330144,ClinicalTrials.gov,2020-03-30,2020-04-01,True,Gangnam Severance Hospital,Not Recruiting,Phase 3,Interventional,No Country Given,Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,2486,https://clinicaltrials.gov/show/NCT04330144,KCT0004907
323,674,NCT04330586,ClinicalTrials.gov,2020-03-31,2020-04-01,False,Korea University Guro Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,A Trial of Ciclesonide in Adults With Mild COVID-19,Drug,Ciclesonide + hydroxychloroquine vs. hydroxychloroquine,Ciclesonide; hydroxychloroquine ,141,https://clinicaltrials.gov/show/NCT04330586,None
324,676,NCT04331613,ClinicalTrials.gov,2020-02-06,2020-01-27,True,Chinese Academy of Sciences,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS,ATMP,Cells (IMRC),Cells (IMRC),9,https://clinicaltrials.gov/show/NCT04331613,None
325,678,NCT04332666,ClinicalTrials.gov,2020-03-27,2020-03-31,False,Erasme University Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial",Drug,Angiotensin (1-7),Angiotensin (1-7),60,https://clinicaltrials.gov/show/NCT04332666,None
326,679,NCT04333251,ClinicalTrials.gov,2020-03-27,2020-04-01,False,Baylor Research Institute,Not Recruiting,Phase 1,Interventional,No Country Given,Study Testing Convalescent Plasma vs Best Supportive Care,ATMP,Plasma,Plasma,115,https://clinicaltrials.gov/show/NCT04333251,None
327,680,NCT04333472,ClinicalTrials.gov,2020-04-01,2020-04-06,False,Can-Fite BioPharma,Not Recruiting,Phase 2,Interventional,Israel,Piclidenoson for Treatment of COVID-19,Drug,Piclidenoson,Piclidenoson,40,https://clinicaltrials.gov/show/NCT04333472,None
328,684,NCT04335201,ClinicalTrials.gov,2020-03-31,2020-04-06,True,IRCCS Ospedale San Raffaele,Not Recruiting,Phase 2,Interventional,No Country Given,Defibrotide in COVID-19 Pneumonia,Drug,Defibrotide,Defibrotide,50,https://clinicaltrials.gov/show/NCT04335201,EUCTR2020-001513-20
329,685,ACTRN12620000443998,ANZCTR,2020-04-06,2020-05-01,False,Flinders Medical Centre,Not Recruiting,Not Applicable,Interventional,Australia,Home rehabilitation for people with COVID-19: Implementing telehealth approaches to care,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,58,https://anzctr.org.au/ACTRN12620000443998.aspx,None
330,687,ACTRN12620000448943,ANZCTR,2020-04-06,2020-06-01,False,Deakin University,Not Recruiting,Not Applicable,Interventional,Australia,Expressive Writing To Combat Distress Associated With The COVID-19 Pandemic In People With Inflammatory Bowel Disease,Other (psych),Psychological,Psychological,154,https://anzctr.org.au/ACTRN12620000448943.aspx,None
331,688,ACTRN12620000447954,ANZCTR,2020-04-06,2020-03-31,True,Royal Brisbane & Women's Hospital,Recruiting,Not Applicable,Interventional,Australia,Use of therapeutic drug monitoring (TDM) to optimise oral/enteral hydroxychloroquine dosing in critically ill patients with COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,150,https://anzctr.org.au/ACTRN12620000447954.aspx,None
332,691,ACTRN12620000454976,ANZCTR,2020-04-08,2020-04-09,False,Austin Health,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,Can intravenous high dose zinc improve clinical outcomes in patients with COVID-19 infection?,Drug,Zinc,Zinc,160,https://anzctr.org.au/ACTRN12620000454976.aspx,None
333,694,ChiCTR2000031834,ChiCTR,2020-04-11,2020-04-20,False,Jiangsu Province Hospital,Not Recruiting,Not Applicable,Interventional,China,A clinical study for the effect of remote monitoring exercise rehabilitation on the discharged patients with novel coronavirus pneumonia (COVID-19),Telehealth,Telehealth,Telehealth,120,http://www.chictr.org.cn/showproj.aspx?proj=52216,None
334,698,ChiCTR2000031781,ChiCTR,2020-04-10,2020-04-09,True,Jiangsu Provincial Center for Disease Control and Prevention,Not Recruiting,Phase 2,Interventional,China,"A randomized, double-blinded, placebo-controlled phase II clinical trial for Recombinant Novel Coronavirus (2019-nCOV) Vaccine (Adenovirus Vector)",ATMP,Vaccine,Vaccine,500,http://www.chictr.org.cn/showproj.aspx?proj=52006,None
335,700,ChiCTR2000031772,ChiCTR,2020-04-09,2020-01-10,True,Fujian Provincial Maternity and Child Health Hospital,Recruiting,Not Applicable,Interventional,No Country Given,Impact of WeChat-based parenting education for children with autism spectrum disorder and their mothers during the epidemic of Coronavirus disease 2019 (COVID-19),Other,Health Education,Health Education,105,http://www.chictr.org.cn/showproj.aspx?proj=52165,None
336,704,ChiCTR2000031735,ChiCTR,2020-04-08,2020-03-01,True,Huzhou Central Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical study for natural killer (NK) cells from umbilical cord blood in the treatment of novel coronavirus pneumonia (COVID-19),ATMP,Cells (NK),Cells (NK),20,http://www.chictr.org.cn/showproj.aspx?proj=50613,None
337,705,ChiCTR2000031734,ChiCTR,2020-04-08,2020-03-19,True,Huo-Shen-Shan Hospital,Recruiting,Not Applicable,Interventional,China,"Evaluation Danorevir sodium tablets combined with ritonavir in the treatment of novel Coronavirus Pneumonia (COVID-19): a randomized, open-label, controlled trial",Drug,Danorevir + ritonavir,Danorevir; ritonavir,40,http://www.chictr.org.cn/showproj.aspx?proj=52103,None
338,710,ChiCTR2000031672,ChiCTR,2020-04-06,2020-04-01,True,Beijing University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Development and application of TCM body regulating protection scheme for the convalescent population of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,http://www.chictr.org.cn/showproj.aspx?proj=51940,None
339,711,ChiCTR2000030750,ChiCTR,2020-03-13,2020-03-01,True,Shenzhen Third People's Hospital,Not Recruiting,Phase 1/Phase 2,Interventional,China,A clinical study for effectiveness and safety evaluation for recombinant chimeric COVID-19 epitope DC vaccine in the treatment of novel coronavirus pneumonia,ATMP,Vaccine,Vaccine,120,http://www.chictr.org.cn/showproj.aspx?proj=50928,None
340,715,EUCTR2020-001301-23-FR,EU Clinical Trials Register,2020-03-26,2020-04-10,False,Assistance Publique  Hpitaux de Paris,Authorised,Phase 3,Interventional,France,Efficacy of Addition of Naproxen for COVID-19 Infection / Enacovid Study,Drug,Naproxen,Naproxen,584,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001301-23,None
341,716,EUCTR2020-001335-28-NL,EU Clinical Trials Register,2020-03-27,2020-03-29,False,InflaRx GmbH,Authorised,Phase 2/Phase 3,Interventional,Netherlands,An open label phase II/III study of IFX-1 in patients with severe COVID-19 Pneumonia,Drug,IFX-1,IFX-1,130,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001335-28,None
342,717,EUCTR2020-001381-11-FR,EU Clinical Trials Register,2020-03-29,2020-04-08,False,Assistance Publique  Hpitaux de Paris,Authorised,Phase 3,Interventional,France,COVID-19 - ACORES-2 study: ACE inhibitors or ARBs discontinuation for Clinical Outcome Risk reduction in patients hospitalized for the Endemic Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,554,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001381-11,None
343,718,EUCTR2020-001442-19-ES,EU Clinical Trials Register,2020-04-03,2020-04-02,True,Institut de Recerca Hospital de la Santa Creu i Sant Pau,Authorised,Phase 2,Interventional,Spain,"Clinical trial of combined use of hydroxychloroquine, azithromycin, and tocilizumab for the treatment of COVID-19",Drug,Tocilizumab + hydroxychloroquine + azithromycin,Tocilizumab; hydroxychloroquine; azithromycin,276,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001442-19,None
344,719,EUCTR2020-001385-11-ES,EU Clinical Trials Register,2020-04-03,2020-03-28,True,Plan Nacional sobre el Sida (PNS),Authorised,Phase 3,Interventional,Spain,EPICOS - Experimental clinical trial for PreventIon or COronavirus in health Care professionalS,Drug (Chemoprophylaxis),Emtricitabine/tenofovir + hydroxychloroquine,Emtricitabine; tenofovir; hydroxychloroquine,4000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001385-11,None
345,720,EUCTR2020-001409-21-ES,EU Clinical Trials Register,2020-04-03,2020-04-01,True,Fundacin para la Formacin e Investigacin Sanitarias de la Regin de Murcia (FFIS),Authorised,Phase 2,Interventional,Spain,DEFIBROTIDE AS PREVENTION AND TREATMENT OF RESPIRATORY DISTRESS AND CYTOKINE RELEASE SYNDROME OF COVID-19,Drug,Defibrotide,Defibrotide,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001409-21,None
346,721,EUCTR2020-001333-13-FR,EU Clinical Trials Register,2020-04-02,2020-04-09,False,Groupe Hospitalier Paris Saint-Joseph,Authorised,Phase 3,Interventional,France,Dexamethasone associated with hydroxychloroquine vs. hydroxychloroquine alone for the early treatment of severe ARDS caused by COVID-19 : a randomized controlled trial,Drug,Dexamethasone + hydroxychloroquine vs. hydroxychloroquine,Dexamethasone; hydroxychloroquine,122,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001333-13,None
347,722,EUCTR2020-001492-33-FR,EU Clinical Trials Register,2020-04-01,2020-04-10,False,L'Hpital Fondation Adolphe de Rothschild,Authorised,Phase 3,Interventional,France,Interest in the administration of Dornase alpha aerosol in Acute Respiratory Distress Syndrome secondary to respiratory infection by the coronavirus SRASCoV-2 / COVID-19,Drug,Dornase alfa,Dornase alfa,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001492-33,None
348,723,EUCTR2020-001194-69-ES,EU Clinical Trials Register,2020-04-07,2020-03-30,True,Felix Gutierrez Rodero,Authorised,Phase 3,Interventional,Spain,Pilot study to evaluate the efficacy and safety of mefloquine as prophylaxis in people exposed to the disease caused by the new SARS-CoV-2 coronavirus (COVID-19),Drug (Chemoprophylaxis),Mefloquine,Mefloquine,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001194-69,None
349,724,EUCTR2020-001565-37-ES,EU Clinical Trials Register,2020-04-07,2020-04-03,True,ISGlobal,Authorised,Phase 3,Interventional,Spain,Prevention of novel Coronavirus infection with hydroxychloroquine,Drug,Hydroxychloroquine,Hydroxychloroquine,440,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001565-37,None
350,725,EUCTR2020-001421-31-ES,EU Clinical Trials Register,2020-04-07,2020-04-06,True,Sociedad Espaola de Farmacia Hospitalaria,Authorised,Phase 4,Interventional,Spain,Clinical trial for evaluation of efficacy and safety of hydroxychloroquine chemoprophylaxis against SARS-CoV-2 (COVID-19) infection in healthcare professionals.,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1530,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001421-31,None
351,726,EUCTR2020-001606-33-ES,EU Clinical Trials Register,2020-04-07,2020-04-07,False,Instituto Investigacin Sanitario Biocruces Bizkaia,Authorised,Phase 3,Interventional,Spain,Randomized clinical trial to evaluate the efficacy of hydroxychloroquine associated or not with azithromycin as a treatment for COVID-19 infection,Drug,Hydroxychloroquine + azithromycin vs. hydroxychloroquine,Hydroxychloroquine; azithromycin,132,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001606-33,None
352,727,EUCTR2020-001307-16-ES,EU Clinical Trials Register,2020-04-08,2020-04-01,True,Fundacin para la Investigacin Biomdica Hospital Ramn y Cajal,Authorised,Phase 3,Interventional,Spain,Efficacy and Safety of corticoids in patients with adult respiratory distress syndrome (ARDS) secondary to coronavirus infection.,Drug,Corticosteroids,Methylprednisolone,104,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001307-16,None
353,730,NCT04252274,ClinicalTrials.gov,2020-01-29,2020-01-30,False,Shanghai Public Health Clinical Center,Recruiting,Phase 3,Interventional,China,Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19,Drug,Darunavir + Cobicistat,Darunavir; Cobicistat,30,https://clinicaltrials.gov/show/NCT04252274,None
354,731,NCT04261517,ClinicalTrials.gov,2020-02-06,2020-02-06,False,Shanghai Public Health Clinical Center,Not Recruiting,Phase 3,Interventional,China,Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,30,https://clinicaltrials.gov/show/NCT04261517,None
355,734,NCT04291729,ClinicalTrials.gov,2020-02-27,2020-02-17,True,The Ninth Hospital of Nanchang,Not Recruiting,Phase 4,Interventional,China,Evaluation of Ganovo (Danoprevir ) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,Drug,Danoprevir + Ritonavir (w/ or w/o Interferon),Danoprevir; Ritonavir; Interferon,11,https://clinicaltrials.gov/show/NCT04291729,None
356,736,NCT04306055,ClinicalTrials.gov,2020-03-08,2020-03-13,False,Guangzhou Blood Center,Not Recruiting,Not Applicable,Interventional,China,Blood Donor Recruitment During Epidemic of COVID-19,Other,No Intervention,No Intervention,19491,https://clinicaltrials.gov/show/NCT04306055,None
357,737,NCT04310228,ClinicalTrials.gov,2020-03-09,2020-03-08,False,Peking University First Hospital,Recruiting,Not Applicable,Interventional,China,Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019,Drug,Favipiravir + tocilizumab vs. favipiravir vs. tocilizumab,Favipiravir; tocilizumab,150,https://clinicaltrials.gov/show/NCT04310228,ChiCTR2000030894
358,738,NCT04315480,ClinicalTrials.gov,2020-03-14,2020-03-12,True,Universit Politecnica delle Marche,Not Recruiting,Phase 2,Interventional,Italy,Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis,Drug,Tocilizumab,Tocilizumab,38,https://clinicaltrials.gov/show/NCT04315480,None
359,739,NCT04317092,ClinicalTrials.gov,2020-03-19,2020-03-19,True,National Cancer Institute,Recruiting,Phase 2,Interventional,Italy,Tocilizumab in COVID-19 Pneumonia (TOCIVID-19),Drug,Tocilizumab,Tocilizumab,400,https://clinicaltrials.gov/show/NCT04317092,EUCTR2020-001110-38
360,743,NCT04322773,ClinicalTrials.gov,2020-03-24,2020-04-05,True,Marius Henriksen,Recruiting,Phase 2,Interventional,Denmark,Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure,Drug,Tocilizumab vs. sarilumab,Tocilizumab; sarilumab,200,https://clinicaltrials.gov/show/NCT04322773,EUCTR2020-001275-32
361,744,NCT04324021,ClinicalTrials.gov,2020-03-25,2020-04-02,False,Swedish Orphan Biovitrum,Recruiting,Phase 2/Phase 3,Interventional,Italy,Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.,Drug,Emapalumab + Anakinra,Emapalumab; anakinra,54,https://clinicaltrials.gov/show/NCT04324021,None
362,745,NCT04325672,ClinicalTrials.gov,2020-03-26,2020-04-01,False,Mayo Clinic,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Limit Coronavirus Associated Complications,ATMP,Plasma,Plasma,0,https://clinicaltrials.gov/show/NCT04325672,None
363,747,NCT04328012,ClinicalTrials.gov,2020-03-27,2020-04-06,False,Bassett Healthcare,Recruiting,Phase 2/Phase 3,Interventional,United States,COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2,Drug,Lopinavir/ritonavir vs. hydroxychloroquine vs. ARB (Losartan),Lopinavir/ritonavir; Hydroxychloroquine; ARB (Losartan),4000,https://clinicaltrials.gov/show/NCT04328012,None
364,749,NCT04330300,ClinicalTrials.gov,2020-03-30,2020-03-30,False,"National University of Ireland, Galway",Recruiting,Phase 4,Interventional,Ireland,Coronavirus (COVID-19) ACEi/ARB Investigation,Drug,ACE inhibitors or ARBs vs. Calcium Channel Blockers or Thiazide/Thiazide-like diuretics,ACE inhibitors; ARBs; Calcium Channel Blockers; Thiazide/Thiazide-like diuretics,2414,https://clinicaltrials.gov/show/NCT04330300,None
365,750,NCT04330495,ClinicalTrials.gov,2020-03-31,2020-04-06,False,Instituto de Investigacin Marqus de Valdecilla,Not Recruiting,Phase 4,Interventional,No Country Given,"Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection",Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,800,https://clinicaltrials.gov/show/NCT04330495,None
366,752,NCT04331470,ClinicalTrials.gov,2020-03-30,2020-04-04,True,Fasa University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19,Drug,Levamisole + budesonide/formoterol + lopinavir/ritonavir + hydroxychloroquine,Levamisole; budesonide; formoterol; Lopinavir/ritonavir; hydroxychloroquine,30,https://clinicaltrials.gov/show/NCT04331470,IRCT20200324046852N1
367,754,NCT04331665,ClinicalTrials.gov,2020-04-01,2020-04-20,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia,Drug,Ruxolitinib,Ruxolitinib,64,https://clinicaltrials.gov/show/NCT04331665,None
368,755,NCT04331834,ClinicalTrials.gov,2020-04-01,2020-04-03,False,Barcelona Institute for Global Health,Recruiting,Phase 3,Interventional,Spain,Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,440,https://clinicaltrials.gov/show/NCT04331834,None
369,756,NCT04332094,ClinicalTrials.gov,2020-03-31,2020-04-02,False,Fundaci Institut de Recerca Hospital de la Santa Creu i Sant Pau,Recruiting,Phase 2,Interventional,Spain,"Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19",Drug,Hydroxychloroquine + Azithromycin + Tocilizumab,Hydroxychloroquine; azithromycin; tocilizumab,276,https://clinicaltrials.gov/show/NCT04332094,None
370,758,NCT04333407,ClinicalTrials.gov,2020-04-01,2020-04-03,False,Imperial College London,Recruiting,Not Applicable,Interventional,United Kingdom,Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.,Drug,Aspirin + clopidogrel + rivaroxaban + atorvastatin + omeprazole,Aspirin; clopidogrel; rivaroxaban; atorvastatin; omeprazole,3170,https://clinicaltrials.gov/show/NCT04333407,None
371,761,NCT04334005,ClinicalTrials.gov,2020-03-29,2020-04-10,False,University of Granada,Not Recruiting,Not Applicable,Interventional,Spain,Vitamin D on Prevention and Treatment of COVID-19,Drug,Vitamin D,Vitamin D,200,https://clinicaltrials.gov/show/NCT04334005,None
372,762,NCT04334382,ClinicalTrials.gov,2020-04-02,2020-04-02,False,"Intermountain Health Care, Inc.",Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19,Drug,Hydroxychloroquine vs. azithromycin,Hydroxychloroquine; azithromycin,1550,https://clinicaltrials.gov/show/NCT04334382,None
373,765,NCT04336254,ClinicalTrials.gov,2020-03-28,2020-04-06,False,Renmin Hospital of Wuhan University,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04336254,None
374,766,NCT04336462,ClinicalTrials.gov,2020-03-25,2020-02-15,True,Shanghai Asclepius Meditec Inc.,Recruiting,Not Applicable,Interventional,China,Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19,Drug,Hydrogen + Oxygen vs Oxygen,Hydrogen; oxygen,100,https://clinicaltrials.gov/show/NCT04336462,None
375,769,NCT04336904,ClinicalTrials.gov,2020-04-03,2020-03-25,True,Giuliano Rizzardini,Not Recruiting,Phase 3,Interventional,Italy,Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19,Drug,Favipiravir,Favipiravir,100,https://clinicaltrials.gov/show/NCT04336904,None
376,772,NCT04337216,ClinicalTrials.gov,2020-04-01,2020-05-01,False,Virginia Commonwealth University,Not Recruiting,Phase 2,Interventional,United States,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in Patients With Severe COVID-19 Pneumonia and Systemic Hyper-inflammation,Drug,Mavrilimumab,Mavrilimumab,10,https://clinicaltrials.gov/show/NCT04337216,None
377,775,NCT04337541,ClinicalTrials.gov,2020-04-02,2020-04-02,False,"Rigshospitalet, Denmark",Recruiting,Not Applicable,Interventional,Denmark,Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System,Other (device),Masks,Masks,6000,https://clinicaltrials.gov/show/NCT04337541,None
378,780,NCT04338698,ClinicalTrials.gov,2020-04-04,2020-04-07,False,Shehnoor Azhar,Not Recruiting,Phase 3,Interventional,No Country Given,"Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT",Drug,"Monotherapy and all Combinations of: Hydroxychloroquine, oseltamivir, and azithromycin",Hydroxychloroquine; osletamivir; azithromycin,500,https://clinicaltrials.gov/show/NCT04338698,None
379,781,NCT04338802,ClinicalTrials.gov,2020-04-01,2020-04-02,False,Huilan Zhang,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19,Drug,Nintedanib,Nintedanib,96,https://clinicaltrials.gov/show/NCT04338802,None
380,782,NCT04338906,ClinicalTrials.gov,2020-04-03,2020-06-01,False,Heinrich-Heine University,Not Recruiting,Phase 4,Interventional,No Country Given,Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19,Drug,Camostat Mesilate + hydroxychloroquine vs. hydroxychloroquine,Camostat Mesilate; hydroxychloroquine,334,https://clinicaltrials.gov/show/NCT04338906,None
381,786,NCT04339660,ClinicalTrials.gov,2020-04-02,2020-02-01,True,Puren Hospital Affiliated to Wuhan University of Science and Technology,Recruiting,Phase 1/Phase 2,Interventional,China,Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04339660,None
382,788,NCT04341038,ClinicalTrials.gov,2020-04-07,2020-04-01,False,Hospital Universitari de Bellvitge,Recruiting,Phase 3,Interventional,Spain,Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury,Drug,Tacrolimus + Corticosteroids,Tacrolimus; Methylprednisolone,84,https://clinicaltrials.gov/show/NCT04341038,EUCTR2020-001445-39
383,790,NCT04341207,ClinicalTrials.gov,2020-04-08,2020-04-03,True,Institut Gustave Roussy,Recruiting,Phase 2,Interventional,France,Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin,1000,https://clinicaltrials.gov/show/NCT04341207,EUCTR2020-001250-21
384,797,NCT04342221,ClinicalTrials.gov,2020-04-08,2020-03-29,True,"University Hospital, Tbingen",Recruiting,Phase 3,Interventional,Germany,Hydroxychloroquine for COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,220,https://clinicaltrials.gov/show/NCT04342221,EUCTR2020-001224-33
385,799,NCT04343677,ClinicalTrials.gov,2020-04-09,2020-04-01,True,United States Department of Defense,Not Recruiting,Phase 2,Interventional,United States,Military COVID-19 Hydroxychloroquine Pre-exposure and Post-exposure Prophylaxis Study,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1450,https://clinicaltrials.gov/show/NCT04343677,None
386,800,NCT04344080,ClinicalTrials.gov,2020-04-09,2020-04-01,False,"University Hospital, Hamburg-Eppendorf",Recruiting,Not Applicable,Interventional,Germany,Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19,Other (device),Cytokine Adsorber,Cytokine Adsorber,24,https://clinicaltrials.gov/show/NCT04344080,DRKS00021199
387,802,ACTRN12620000468921,ANZCTR,2020-04-14,2020-04-20,False,UNSW Sydney,Not Recruiting,Not Applicable,Interventional,Australia,Effect of a Brief Problem Management Intervention on Covid 19-Related Anxiety and Depression,Other (psych),Psychological,Psychological,140,https://anzctr.org.au/ACTRN12620000468921.aspx,None
388,803,ACTRN12620000477921,ANZCTR,2020-04-16,2020-04-20,False,Dr. Michael Soares,Not Recruiting,Not Applicable,Interventional,Australia,The design of an updated iron lung ventilator which can be easily built and used by people with minimal training in situations such as COVID-19 where skilled doctors or normal ventilators are unavailable.,Other (physical),Mechanical ventilation,Mechanical ventilation,1,https://anzctr.org.au/ACTRN12620000477921.aspx,None
389,804,ACTRN12620000472976,ANZCTR,2020-04-15,2020-04-27,False,Dr. Simon Joosten,Not Recruiting,Not Applicable,Interventional,Australia,Adapting the Decathlon Group Easybreathe snorkelling face mask for the safer administration of oxygen and/or continuous positive airway pressure and in the intra/interhospital transportation of patients with proven or suspected COVID 19 infection.,Other (device),Masks,Masks,100,https://anzctr.org.au/ACTRN12620000472976.aspx,None
390,806,ACTRN12620000470998,ANZCTR,2020-04-14,2020-04-20,False,Firebrick Pharma Pty Ltd,Not Recruiting,Not Applicable,Interventional,Australia,Virucidal pilot study of Nasodine Antiseptic Nasal Spray (povidone-iodine 0.5%) in people with COVID-19 and confirmed nasal shedding of SARS-CoV-2 virus.,Drug,Povidone Iodine,Povidone Iodine,20,https://anzctr.org.au/ACTRN12620000470998.aspx,None
391,807,ACTRN12620000473965,ANZCTR,2020-04-15,2020-06-01,False,University of Queensland,Not Recruiting,Phase 3,Interventional,Australia,Reducing acute severe respiratory events in health care workers during the Covid-19 pandemic with OM85,Drug (Chemoprophylaxis),OM85,OM85,1000,https://anzctr.org.au/ACTRN12620000473965.aspx,None
392,809,ACTRN12620000478910,ANZCTR,2020-04-16,2020-06-01,False,Monash Health,Not Recruiting,Not Applicable,Interventional,Australia,Cord Blood Therapy to prevent progression of COVID-19 related pneumonia,ATMP,Cells (stem cells),Cells (stem cells),24,https://anzctr.org.au/ACTRN12620000478910.aspx,None
393,810,ACTRN12620000480987,ANZCTR,2020-04-16,2020-06-01,False,University of Auckland,Not Recruiting,Not Applicable,Interventional,New Zealand,Stress-reduction Using Probiotics to Promote Ongoing Resilience Throughout COVID-19 for Healthcare Workers (SUPPORT COVID-19 Healthcare Workers),Supplement,Probiotics,Probiotics,507,https://anzctr.org.au/ACTRN12620000480987.aspx,None
394,811,ChiCTR2000032098,ChiCTR,2020-04-19,2020-01-20,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,Danggui Shaoyao Powder in the synergistic treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=52477,None
395,814,ChiCTR2000032013,ChiCTR,2020-04-17,2020-02-02,True,The Fourth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,The prevention and treatment strategy of the protective respirator related facial pressure injuries among healthcare professionals fighting novel coronavirus pneumonia (COVID-19),Other (physical),Mechanical ventilation,Mechanical ventilation,8,http://www.chictr.org.cn/showproj.aspx?proj=52483,None
396,815,ChiCTR2000032011,ChiCTR,2020-04-17,2020-04-17,False,The Sixth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,Effecacy and Safety of Hyperbaric Oxygen Therapy to patients with novel coronavirus pneumonia (COVID-19),Drug,Oxygen,Oxygen,45,http://www.chictr.org.cn/showproj.aspx?proj=52142,None
397,819,ChiCTR2000031955,ChiCTR,2020-04-16,2020-04-01,True,Beijing University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Study for prevention of novel coronavirus pneumonia (COVID-19) in high risk population by Chinese medicine,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3808,http://www.chictr.org.cn/showproj.aspx?proj=52364,None
398,821,ChiCTR2000031944,ChiCTR,2020-04-15,2020-04-16,False,China Academy of Chinese Medical Sciences,Recruiting,Not Applicable,Interventional,China,Efficacy of Chinese Herbal Tea in the Prevention of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,2000,http://www.chictr.org.cn/showproj.aspx?proj=52414,None
399,824,ChiCTR2000031888,ChiCTR,2020-04-13,2020-02-11,True,Guangzhou Eighth People's Hospital,Recruiting,Not Applicable,Interventional,China,A medical records based study for ''Guangdong Pneumonia NO.1'' in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=52106,None
400,827,ChiCTR2000029976,ChiCTR,2020-02-18,2020-02-18,False,Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,The effect of Gymnastic Qigong Yangfeifang on functional recovery and quality of life in patients with mild novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,160,http://www.chictr.org.cn/showproj.aspx?proj=49631,None
401,828,ChiCTR2000029434,ChiCTR,2020-02-01,2020-02-01,False,Hebei Yiling Hospital; Renmin Hospital of Wuhan University,Not Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule /Granule in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,240,http://www.chictr.org.cn/showproj.aspx?proj=48889,None
402,829,ChiCTR2000029433,ChiCTR,2020-02-01,2020-02-01,False,Hebei Yiling Hospital; Renmin Hospital of Wuhan University,Not Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule/Granule in the treatment of suspected novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,240,http://www.chictr.org.cn/showproj.aspx?proj=48898,None
403,830,EUCTR2020-001156-18-ES,EU Clinical Trials Register,2020-04-03,2020-03-27,True,Fundacin para la Investigacin Biomdica Hospital Universitario La Paz (FIBHULP),Authorised,Phase 3,Interventional,Spain,Efficacy of different treatments in patients infected with COVID-19,Drug,"Dolquine, Azithromycin, Lopinavir/ritonavir",Dolquine; Azithromycin; Lopinavir/ritonavir,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001156-18,None
404,832,EUCTR2020-001160-28-ES,EU Clinical Trials Register,2020-04-13,2020-04-09,True,Medica Scientia Innovation Research S.L. (MEDSIR),Authorised,Phase 2,Interventional,Spain,Tocilizumab plus Pembrolizumab in COVID-19,Drug,Tocilizumab + Pembrolizumab,Tocilizumab; Pembrolizumab,24,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001160-28,None
405,833,EUCTR2020-001262-11-ES,EU Clinical Trials Register,2020-04-13,2020-04-09,False,Instituto de Investigacin Sanitaria Fundacin Jimenez Diaz,Authorised,Phase 4,Interventional,Spain,Clinical trial to assess the efficacy and safety of cyclosporin A treatment associated with standard treatment versus standard treatment only in hospitalized patients with confirmed coronavirus infection,Drug,Cyclosporine A vs. lopinavir/ritonavir + interferon beta + darunavir + spironolactone + tocilizumab + chloroquine,Cyclosporine; lopinavir/ritonavir; interferon beta; darunavir; spironolactone; tocilizumab; chloroquine,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001262-11,NCT04392531
406,834,EUCTR2020-001290-74-ES,EU Clinical Trials Register,2020-04-13,2020-04-11,True,Consorci Parc de Salut Mar (PSMAR),Authorised,Phase 3,Interventional,Spain,Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care,Drug,Sarilumab vs. Hydroxychloroquine + Azithromycin,Sarilumab; Hydroxychloroquine; Azithromycin,216,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001290-74,None
407,835,EUCTR2020-001406-27-FR,EU Clinical Trials Register,2020-04-03,2020-04-07,False,"University Hospital, Montpellier",Authorised,Phase 3,Interventional,France,efficacy and safety of a bitherapy by hydroxychloroquine + azythromycin vs monotherapy by hydroxychoroquine in adult patients with documentated infection by covid19,Drug,Hydroxychloroquine vs. Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001406-27,None
408,836,EUCTR2020-001321-31-ES,EU Clinical Trials Register,2020-04-13,2020-04-11,True,Hospital Universitario de Fuenlabrada,Authorised,Phase 2,Interventional,Spain,Clinical trial phase II to evaluate the efficacy of  3 types of treatment in patients with pneumonia by COVID-19,Drug,Hydroxychloroquine + baricitinib or imatinib or lopinavir/ritonavir,Hydroxychloroquine; baricitinib; imatinib; lopinavir/ritonavir,165,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001321-31,None
409,837,EUCTR2020-001437-12-ES,EU Clinical Trials Register,2020-04-13,2020-04-09,True,Vall d'Hebron Research Institute (VHIR),Authorised,Phase 4,Interventional,Spain,"Random, controlled, open, one-site clinical trial in adult patients with COVID-19 severe pneumonia treated with immunomodulatory drugs",Drug,"Cyclosporine, Tocilizumab",Cyclosporine; Tocilizumab,290,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001437-12,None
410,838,EUCTR2020-001530-35-ES,EU Clinical Trials Register,2020-04-13,2020-04-09,True,Fundacin para la investigacin Biomdica Hospital Universitario La Paz (FIBHULP),Authorised,Phase 4,Interventional,Spain,Clinical trial to avoid infection by SARS-CoV-2 in high-risk population. COVID-19,Drug,Melatonin,Melatonin,450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001530-35,None
411,839,EUCTR2020-001587-29-ES,EU Clinical Trials Register,2020-04-13,2020-04-08,True,Barcelona Institute for Global Health,Authorised,Phase 4,Interventional,Spain,Preventing SARS-CoV-2 virus infection and severity of COVID-19 diseases during pregnancy with hydroxychloroquine,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,714,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001587-29,None
412,840,EUCTR2020-001689-12-ES,EU Clinical Trials Register,2020-04-13,2020-04-11,True,Montreal Heart Institute,Authorised,Phase 3,Interventional,Spain,COLCHICINA TEST IN THE SARS-COV2 CORONAVIRUS (COLCORONA-COVID-19),Drug,Colchicine,Colchicine,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001689-12,None
413,841,EUCTR2020-001765-37-ES,EU Clinical Trials Register,2020-04-13,2020-04-11,True,Institut Catal d'Oncologia,Authorised,Phase 2,Interventional,Spain,Pragmatic clinical trial of hydroxychloroquine in the treatment of oncohematological patients and health professionals with COVID-19 infection without radiological alteration.,Drug,Hydroxychloroquine,Hydroxychloroquine,103,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001765-37,None
414,842,EUCTR2020-001379-34-ES,EU Clinical Trials Register,2020-04-14,2020-04-14,False,Instituto de Investigacin Sanitaria INCLIVA,Authorised,Phase 4,Interventional,Spain,Sedation with sevoflurane versus propofol in patients with Acute Respiratory Distress Syndrome caused by COVID-19 infection,Drug,Sevoflurane vs. Propofol,Sevoflurane; Propofol,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001379-34,None
415,843,EUCTR2020-001511-25-ES,EU Clinical Trials Register,2020-04-15,2020-04-14,True,Fundacin para la Formacin e Investigacin Sanitarias de la Regin de Murcia (FFIS),Authorised,Phase 3,Interventional,Spain,Randomized open-blind controlled trial to study the benefit of Colchicine in Patients with COVID-19,Drug,Colchicine,Colchicine,102,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001511-25,None
416,844,EUCTR2020-001266-11-ES,EU Clinical Trials Register,2020-04-16,2020-04-16,False,Fundacin Instituto de Investigacin Sanitaria Fundacin Jimenez Diaz,Authorised,Phase 2,Interventional,Spain,Clinical trial of administration of MSC to patients with respiratory distress type COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001266-11,None
417,845,EUCTR2020-001254-22-BE,EU Clinical Trials Register,2020-03-24,2020-03-24,False,"University Hospital, Ghent",Authorised,Phase 4,Interventional,Belgium,Sargramostim in patients with acute hypoxic respiratory failure due to COVID-19,Drug,Sargramostin,Sargramostin,80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001254-22,None
418,846,IRCT20200310046736N1,IRCT,2020-04-01,2020-04-01,False,Ahvaz University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of The Therapeutic Effect of Convalescent Plasma and Plasma-derived Immunoglobulin-enriched solution on COVID-19 Patients,ATMP,Plasma,Plasma,45,http://en.irct.ir/trial/46424,None
419,847,IRCT20151113025025N3,IRCT,2020-03-29,2020-04-05,False,Tehran University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Clinical Trial of renin-angiotensin-aldosterone system inhibitors with halting their administration and the effect on clinical outcomes of patients with corona virus disease-2019 (COVID-19) referring to Sina Hospital in 2020,Drug,RAAS inhibitors,RAAS inhibitors,60,http://en.irct.ir/trial/46531,None
420,848,IRCT20100228003449N30,IRCT,2020-03-22,2020-03-15,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Combination therapy in COVID 19,Drug,Hydroxychloroquine +  Oseltamivir + Lopinavir/ritonavir or Atazanavir/ritonavir ,Hydroxychloroquine; Oseltamivir; Lopinavir/ritonavir; Lopinavir/atazanavir,50,http://en.irct.ir/trial/46536,None
421,849,IRCT20100228003449N28,IRCT,2020-03-19,2020-03-15,True,Tehran University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon in treatment of COVID-19,Drug,Interferon beta vs. hydroxychloroquine + oseltamivir + Lopinavir/ritonavir,Interferon beta; hydroxychloroquine; oseltamivir; lopinavir/ritonavir,30,http://en.irct.ir/trial/46538,None
422,850,IRCT20100228003449N27,IRCT,2020-03-16,2020-03-15,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon  in treatment  of COVID-19,Drug,Interferon beta vs. hydroxychloroquine + oseltamivir + Lopinavir/ritonavir,Interferon beta; hydroxychloroquine; oseltamivir; lopinavir/ritonavir,30,http://en.irct.ir/trial/46545,None
423,851,IRCT20200316046792N1,IRCT,2020-03-17,2020-03-16,True,Iran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of herbal syrup and solution in treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,http://en.irct.ir/trial/46554,None
424,852,IRCT20151227025726N12,IRCT,2020-03-23,2020-03-03,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluting the therapeutic and adverse effects of Interferon beta 1-a in patients with novel Coronavirus(COVID-19),Drug,Interferon beta + hydroxychloroquine + osletamivir + lopinavir/ritonavir,Interferon beta; hydroxychloroquine; oseltamivir; lopinavir/ritonavir,20,http://en.irct.ir/trial/46561,None
425,853,IRCT20170117032004N3,IRCT,2020-03-29,2020-04-03,False,Tabriz University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of vitamin A in patients with COVID19,Drug,Vitamin A,Vitamin A,30,http://en.irct.ir/trial/46564,None
426,854,IRCT20100228003449N29,IRCT,2020-03-19,2020-03-18,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,?Effect of sofosbuvir/ ledipasvir on COVID-19,Drug,Sofosbuvir + Ledipasvir vs. Hydroxychloroquine + Oseltamivir + Lopinavir/ritonavir,Sofosbuvir; Ledipasvir; Hydroxychloroquine; Oseltamivir; Lopinavir/ritonavir,50,http://en.irct.ir/trial/46567,None
427,855,IRCT20200317046797N1,IRCT,2020-04-03,2020-04-08,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Camostate mesylate on the outcome of Coronavirus (COVID-19)-induced pneumonia,Drug,Camostat Mesilate,Camostat Mesilate,40,http://en.irct.ir/trial/46573,None
428,856,IRCT20160625028622N1,IRCT,2020-03-22,2020-03-19,True,Qazvin University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,The effect of Noscapine  on clinical and pulmonary manifestations of COVID-19 patients,Drug,Noscapine,Noscapine,125,http://en.irct.ir/trial/46576,None
429,857,IRCT20120826010664N6,IRCT,2020-04-05,2020-03-29,True,Tehran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of hydroxychloroquine on prevention of covid-19 virus,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,310,http://en.irct.ir/trial/46603,None
430,858,IRCT20131113015393N6,IRCT,2020-03-30,2020-02-28,True,Sabzevar University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of Benson Relaxation on Quality of Life and job stress  in nurses,Other (psych),Psychological,Psychological,62,http://en.irct.ir/trial/46609,None
431,859,IRCT20140528017891N8,IRCT,2020-03-28,2020-03-24,True,MOM Research and Innovation Center,Not Recruiting,Phase 3,Interventional,Iran,The effect of stem cell transplantation in the treatment of COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),10,http://en.irct.ir/trial/46623,None
432,860,IRCT20200321046828N1,IRCT,2020-03-26,2020-03-22,True,RNA Biotechnology,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Remedy of human coroviruse infection with genetic nanocomposit drug,Drug,Unspecified,Unspecified,30,http://en.irct.ir/trial/46624,None
433,861,IRCT20190727044343N1,IRCT,2020-04-05,2020-03-16,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,?Effect of febuxostat against coronavirus,Drug,Acetaminophen + Febuxostat vs.  Acetaminophen + Hydroxychloroquine,Febuxostat; Acetaminophen; Hydroxychloroquine,60,http://en.irct.ir/trial/46629,None
434,862,IRCT20140617018126N2,IRCT,2020-03-29,2020-04-03,False,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Persian Medicine Products in Covid-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46637,None
435,863,IRCT20150914024017N1,IRCT,2020-04-03,2020-03-27,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,ReciGen for treatment of Covid-19,Drug,Interferon beta,Interferon beta,40,http://en.irct.ir/trial/46665,None
436,864,IRCT20140911019125N6,IRCT,2020-04-04,2020-04-04,False,Kerman University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The effect of dental pulp mesenchymal stem cells in treatment of  corona disease,ATMP,Cells (mesenchymal),Cells (mesenchymal),10,http://en.irct.ir/trial/46668,None
437,865,IRCT20160316027081N1,IRCT,2020-03-31,2020-03-23,True,Artesh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of Licorice in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,374,http://en.irct.ir/trial/46678,None
438,866,IRCT20151227025726N13,IRCT,2020-03-26,2020-03-11,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation the Efficacy and Safety of Tocilizumab in COVID-19,Drug,Tocilizumab + hydroxychloroquine + oseltamivir + lopinavir/ritonavir,Tocilizumab; hydroxychloroquine; oseltamivir; lopinavir/ritonavir,40,http://en.irct.ir/trial/46681,None
439,867,IRCT20160310026998N11,IRCT,2020-03-27,2020-03-20,True,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of metformin in COVID-19  symptom improvement and death,Drug,Metformin,Metformin,200,http://en.irct.ir/trial/46690,None
440,868,IRCT20160310026998N10,IRCT,2020-03-26,2020-03-20,True,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Study of the metformin effect on the survival and recovery rate of patients with COVID-19,Drug,Metformin,Metformin,200,http://en.irct.ir/trial/46693,None
441,869,IRCT20180610040049N3,IRCT,2020-03-29,2020-04-08,False,Arak University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of Trachyspermum copticum syrup on clinical manifestations of patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46697,None
442,870,IRCT20200324046847N1,IRCT,2020-03-31,2020-03-28,True,Tehran University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Treatment of patients with Corona virus infection,Drug,Septimeb,Septimeb,30,http://en.irct.ir/trial/46720,None
443,871,IRCT20140907019073N4,IRCT,2020-03-29,2020-04-03,False,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of Ipecac homeopathic remedy  in control of Clinical manifestations of COVID-19,Other,Homeopathy,Homeopathy,60,http://en.irct.ir/trial/46736,None
444,872,IRCT20200324046850N5,IRCT,2020-04-04,2020-04-19,False,Abadan University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Study of the effect of vitamin C in patients with Covid-19,Drug,Vitamin C w or w/o Hydroxychloroquine or Chloroquine + Lopinavir/Ritonavir,Vitamin C; Hydroxychloroquine; Chloroquine; Lopinavir/Ritonavir,40,http://en.irct.ir/trial/46751,None
445,873,IRCT20200325046860N1,IRCT,2020-03-30,2020-03-15,True,Darmanara Co.,Recruiting,Not Applicable,Interventional,Iran,Convalescent Plasma therapy for COVID-19 Patients,ATMP,Plasma,Plasma,200,http://en.irct.ir/trial/46759,None
446,874,IRCT20101219005416N2,IRCT,2020-04-03,2020-03-24,True,Kerman University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of  the effect of traditional  Iranian medicine product on improvement of clinical menifestation of COVID -19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/46775,None
447,875,IRCT20200317046797N2,IRCT,2020-04-03,2020-04-08,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Fingolimod for treatment of COVID-19-induced cytokine storm,Drug,Fingolimod,Fingolimod,40,http://en.irct.ir/trial/46786,None
448,876,IRCT20200325046860N2,IRCT,2020-04-01,2020-03-28,True,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 1,Interventional,Iran,Mesenchymal Stem Cell therapy in COVID19,ATMP,Cells (mesenchymal),Cells (mesenchymal),5,http://en.irct.ir/trial/46789,None
449,877,IRCT20170611034452N11,IRCT,2020-03-31,2020-03-30,True,Kerman University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Investigating the effectiveness of psychological interventions on mental health,Other (psych),Psychological,Psychological,60,http://en.irct.ir/trial/46803,None
450,878,IRCT20190917044805N2,IRCT,2020-03-31,2020-04-03,False,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effects of High-dose Vitamin C on COVID-19,Drug,Vitamin C,Vitamin C,60,http://en.irct.ir/trial/46804,None
451,879,IRCT20120225009124N4,IRCT,2020-04-02,2020-04-18,False,Gorgan University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Efficacy of dexamethasone, IV-IG and Interferone beta for treatment of patients with severe COVID-19",Drug (+ ATMP),"Intreventional: Dexamethason + Immunoglobulin vs. Dexamethason + Immunoglobulin + interferon beta

All Arms: Hydroxychloroquine + antiviral ",Dexamethason; Immunoglobulin; interferon beta; Hydroxychloroquine,105,http://en.irct.ir/trial/46810,None
452,880,IRCT20180802040678N4,IRCT,2020-04-01,2020-03-31,True,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effects of Losartan in patients with corona virus disease 2019,Drug,Losartan vs. amlodipine,Losartan; amlodipine,100,http://en.irct.ir/trial/46824,None
453,881,IRCT20150704023055N2,IRCT,2020-04-03,2020-03-24,True,Babol University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Hemoperfusion in patients with COVID-19,Other (device),Hemoperfusion,Hemoperfusion,10,http://en.irct.ir/trial/46837,None
454,882,IRCT20200319046819N1,IRCT,2020-04-04,2020-04-02,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,supplementation in COVID-19,Drug,Vitamin A + Vitamin D + Vitamin C + Vitamin B,Vitamin A; Vitamin D; Vitamin C; Vitamin B,60,http://en.irct.ir/trial/46838,None
455,883,JPRN-JapicCTI-205238,JPRN,2020-03-27,2020-03-31,False,"FUJIFILM Toyama Chemical Co., Ltd.",Recruiting,Phase 3,Interventional,Japan,Phase 3 Clinical Study of Favipiravir in Patients with COVID-19 Non-Severe Pneumonia,Drug,Favipiravir,Favipiravir,96,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205238,None
456,884,JPRN-jRCTs031190226,JPRN,2020-02-27,2020-03-14,False,Tokue Yutaka,Recruiting,Phase 2,Interventional,Japan,Favipiravir in patients infected with COVID-19,Drug,Favipiravir,Favipiravir,50,https://jrct.niph.go.jp/latest-detail/jRCTs031190226,None
457,891,NCT04252118,ClinicalTrials.gov,2020-01-27,2020-01-27,False,Beijing 302 Hospital,Recruiting,Phase 1,Interventional,China,Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04252118,None
458,892,NCT04252664,ClinicalTrials.gov,2020-01-31,2020-02-12,False,Capital Medical University,Not Recruiting,Phase 3,Interventional,China,A Trial of Remdesivir in Adults With Mild and Moderate COVID-19,Drug,Remdesivir,Remdesivir,308,https://clinicaltrials.gov/show/NCT04252664,None
459,893,NCT04257656,ClinicalTrials.gov,2020-01-31,2020-02-06,False,Capital Medical University,Not Recruiting,Phase 3,Interventional,China,A Trial of Remdesivir in Adults With Severe COVID-19,Drug,Remdesivir,Remdesivir,237,https://clinicaltrials.gov/show/NCT04257656,None
460,894,NCT04273646,ClinicalTrials.gov,2020-02-14,2020-04-20,False,"Wuhan Union Hospital, China",Not Recruiting,Not Applicable,Interventional,China,Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),48,https://clinicaltrials.gov/show/NCT04273646,None
461,895,NCT04276688,ClinicalTrials.gov,2020-02-11,2020-02-10,True,University of Hong Kong,Not Recruiting,Phase 2,Interventional,Hong Kong,"Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment",Drug,Lopinavir/ritonavir + Ribavirin + Interferon beta,Lopinavir/ritonavir; Ribavirin; Interferon beta,127,https://clinicaltrials.gov/show/NCT04276688,None
462,896,NCT04280224,ClinicalTrials.gov,2020-02-13,2020-02-15,False,Xinxiang Medical University,Recruiting,Phase 1,Interventional,China,NK Cells Treatment for COVID-19,ATMP,Cells (NK),Cells (NK),30,https://clinicaltrials.gov/show/NCT04280224,None
463,897,NCT04299152,ClinicalTrials.gov,2020-02-28,2020-05-10,False,Tianhe Stem Cell Biotechnologies Inc.,Not Recruiting,Phase 2,Interventional,No Country Given,Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19,ATMP,Cells (stem cells),Cells (stem cells),20,https://clinicaltrials.gov/show/NCT04299152,None
464,898,NCT04304690,ClinicalTrials.gov,2020-03-09,2020-03-16,False,Assistance Publique  Hpitaux de Paris,Recruiting,Not Applicable,Interventional,France,"COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic",Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04304690,None
465,899,NCT04315896,ClinicalTrials.gov,2020-03-18,2020-04-14,False,"National Institute of Respiratory Diseases, Mexico",Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial),Drug,Hydroxychloroquine,Hydroxychloroquine,500,https://clinicaltrials.gov/show/NCT04315896,None
466,900,NCT04318015,ClinicalTrials.gov,2020-03-19,2020-04-14,False,"National Institute of Respiratory Diseases, Mexico",Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,400,https://clinicaltrials.gov/show/NCT04318015,None
467,901,NCT04320277,ClinicalTrials.gov,2020-03-20,2020-05-16,False,Hospital of Prato,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,"Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.",Drug,Baricitinib,Baricitinib,200,https://clinicaltrials.gov/show/NCT04320277,None
468,902,NCT04320953,ClinicalTrials.gov,2020-03-21,2020-03-16,True,Changhai Hospital,Not Recruiting,Not Applicable,Interventional,China,Non-contact Endoscopy at Covid-19 Outbreak,Other (device),Non-contact Endoscopy,Non-contact Endoscopy,5,https://clinicaltrials.gov/show/NCT04320953,None
469,903,NCT04321174,ClinicalTrials.gov,2020-03-18,2020-04-17,False,Darrell Tan,Recruiting,Phase 3,Interventional,Canada,COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir,Drug,Lopinavir/ritonavir,Lopinavir/ritonavir,1220,https://clinicaltrials.gov/show/NCT04321174,None
470,905,NCT04323345,ClinicalTrials.gov,2020-03-23,2020-04-15,False,Misr University for Science and Technology,Recruiting,Phase 3,Interventional,Egypt,Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,1000,https://clinicaltrials.gov/show/NCT04323345,None
471,907,NCT04324073,ClinicalTrials.gov,2020-03-25,2020-03-27,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2/Phase 3,Interventional,France,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI,Drug,Sarilumab,Sarilumab,239,https://clinicaltrials.gov/show/NCT04324073,None
472,908,NCT04324190,ClinicalTrials.gov,2020-03-26,2020-04-08,False,Gunther Meinlschmidt,Recruiting,Not Applicable,Interventional,Germany,DIgital Online SuPport for COVID-19 StrEss,Other (psych),Psychological,Psychological,600,https://clinicaltrials.gov/show/NCT04324190,None
473,911,NCT04325061,ClinicalTrials.gov,2020-03-25,2020-04-03,True,Dr. Negrin University Hospital,Recruiting,Phase 4,Interventional,Spain,Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19,Drug,Corticosteroids,Dexamethasone,200,https://clinicaltrials.gov/show/NCT04325061,EUCTR2020-001278-31
474,912,NCT04325633,ClinicalTrials.gov,2020-03-26,2020-04-13,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection,Drug,Naproxen,Naproxen,584,https://clinicaltrials.gov/show/NCT04325633,None
475,913,NCT04326426,ClinicalTrials.gov,2020-03-26,2020-04-13,False,Vanda Pharmaceuticals,Recruiting,Phase 3,Interventional,United States,ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection,Drug,Tradipitant,Tradipitant,300,https://clinicaltrials.gov/show/NCT04326426,None
476,915,NCT04329650,ClinicalTrials.gov,2020-03-31,2020-04-15,True,Judit Pich Martnez,Recruiting,Phase 2,Interventional,Spain,Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia,Drug,Siltuximab vs. Corticosteroids,Siltuximab; Methylprednisolone,200,https://clinicaltrials.gov/show/NCT04329650,EUCTR2020-001413-20
477,916,NCT04331054,ClinicalTrials.gov,2020-03-29,2020-04-13,True,Assistance Publique  Hpitaux de Paris,Recruiting,Phase 3,Interventional,France,Protective Role of Inhaled Steroids for Covid-19 Infection,Drug,Corticosteroids + formoterol,Budesonide; formoterol,436,https://clinicaltrials.gov/show/NCT04331054,EUCTR2020-001306-35
478,918,NCT04333420,ClinicalTrials.gov,2020-04-01,2020-03-31,True,InflaRx GmbH,Recruiting,Phase 2/Phase 3,Interventional,Netherlands,"Open-label, Randomized Study of IFX-1 in Patients With Severe COVID-19 Pneumonia",Drug,IFX-1,IFX-1,130,https://clinicaltrials.gov/show/NCT04333420,EUCTR2020-001335-28
479,919,NCT04333628,ClinicalTrials.gov,2020-04-01,2020-04-01,False,"HaEmek Medical Center, Israel",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Chloroquine for Mild Symptomatic and Asymptomatic COVID-19,Drug,Chloroquine,Chloroquine,210,https://clinicaltrials.gov/show/NCT04333628,None
480,920,NCT04334044,ClinicalTrials.gov,2020-04-01,2020-04-15,False,Grupo Cooperativo Hemopatas Malignas,Recruiting,Phase 1/Phase 2,Interventional,Mexico,Treatment of SARS Caused by COVID-19 With Ruxolitinib,Drug,Ruxolitinib,Ruxolitinib,20,https://clinicaltrials.gov/show/NCT04334044,None
481,921,NCT04334434,ClinicalTrials.gov,2020-04-02,2020-04-20,False,Kubra Koce,Not Recruiting,Not Applicable,Interventional,Turkey,Telerehabilitation in Individuals Over 65 Years of Age Having Social Isolation Due to Coronavirus (Covid-19),Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,30,https://clinicaltrials.gov/show/NCT04334434,None
482,925,NCT04338568,ClinicalTrials.gov,2020-04-04,2020-04-13,False,Hasselt University,Recruiting,Not Applicable,Interventional,Belgium,Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04338568,None
483,930,NCT04341584,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,No Country Given,CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection,Drug,Anakinra,Anakinra,240,https://clinicaltrials.gov/show/NCT04341584,None
484,931,NCT04342156,ClinicalTrials.gov,2020-04-08,2020-04-01,True,Tan Tock Seng Hospital,Not Recruiting,Phase 3,Interventional,No Country Given,Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1200,https://clinicaltrials.gov/show/NCT04342156,None
485,932,NCT04342169,ClinicalTrials.gov,2020-04-07,2020-04-14,False,University of Utah,Recruiting,Phase 2,Interventional,United States,University of Utah COVID-19 Hydrochloroquine Trial,Drug,Hydroxychloroquine,Hydroxychloroquine,400,https://clinicaltrials.gov/show/NCT04342169,None
486,934,NCT04342650,ClinicalTrials.gov,2020-04-04,2020-04-08,False,Fundao de Medicina Tropical Dr. Heitor Vieira Dourado,Recruiting,Phase 2,Interventional,Brazil,Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection,Drug,Chloroquine,Chloroquine,210,https://clinicaltrials.gov/show/NCT04342650,None
487,935,NCT04343001,ClinicalTrials.gov,2020-04-08,2020-04-01,True,London School of Hygiene and Tropical Medicine,Not Recruiting,Phase 3,Interventional,"Pakistan, Nigeria",Coronavirus Response - Active Support for Hospitalised Covid-19 Patients,Drug,"Monotherapy and all Combinations of: ARB (Losartan), simvastatin, and aspirin",ARB (Losartan); simvastatin; aspirin,10000,https://clinicaltrials.gov/show/NCT04343001,None
488,936,NCT04343144,ClinicalTrials.gov,2020-04-09,2020-04-15,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,"Trial Evaluating Efficacy and Safety of Nivolumab (Optivo) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort.",Drug,Nivolumab,Nivolumab,92,https://clinicaltrials.gov/show/NCT04343144,None
489,937,NCT04343183,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Ochsner Health System,Not Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection,Drug,Oxygen,Oxygen,48,https://clinicaltrials.gov/show/NCT04343183,None
490,940,NCT04343690,ClinicalTrials.gov,2020-04-09,2020-04-13,False,Duke University,Not Recruiting,Not Applicable,Interventional,United States,COPING With COVID-19( CWC-19),Other (psych),Psychological,Psychological,100,https://clinicaltrials.gov/show/NCT04343690,None
491,941,NCT04343755,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Hackensack Meridian Health,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection,ATMP,Plasma,Plasma,55,https://clinicaltrials.gov/show/NCT04343755,None
492,942,NCT04343794,ClinicalTrials.gov,2020-02-20,2020-04-01,False,University of Hong Kong,Recruiting,Not Applicable,Interventional,Hong Kong,Using Biovitals Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19,Other (device),Biosensors,Biosensors,200,https://clinicaltrials.gov/show/NCT04343794,None
493,943,NCT04343963,ClinicalTrials.gov,2020-04-09,2020-04-04,True,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Recruiting,Phase 2/Phase 3,Interventional,Mexico,Pyridostigmine in Severe SARS-CoV-2 Infection,Drug,Pyridostigmine,Pyridostigmine,436,https://clinicaltrials.gov/show/NCT04343963,None
494,944,NCT04344106,ClinicalTrials.gov,2020-04-08,2020-04-01,True,ELHARRAR Xavier,Recruiting,Not Applicable,Interventional,France,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,Procedure,Positioning,Positioning,25,https://clinicaltrials.gov/show/NCT04344106,None
495,946,NCT04344210,ClinicalTrials.gov,2020-04-07,2020-04-17,False,Federal University of Rio Grande do Sul,Recruiting,Not Applicable,Interventional,Brazil,Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus,Telehealth,Telehealth,Telehealth,149,https://clinicaltrials.gov/show/NCT04344210,None
496,947,NCT04344236,ClinicalTrials.gov,2020-04-08,2020-04-09,False,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19,Drug,Povidone Iodine,Povidone Iodine,48,https://clinicaltrials.gov/show/NCT04344236,None
497,948,NCT04344444,ClinicalTrials.gov,2020-04-10,2020-04-10,False,LCMC Health,Recruiting,Phase 3,Interventional,United States,Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin,600,https://clinicaltrials.gov/show/NCT04344444,None
498,949,NCT04344535,ClinicalTrials.gov,2020-04-10,2020-04-08,True,Stony Brook University,Recruiting,Phase 1/Phase 2,Interventional,United States,Convalescent Plasma vs. Standard Plasma for COVID-19,ATMP,Plasma,Plasma,500,https://clinicaltrials.gov/show/NCT04344535,None
499,950,NCT04344548,ClinicalTrials.gov,2020-04-10,2020-04-13,False,National University of Colombia,Not Recruiting,Phase 1/Phase 2,Interventional,Colombia,Phase I / II Clinical Study of Immunotherapy Based on Adoptive Cell Transfer as a Therapeutic Alternative for Patients With COVID-19 in Colombia,ATMP,Cells (NK),Cells (NK),10,https://clinicaltrials.gov/show/NCT04344548,None
500,951,NCT04344730,ClinicalTrials.gov,2020-04-09,2020-04-10,True,Assistance Publique  Hpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia,Drug,"Dexamethasone, Oxygen",Dexamethasone; Oxygen,550,https://clinicaltrials.gov/show/NCT04344730,EUCTR2020-001457-43
501,952,NCT04344756,ClinicalTrials.gov,2020-04-09,2020-04-20,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,"Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",Drug,Tinzaparin or Heparin,Tinzaparin; Heparin,808,https://clinicaltrials.gov/show/NCT04344756,None
502,953,NCT04344782,ClinicalTrials.gov,2020-04-09,2020-04-15,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,No Country Given,"Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin/Zeribev) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",Drug,Bevacizumab,Bevacizumab,130,https://clinicaltrials.gov/show/NCT04344782,None
503,958,NCT04345406,ClinicalTrials.gov,2020-04-11,2020-04-15,False,Tanta University,Not Recruiting,Phase 3,Interventional,Egypt,Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19,Drug,ACE inhibitors,ACE inhibitors,60,https://clinicaltrials.gov/show/NCT04345406,None
504,959,NCT04345445,ClinicalTrials.gov,2020-04-08,2020-04-15,False,University of Malaya,Not Recruiting,Phase 3,Interventional,Malaysia,Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression,Drug,Tocilizumab vs. Corticosteroids,Tocilizumab; Methylprednisolone,310,https://clinicaltrials.gov/show/NCT04345445,None
505,961,NCT04345523,ClinicalTrials.gov,2020-04-02,2020-04-03,False,Cristina Avendao-Sol,Recruiting,Phase 2,Interventional,Spain,Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients,ATMP,Plasma,Plasma,278,https://clinicaltrials.gov/show/NCT04345523,None
506,963,NCT04345549,ClinicalTrials.gov,2020-04-10,2020-02-26,True,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,18,https://clinicaltrials.gov/show/NCT04345549,None
507,965,NCT04345887,ClinicalTrials.gov,2020-04-10,2020-04-21,False,Istanbul University-Cerrahpasa,Not Recruiting,Phase 4,Interventional,Turkey,Spironolactone in Covid-19 Induced ARDS,Drug,Spironolactone,Spironolactone,60,https://clinicaltrials.gov/show/NCT04345887,None
508,966,NCT04346017,ClinicalTrials.gov,2020-04-13,2020-03-20,True,Francis Corazza,Recruiting,Not Applicable,Interventional,Belgium,Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04346017,None
509,972,NCT04346329,ClinicalTrials.gov,2020-04-10,2020-04-20,False,National University of Colombia,Not Recruiting,Phase 3,Interventional,Colombia,Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,86,https://clinicaltrials.gov/show/NCT04346329,None
510,974,NCT04346368,ClinicalTrials.gov,2020-03-23,2020-04-01,False,Guangzhou Institute of Respiratory Disease,Not Recruiting,Phase 1/Phase 2,Interventional,China,Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04346368,None
511,976,NCT04346927,ClinicalTrials.gov,2020-04-13,2020-04-10,True,Yasemin rak,Not Recruiting,Not Applicable,Interventional,No Country Given,Telerehabilitation for Patients Diagnosed With Coronavirus,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,30,https://clinicaltrials.gov/show/NCT04346927,None
512,977,NCT04346953,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Istinye University,Not Recruiting,Not Applicable,Interventional,No Country Given,Video-Based Exercise for Individuals With Social Isolation Due to Coronavirus (COVID-19),Other (exercise),Exercise,Exercise,128,https://clinicaltrials.gov/show/NCT04346953,None
513,983,NCT04347889,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Stony Brook University,Not Recruiting,Phase 2,Interventional,No Country Given,Preventing COVID-19 in Healthcare Workers With HCQ: A RCT,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Vitamin C,Hydroxychloroquine; Vitamin C,1212,https://clinicaltrials.gov/show/NCT04347889,None
514,984,NCT04347941,ClinicalTrials.gov,2020-04-08,2020-04-11,False,University College Hospital Galway,Not Recruiting,Not Applicable,Interventional,Ireland,Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE,Procedure,Positioning,Positioning,200,https://clinicaltrials.gov/show/NCT04347941,None
515,985,NCT04347980,ClinicalTrials.gov,2020-04-09,2020-04-01,True,Centre Chirurgical Marie Lannelongue,Recruiting,Phase 3,Interventional,France,Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19,Drug,Dexamethasone + Hydroxychloroquine vs. Hydroxychloroquine,Dexamethasone; Hydroxychloroquine,122,https://clinicaltrials.gov/show/NCT04347980,None
516,987,NCT04348383,ClinicalTrials.gov,2020-04-08,2020-04-08,False,Fundacin para la Formacin e Investigacin Sanitarias de la Regin de Murcia (FFIS),Recruiting,Phase 2,Interventional,Spain,Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.,Drug,Defibrotide,Defibrotide,120,https://clinicaltrials.gov/show/NCT04348383,None
517,991,NCT04348461,ClinicalTrials.gov,2020-04-10,2020-04-06,True,Instituto de Investigacin Sanitaria Fundacin Jimenez Diaz,Not Recruiting,Phase 2,Interventional,No Country Given,BAttLe Against COVID-19 Using MesenchYmal Stromal Cells,ATMP,Cells (mesenchymal),Cells (mesenchymal),100,https://clinicaltrials.gov/show/NCT04348461,None
518,992,NCT04348695,ClinicalTrials.gov,2020-04-13,2020-04-12,False,La Fundacin de Investigacin HM,Recruiting,Phase 2,Interventional,Spain,Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.,Drug,Ruxolitinib + Simvastatin,Ruxolitinib; Simvastatin,94,https://clinicaltrials.gov/show/NCT04348695,EUCTR2020-001405-23
519,993,NCT04348864,ClinicalTrials.gov,2020-04-13,2020-04-16,False,Neuroganics LLC,Recruiting,Not Applicable,Interventional,United States,COVID-19 Antibody Self-testing Using Virtual Point-of-care,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04348864,None
520,994,NCT04348877,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Ain Shams University,Not Recruiting,Not Applicable,Interventional,Egypt,Plasma Rich Antibodies From Recovered Patients From COVID19,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04348877,None
521,995,NCT04349371,ClinicalTrials.gov,2020-04-12,2020-04-01,True,Columbia University,Recruiting,Phase 2,Interventional,United States,Saved From COVID-19,Drug (Chemoprophylaxis),Chloroquine,Chloroquine,350,https://clinicaltrials.gov/show/NCT04349371,None
522,996,NCT04349410,ClinicalTrials.gov,2020-04-11,2020-04-11,False,The Camelot Foundation,Recruiting,Phase 2/Phase 3,Interventional,United States,The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol,Drug (+ ATMP),Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Doxycycline vs. Hydroxychloroquine + Clindamycin vs. Hydroxychloroquine  + Clindamycin + Primaquine vs. Remdesivir vs. Tocilizumab vs. Corticosteroids vs. Interferon alpha vs. Losartan vs. Plasma,Hydroxychloroquine;  Azithromycin;  Doxycycline; Clindamycin; Primaquine; Remdesivir; Tocilizumab; Corticosteroids; Interferon alpha; Losartan; Plasma,500,https://clinicaltrials.gov/show/NCT04349410,None
523,997,NCT04349618,ClinicalTrials.gov,2020-04-08,2020-04-14,False,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Interventional,France,Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia,Other (physical),Mechanical ventilation,Mechanical ventilation,200,https://clinicaltrials.gov/show/NCT04349618,None
524,999,NCT04350086,ClinicalTrials.gov,2020-04-13,2020-04-20,False,"University Hospital, Limoges",Not Recruiting,Phase 4,Interventional,France,Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection,Drug,Dexmedetomidine,Dexmedetomidine,10,https://clinicaltrials.gov/show/NCT04350086,None
525,1001,NCT04350281,ClinicalTrials.gov,2020-04-13,2020-04-09,True,University of Hong Kong,Recruiting,Phase 2,Interventional,Hong Kong,Double Therapy With IFN-beta 1b and Hydroxychloroquine,Drug,Interferon beta + Hydroxychloroquine vs. Hydroxychloroquine,Interferon beta; Hydroxychloroquine,80,https://clinicaltrials.gov/show/NCT04350281,None
526,1002,NCT04350671,ClinicalTrials.gov,2020-04-14,2020-04-15,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Interferon Beta 1a in Hospitalized COVID-19 Patients,Drug,Interferon beta + Lopinavir/Ritonavir + Hydroxychlroquine vs. Lopinavir/Ritonavir + Hydroxychloroquine,Interferon beta; Lopinavir/Ritonavir; Hydroxychloroquine,40,https://clinicaltrials.gov/show/NCT04350671,None
527,1003,NCT04350684,ClinicalTrials.gov,2020-04-14,2020-04-15,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Umifenovir in Hospitalized COVID-19 Patients,Drug,Umifenovir + Interferon beta + Lopinavir/Ritonavir + Hydroxychloroquine vs. Interferon beta + Lopinavir/Ritonavir + Hydroxycholroquine,Umifenovir; Interferon beta; Lopinavir/Ritonavir; Hydroxychloroquine,40,https://clinicaltrials.gov/show/NCT04350684,None
528,1004,NCT04350931,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Ain Shams University,Not Recruiting,Phase 3,Interventional,Egypt,Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19,ATMP,Vaccine,Vaccine,900,https://clinicaltrials.gov/show/NCT04350931,None
529,1005,NCT04351295,ClinicalTrials.gov,2020-04-15,2020-04-17,False,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,Efficacy of Faviprevir in COVID-19 Treatment,Drug,Favipiravir,Favipiravir,40,https://clinicaltrials.gov/show/NCT04351295,None
530,1006,NCT04351490,ClinicalTrials.gov,2020-04-14,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Interventional,No Country Given,Impact of Zinc and Vitamin D3 Supplementation on the Survival of Aged Patients Infected With COVID-19,Drug,Zinv + Vitamin D,Zinc; Vitamin D,3140,https://clinicaltrials.gov/show/NCT04351490,None
531,1008,NCT04351542,ClinicalTrials.gov,2020-04-14,2020-03-06,True,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda for Flu Like Illness During Covid-19 Outbreak,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,32,https://clinicaltrials.gov/show/NCT04351542,None
532,1009,NCT04351620,ClinicalTrials.gov,2020-04-14,2020-04-01,True,University of Chicago,Recruiting,Phase 1,Interventional,United States,High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,20,https://clinicaltrials.gov/show/NCT04351620,None
533,1013,NCT04351763,ClinicalTrials.gov,2020-04-14,2020-04-27,False,Nicolaus Copernicus University,Recruiting,Phase 2/Phase 3,Interventional,Poland,Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms,Drug,Amiodarone or Verapamil,Amiodarone; Verapamil,804,https://clinicaltrials.gov/show/NCT04351763,None
534,1014,NCT04351789,ClinicalTrials.gov,2020-04-11,2020-04-01,True,"Copenhagen University Hospital, Hvidovre",Not Recruiting,Not Applicable,Interventional,No Country Given,Impact of a Minimal Psychoeducational Intervention on Anxiety Among Hospitalized COVID-19 Patients in Denmark,Other (psych),Psychological,Psychological,66,https://clinicaltrials.gov/show/NCT04351789,None
535,1016,NCT04352400,ClinicalTrials.gov,2020-04-03,2020-04-01,True,University Hospital Padova,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy of Nafamostat in Covid-19 Patients (RACONA Study),Drug,Nafamostat,Nafamostat,256,https://clinicaltrials.gov/show/NCT04352400,None
536,1019,NCT04352803,ClinicalTrials.gov,2020-04-16,2020-04-01,True,Regeneris Medical,Not Recruiting,Phase 1,Interventional,No Country Given,Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04352803,None
537,1020,NCT04352959,ClinicalTrials.gov,2020-04-15,2020-04-27,False,Claude Bernard University,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses,Drug,Bta-cyclodextrin + citrox,Bta-cyclodextrin; citrox,178,https://clinicaltrials.gov/show/NCT04352959,None
538,1022,NCT04354155,ClinicalTrials.gov,2020-04-13,2020-05-15,False,Neil Goldenberg,Not Recruiting,Phase 2,Interventional,United States,COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial,Drug,Heparin,Heparin,38,https://clinicaltrials.gov/show/NCT04354155,None
539,1028,NCT04355026,ClinicalTrials.gov,2020-04-15,2020-04-10,True,Celje General Hospital,Recruiting,Phase 4,Interventional,Slovenia,Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia,Drug,Bromhexine + Hydroxychloroquine vs. Hydroxychloroquine,Bromhexine; Hydroxychloroquine,90,https://clinicaltrials.gov/show/NCT04355026,None
540,1029,NCT04355247,ClinicalTrials.gov,2020-04-17,2020-04-14,True,Auxilio Mutuo Cancer Center,Recruiting,Phase 2,Interventional,Puerto Rico,Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm,Drug (Chemoprophylaxis),Corticosteroids,Methylprednisolone,20,https://clinicaltrials.gov/show/NCT04355247,None
541,1031,NCT04355676,ClinicalTrials.gov,2020-04-17,2020-04-30,False,Karyopharm Therapeutics Inc,Not Recruiting,Phase 2,Interventional,No Country Given,Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19,Drug,Selinexor,Selinexor,80,https://clinicaltrials.gov/show/NCT04355676,None
542,1035,NCT04356508,ClinicalTrials.gov,2020-04-10,2020-04-14,False,Dr. Gerry Gin Wai Kwok,Not Recruiting,Phase 2,Interventional,No Country Given,COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1,Drug,Nivolumab,Nivolumab,15,https://clinicaltrials.gov/show/NCT04356508,None
543,1039,ACTRN12620000417987,ANZCTR,2020-03-30,2020-03-30,False,Australian Defence Force Malaria and Infectious Disease Institute,Recruiting,Phase 4,Interventional,Australia,Chloroquine Chemorophylaxis Countermeasure against COVID-19,Drug,Chloroquine,Chloroquine,680,https://anzctr.org.au/ACTRN12620000417987.aspx,None
544,1041,ACTRN12620000457943,ANZCTR,2020-04-08,2020-04-14,False,Medical Research Institute of New Zealand,Not Recruiting,Phase 2,Interventional,New Zealand,Hydroxychloroquine for the Community-Based Treatment of COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,70,https://anzctr.org.au/ACTRN12620000457943.aspx,None
545,1042,ACTRN12620000492954,ANZCTR,2020-04-20,2020-05-01,False,University of New South Wales,Not Recruiting,Not Applicable,Interventional,Australia,A Facebook delivered physical activity focused group lifestyle intervention for older adults during the COVID-19 pandemic,Other (exercise),Exercise,Exercise,20,https://anzctr.org.au/ACTRN12620000492954.aspx,None
546,1043,ACTRN12620000482965,ANZCTR,2020-04-17,2020-03-17,True,Juan Pedro Fuentes Garca,Not Recruiting,Not Applicable,Interventional,Spain,"Impact of high intensity interval training and aerobic training on stress, depression symptoms, anxiety and resilience in self-isolated people during the COVID-19 health emergency in Spain",Other (exercise),Exercise,Exercise,34,https://anzctr.org.au/ACTRN12620000482965.aspx,None
547,1047,ChiCTR2000032400,ChiCTR,2020-04-27,2020-01-01,True,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Recruiting,Not Applicable,Interventional,China,"the efficacy and safety of high dose intravenous vitamin C in the treatment of novel coronavirus pneumonia (COVID-19): a prospective, randomize, controlled trial",Drug,Vitamin C,Vitamin C,120,http://www.chictr.org.cn/showproj.aspx?proj=52958,None
548,1048,ChiCTR2000032399,ChiCTR,2020-04-27,2020-04-20,True,Xiaogan Traditional Chinese Medicine Hospital,Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, double-blind, placebo-controlled trial for Xiaoyao capsule in the improvement of sleep mood disorder of convalescence patients of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=52942,None
549,1050,ChiCTR2000032367,ChiCTR,2020-04-26,2020-02-19,True,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Recruiting,Not Applicable,Interventional,China,Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19):  a randomized controlled trial,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,186,http://www.chictr.org.cn/showproj.aspx?proj=52972,None
550,1051,ChiCTR2000032346,ChiCTR,2020-04-26,2020-04-21,True,The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"Lingnan Fire-Needle Therapy Improves the Quality of Life in General Population Under the Pandemic of novel coronavirus pneumonia (COVID-19): A Prospective, Randomized Controlled Trial",Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=52692,None
551,1052,ChiCTR2000032314,ChiCTR,2020-04-25,2020-03-01,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Interventional,China,A randomized clinical trial for the efficacy and safety of Aliskiren and Nifedipine in novel coronavirus pneumonia (COVID-19) patients with hypertension,Drug,Aliskiren vs. Nifedipine,Aliskiren; Nifedipine,242,http://www.chictr.org.cn/showproj.aspx?proj=52867,None
552,1053,ChiCTR2000032313,ChiCTR,2020-04-25,2020-05-01,False,"Beijing University of Chinese Medicine, Third Affiliated Hospital",Not Recruiting,Not Applicable,Interventional,China,Study for efficacy and safety of Jie-Xing-Jun-Zi granules in the Treatment of convalescent patients of novel coronavious pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=52916,None
553,1054,ChiCTR2000032242,ChiCTR,2020-04-24,2020-04-24,False,Mudanjiang Kang'an Hospital,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, open, controlled trial for the efficacy and safety of oral kolimycin in the treatment of patients with new coronavirus pneumonia (CoVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,350,http://www.chictr.org.cn/showproj.aspx?proj=52824,None
554,1056,ChiCTR2000032237,ChiCTR,2020-04-23,2020-04-01,True,Ezhou Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,No Country Given,"A multicenter, randomized, double-blind, placebo-controlled trial for Xiang-Sha-Liu-Jun Pill in the treatment of novel coronavirus pneumonia (COVID-19) decline in digestive function during convalescence",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=52699,None
555,1058,ChiCTR2000032214,ChiCTR,2020-04-23,2020-05-01,False,Hubei Hospital of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Screening of proprietary Chinese medicines in convalescent rehabilitation of novel coronavirus pneumonia (COVID-19) convalescent patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=52781,None
556,1060,ChiCTR2000032205,ChiCTR,2020-04-23,2020-04-15,True,Wuhan Hospital Of Traditional Chinese and Western Medicine,Not Recruiting,Not Applicable,Interventional,China,"A multicenter randomized, double-blind, placebo-controlled trial for Sheng-Mai-Yin for improvement of the pulmonary heart function related symptoms of convalescence patients of new coronavirus pneumonia",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=52662,None
557,1061,ChiCTR2000032165,ChiCTR,2020-04-21,2020-04-25,False,Hubei Hospital of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, double-blind, parallel-controlled trial for Qi-Mai-Fei-Luo-Ping Mixture in the improvement of lung function of novel coronavirus pneumonia (COVID-19) in the convalescent period",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=52679,None
558,1067,ISRCTN16912075,ISRCTN,2020-04-06,2020-04-06,False,University of Warwick,Recruiting,Not Applicable,Interventional,United Kingdom,"RECOVERY Respiratory Support: Respiratory Strategies in patients with coronavirus COVID-19  CPAP, high-flow nasal oxygen, and standard care",Drug,Oxygen,Oxygen,4002,http://isrctn.com/ISRCTN16912075,None
559,1070,EUCTR2020-001391-15-IE,EU Clinical Trials Register,2020-03-31,2020-04-24,False,Royal College of Surgeons Ireland,Authorised,Phase 2,Interventional,Ireland,A randomized double-blind placebo-controlled trial of intravenous plasma-purified alpha-1 antitrypsin for severe COVID-19 illness.,ATMP,Alpha-1-proteinase inhibitor,Alpha-1-proteinase inhibitor,36,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001391-15,None
560,1071,EUCTR2020-001329-30-AT,EU Clinical Trials Register,2020-04-03,2020-04-09,False,Massachusetts General Hospital,Authorised,Phase 4,Interventional,"United States, China, Austria",Therapy with Inhaled Nitric Oxide for Patients Infected with Coronavirus Suffering form Lung Failure,Drug,Nitric oxide,Nitric oxide,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001329-30,None
561,1072,EUCTR2020-001527-14-NL,EU Clinical Trials Register,2020-04-06,2020-04-21,False,Erasmus MC,Authorised,Phase 4,Interventional,Netherlands,COVID-19: addition of azithromycin to chloroquine treatment,Drug,Chloroquine + Azithromycin,Chloroquine; Azithromycin,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001527-14,None
562,1074,EUCTR2020-001255-40-ES,EU Clinical Trials Register,2020-04-20,2020-04-16,True,Clnica Universidad de Navarra,Authorised,Phase 2,Interventional,Spain,Sarilumab Treatment In cytoKinE storm caused by infection with COVID-19.,Drug,Sarilumab,Sarilumab,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001255-40,None
563,1075,EUCTR2020-001659-42-ES,EU Clinical Trials Register,2020-04-20,2020-04-18,True,Fundacin para la Investigacin Biomdica de Crdoba,Authorised,Phase 2,Interventional,Spain,Study of antithrombin as prophylaxis of acute respiratory disease in patients with COVID-19,Drug (Chemoprophylaxis),Antithrombin,Antithrombin,46,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001659-42,None
564,1076,EUCTR2020-001622-64-ES,EU Clinical Trials Register,2020-04-20,2020-04-19,True,Dr. Ana Pueyo Bastida,Authorised,Phase 4,Interventional,Spain,OUTPATIENT TREATMENT OF COVID-19 WITH EARLY PULMONARY CORTICOSTEROIDS AS AN OPPORTUNITY TO MODIFY THE COURSE OF THE DISEASE,Drug,Corticosteroids,Prednisone,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001622-64,None
565,1077,EUCTR2020-001440-26-ES,EU Clinical Trials Register,2020-04-20,2020-04-19,True,Fundacin Pblica Andaluza para la Gestin de la Investigacin en Salud de Sevilla (FISEVI),Authorised,Phase 3,Interventional,Spain,Study for the prevention of COVID-19 infection in healthcare personnel,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,184,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001440-26,None
566,1078,EUCTR2020-001327-13-AT,EU Clinical Trials Register,2020-03-30,2020-04-14,False,Medical University of Vienna,Authorised,Phase 2,Interventional,Austria,"A SINGLE-BLINDED RANDOMIZED, PLACEBO-CONTROLLED PHASE II TRIAL OF PROPHYLACTIC TREATMENT WITH ORAL AZITHROMYCIN VERSUS PLACEBO IN CANCER PATIENTS UNDERGOING ANTINEOPLASTIC TREATMENT DURING THE COVID-19 PANDEMIC",Drug,Azithromycin,Azithromycin,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001327-13,None
567,1079,EUCTR2020-001459-42-DK,EU Clinical Trials Register,2020-04-14,2020-04-22,False,Zealand University Hospital,Authorised,Phase 2,Interventional,Denmark,"Ruxolitinib Treatment in Patients with Severe COVID-19 Infection. A Danish Safety and Efficacy Study.
",Drug,Ruxolitinib,Ruxolitinib,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001459-42,None
568,1080,EUCTR2020-001417-21-BE,EU Clinical Trials Register,2020-04-01,2020-04-12,False,Institute of Tropical Medicine,Authorised,Phase 2,Interventional,Belgium,An open label single center randomized controlled trial to evaluate the effect of hydroxychloroquine on viral shedding in mild COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,206,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001417-21,None
569,1081,EUCTR2020-001500-41-BE,EU Clinical Trials Register,2020-04-04,2020-04-03,True,"University Hospital, Ghent",Authorised,Phase 3,Interventional,Belgium,Treatment of COVID-19 patients with anti-interleukin drugs,Drug,Anakinra or tocilizumab or siltuximab,Anakinra; tocilizumab; siltuximab,342,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001500-41,None
570,1084,NCT04318444,ClinicalTrials.gov,2020-03-20,2020-03-29,False,Columbia University,Recruiting,Phase 2/Phase 3,Interventional,United States,Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1600,https://clinicaltrials.gov/show/NCT04318444,None
571,1086,NCT04319445,ClinicalTrials.gov,2020-03-20,2020-03-22,False,Wake Forest University,Recruiting,Not Applicable,Interventional,United States,Mindfulness During COVID-19,Other (psych),Psychological,Psychological,200,https://clinicaltrials.gov/show/NCT04319445,None
572,1088,NCT04320056,ClinicalTrials.gov,2020-03-19,2020-04-20,False,Laval University,Recruiting,Not Applicable,Interventional,Canada,Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19),Drug,Oxygen,Oxygen,216,https://clinicaltrials.gov/show/NCT04320056,None
573,1091,NCT04326920,ClinicalTrials.gov,2020-03-24,2020-03-24,False,"University Hospital, Ghent",Recruiting,Phase 4,Interventional,"Belgium, Italy",Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC),Drug,Sargramostim,Sargramostim,80,https://clinicaltrials.gov/show/NCT04326920,None
574,1093,NCT04329572,ClinicalTrials.gov,2020-03-29,2020-04-23,False,Azidus Brasil,Not Recruiting,Phase 1,Interventional,Brazil,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,400,https://clinicaltrials.gov/show/NCT04329572,None
575,1095,NCT04330638,ClinicalTrials.gov,2020-03-31,2020-04-01,False,"University Hospital, Ghent",Recruiting,Phase 3,Interventional,Belgium,Treatment of COVID-19 Patients With Anti-interleukin Drugs,Drug,Anakinta + Siltuximab vs. Tocilizumab + Anakinra vs. Tocilizumab vs. Siltuximab vs. Anakinra,Anakinra; Siltuximab; Tocilizumab,342,https://clinicaltrials.gov/show/NCT04330638,None
576,1096,NCT04331808,ClinicalTrials.gov,2020-03-31,2020-03-30,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI),Drug,Tocilizumab,Tocilizumab,228,https://clinicaltrials.gov/show/NCT04331808,None
577,1097,NCT04332380,ClinicalTrials.gov,2020-03-30,2020-05-01,False,Del Rosario University,Not Recruiting,Phase 2,Interventional,Colombia,Convalescent Plasma for Patients With COVID-19: A Pilot Study,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04332380,None
578,1098,NCT04332835,ClinicalTrials.gov,2020-03-31,2020-05-01,False,Del Rosario University,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,"Convalescent Plasma for Patients With COVID-19: A Randomized, Open Label, Parallel, Controlled Clinical Study",ATMP (+ Drug),Plasma + Hydroxychloroquine vs. Hydroxychloroquine,Plasma; Hydroxychloroquine,80,https://clinicaltrials.gov/show/NCT04332835,None
579,1099,NCT04333589,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Peking University First Hospital,Recruiting,Not Applicable,Interventional,China,Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive,Drug,Favipiravir,Favipiravir,210,https://clinicaltrials.gov/show/NCT04333589,None
580,1100,NCT04334265,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Peking University First Hospital,Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,750,https://clinicaltrials.gov/show/NCT04334265,None
581,1102,NCT04334980,ClinicalTrials.gov,2020-03-31,2020-04-30,False,Symvivo Corporation,Not Recruiting,Phase 1,Interventional,Canada,"Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19",ATMP,Vaccine,Vaccine,84,https://clinicaltrials.gov/show/NCT04334980,None
582,1103,NCT04335032,ClinicalTrials.gov,2020-04-01,2020-04-13,False,S.L.A. Pharma AG,Not Recruiting,Phase 3,Interventional,No Country Given,EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2),Drug,Eicosapentaenoic acid,Eicosapentaenoic acid,240,https://clinicaltrials.gov/show/NCT04335032,None
583,1104,NCT04335123,ClinicalTrials.gov,2020-03-31,2020-03-25,True,University of Kansas Medical Center,Recruiting,Phase 1,Interventional,United States,Study of Open Label Losartan in COVID-19,Drug,ARB (Losartan),ARB (Losartan),50,https://clinicaltrials.gov/show/NCT04335123,None
584,1105,NCT04337008,ClinicalTrials.gov,2020-04-03,2020-04-03,False,Assistance Publique  Hpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,Renin Angiotensin System - CoronaVirus,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04337008,None
585,1106,NCT04338009,ClinicalTrials.gov,2020-04-01,2020-03-31,True,University of Pennsylvania,Recruiting,Not Applicable,Interventional,United States,Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,152,https://clinicaltrials.gov/show/NCT04338009,None
586,1107,NCT04339712,ClinicalTrials.gov,2020-04-01,2020-04-02,True,Hellenic Institute for the Study of Sepsis,Recruiting,Phase 2,Interventional,Greece,Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction,Drug,Anakinra or Tocilizumab,Anakinra; Tocilizumab,40,https://clinicaltrials.gov/show/NCT04339712,EUCTR2020-001039-29
587,1108,NCT04341493,ClinicalTrials.gov,2020-04-07,2020-04-06,True,Hugo Mendieta Zeron,Recruiting,Phase 4,Interventional,Mexico,Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19,Drug,Hydroxychloroquine vs. Nitazoxanide,Hydroxychloroquine; nitazoxanide,86,https://clinicaltrials.gov/show/NCT04341493,None
588,1109,NCT04344184,ClinicalTrials.gov,2020-04-09,2020-06-01,False,Virginia Commonwealth University,Not Recruiting,Phase 2,Interventional,United States,Early Infusion of Vitamin C for Treatment of Novel COVID-19 Acute Lung Injury (EVICT-CORONA-ALI),Drug,Vitamin C,Vitamin C,200,https://clinicaltrials.gov/show/NCT04344184,None
589,1111,NCT04344431,ClinicalTrials.gov,2020-04-09,2020-04-14,False,Direction Centrale du Service de Sant des Armes,Recruiting,Phase 2/Phase 3,Interventional,France,Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19),Drug,Oxygen,Oxygen,100,https://clinicaltrials.gov/show/NCT04344431,None
590,1112,NCT04345601,ClinicalTrials.gov,2020-04-10,2020-05-01,False,Baylor University,Not Recruiting,Phase 1,Interventional,United States,Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease),ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04345601,None
591,1113,NCT04345679,ClinicalTrials.gov,2020-04-11,2020-04-14,False,Orthosera Kft.,Not Recruiting,Phase 1,Interventional,No Country Given,Anti COVID-19 Convalescent Plasma Therapy,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04345679,None
592,1115,NCT04346797,ClinicalTrials.gov,2020-04-06,2020-04-16,False,Assistance Publique  Hpitaux de Paris,Recruiting,Phase 2,Interventional,France,"CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort",Drug,Eculizumab,Eculizumab,120,https://clinicaltrials.gov/show/NCT04346797,None
593,1118,NCT04348474,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Azidus Brasil,Not Recruiting,Phase 1,Interventional,Brazil,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19,Drug,Hydroxychloroquine + Azithromycin ,Hydroxychloroquine; Azithromycin ,200,https://clinicaltrials.gov/show/NCT04348474,None
594,1119,NCT04348929,ClinicalTrials.gov,2020-04-10,2020-04-16,False,CHU de Nancy,Recruiting,Not Applicable,Interventional,France,Birth Experience During COVID-19 Confinement,Clinical Presentation,No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04348929,None
595,1121,NCT04350580,ClinicalTrials.gov,2020-04-08,2020-04-11,True,Centre Hospitalier St. Anne,Recruiting,Phase 3,Interventional,France,Polyvalent Immunoglobulin in COVID-19 Related ARds,ATMP,Immunoglobulin,Immunoglobulin,138,https://clinicaltrials.gov/show/NCT04350580,EUCTR2020-001570-30
596,1122,NCT04351724,ClinicalTrials.gov,2020-04-10,2020-04-16,True,Medical University of Vienna,Recruiting,Phase 2/Phase 3,Interventional,Austria,Austrian CoronaVirus Adaptive Clinical Trial (COVID-19),Drug,"Chloroquine or Hydroxychloroquine vs. lopinavir/ritonavir

Substudies: Rovaroxaban, Clazakizumab, Candesartan",Chloroquine; Hydroxychloroquine; Lopinavir/Ritonavir; Rovaroxaban; Clazakizumab; Candesartan,500,https://clinicaltrials.gov/show/NCT04351724,EUCTR2020-001302-30
597,1124,NCT04352608,ClinicalTrials.gov,2020-04-14,2020-04-16,False,"Sinovac Research and Development Co., Ltd.",Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19),ATMP,Vaccine,Vaccine,744,https://clinicaltrials.gov/show/NCT04352608,None
598,1126,NCT04352946,ClinicalTrials.gov,2020-04-16,2020-04-24,False,GeoSentinel Foundation,Not Recruiting,Phase 3,Interventional,United States,HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,374,https://clinicaltrials.gov/show/NCT04352946,None
599,1127,NCT04353037,ClinicalTrials.gov,2020-04-09,2020-04-07,True,UnitedHealth Group,Recruiting,Phase 2,Interventional,United States,PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine,Drug,Hydroxychloroquine,Hydroxychloroquine,850,https://clinicaltrials.gov/show/NCT04353037,None
600,1128,NCT04353518,ClinicalTrials.gov,2020-04-16,2020-04-30,False,Cadila Pharnmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19,Drug,Mycobacterium,Mycobacterium,4000,https://clinicaltrials.gov/show/NCT04353518,None
601,1130,NCT04354870,ClinicalTrials.gov,2020-04-16,2020-04-03,True,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,COVID-19 PrEP HCW HCQ Study,Drug,Hydroxychloroquine,Hydroxychloroquine,350,https://clinicaltrials.gov/show/NCT04354870,None
602,1131,NCT04355052,ClinicalTrials.gov,2020-04-16,2020-04-11,True,Sheba Medical Center,Recruiting,Phase 3,Interventional,Israel,"Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to ""no Treatment"" in SARS CoV 2 Virus",Drug,Camostat Mesilate + Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,Camostat Mesilate; Hydroxychloroquine; Azithromycin,250,https://clinicaltrials.gov/show/NCT04355052,None
603,1132,NCT04355234,ClinicalTrials.gov,2020-04-17,2020-04-24,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,"Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns",Clinical Presentation (Epidemiology),No Intervention,No Intervention,2200,https://clinicaltrials.gov/show/NCT04355234,None
604,1134,NCT04355429,ClinicalTrials.gov,2020-04-17,2020-05-05,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID),Drug,Captopril,Captopril,230,https://clinicaltrials.gov/show/NCT04355429,None
605,1138,NCT04355754,ClinicalTrials.gov,2020-04-16,2020-04-15,True,Medical University of Gdask,Recruiting,Not Applicable,Interventional,Poland,Ventil Device Usefulness in Mechanically Ventilated ICU Patients,Other (physical),Mechanical ventilation,Mechanical ventilation,40,https://clinicaltrials.gov/show/NCT04355754,None
606,1141,NCT04355962,ClinicalTrials.gov,2020-03-26,2020-04-23,False,University of Zurich,Recruiting,Phase 3,Interventional,Switzerland,Sevoflurane in COVID-19 ARDS (SevCov),Drug,Sevoflurane,Sevoflurane,64,https://clinicaltrials.gov/show/NCT04355962,None
607,1145,NCT04356677,ClinicalTrials.gov,2020-04-20,2020-04-01,True,"Bausch Health Americas, Inc.",Not Recruiting,Phase 1,Interventional,No Country Given,Study to Evaluate the Safety and Efficacy of VIRAZOLE in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19,Drug,Ribavirin,Ribavirin,50,https://clinicaltrials.gov/show/NCT04356677,None
608,1146,NCT04357106,ClinicalTrials.gov,2020-04-14,2020-04-13,True,Centro de Hematologia y Medicina Interna,Recruiting,Phase 2,Interventional,Mexico,COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04357106,None
609,1147,NCT04357327,ClinicalTrials.gov,2020-04-15,2020-04-16,False,Universit Libre de Bruxelles,Recruiting,Not Applicable,Interventional,Italy,Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04357327,None
610,1148,NCT04357366,ClinicalTrials.gov,2020-04-20,2020-04-15,True,Hellenic Institute for the Study of Sepsis,Recruiting,Phase 2,Interventional,Greece,suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE),Drug,Anakinra + trimethoprim/sulfamethoxazole,Anakinra; trimethoprim; sulfamethoxazole,100,https://clinicaltrials.gov/show/NCT04357366,EUCTR2020-001466-11
611,1152,NCT04357613,ClinicalTrials.gov,2020-04-20,2020-05-01,False,Versailles Hospital,Not Recruiting,Phase 2,Interventional,France,IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS.,Drug,Imatinib,Imatinib,99,https://clinicaltrials.gov/show/NCT04357613,None
612,1153,NCT04357782,ClinicalTrials.gov,2020-04-17,2020-04-16,True,Veteran Affairs Medical Center,Recruiting,Phase 1/Phase 2,Interventional,United States,Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation,Drug,Vitamin C,Vitamin C,20,https://clinicaltrials.gov/show/NCT04357782,None
613,1154,NCT04357808,ClinicalTrials.gov,2020-04-14,2020-04-13,True,Maria del Rosario Garcia de Vicua Pinedo,Recruiting,Phase 2,Interventional,Spain,Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID),Drug,Sarilumab,Sarilumab,30,https://clinicaltrials.gov/show/NCT04357808,EUCTR2020-001634-36
614,1156,NCT04357860,ClinicalTrials.gov,2020-04-20,2020-04-27,True,Maimonides Biomedical Research Institute of Cordoba,Not Recruiting,Phase 2,Interventional,Spain,Clinical Trial of Sarilumab in Adults With COVID-19,Drug,Sarilumab,Sarilumab,120,https://clinicaltrials.gov/show/NCT04357860,EUCTR2020-001531-27
615,1160,NCT04358406,ClinicalTrials.gov,2020-04-16,2020-06-01,False,BioAegis Therapeutics Inc.,Not Recruiting,Phase 2,Interventional,No Country Given,Rhu-pGSN for Severe Covid-19 Pneumonia,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04358406,None
616,1163,NCT04358614,ClinicalTrials.gov,2020-04-19,2020-03-16,True,Fabrizio Cantini,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,Baricitinib Therapy in COVID-19,Drug,Baricitinib,Baricitinib,12,https://clinicaltrials.gov/show/NCT04358614,None
617,1166,NCT04358809,ClinicalTrials.gov,2020-04-21,2020-04-30,False,Cadila Pharnmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,"Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill",Drug,Mycobacterium,Mycobacterium,480,https://clinicaltrials.gov/show/NCT04358809,None
618,1167,NCT04359095,ClinicalTrials.gov,2020-04-15,2020-05-11,False,National University of Colombia,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Lopinavir/Ritonavir vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin; Lopinavir/Ritonavir,1600,https://clinicaltrials.gov/show/NCT04359095,None
619,1168,NCT04359251,ClinicalTrials.gov,2020-04-13,2020-03-05,True,"Southeast University, China",Not Recruiting,Not Applicable,Interventional,China,Different PEEP Settings of COVID-19 Induced ARDS,Other (physical),Mechanical ventilation,Mechanical ventilation,20,https://clinicaltrials.gov/show/NCT04359251,None
620,1169,NCT04359290,ClinicalTrials.gov,2020-04-15,2020-05-01,False,Philipps University Marburg Medical Center,Not Recruiting,Phase 2,Interventional,No Country Given,Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS,Drug,Ruxolitinib,Ruxolitinib,15,https://clinicaltrials.gov/show/NCT04359290,None
621,1170,NCT04359316,ClinicalTrials.gov,2020-04-18,2020-04-20,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 4,Interventional,Iran,Azithromycin in Hospitalized COVID-19 Patients,Drug,Azithromycin vs. Hydroxychloroquine,Azithromycin; Hydroxychloroquine,40,https://clinicaltrials.gov/show/NCT04359316,None
622,1171,NCT04359329,ClinicalTrials.gov,2020-04-21,2020-04-20,True,Sharon Nachman,Recruiting,Phase 2,Interventional,United States,Estrogen Patch for COVID-19 Symptoms,Drug,Estradiol,Estradiol,110,https://clinicaltrials.gov/show/NCT04359329,None
623,1173,NCT04359615,ClinicalTrials.gov,2020-04-18,2020-04-20,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 4,Interventional,Iran,Favipiravir in Hospitalized COVID-19 Patients,Drug,Favipiravir + Hydroxychloroquine vs. Hydroxychloroquine,Favipiravir; Hydroxychloroquine,40,https://clinicaltrials.gov/show/NCT04359615,None
624,1176,NCT04359875,ClinicalTrials.gov,2020-04-18,2020-04-01,True,CHU de Tours,Not Recruiting,Not Applicable,Interventional,France,A Phone-call With a Student/General Practitioner Team to Impact Morbidity of Chronic Patients During COVID-19 Containment,Telehealth,Telehealth,Telehealth,22000,https://clinicaltrials.gov/show/NCT04359875,None
625,1178,NCT04359953,ClinicalTrials.gov,2020-04-17,2020-04-24,True,"University Hospital, Strasbourg",Not Recruiting,Phase 3,Interventional,France,"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19",Drug,Hydroxychloroquine + Telmisartan + Azithromycin,Hydroxychloroquine; Telmisartan; Azithromycin,1600,https://clinicaltrials.gov/show/NCT04359953,EUCTR2020-001303-16
626,1180,NCT04360096,ClinicalTrials.gov,2020-04-21,2020-06-01,False,"NeuroRx, Inc.",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Inhaled Aviptadil for the Treatment of Non-Acute Lung Injury in COVID-19,Drug,Aviptadil,Aviptadil,144,https://clinicaltrials.gov/show/NCT04360096,None
627,1181,NCT04360356,ClinicalTrials.gov,2020-04-19,2020-05-01,False,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Ivermectin and Nitazoxanide Combination Therapy for COVID-19,Drug,Ivermectin + Nitazoxanide,Ivermectin; Nitazoxanide,100,https://clinicaltrials.gov/show/NCT04360356,None
628,1184,NCT04360551,ClinicalTrials.gov,2020-04-21,2020-07-01,False,University of Hawaii,Not Recruiting,Phase 2,Interventional,United States,Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients,Drug,Telmisartan,Telmisartan,40,https://clinicaltrials.gov/show/NCT04360551,None
629,1186,NCT04360759,ClinicalTrials.gov,2020-04-22,2020-05-01,False,University of Cape Town,Not Recruiting,Phase 3,Interventional,South Africa,Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19,Drug,Chloroquine or hydroxychloroquine,Chloroquine; hydroxychloroquine,560,https://clinicaltrials.gov/show/NCT04360759,None
630,1187,NCT04360811,ClinicalTrials.gov,2020-04-22,2020-04-17,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,"Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,3600,https://clinicaltrials.gov/show/NCT04360811,None
631,1190,NCT04360876,ClinicalTrials.gov,2020-04-22,2020-05-01,False,"University of Colorado, Denver",Not Recruiting,Phase 2,Interventional,No Country Given,Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial,Drug,Corticosteroids,Dexamethasone,90,https://clinicaltrials.gov/show/NCT04360876,None
632,1192,NCT04360980,ClinicalTrials.gov,2020-04-22,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection,Drug,Colchicine,Colchicine,80,https://clinicaltrials.gov/show/NCT04360980,None
633,1194,NCT04361318,ClinicalTrials.gov,2020-04-18,2020-05-01,False,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19,Drug,Hydroxychloroquine + Nitazoxanide,Hydroxychloroquine; Nitazoxanide,100,https://clinicaltrials.gov/show/NCT04361318,None
634,1195,NCT04361422,ClinicalTrials.gov,2020-04-21,2020-04-21,False,Tanta University,Not Recruiting,Phase 3,Interventional,No Country Given,Isotretinoin in Treatment of COVID-19,Drug,Isotretinoin,Isotretinoin,300,https://clinicaltrials.gov/show/NCT04361422,None
635,1196,NCT04361435,ClinicalTrials.gov,2020-04-12,2020-05-01,False,St. Justine's Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Lung Recruitment Device for COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,50,https://clinicaltrials.gov/show/NCT04361435,None
636,1197,NCT04361448,ClinicalTrials.gov,2020-04-20,2020-04-20,False,Jessa Hospital,Not Recruiting,Not Applicable,Interventional,Belgium,Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,https://clinicaltrials.gov/show/NCT04361448,None
637,1198,NCT04361461,ClinicalTrials.gov,2020-04-22,2020-05-04,False,Apsen Farmaceutica S.A.,Not Recruiting,Phase 3,Interventional,Brazil,Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19),Drug,Hydroxychloroquine + Azythromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithormycin,500,https://clinicaltrials.gov/show/NCT04361461,None
638,1200,NCT04361526,ClinicalTrials.gov,2020-04-21,2020-04-17,True,Manuel Castella,Recruiting,Not Applicable,Interventional,Spain,Pilot Study on Cytokine Filtration in COVID-19 ARDS,Other (device),Cytokine Adsorber,Cytokine Adsorber,40,https://clinicaltrials.gov/show/NCT04361526,None
639,1205,NCT04361916,ClinicalTrials.gov,2020-04-14,2020-04-21,False,Mario Negri Institute for Pharmacological Research,Recruiting,Not Applicable,Interventional,Italy,Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino),Other,Other,Other,425,https://clinicaltrials.gov/show/NCT04361916,None
640,1207,NCT04362111,ClinicalTrials.gov,2020-04-21,2020-05-01,False,University of Alabama at Birmingham,Not Recruiting,Phase 3,Interventional,No Country Given,Early Identification and Treatment of Cytokine Storm Syndrome in Covid-19,Drug,Anakinra,Anakinra,20,https://clinicaltrials.gov/show/NCT04362111,None
641,1208,NCT04362124,ClinicalTrials.gov,2020-04-21,2020-04-01,True,University of Antioquia,Not Recruiting,Phase 3,Interventional,Colombia,Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of SARS-COV-2 Infection,ATMP,Vaccine,Vaccine,1000,https://clinicaltrials.gov/show/NCT04362124,None
642,1209,NCT04362358,ClinicalTrials.gov,2020-04-21,2020-05-01,False,"University Hospital, Strasbourg",Not Recruiting,Not Applicable,Interventional,No Country Given,Online Cognitive Behavioral Therapy (CBT) for Stress Disorders in Health Workers Involved in the Care of Patients During the Covid-19 Epidemic,Other (psych),Psychological,Psychological,120,https://clinicaltrials.gov/show/NCT04362358,None
643,1214,NCT04363372,ClinicalTrials.gov,2020-04-24,2020-05-01,False,4D Pharma,Not Recruiting,Phase 2,Interventional,No Country Given,A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19,Drug,MRx-4DP0004,MRx-4DP0004,90,https://clinicaltrials.gov/show/NCT04363372,None
644,1216,NCT04363528,ClinicalTrials.gov,2020-04-23,2020-04-27,False,Versailles Hospital,Not Recruiting,Not Applicable,Interventional,France,Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04363528,None
645,1217,NCT04363541,ClinicalTrials.gov,2020-04-23,2020-04-01,True,Instituto Nacional de Perinatologa,Not Recruiting,Not Applicable,Interventional,No Country Given,Local Thermotherapy for Patients With Moderate Symptoms of COVID-19,Other (device),Heating pad,Heating pad,298,https://clinicaltrials.gov/show/NCT04363541,None
646,1219,NCT04363749,ClinicalTrials.gov,2020-04-20,2020-04-27,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Infection: Exploration of Respiratory Control Center Abnormalities,Other,Other,Other,30,https://clinicaltrials.gov/show/NCT04363749,None
647,1221,NCT04363840,ClinicalTrials.gov,2020-04-24,2020-05-01,False,Louisiana State University Health Sciences Center in New Orleans,Not Recruiting,Phase 2,Interventional,No Country Given,"The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations",Drug,Aspirin + Vitamin D vs. Aspirin,Aspirin; Vitamin D,1080,https://clinicaltrials.gov/show/NCT04363840,None
648,1222,NCT04363866,ClinicalTrials.gov,2020-04-24,2020-05-01,False,Oregon Health and Science University,Not Recruiting,Phase 4,Interventional,United States,A Pilot Study to Assess Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19),Drug,Hydroxychloroquine,Hydroxychloroquine,40,https://clinicaltrials.gov/show/NCT04363866,None
649,1223,NCT04364022,ClinicalTrials.gov,2020-04-23,2020-04-01,True,Calmy Alexandra,Recruiting,Phase 3,Interventional,Switzerland,Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Lopinavir/Ritonavir,Hydroxychloroquine; Lopinavir/Ritonavir,420,https://clinicaltrials.gov/show/NCT04364022,None
650,1226,NCT04365127,ClinicalTrials.gov,2020-04-24,2020-04-27,False,Sara Ghandehari,Recruiting,Phase 1,Interventional,United States,Progesterone for the Treatment of COVID-19 in Hospitalized Men,Drug,Progesterone,Progesterone,40,https://clinicaltrials.gov/show/NCT04365127,None
651,1227,NCT04365439,ClinicalTrials.gov,2020-04-18,2020-04-27,False,Enos Bernasconi,Not Recruiting,Not Applicable,Interventional,No Country Given,Convalescent Plasma for COVID-19,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04365439,None
652,1229,NCT04365699,ClinicalTrials.gov,2020-04-25,2020-04-08,True,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,Cardiovascular Effects of COVID-19,Drug,AT-001,AT-001,500,https://clinicaltrials.gov/show/NCT04365699,None
653,1230,NCT04365738,ClinicalTrials.gov,2020-04-26,2020-03-11,True,Istanbul Bilgi University,Not Recruiting,Not Applicable,Interventional,Turkey,Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,270,https://clinicaltrials.gov/show/NCT04365738,None
654,1233,NCT04366050,ClinicalTrials.gov,2020-04-24,2020-04-01,True,"University of California, San Diego",Not Recruiting,Phase 2,Interventional,No Country Given,Ramipril for the Treatment of COVID-19,Drug,Ramipril,Ramipril,560,https://clinicaltrials.gov/show/NCT04366050,None
655,1237,ACTRN12620000516987,ANZCTR,2020-04-27,2020-06-02,False,University of Auckland,Not Recruiting,Not Applicable,Interventional,New Zealand,Testing a wellbeing app to support wellbeing during the Covid-19 pandemic,Other (psych),Psychological,Psychological,90,https://anzctr.org.au/ACTRN12620000516987.aspx,None
656,1238,ACTRN12620000517976,ANZCTR,2020-04-27,2020-05-21,False,"St. Vincents Hospital, Melbourne",Not Recruiting,Phase 3,Interventional,Australia,COVID-19: Can Nebulised HepArin Reduce Time to Extubation in SARS-CoV-2 patients requiring mechanical ventilation (CHARTER Study),Drug,Heparin,Heparin,172,https://anzctr.org.au/ACTRN12620000517976.aspx,None
657,1240,ISRCTN13311119,ISRCTN,2020-04-24,2020-04-30,False,Eminentlabs GmbH,Recruiting,Phase 2,Interventional,India,START (Siddha Treatment Accelerating Recovery from SARS-CoV-2 Test) trial of Siddha treatment for patients with novel coronavirus infectious disease (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,116,http://isrctn.com/ISRCTN13311119,None
658,1241,ISRCTN17898730,ISRCTN,2020-04-23,2020-04-07,True,Psychosocial Innovation Network,Recruiting,Not Applicable,Interventional,Serbia,Expressive writing for the reduction of psychological difficulties during the COVID-19 pandemic,Other (psych),Psychological,Psychological,150,http://isrctn.com/ISRCTN17898730,None
659,1242,ISRCTN83971151,ISRCTN,2020-03-25,2020-03-26,True,World Health Organization,Recruiting,Phase 3,Interventional,"Brazil, Germany, Saudi Arabia, Indonesia, Argentina, South Africa, Honduras, Kenya, Philippines, Peru, Lebanon, Qatar, Spain, India, Ireland, Thailand, Canada, Italy, Iran, Malaysia, Norway, Switzerland, Israel",Public health emergency SOLIDARITY trial of treatments for COVID-19 infection in hospitalized patients,Drug,Remdesivir vs. chloroquine/hydroxychloroquine vs. lopinavir/ritonavir vs. interferon beta,Remdesivir; chlorquine; hydroxychloroquine; lopinavir/ritonavir; interferon beta,10000,http://isrctn.com/ISRCTN83971151,EUCTR2020-001366-11; NCT04330690; PER-010-20; IRCT20200405046953N1; NCT04321616; EUCTR2020-000982-18; CTRI/2020/04/024773; LBCTR2020043495; EUCTR2020-002060-31; EUCTR2020-001549-38
660,1243,ChiCTR2000032632,ChiCTR,2020-05-04,2020-03-20,True,The First Affiliated Hospital of Xinjiang Medical University,Recruiting,Not Applicable,Interventional,China,The influence of COVID-19 pandemic on cardiovascular patients,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=53190,None
661,1245,ChiCTR2000032573,ChiCTR,2020-05-03,2020-05-02,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, controlled trial for Bu-Fei-Huo-Xue Capsule in the treatment of novel coronavirus pneumonia (COVID-19) convalescence patient with ''Fei-Pi-Qi-Xu zhen''",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=53225,None
662,1248,ChiCTR2000032487,ChiCTR,2020-04-29,2020-03-26,True,Shanghai Public Health Clinical Center,Not Recruiting,Phase 4,Interventional,China,Study for using sulfate in the prevention and control of novel coronavirus pneumonia (COVID-19) in high and low prevalence communities,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,2000,http://www.chictr.org.cn/showproj.aspx?proj=52394,None
663,1254,ChiCTR2000032459,ChiCTR,2020-04-29,2020-04-29,False,Henan Provincial Center for Disease Control and Prevention,Recruiting,Phase 1/Phase 2,Interventional,China,A phase I/II clinical trial for inactivated novel coronavirus (2019-CoV) vaccine (Vero cells),ATMP,Vaccine,Vaccine,288,http://www.chictr.org.cn/showproj.aspx?proj=53003,None
664,1257,ChiCTR2000032456,ChiCTR,2020-04-29,2020-03-01,True,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Interventional,No Country Given,A Randomized Controlled Trial for the Effects of Low-Oxygen Consumption Instruction on the Prognosis of Patients with Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=53048,None
665,1258,ChiCTR2000032455,ChiCTR,2020-04-29,2020-04-28,True,Ningxia Ning'an Hospital,Recruiting,Not Applicable,Interventional,China,A study for the mental health status of novel coronavirus pneumonia (COVID-19) convalescent patients and first-line medical staff and Isolate residents and Hospital staffand the intervention strategy of psychological crisis in Ningxia,Other (psych),No Intervention,No Intervention,140,http://www.chictr.org.cn/showproj.aspx?proj=53050,None
666,1259,ChiCTR2000032135,ChiCTR,2020-04-20,2020-04-22,False,Shanghai Public Health Clinical Center,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of ulinastatin in the Treatment of novel coronavirus pneumonia (COVID-19),Drug,Ulinastatin,Ulinastatin,50,http://www.chictr.org.cn/showproj.aspx?proj=52506,None
667,1262,ChiCTR2000031174,ChiCTR,2020-03-23,2020-03-23,False,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Interventional,China,Effectiveness and safety of hydroxychloroquine sulfate in the preventive treatment of novel coronavirus pneumonia (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1000,http://www.chictr.org.cn/showproj.aspx?proj=51437,None
668,1263,EUCTR2020-001723-13-FR,EU Clinical Trials Register,2020-04-08,2020-04-17,False,Groupe Hospitalier Paris Saint-Joseph,Authorised,Phase 3,Interventional,France,A randomized trial of efficacy and safety of an early OUTpatient treatment of COVID-19 in patients with risk factor for poor outcome : a strategy to prevent hospitalization : OUTCOV Study,Drug,"Azithromycin, Hydroxychloroquine, Lopinavir/Ritonavir",Azithromycin; Hydroxychloroquine; Lopinavir/Ritonavir,640,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001723-13,None
669,1264,EUCTR2020-001198-55-DK,EU Clinical Trials Register,2020-03-21,2020-04-03,False,Chronic Obstructive Pulmonary Disease Trial Network,Authorised,Phase 2,Interventional,Denmark,Early Treatment to Patients with Coronavirus (COVID),Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,226,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001198-55,None
670,1265,EUCTR2020-001686-36-FR,EU Clinical Trials Register,2020-04-14,2020-04-23,False,Assistance Publique  Hpitaux de Marseille,Authorised,Phase 2,Interventional,France,"A double-blind, randomized study versus placebo of avdoralimab (IPH5401), an anti-C5aR antibody, in patients with COVID-19 induced pneumonia",Drug,Avdoralimab,Avdoralimab,116,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001686-36,None
671,1266,EUCTR2020-001823-15-FR,EU Clinical Trials Register,2020-04-15,2020-04-28,False,CHU de Saint Etienne,Authorised,Phase 4,Interventional,France,Evaluation of the concentration-effect relationship of enoxaparin for thromboembolic prevention in COVID-19 resuscitation patients. COV-ENOX study,Drug,Enoxaparine,Enoxaparine,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001823-15,None
672,1267,EUCTR2020-001722-66-ES,EU Clinical Trials Register,2020-04-27,2020-04-23,True,Fundaci Clnic per a la Recerca Biomdica,Authorised,Phase 2,Interventional,Spain,Plasma turnover in patients with COVID-19 disease and invasive mechanical ventilation,ATMP,Plasma,Plasma,116,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001722-66,None
673,1268,EUCTR2020-001505-22-ES,EU Clinical Trials Register,2020-04-27,2020-04-23,True,Banc de Sang i Teixits,Authorised,Phase 1/Phase 2,Interventional,Spain,Efficacy and safety evaluation of umbilical cord mesenchymal stem cells for the treatment of patients with respiratory failure due to coronavirus (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001505-22,None
674,1269,EUCTR2020-001717-20-ES,EU Clinical Trials Register,2020-04-27,2020-04-20,True,Fundacin para la Investigacin Biomdica de Crdoba,Authorised,Phase 2,Interventional,Spain,Prevention and treatment with Calcifediol of respiratory problems caused by COVID-19,Drug,Calcifediol,Calcifediol,1008,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001717-20,None
675,1270,EUCTR2020-001541-39-ES,EU Clinical Trials Register,2020-04-27,2020-04-24,True,Fundacin para la Investigacin Biomdica de Crdoba,Authorised,Phase 2,Interventional,Spain,Pilot study of bevacizumab as a treatment for respiratory distress in patients with COVID-19,Drug,Bevacizumab,Bevacizumab,22,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001541-39,None
676,1271,EUCTR2020-001618-39-ES,EU Clinical Trials Register,2020-04-27,2020-04-24,True,Oryzon Genomics S. A.,Authorised,Phase 2,Interventional,Spain,Study to evaluate the efficacy and tolerability of treatment with vafidemstat in combination with standard of care treatment to prevent Acute Respiratory Distress Syndrome in adult severely ill patients with COVID-19.,Drug,Vafidemstat,Vafidemstat,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001618-39,None
677,1272,EUCTR2020-001408-41-DE,EU Clinical Trials Register,2020-04-07,2020-04-21,True,"University Hospital, Freiburg",Authorised,Phase 2,Interventional,Germany,Evaluation of efficacy and safety of an tocilizumab treatment in patients with severe COVID-19 pneumonia,Drug,Tocilizumab,Tocilizumab,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001408-41,DRKS00021238
678,1273,EUCTR2020-001345-38-GR,EU Clinical Trials Register,2020-03-31,2020-04-02,False,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Authorised,Phase 2,Interventional,Greece,CHROLOQUINE PHOSPHATE AGAINST INFECTION BY THE NOVEL CORONAVIRUS,Drug,Chloroquine,Chloroquine,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001345-38,None
679,1274,NCT04273763,ClinicalTrials.gov,2020-02-14,2020-02-16,False,The Second Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19),Drug,Bromhexine + Umifenovir + Interferon alpha vs. Umifenovir + interferon alpha,Bromhexine; Umifenovir; interferon alpha,18,https://clinicaltrials.gov/show/NCT04273763,None
680,1276,NCT04321096,ClinicalTrials.gov,2020-03-23,2020-04-04,True,Aarhus University,Recruiting,Phase 1/Phase 2,Interventional,Denmark,The Impact of Camostat Mesilate on COVID-19 Infection,Drug,Camostat Mesilate,Camostat Mesilate,580,https://clinicaltrials.gov/show/NCT04321096,EUCTR2020-001200-42
681,1277,NCT04328441,ClinicalTrials.gov,2020-03-27,2020-03-25,True,UMC Utrecht,Recruiting,Phase 3,Interventional,Netherlands,Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine,ATMP,Vaccine,Vaccine,1500,https://clinicaltrials.gov/show/NCT04328441,None
682,1278,NCT04328480,ClinicalTrials.gov,2020-03-30,2020-04-17,False,Estudios Clnicos Latino Amrica,Recruiting,Phase 3,Interventional,Argentina,The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.,Drug,Colchicine,Colchicine,2500,https://clinicaltrials.gov/show/NCT04328480,None
683,1279,NCT04329923,ClinicalTrials.gov,2020-03-30,2020-04-09,False,"Ravi Amaravadi, MD",Recruiting,Phase 2,Interventional,United States,The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine),Drug,Hydroxychloroquine,Hydroxychloroquine,400,https://clinicaltrials.gov/show/NCT04329923,None
684,1280,NCT04334928,ClinicalTrials.gov,2020-04-02,2020-04-15,False,Plan Nacional sobre el Sida (PNS),Recruiting,Phase 3,Interventional,Spain,Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel,Drug,Emtricitabine/tenofovir disoproxil + hydroxychloroquine vs. hydroxychloroquine vs. Emtricitabine/tenofovir disoproxil,Emtricitabine/tenofovir disoproxil; hydroxychloroquine,4000,https://clinicaltrials.gov/show/NCT04334928,None
685,1281,NCT04335071,ClinicalTrials.gov,2020-04-02,2020-04-26,False,"University Hospital, Bern",Recruiting,Phase 2,Interventional,Switzerland,Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19),Drug,Tocilizumab,Tocilizumab,100,https://clinicaltrials.gov/show/NCT04335071,None
686,1282,NCT04338958,ClinicalTrials.gov,2020-04-07,2020-04-22,True,University of Jena,Recruiting,Phase 2,Interventional,Germany,Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation,Drug,Ruxolitinib,Ruxolitinib,200,https://clinicaltrials.gov/show/NCT04338958,EUCTR2020-001481-11
687,1284,NCT04344457,ClinicalTrials.gov,2020-04-08,2020-04-16,False,"Perseverance Research Center, LLC",Recruiting,Phase 1/Phase 2,Interventional,United States,"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19",Drug,Hydroxychloroquine + Indomethacin + Azithromycin,Hydroxychloroquine; Indomethacin; Azithromycin,80,https://clinicaltrials.gov/show/NCT04344457,None
688,1285,NCT04345848,ClinicalTrials.gov,2020-04-07,2020-04-28,False,"University Hospital, Geneva",Recruiting,Phase 3,Interventional,Switzerland,Preventing COVID-19 Complications With Low- and High-dose Anticoagulation,Drug,Heparin,Heparin,200,https://clinicaltrials.gov/show/NCT04345848,None
689,1286,NCT04347226,ClinicalTrials.gov,2020-04-02,2020-04-16,False,Matthew Dallos,Recruiting,Phase 2,Interventional,United States,Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19,Drug,Anti-Interleukin-8,Anti-Interleukin-8,138,https://clinicaltrials.gov/show/NCT04347226,None
690,1287,NCT04348435,ClinicalTrials.gov,2020-04-14,2020-04-23,False,Hope Biosciences,Recruiting,Phase 2,Interventional,United States,"A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19",ATMP,Cells (mesenchymal),Cells (mesenchymal),100,https://clinicaltrials.gov/show/NCT04348435,None
691,1288,NCT04349631,ClinicalTrials.gov,2020-04-06,2020-05-07,False,Hope Biosciences,Recruiting,Phase 2,Interventional,United States,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),56,https://clinicaltrials.gov/show/NCT04349631,None
692,1289,NCT04351191,ClinicalTrials.gov,2020-04-14,2020-04-15,False,"Government of Punjab, Specialized Healthcare and Medical Education Department",Recruiting,Phase 4,Interventional,Pakistan,PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Chloroquine ,Hydroxychloroquine; Chloroquine ,400,https://clinicaltrials.gov/show/NCT04351191,None
693,1290,NCT04352465,ClinicalTrials.gov,2020-04-15,2020-05-01,False,Azidus Brasil,Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients,Drug,Methotrexate,Methotrexate,42,https://clinicaltrials.gov/show/NCT04352465,None
694,1291,NCT04353271,ClinicalTrials.gov,2020-03-25,2020-04-17,False,University of South Alabama,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Trial of Hydroxychloroquine In Covid-19 Kinetics,Drug,Hydroxychloroquine,Hydroxychloroquine,58,https://clinicaltrials.gov/show/NCT04353271,None
695,1293,NCT04356833,ClinicalTrials.gov,2020-04-14,2020-04-22,True,"University College, London",Recruiting,Phase 2,Interventional,United Kingdom,Nebulised Rt-PA for ARDS Due to COVID-19,Drug,Recombinant Tissue-Plasminogen Activator,Recombinant Tissue-Plasminogen Activator,24,https://clinicaltrials.gov/show/NCT04356833,EUCTR2020-001640-26
696,1295,NCT04358939,ClinicalTrials.gov,2020-04-16,2020-04-27,False,CHU de Tours,Recruiting,Not Applicable,Interventional,France,Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19),Procedure,Positioning,Positioning,248,https://clinicaltrials.gov/show/NCT04358939,None
697,1296,NCT04359225,ClinicalTrials.gov,2020-04-16,2020-06-30,False,NHS Greater Glasgow and Clyde,Not Recruiting,Not Applicable,Interventional,United Kingdom,A Comparison of 3D and 2D Telemedicine During Covid 19,Telehealth,Telehealth,Telehealth,80,https://clinicaltrials.gov/show/NCT04359225,None
698,1297,NCT04359654,ClinicalTrials.gov,2020-04-21,2020-05-01,False,"University College, London",Not Recruiting,Phase 2,Interventional,United Kingdom,Nebulised Dornase Alfa for Treatment of COVID-19,Drug,Dornase alfa,Dornase alfa,50,https://clinicaltrials.gov/show/NCT04359654,None
699,1299,NCT04359797,ClinicalTrials.gov,2020-04-20,2020-04-27,False,Vanderbilt University,Recruiting,Not Applicable,Interventional,United States,COVID-19 Patient Positioning Pragmatic Trial,Procedure,Positioning,Positioning,300,https://clinicaltrials.gov/show/NCT04359797,None
700,1300,NCT04359810,ClinicalTrials.gov,2020-04-21,2020-04-21,False,Max R. O'Donnell,Recruiting,Phase 2,Interventional,United States,Plasma Therapy of COVID-19 in Critically Ill Patients,ATMP,Plasma,Plasma,105,https://clinicaltrials.gov/show/NCT04359810,None
701,1302,NCT04361643,ClinicalTrials.gov,2020-04-23,2020-04-27,False,Hospital Universitario Getafe,Not Recruiting,Phase 4,Interventional,Spain,Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial,Drug,Lenalidomide,Lenalidomide,120,https://clinicaltrials.gov/show/NCT04361643,None
702,1304,NCT04361942,ClinicalTrials.gov,2020-04-17,2020-04-01,False,Red de Terapia Celular,Recruiting,Phase 2,Interventional,Spain,Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV),ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://clinicaltrials.gov/show/NCT04361942,EUCTR2020-001682-36
703,1305,NCT04362176,ClinicalTrials.gov,2020-04-21,2020-04-24,False,Vanderbilt University,Recruiting,Phase 3,Interventional,United States,Passive Immunity Trial of Nashville II for COVID-19,ATMP,Plasma,Plasma,500,https://clinicaltrials.gov/show/NCT04362176,None
704,1310,NCT04363060,ClinicalTrials.gov,2020-04-23,2020-04-30,False,Nantes University Hospital,Not Recruiting,Phase 3,Interventional,France,Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit,Drug,Azithromycin + Amoxicillin/Clavulanate vs. Amoxicillin/Clavulanate,Azithromycin; Amoxicillin/Clavulanate,104,https://clinicaltrials.gov/show/NCT04363060,None
705,1311,NCT04363450,ClinicalTrials.gov,2020-04-23,2020-04-27,False,Louisiana State University Health Sciences Center in New Orleans,Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1700,https://clinicaltrials.gov/show/NCT04363450,None
706,1312,NCT04364828,ClinicalTrials.gov,2020-04-22,2020-04-01,True,"University Hospital, Tbingen",Not Recruiting,Not Applicable,Interventional,No Country Given,NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://clinicaltrials.gov/show/NCT04364828,None
707,1313,NCT04365231,ClinicalTrials.gov,2020-04-23,2020-04-01,True,"Hospital St. Joseph, Marseille",Not Recruiting,Phase 3,Interventional,France,Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,50,https://clinicaltrials.gov/show/NCT04365231,None
708,1314,NCT04365309,ClinicalTrials.gov,2020-04-24,2020-02-10,True,Xijing Hospital,Recruiting,Phase 2/Phase 3,Interventional,China,Protective Effect of Aspirin on COVID-19 Patients,Drug,Aspirin,Aspirin,128,https://clinicaltrials.gov/show/NCT04365309,None
709,1316,NCT04365608,ClinicalTrials.gov,2020-04-24,2020-03-20,True,Lazarski University,Recruiting,Not Applicable,Interventional,Poland,Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment,Other (physical),Mechanical ventilation,Mechanical ventilation,90,https://clinicaltrials.gov/show/NCT04365608,None
710,1319,NCT04366063,ClinicalTrials.gov,2020-04-20,2020-04-05,False,Royan Institute,Recruiting,Phase 2/Phase 3,Interventional,Iran,Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome,ATMP,Cells (mesenchymal),Cells (mesenchymal),60,https://clinicaltrials.gov/show/NCT04366063,IRCT20200217046526N2
711,1320,NCT04366089,ClinicalTrials.gov,2020-04-22,2020-03-26,True,Dr. Roberto Poscia,Recruiting,Phase 2,Interventional,Italy,Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora,Drug,Oxygen + Ozone,Oxygen; Ozone,152,https://clinicaltrials.gov/show/NCT04366089,None
712,1323,NCT04366180,ClinicalTrials.gov,2020-04-27,2020-04-24,True,Biosearch S.A.,Recruiting,Not Applicable,Interventional,Spain,Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers,Supplement,Probiotics,Probiotics,314,https://clinicaltrials.gov/show/NCT04366180,None
713,1325,NCT04366297,ClinicalTrials.gov,2020-04-23,2020-01-12,True,Lazarski University,Not Recruiting,Not Applicable,Interventional,Poland,Intravascular Access of COVID-19 Patient Under Personal Protective Equipment,Other (device),Intraosseous/Intravenous access device,Intraosseous/Intravenous access device,41,https://clinicaltrials.gov/show/NCT04366297,None
714,1326,NCT04366739,ClinicalTrials.gov,2020-04-24,2020-04-29,False,Centre Hospitalier St. Anne,Not Recruiting,Phase 3,Interventional,France,Repurposing of Chlorpromazine in Covid-19 Treatment,Drug,Chlorpromazine,Chlorpromazine,40,https://clinicaltrials.gov/show/NCT04366739,None
715,1328,NCT04366817,ClinicalTrials.gov,2020-04-20,2020-04-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic Short Title : Isolement and Childbirth: Psychological Impact,Other (psych),No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04366817,None
716,1329,NCT04366856,ClinicalTrials.gov,2020-04-26,2020-04-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study),Procedure,Positioning,Positioning,500,https://clinicaltrials.gov/show/NCT04366856,None
717,1330,NCT04366882,ClinicalTrials.gov,2020-04-22,2020-04-14,True,Jessa Hospital,Recruiting,Not Applicable,Interventional,Belgium,Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,45,https://clinicaltrials.gov/show/NCT04366882,None
718,1331,NCT04366908,ClinicalTrials.gov,2020-04-25,2020-04-28,False,Maimonides Biomedical Research Institute of Cordoba,Not Recruiting,Phase 2,Interventional,No Country Given,Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome,Drug,Calcifediol,Calcifediol,1008,https://clinicaltrials.gov/show/NCT04366908,None
719,1333,NCT04366947,ClinicalTrials.gov,2020-04-23,2020-04-14,True,Lazarski University,Not Recruiting,Not Applicable,Interventional,Poland,Intravascular Access in Suspected/Confirmed COVID-19 Patient,Other (device),Intraosseous/Intravenous access device,Intraosseous/Intravenous access device,60,https://clinicaltrials.gov/show/NCT04366947,None
720,1340,NCT04367636,ClinicalTrials.gov,2020-04-20,2020-04-20,False,University of Ghent,Not Recruiting,Not Applicable,Interventional,Belgium,The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19,Other (psych),Psychological,Psychological,100,https://clinicaltrials.gov/show/NCT04367636,None
721,1346,NCT04368013,ClinicalTrials.gov,2020-04-27,2020-04-28,False,Johan Normark,Not Recruiting,Not Applicable,Interventional,Sweden,"Host-pathogen Interactions, Immune Response, and Clinical Prognosis at COVID-19 - the CoVUm Trial",Prognosis,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04368013,None
722,1349,NCT04368156,ClinicalTrials.gov,2020-04-20,2020-04-20,False,Carlos Tornero,Recruiting,Not Applicable,Interventional,Spain,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,Other (device),Vagus nerve stimulation,Vagus nerve stimulation,90,https://clinicaltrials.gov/show/NCT04368156,None
723,1352,NCT04368260,ClinicalTrials.gov,2020-04-24,2020-04-24,False,University of Virginia,Recruiting,Not Applicable,Interventional,United States,Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,40,https://clinicaltrials.gov/show/NCT04368260,None
724,1353,NCT04368299,ClinicalTrials.gov,2020-04-25,2020-05-01,False,Chinese University of Hong Kong,Not Recruiting,Not Applicable,Interventional,No Country Given,Telemedicine for Follow-up of Systemic Lupus Erythematosus,Telehealth,Telehealth,Telehealth,150,https://clinicaltrials.gov/show/NCT04368299,None
725,1357,NCT04368377,ClinicalTrials.gov,2020-04-23,2020-04-06,True,University of Milan,Not Recruiting,Phase 2,Interventional,Italy,Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19,Drug,Tirofiban + Clopidogrel + Aspirin + Fondaparinux,Tirofiban; Clopidogrel; Aspirin; Fondaparinux,5,https://clinicaltrials.gov/show/NCT04368377,None
726,1359,NCT04368676,ClinicalTrials.gov,2020-04-26,2020-05-10,False,Lawson Health Research Institute,Not Recruiting,Phase 1,Interventional,Canada,Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness,Traditional Medicine (other),Traditional Medicine,Traditional Medicine,60,https://clinicaltrials.gov/show/NCT04368676,None
727,1362,NCT04369274,ClinicalTrials.gov,2020-04-23,2020-05-01,False,Massachusetts General Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Repeated Measures Trial of Temporary Automated Manual Ventilation Versus Noninvasive Oxygenation or Conventional Vent,Other (physical),Mechanical ventilation,Mechanical ventilation,30,https://clinicaltrials.gov/show/NCT04369274,None
728,1364,NCT04369365,ClinicalTrials.gov,2020-04-27,2020-04-27,False,Dr. Matthias Preusser,Recruiting,Phase 2,Interventional,Austria,"A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic",Drug (Chemoprophylaxis),Azithromycin,Azithromycin,200,https://clinicaltrials.gov/show/NCT04369365,None
729,1365,NCT04369378,ClinicalTrials.gov,2020-04-24,2020-05-02,False,Lake Erie College of Osteopathic Medicine,Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic,Other (psych),Psychological,Psychological,100,https://clinicaltrials.gov/show/NCT04369378,None
730,1366,NCT04369469,ClinicalTrials.gov,2020-04-28,2020-05-01,False,Alexion Pharmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia,Drug,Ravulizumab,Ravulizumab,270,https://clinicaltrials.gov/show/NCT04369469,None
731,1368,NCT04369794,ClinicalTrials.gov,2020-04-27,2020-06-01,False,"University of Campinas, Brazil",Not Recruiting,Phase 4,Interventional,Brazil,"COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement",ATMP,Vaccine,Vaccine,1000,https://clinicaltrials.gov/show/NCT04369794,None
732,1374,NCT04370938,ClinicalTrials.gov,2020-04-29,2020-04-29,False,University of Pittsburgh,Recruiting,Not Applicable,Interventional,United States,Provider Burnout During COVID-19,Other (psych),Psychological,Psychological,250,https://clinicaltrials.gov/show/NCT04370938,None
733,1377,NCT04371523,ClinicalTrials.gov,2020-04-28,2020-05-01,False,St. Joseph's Healthcare Hamilton,Not Recruiting,Phase 3,Interventional,Canada,Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1100,https://clinicaltrials.gov/show/NCT04371523,None
734,1383,ACTRN12620000524998,ANZCTR,2020-04-28,2020-04-28,False,South Eastern Sydney Local Health District,Not Recruiting,Not Applicable,Interventional,Australia,Evaluation of a remote monitoring smartphone application and care model of COVID-19 patients in the community  (ReCOVER),Other (software),eHealth,eHealth,2000,https://anzctr.org.au/ACTRN12620000524998.aspx,None
735,1385,ChiCTR2000032769,ChiCTR,2020-05-09,2020-05-12,False,Beijing Ditan Hospital,Recruiting,Not Applicable,Interventional,China,"A randomized,double blinded, parallel  controlled clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,Azvudine,342,http://www.chictr.org.cn/showproj.aspx?proj=53368,None
736,1389,ChiCTR2000032737,ChiCTR,2020-05-08,2020-05-08,False,The First Affiliated Hospital of Guangdong Pharmaceutical University; Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical trial for the washed microbiota transplantation in the treatment of novel coronavirus pneumonia (COVID-19) patients suspected with gut microbiota dysbiosis,Other,Washed microbiota transplantation,Washed microbiota transplantation,60,http://www.chictr.org.cn/showproj.aspx?proj=53458,None
737,1390,ChiCTR2000032717,ChiCTR,2020-05-08,2020-02-12,True,Xi'an International Medical Center Hospital,Not Recruiting,Not Applicable,Interventional,China,Efficacy and safety of high-dose vitamin C combined with traditional Chinese medicine in the treatment of moderate and severe novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine + Vitamin C,Traditional Medicine; Vitamin C,40,http://www.chictr.org.cn/showproj.aspx?proj=53322,None
738,1391,ChiCTR2000032716,ChiCTR,2020-05-08,2020-02-05,True,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Not Applicable,Interventional,China,High dose intravenous vitamin C might be used as an important rescue therapy for aggravation of severe and critical novel coronavirus pneumonia (COVID-19) patients,Drug,Vitamin C,Vitamin C,12,http://www.chictr.org.cn/showproj.aspx?proj=53389,None
739,1394,ChiCTR2000032635,ChiCTR,2020-05-04,2020-05-06,False,Hubei Hospital of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Study for Screening of Chinese Patent Drugs in the Rehabilitation Treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=52671,None
740,1396,EUCTR2020-001700-42-FR,EU Clinical Trials Register,2020-04-11,2020-05-06,False,Assistance Publique  Hpitaux de Paris,Authorised,Phase 2,Interventional,France,Efficacy of captopril  in Covid-19 patients suffering of pneumonia,Drug,Captopril,Captopril,230,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001700-42,None
741,1397,EUCTR2020-001635-27-FR,EU Clinical Trials Register,2020-04-06,2020-05-04,False,AB Science,Authorised,Phase 2,Interventional,France,Evaluation of a combination of Masitinib and Isoquercetin in the Treatment of Hospitalized COVID-19 Patients.,Drug,Masitinib + Isoquercetin vs. Hydroxychloroquine,Masitinib; Isoquercetin; Hydroxychloroquine,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001635-27,None
742,1398,EUCTR2020-001766-11-FR,EU Clinical Trials Register,2020-04-15,2020-04-29,False,Assistance Publique  Hpitaux de Marseille,Authorised,Phase 2,Interventional,France,Losartan and spironolactone treatment for COVID-19 patients with acute respiratory failure in intensive care unit,Drug,Losartan + Spironolactone,Losartan; Spironolactone,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001766-11,None
743,1399,EUCTR2020-001370-30-GB,EU Clinical Trials Register,2020-04-15,2020-04-28,False,Novartis Pharmaceuticals,Authorised,Phase 3,Interventional,"United States, United Kingdom, Italy, France, Germany, Spain",Study of efficacy and safety of canakinumab treatment for CRS in participants with COVID-19-induced pneumonia.,Drug,Canakinumab,Canakinumab,450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001370-30,None
744,1400,EUCTR2020-001709-21-FR,EU Clinical Trials Register,2020-04-16,2020-04-29,False,CHU de Nancy,Authorised,Phase 4,Interventional,France,Low-molecular-weight heparin to prevent venous thromboembolism in COVID-19 patients : a randomized controlled trial of different doses,Drug,Heparin,Heparin,550,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001709-21,None
745,1401,EUCTR2020-001768-27-FR,EU Clinical Trials Register,2020-04-16,2020-04-27,False,Centre Hospitalier de Versailles,Authorised,Phase 2,Interventional,France,"""STUDY OF THE EFFICIENCY OF NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE"" GERONIMO 19",ATMP,Immunoglobulin,Immunoglobulin,39,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001768-27,None
746,1402,EUCTR2020-001598-66-FR,EU Clinical Trials Register,2020-04-16,2020-05-04,False,Centre Hospitalier de Versailles,Authorised,Phase 2,Interventional,France,Curosurf in Adult Acute Respiratory Distress Syndrome  1,Drug,Poractant alfa,Poractant alfa,20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001598-66,None
747,1403,EUCTR2020-001786-36-GB,EU Clinical Trials Register,2020-04-15,2020-05-06,False,Revimmune,Authorised,Phase 2,Interventional,"Belgium, United States, United Kingdom, Italy, France, Spain",Study of investigational medicinal product of CYT107 in patients with COVID-19 infection who have low number of lymphocytes in their blood (ILIAD 7 trial),Drug,CYT107,CYT107,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001786-36,None
748,1404,EUCTR2020-001632-10-DE,EU Clinical Trials Register,2020-04-20,2020-05-04,False,"University Hospital, Heidelberg",Authorised,Phase 2,Interventional,Germany,A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease,ATMP,Plasma,Plasma,174,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001632-10,None
749,1405,EUCTR2020-001783-28-HU,EU Clinical Trials Register,2020-04-29,2020-05-06,False,National Kornyi Institute of Pulmonology,Authorised,Phase 3,Interventional,Hungary,BCG vaccination against COVID-19 infection in Hungary,ATMP,Vaccine,Vaccine,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001783-28,None
750,1406,EUCTR2020-000705-86-ES,EU Clinical Trials Register,2020-05-05,2020-04-26,True,Vall d'Hebron University Hospital,Authorised,Phase 4,Interventional,Spain,Control of inflammatory parameters with fish oil in parenteral nutrition,Supplement,Fish oil,Fish oil,117,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000705-86,None
751,1407,EUCTR2020-001891-14-ES,EU Clinical Trials Register,2020-05-05,2020-05-04,True,Fundacin Neumosur,Authorised,Phase 2,Interventional,Spain,"Impact of the use of low molecular weight heparins (LMWH), at prophylactic versus intermediate doses, on SARS-CoV2 infection (COVID-19)",Drug,Heparin,Heparin,140,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001891-14,None
752,1408,EUCTR2020-001825-29-ES,EU Clinical Trials Register,2020-05-05,2020-04-28,True,Navarrabiomed - Fundacin Miguel Servet,Authorised,Phase 2/Phase 3,Interventional,Spain,CLINICAL TRIAL OF THE USE OF ANAKINRA (ANTI IL-1) IN CYTOKINE STORM SYNDROME (CSS) SECONDARY TO COVID-19,Drug,Anakinra vs. Hydoxychloroquine + Azithromycin + Lopinavir/ritonavir,Anakinra; Hydoxychloroquine; Azithromycin; Lopinavir/ritonavir,180,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001825-29,None
753,1409,EUCTR2020-002032-69-ES,EU Clinical Trials Register,2020-05-05,2020-05-04,True,Fundacin para la Investigacin Biomdica Hospital Ramn y Cajal,Authorised,Phase 2,Interventional,Spain,Clinical trial on the efficacy of tocilizumab in modifying the inflammatory parameters of patients with COVID-19,Drug,Tocilizumab,Tocilizumab,78,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002032-69,None
754,1410,EUCTR2020-001697-30-ES,EU Clinical Trials Register,2020-05-07,2020-04-23,True,Navarrabiomed - Fundacin Miguel Servet,Authorised,Phase 3,Interventional,Spain,PRE-EXPOSURE PROPHYLAXIS WITH HYDROXYCHLOROQUINE IN SANITARIES HIGHLY EXPOSED TO COVID-19. (COVIDNA),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001697-30,None
755,1411,EUCTR2020-001603-16-ES,EU Clinical Trials Register,2020-05-08,2020-05-06,True,Instituto de Investigacin Marqus de Valdecilla (IDIVAL),Authorised,Phase 3,Interventional,Spain,Ensayo clnico aleatorizado para investigar la eficacia de la administracin anticipada de la colchicina en pacientes mayores de 70 aos y de alto riesgo en tener complicaciones pulmonares como neumona asociada al coronavirus.,Drug,Colchicine,Colchicine,1024,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001603-16,None
756,1412,EUCTR2020-001375-32-NL,EU Clinical Trials Register,2020-04-03,2020-04-03,True,University Medical Center Groningen,Authorised,Phase 2,Interventional,Netherlands,Early intervention with Tocilizumab in patients with COVID-19 and hypoxia,Drug,Tocilizumab,Tocilizumab,354,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001375-32,NL8504
757,1413,EUCTR2020-001994-66-ES,EU Clinical Trials Register,2020-05-08,2020-05-06,True,Fundaci Assistencial Mtua Terrassa,Authorised,Phase 3,Interventional,Spain,Study of the efficacy of ivermectin in the treatment and prevention of COVID-19,Drug,Ivermectin,Ivermectin,266,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001994-66,None
758,1414,EUCTR2020-001934-37-ES,EU Clinical Trials Register,2020-05-08,2020-05-07,True,Instituto de Investigacin Marqus de Valdecilla (IDIVAL),Authorised,Phase 4,Interventional,Spain,USE OF CORTICOSTEROIDS IN PATIENTS WITH SARS-COV2 CORONAVIRUS INFECTION,Drug,Corticosteroids,Methylprednisolone,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001934-37,None
759,1415,EUCTR2020-002123-11-ES,EU Clinical Trials Register,2020-05-08,2020-05-07,True,Tatiana Cobo-Ibez,Authorised,Phase 4,Interventional,Spain,CLINICAL STUDY IN WHICH PATIENTS ARE RANDOMIZED TO RECEIVE HYDROXYCHLOROQUINE VS. CYCLOSPORINE - HYDROXYCHLOROQUINE TO COMPARE THEIR EFFICACY IN THE TREATMENT OF COVID-19 PNEUMONIA.,Drug,Hydroxychloroquine vs. Hydroxychloroquine + Cyclosporine,Hydroxychloroquine; Cyclosporine,280,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002123-11,None
760,1416,EUCTR2020-001474-29-ES,EU Clinical Trials Register,2020-05-08,2020-05-07,True,Clnica Universidad de Navarra,Authorised,Phase 2,Interventional,Spain,Pilot study to evaluate the potential of ivermectin to reduce COVID-19 transmission,Drug,Ivermectin,Ivermectin,24,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001474-29,None
761,1417,EUCTR2020-001953-36-ES,EU Clinical Trials Register,2020-05-08,2020-05-08,False,"Grifols, S.A.",Authorised,Phase 2,Interventional,Spain,Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Patients with Coronavirus Disease (COVID-19),Drug,Alpha-1-proteinase inhibitor,Alpha-1-proteinase inhibitor,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001953-36,None
762,1418,NCT04324489,ClinicalTrials.gov,2020-03-25,2020-03-06,True,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,DAS181 for Severe COVID-19: Compassionate Use,Drug,DAS181,DAS181,4,https://clinicaltrials.gov/show/NCT04324489,None
763,1419,NCT04333550,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Kermanshah University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Application of Desferal to Treat COVID-19,Drug,Deferoxamine,Deferoxamine,50,https://clinicaltrials.gov/show/NCT04333550,None
764,1423,NCT04343768,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial",Drug,Hydroxychloroquine + Lopinavir/ritonavir + interferon beta 1a vs. hydroxychloroquine + Lopinavir/ritonavir + interferon beta 1b vs. hydroxychloroquine + Lopinavir/ritonavir,Hydroxychloroquine; Lopinavir/ritonavir; interferon beta,60,https://clinicaltrials.gov/show/NCT04343768,None
765,1424,NCT04345614,ClinicalTrials.gov,2020-04-07,2020-04-08,False,"CalciMedica, Inc.",Recruiting,Phase 2,Interventional,United States,A Study of CM4620-Injectable Emulsion (IE) in Patients With Severe COVID-19 Pneumonia,Drug,CM4620-Injectable Emulsion,CM4620-Injectable Emulsion,120,https://clinicaltrials.gov/show/NCT04345614,None
766,1425,NCT04346667,ClinicalTrials.gov,2020-04-13,2020-04-14,False,"Government of Punjab, Specialized Healthcare and Medical Education Department",Recruiting,Phase 4,Interventional,Pakistan,Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Chloroquine ,Hydroxychloroquine; chloroquine ,400,https://clinicaltrials.gov/show/NCT04346667,None
767,1426,NCT04350320,ClinicalTrials.gov,2020-04-14,2020-04-30,False,Fundacin para la Formacin e Investigacin Sanitarias de la Regin de Murcia (FFIS),Recruiting,Phase 3,Interventional,Spain,Trial to Study the Benefit of Colchicine in Patients With COVID-19,Drug,Colchicine,Colchicine,102,https://clinicaltrials.gov/show/NCT04350320,None
768,1427,NCT04354597,ClinicalTrials.gov,2020-04-09,2020-05-01,False,King Hussein Cancer Center,Not Recruiting,Not Applicable,Interventional,Jordan,Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients,Drug (Chemoprophylaxis),Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,200,https://clinicaltrials.gov/show/NCT04354597,None
769,1430,NCT04358926,ClinicalTrials.gov,2020-04-21,2020-04-30,False,Assaf-Harofeh Medical Center,Recruiting,Not Applicable,Interventional,Israel,Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19),Drug,Oxygen,Oxygen,30,https://clinicaltrials.gov/show/NCT04358926,None
770,1433,NCT04360122,ClinicalTrials.gov,2020-04-15,2020-05-20,False,Ain Shams University,Not Recruiting,Phase 3,Interventional,Egypt,Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19,Drug (Chemoprophylaxis),Levamisole + Isoprinosine vs. Levamisole vs. Isoprinosine,Levamisole; Isoprinosine,100,https://clinicaltrials.gov/show/NCT04360122,None
771,1434,NCT04361032,ClinicalTrials.gov,2020-04-22,2020-05-04,False,Abderrahmane Mami Hospital,Not Recruiting,Phase 3,Interventional,Tunisia,"Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia",Drug,Tocilizumab,Tocilizumab,260,https://clinicaltrials.gov/show/NCT04361032,None
772,1435,NCT04364815,ClinicalTrials.gov,2020-04-22,2020-05-01,False,University of the Philippines,Not Recruiting,Phase 3,Interventional,No Country Given,The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,960,https://clinicaltrials.gov/show/NCT04364815,None
773,1437,NCT04369456,ClinicalTrials.gov,2020-04-27,2020-04-22,True,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients,Clinical Presentation,No Intervention,No Intervention,115,https://clinicaltrials.gov/show/NCT04369456,None
774,1438,NCT04369820,ClinicalTrials.gov,2020-04-29,2020-03-31,True,Assistance Publique  Hpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,C5a Receptor Expression - COVID-19 (C5-COV),Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04369820,None
775,1441,NCT04370288,ClinicalTrials.gov,2020-04-29,2020-04-19,True,Mashhad University of Medical Sciences,Recruiting,Phase 1,Interventional,Iran,Clinical Application of Methylene Blue for Treatment of Covid-19 Patients,Drug,Methylene blue + Vitamin C + N-acetyl cysteine,Methylene blue; Vitamin C; N-acetyl cysteine,20,https://clinicaltrials.gov/show/NCT04370288,None
776,1443,NCT04371367,ClinicalTrials.gov,2020-04-29,2020-04-27,True,Assistance Publique  Hpitaux de Marseille,Recruiting,Phase 2,Interventional,France,"Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )",Drug,Avdoralimab,Avdoralimab,108,https://clinicaltrials.gov/show/NCT04371367,None
777,1444,NCT04371406,ClinicalTrials.gov,2020-04-29,2020-05-02,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,2770,https://clinicaltrials.gov/show/NCT04371406,None
778,1445,NCT04371510,ClinicalTrials.gov,2020-04-28,2020-04-22,True,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients,Clinical Presentation,No Intervention,No Intervention,115,https://clinicaltrials.gov/show/NCT04371510,None
779,1447,NCT04371601,ClinicalTrials.gov,2020-03-25,2020-03-01,True,Fuzhou General Hospital,Not Recruiting,Phase 1,Interventional,China,Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019,ATMP (+ Drug),Cells (mesenchymal) + Oseltamivir + Oxygen + Hormones vs. Oseltamivir + Oxygen + Hormones,Cells (mesenchymal); Oseltamivir; Oxygen; Hormones,60,https://clinicaltrials.gov/show/NCT04371601,None
780,1451,NCT04371965,ClinicalTrials.gov,2020-04-29,2020-05-01,False,Poitiers University Hospital,Not Recruiting,Phase 2,Interventional,France,"Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19",Drug,Povidone Iodine,Povidone Iodine,24,https://clinicaltrials.gov/show/NCT04371965,None
781,1452,NCT04371978,ClinicalTrials.gov,2020-04-30,2020-05-15,False,Rabin Medical Center,Not Recruiting,Phase 3,Interventional,Israel,Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19,Drug,Linagliptin,Linagliptin,100,https://clinicaltrials.gov/show/NCT04371978,None
782,1453,NCT04372030,ClinicalTrials.gov,2020-04-22,2020-05-01,False,UCLouvain,Not Recruiting,Not Applicable,Interventional,No Country Given,Health Care Use During the Covid19 Crisis,Health System,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04372030,None
783,1454,NCT04372082,ClinicalTrials.gov,2020-04-30,2020-05-01,False,"University Hospital, Lille",Not Recruiting,Phase 3,Interventional,No Country Given,Hydroxychloroquine or Diltiazem-Niclosamide for the Treatment of COVID-19,Drug,Hydroxychloroquine vs. Diltiazem/Niclosamide,Hydroxychloroquine; Diltiazem/Niclosamide,480,https://clinicaltrials.gov/show/NCT04372082,None
784,1457,NCT04372602,ClinicalTrials.gov,2020-04-30,2020-06-30,False,Washington University in St. Louis,Not Recruiting,Phase 2,Interventional,United States,Duvelisib to Combat COVID-19,Drug,Duvelisib,Duvelisib,25,https://clinicaltrials.gov/show/NCT04372602,None
785,1458,NCT04372680,ClinicalTrials.gov,2020-04-30,2020-04-22,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound,Other (physical),Mechanical ventilation,Mechanical ventilation,200,https://clinicaltrials.gov/show/NCT04372680,None
786,1459,NCT04372693,ClinicalTrials.gov,2020-04-27,2020-02-01,True,Kasr El Aini Hospital,Recruiting,Not Applicable,Interventional,Egypt,Unplanned Shifting to Online Distance Learning: Nursing Students' Perception and Achievement,Other,Other,Other,180,https://clinicaltrials.gov/show/NCT04372693,None
787,1460,NCT04373005,ClinicalTrials.gov,2020-04-30,2020-05-04,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,Screening of Cancer Patients to Assess Impact of COVID-19,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04373005,None
788,1464,NCT04373291,ClinicalTrials.gov,2020-05-01,2020-05-01,True,Bandim Health Project,Not Recruiting,Phase 3,Interventional,No Country Given,Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic,ATMP,Vaccine,Vaccine,1500,https://clinicaltrials.gov/show/NCT04373291,EUCTR2020-001888-90
789,1465,NCT04373382,ClinicalTrials.gov,2020-04-30,2020-06-01,False,"Mount Sinai Hospital, Canada",Not Recruiting,Not Applicable,Interventional,Canada,Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic,Other (psych),Psychological,Psychological,1000,https://clinicaltrials.gov/show/NCT04373382,None
790,1467,NCT04373824,ClinicalTrials.gov,2020-04-26,2020-04-25,True,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Interventional,India,Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study,Drug,Ivermectin,Ivermectin,50,https://clinicaltrials.gov/show/NCT04373824,None
791,1471,NCT04374149,ClinicalTrials.gov,2020-04-20,2020-04-30,False,Prisma Health-Upstate,Not Recruiting,Phase 2,Interventional,No Country Given,Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS,ATMP (+ Drug),Plasma vs. Plasma + Ruxolitinib,Plasma; Ruxolitinib,20,https://clinicaltrials.gov/show/NCT04374149,None
792,1473,NCT04374474,ClinicalTrials.gov,2020-04-29,2020-06-01,False,Lawson Health Research Institute,Not Recruiting,Phase 4,Interventional,Canada,Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,75,https://clinicaltrials.gov/show/NCT04374474,None
793,1474,NCT04374487,ClinicalTrials.gov,2020-04-29,2020-05-09,False,Max Healthcare Insititute Limited,Not Recruiting,Phase 2,Interventional,India,"A Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications",ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04374487,None
794,1475,NCT04374539,ClinicalTrials.gov,2020-05-02,2020-04-29,True,Fundaci Clnic per a la Recerca Biomdica,Recruiting,Phase 2,Interventional,Spain,Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial,ATMP,Plasma,Plasma,116,https://clinicaltrials.gov/show/NCT04374539,None
795,1476,NCT04374552,ClinicalTrials.gov,2020-05-02,2020-05-05,False,Rutgers University,Not Recruiting,Phase 2,Interventional,United States,Asymptomatic COVID-19 Trial,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,140,https://clinicaltrials.gov/show/NCT04374552,None
796,1478,NCT04374903,ClinicalTrials.gov,2020-05-03,2020-05-01,True,King Hussein Cancer Center,Not Recruiting,Not Applicable,Interventional,Jordan,Hydroxychloroquine in Combination With Azithromycin or Sirolimus for Treating COVID-19 Patients,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Sirolimus,Azithromycin; Hydroxychloroquine; Sirolimus,58,https://clinicaltrials.gov/show/NCT04374903,None
797,1480,NCT04375202,ClinicalTrials.gov,2020-04-29,2020-04-18,False,University of Perugia,Recruiting,Phase 2,Interventional,Italy,Colchicine in COVID-19: a Pilot Study,Drug,Colchicine,Colchicine,308,https://clinicaltrials.gov/show/NCT04375202,EUCTR2020-001475-33
798,1481,NCT04251871,ClinicalTrials.gov,2020-01-28,2020-01-22,True,Beijing 302 Hospital,Recruiting,Not Applicable,Interventional,China,Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,150,https://clinicaltrials.gov/show/NCT04251871,None
799,1482,NCT04280705,ClinicalTrials.gov,2020-02-20,2020-02-21,True,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Phase 3,Interventional,"Denmark, United States, Singapore, United Kingdom, Japan, Germany, Mexico, Greece, South Korea, Spain",Adaptive COVID-19 Treatment Trial (ACTT),Drug,Remdesivir,Remdesivir,800,https://clinicaltrials.gov/show/NCT04280705,EUCTR2020-001052-18; JPRN-jRCT2031190264
800,1484,NCT04326790,ClinicalTrials.gov,2020-03-26,2020-04-03,True,National and Kapodistrian University of Athens,Recruiting,Phase 2,Interventional,Gibraltar,The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention,Drug,Colchicine,Colchicine,180,https://clinicaltrials.gov/show/NCT04326790,EUCTR2020-001455-40
801,1485,NCT04333225,ClinicalTrials.gov,2020-04-01,2020-04-03,False,Baylor Research Institute,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,228,https://clinicaltrials.gov/show/NCT04333225,None
802,1486,NCT04333355,ClinicalTrials.gov,2020-03-31,2020-05-25,False,Hospital San Jose Tec de Monterrey,Recruiting,Phase 1,Interventional,Mexico,Safety in Convalescent Plasma Transfusion to COVID-19,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04333355,None
803,1487,NCT04333732,ClinicalTrials.gov,2020-03-31,2020-05-01,True,Washington University in St. Louis,Not Recruiting,Phase 3,Interventional,"Ireland, Australia, United States, United Kingdom, Zambia, South Africa, Canada",CROWN CORONATION: Chloroquine RepurpOsing to healthWorkers for Novel CORONAvirus mitigaTION,Drug (Chemoprophylaxis),Chloroquine/hydroxychloroquine,Chloroquine; hydroxychloroquine,55000,https://clinicaltrials.gov/show/NCT04333732,ISRCTN99916292
804,1488,NCT04336332,ClinicalTrials.gov,2020-03-31,2020-04-01,False,Rutgers University,Recruiting,Phase 2,Interventional,United States,Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19,Drug,Hydroxychloroquine + azithromycin vs. hydroxychloroquine,Hydroxychloroquine; azithromycin,160,https://clinicaltrials.gov/show/NCT04336332,None
805,1489,NCT04336774,ClinicalTrials.gov,2020-04-03,2020-05-01,False,Duke University,Recruiting,Not Applicable,Interventional,United States,CAPTION AI to Minimize Risk of COVID Exposure,Other (software),Other,Other,500,https://clinicaltrials.gov/show/NCT04336774,None
806,1490,NCT04340232,ClinicalTrials.gov,2020-04-03,2020-06-01,False,"University of Colorado, Denver",Not Recruiting,Phase 2/Phase 3,Interventional,United States,Safety and Efficacy of Baricitinib for COVID-19,Drug,Baricitinib,Baricitinib,80,https://clinicaltrials.gov/show/NCT04340232,None
807,1491,NCT04341441,ClinicalTrials.gov,2020-04-07,2020-04-07,False,Henry Ford Health System,Recruiting,Phase 3,Interventional,United States,Will Hydroxychloroquine Impede or Prevent COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,3000,https://clinicaltrials.gov/show/NCT04341441,None
808,1492,NCT04341870,ClinicalTrials.gov,2020-04-06,2020-04-11,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2/Phase 3,Interventional,France,"Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO",Drug,Sarilumab + Azithromycin + Hydroxychloroquine vs. Sarilumab,Sarilumab; azithromycin; hydroxychloroquine,27,https://clinicaltrials.gov/show/NCT04341870,None
809,1495,NCT04343989,ClinicalTrials.gov,2020-04-09,2020-03-31,True,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug,Clazakizumab,Clazakizumab,90,https://clinicaltrials.gov/show/NCT04343989,None
810,1496,NCT04344041,ClinicalTrials.gov,2020-04-09,2020-04-15,True,"University Hospital, Angers",Recruiting,Phase 3,Interventional,France,COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial),Drug,Vitamin D,Vitamin D,260,https://clinicaltrials.gov/show/NCT04344041,EUCTR2020-001602-34
811,1497,NCT04346082,ClinicalTrials.gov,2020-04-07,2020-05-01,False,Chinese University of Hong Kong,Not Recruiting,Not Applicable,Interventional,Hong Kong,Feasibility of Online Based Mindfulness Interventions During COVID-19 Outbreak,Other (psych),Psychological,Psychological,30,https://clinicaltrials.gov/show/NCT04346082,None
812,1498,NCT04348071,ClinicalTrials.gov,2020-04-13,2020-06-01,False,"University of Colorado, Denver",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Safety and Efficacy of Ruxolitinib for COVID-19,Drug,Ruxolitinib,Ruxolitinib,80,https://clinicaltrials.gov/show/NCT04348071,None
813,1499,NCT04349098,ClinicalTrials.gov,2020-04-14,2020-04-17,True,Karyopharm Therapeutics Inc,Recruiting,Phase 2,Interventional,"United States, United Kingdom, France, Austria, Israel, Spain",Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection,Drug,Selinexor,Selinexor,230,https://clinicaltrials.gov/show/NCT04349098,EUCTR2020-001411-25
814,1500,NCT04351906,ClinicalTrials.gov,2020-04-09,2020-05-03,False,University of Giessen,Recruiting,Not Applicable,Interventional,Germany,Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome,Other (device),ECCO2R,ECCO2R,20,https://clinicaltrials.gov/show/NCT04351906,None
815,1503,NCT04354610,ClinicalTrials.gov,2020-04-14,2020-04-27,False,CHU de Nancy,Recruiting,Not Applicable,Interventional,France,Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection,Clinical Presentation,No Intervention,No Intervention,57,https://clinicaltrials.gov/show/NCT04354610,None
816,1504,NCT04355637,ClinicalTrials.gov,2020-04-15,2020-04-21,True,Sara Varea,Recruiting,Phase 4,Interventional,Spain,Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia,Drug,Corticosteroids,Budesonide,300,https://clinicaltrials.gov/show/NCT04355637,EUCTR2020-001616-18
817,1507,NCT04357990,ClinicalTrials.gov,2020-04-20,2020-05-01,False,Kerecis Ltd.,Recruiting,Not Applicable,Interventional,Iceland,Kerecis Oral and Nasal Spray for Treating the Symptoms of COVID-19,Drug,Omega 3,Omega 3,81,https://clinicaltrials.gov/show/NCT04357990,None
818,1512,NCT04363216,ClinicalTrials.gov,2020-04-23,2020-05-01,False,Thomas Jefferson University,Not Recruiting,Phase 2,Interventional,No Country Given,Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment,Drug,Vitamin C,Vitamin C,66,https://clinicaltrials.gov/show/NCT04363216,None
819,1513,NCT04363437,ClinicalTrials.gov,2020-04-23,2020-04-26,False,Maimonides Medical Center,Recruiting,Phase 2,Interventional,United States,COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19,Drug,Colchicine,Colchicine,70,https://clinicaltrials.gov/show/NCT04363437,None
820,1514,NCT04363593,ClinicalTrials.gov,2020-04-24,2020-05-04,False,Centre Hospitalier de Cornouaille,Recruiting,Not Applicable,Interventional,France,Serology COVID-19 From the Cornwall Hospital Union,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3200,https://clinicaltrials.gov/show/NCT04363593,None
821,1515,NCT04365972,ClinicalTrials.gov,2020-04-24,2020-04-23,True,Tel Aviv University,Not Recruiting,Not Applicable,Interventional,Israel,Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic,Other (psych),Psychological,Psychological,20,https://clinicaltrials.gov/show/NCT04365972,None
822,1519,NCT04370015,ClinicalTrials.gov,2020-04-27,2020-05-15,False,"Services Institute of Medical Sciences, Pakistan",Not Recruiting,Not Applicable,Interventional,No Country Given,Hydroxychloroquine Chemoprophylaxis for COVID-19 Infection in High-risk Healthcare Workers.,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,374,https://clinicaltrials.gov/show/NCT04370015,None
823,1522,NCT04371640,ClinicalTrials.gov,2020-04-28,2020-05-01,False,Walter K. Kraft,Recruiting,Phase 1,Interventional,United States,Sirolimus in COVID-19 Phase 1,Drug,Sirolimus,Sirolimus,40,https://clinicaltrials.gov/show/NCT04371640,None
824,1523,NCT04372004,ClinicalTrials.gov,2020-04-29,2020-05-01,False,Texas Cardiac Arrhythmia Research Foundation,Not Recruiting,Not Applicable,Interventional,No Country Given,Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04372004,None
825,1524,NCT04373161,ClinicalTrials.gov,2020-04-30,2020-03-20,True,Swedish Hospital,Not Recruiting,Not Applicable,Interventional,United States,Home Pulse Oximeter Use in Patients With COVID-19,Other (device),Biosensors,Biosensors,209,https://clinicaltrials.gov/show/NCT04373161,None
826,1526,NCT04374019,ClinicalTrials.gov,2020-05-01,2020-05-01,False,Susanne Arnold,Recruiting,Phase 2,Interventional,United States,Novel Agents for Treatment of High-risk COVID-19 Positive Patients,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Ivermectin vs. Hydroxychloroquine vs. Camostat Mesilate,Azithromycin; Hydroxychloroquine; Ivermectin; Camostat Mesilate,240,https://clinicaltrials.gov/show/NCT04374019,None
827,1527,NCT04374032,ClinicalTrials.gov,2020-04-30,2020-05-01,False,Bosnalijek D.D,Recruiting,Phase 2/Phase 3,Interventional,Bosnia and Herzegovina,Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection,Drug,Metenkefalin + Tridecactide,Metenkefalin; Tridecactide,120,https://clinicaltrials.gov/show/NCT04374032,None
828,1531,NCT04374279,ClinicalTrials.gov,2020-05-04,2020-06-01,False,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Not Recruiting,Phase 2,Interventional,United States,Trial to Promote Recovery From COVID-19 With Ivermectin or Endocrine Therapy,Drug,Bicalutamide vs. Ivermectin,Bicalutamide; Ivermectin,60,https://clinicaltrials.gov/show/NCT04374279,None
829,1535,NCT04374942,ClinicalTrials.gov,2020-04-30,2020-04-30,True,Megan Landes,Recruiting,Phase 3,Interventional,Canada,Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus?,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,988,https://clinicaltrials.gov/show/NCT04374942,ISRCTN14326006
830,1539,NCT04375774,ClinicalTrials.gov,2020-04-17,2020-05-01,False,"University Clinic, UCLouvain",Recruiting,Not Applicable,Interventional,Belgium,Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE),Other (device),Masks,Masks,10,https://clinicaltrials.gov/show/NCT04375774,None
831,1541,NCT04376515,ClinicalTrials.gov,2020-03-31,2020-03-20,True,"University of California, Irvine",Not Recruiting,Not Applicable,Interventional,United States,Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19),Other (psych),Psychological,Psychological,300,https://clinicaltrials.gov/show/NCT04376515,None
832,1542,NCT04376593,ClinicalTrials.gov,2020-05-03,2020-05-01,True,"University of California, Davis",Recruiting,Phase 1,Interventional,United States,PET/CT Imaging in COVID-19 Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10,https://clinicaltrials.gov/show/NCT04376593,None
833,1544,NCT04376788,ClinicalTrials.gov,2020-05-01,2020-05-05,False,Ain Shams University,Not Recruiting,Phase 2,Interventional,Egypt,Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19,ATMP,Plasma + Methylene Blue,Plasma; Methylene Blue,15,https://clinicaltrials.gov/show/NCT04376788,None
834,1551,NCT04377308,ClinicalTrials.gov,2020-04-18,2020-05-01,False,University of Toledo,Recruiting,Phase 4,Interventional,United States,Fluoxetine to Reduce Intubation and Death After COVID19 Infection,Drug,Fluoxetine,Fluoxetine,2000,https://clinicaltrials.gov/show/NCT04377308,None
835,1555,NCT04377477,ClinicalTrials.gov,2020-05-04,2020-05-10,False,Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,Recruiting,Not Applicable,Interventional,Italy,COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19),Other,Radiation,Radiation,30,https://clinicaltrials.gov/show/NCT04377477,None
836,1556,NCT04377503,ClinicalTrials.gov,2020-05-02,2020-05-01,True,Hospital Sao Domingos,Not Recruiting,Phase 2,Interventional,No Country Given,Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19,Drug,Tocilizumab vs. Corticosteroids,Tocilizumab; Methylprednisolone,40,https://clinicaltrials.gov/show/NCT04377503,None
837,1558,NCT04377646,ClinicalTrials.gov,2020-05-01,2020-05-04,False,Military Hospital of Tunis,Not Recruiting,Phase 3,Interventional,Tunisia,A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine + Zinc,Hydroxychloroquine + Zinc,660,https://clinicaltrials.gov/show/NCT04377646,None
838,1559,NCT04377750,ClinicalTrials.gov,2020-04-23,2020-04-08,True,Hadassah Medical Organization,Recruiting,Phase 4,Interventional,Israel,The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation,Drug,Tocilizumab,Tocilizumab,500,https://clinicaltrials.gov/show/NCT04377750,None
839,1561,NCT04377802,ClinicalTrials.gov,2020-05-04,2020-05-17,False,King Fahad Specialist Hospital,Not Recruiting,Not Applicable,Interventional,Saudi Arabia,Safe Return to Regular Clinical Operation After COVID-19 Pandemic,Health System,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04377802,None
840,1563,NCT04377997,ClinicalTrials.gov,2020-05-01,2020-05-15,False,Massachusetts General Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19,Drug,Enoxaparin,Enoxaparin,300,https://clinicaltrials.gov/show/NCT04377997,None
841,1564,NCT04378244,ClinicalTrials.gov,2020-05-04,2020-06-12,False,Aveni Foundation,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19,Other,Gene Therapy,Gene Therapy,18,https://clinicaltrials.gov/show/NCT04378244,None
842,1565,NCT04378257,ClinicalTrials.gov,2020-05-02,2020-06-01,False,Sultan Qaboos University,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Therapist Guided e-Therapy Versus Self-Help Therapy on Psychological Distress Among Individuals in Oman During COVID-19 Pandemic,Other (psych),Psychological,Psychological,70,https://clinicaltrials.gov/show/NCT04378257,None
843,1570,NCT04379037,ClinicalTrials.gov,2020-05-05,2020-07-01,False,Nemechek Technologies,Not Recruiting,Not Applicable,Interventional,No Country Given,Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients,Other (device),Vagus nerve stimulation,Vagus nerve stimulation,50,https://clinicaltrials.gov/show/NCT04379037,None
844,1572,NCT04379154,ClinicalTrials.gov,2020-04-28,2020-04-14,True,Hpital Foch,Recruiting,Not Applicable,Interventional,France,Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-CoV-2 (COVID-19),Other,Other,Other,60,https://clinicaltrials.gov/show/NCT04379154,None
845,1576,NCT04379336,ClinicalTrials.gov,2020-05-04,2020-05-04,False,TASK Applied Science,Recruiting,Phase 3,Interventional,South Africa,BCG Vaccination for Healthcare Workers in COVID-19 Pandemic,ATMP,Vaccine,Vaccine,500,https://clinicaltrials.gov/show/NCT04379336,None
846,1579,NCT04379479,ClinicalTrials.gov,2020-05-01,2020-05-01,False,"National Polytechnic Institute, Mexico",Not Recruiting,Phase 2,Interventional,Mexico,Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T),Drug,Dialyzable Leukocyte,Dialyzable Leukocyte,562,https://clinicaltrials.gov/show/NCT04379479,None
847,1580,NCT04379518,ClinicalTrials.gov,2020-05-06,2020-05-30,False,Roswell Park Cancer Institute,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Rintatolimod and IFN Alpha-2b for the Treatment of Mild or Moderate COVID-19 Infection in Cancer Patients,Drug,Interferon alfa + Rintatolimod,Interferon alfa; Rintatolimod,80,https://clinicaltrials.gov/show/NCT04379518,None
848,1581,NCT04379661,ClinicalTrials.gov,2020-05-05,2020-04-03,True,Columbia University,Recruiting,Not Applicable,Interventional,United States,SUNLIGHT Study: Online Support Groups for MS to Address COVID-19,Other,Other,Other,52,https://clinicaltrials.gov/show/NCT04379661,None
849,1582,NCT04380519,ClinicalTrials.gov,2020-05-06,2020-04-23,True,"R-Pharm International, LLC",Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19),Drug,RPH -104 vs. Olokizumab,RPH -104; Olokizumab,372,https://clinicaltrials.gov/show/NCT04380519,None
850,1584,NCT04380948,ClinicalTrials.gov,2020-05-06,2020-07-31,False,Washington University in St. Louis,Not Recruiting,Phase 1,Interventional,United States,"A Pilot Study Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Enhance Immune Clearance of SARS-CoV-2 (COVID-19)",Drug,NT-17,NT-17,30,https://clinicaltrials.gov/show/NCT04380948,None
851,1589,ChiCTR2000033003,ChiCTR,2020-05-17,2020-06-01,False,Beijing TIL Therapeutics,Not Recruiting,Not Applicable,Prevention,China,Novel coronavirus pneumonia (COVID-19) s-vax loaded autologous dendritic cell trial,ATMP,Cells (dendritic),Cells (dendritic),25,http://www.chictr.org.cn/showproj.aspx?proj=53790,None
852,1590,ChiCTR2000032919,ChiCTR,2020-05-15,2020-05-08,True,Wuhan Third Hospital,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, double-blind, placebo-controlled trial for Lu-Dang-Shen oral liquid in the treatment of reduced digestion function of convalescent new coronavirus pneumonia (COVID-19) patient",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=53274,None
853,1591,ChiCTR2000032915,ChiCTR,2020-05-15,2020-05-07,True,Hongqi Hospital Affiliated to Mudangjiang Medical University,Recruiting,Phase 4,Interventional,China,A randomized controlled trial for the efficacy and safety of artemisinin-pipequine tablets in the treatment of the mild and common type novel coronavirus pneumonia (COVID-19) patients whose nCoV Nucleic acid did not turn negative after treated by hydroxychloroquine and Abidor,Drug,Artemisinin/piperaquine,Artemisinin/piperaquine,240,http://www.chictr.org.cn/showproj.aspx?proj=53658,None
854,1595,ChiCTR2000030262,ChiCTR,2020-02-26,2020-02-11,True,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Interventional,China,Clinical study of novel coronavirus (SARS-Cov-2) infection treated with aerosol inhalation (IFN-? plus anti-inflammatory factor TFF2),Drug,Interferon kappa + trefoil factor 2 (a gene-derived protein),Interferon Kappa; Gene-derived protein (trefoil factor 2),140,http://www.chictr.org.cn/showproj.aspx?proj=50136,None
855,1596,ChiCTR2000029638,ChiCTR,2020-02-08,2020-02-10,False,West China Hospital of Sichuan University,Recruiting,Not Applicable,Interventional,China,"A Multicenter, Randomized, Controlled trial for Recombinant Super-Compound Interferon (rSIFN-co) in the Treatment of 2019 Novel Coronavirus (2019-nCoV) Infected Pneumonia",Drug,Interferon,Interferon,100,http://www.chictr.org.cn/showproj.aspx?proj=49224,None
856,1597,ChiCTR2000029605,ChiCTR,2020-02-06,2020-02-06,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Shuang-Huang-Lian oral solution in the treatment of ovel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=49051,None
857,1598,ACTRN12620000555954,ANZCTR,2020-05-11,2020-06-01,False,UNSW Sydney,Not Recruiting,Not Applicable,Interventional,Australia,"Randomised controlled trial of an app-based intervention, Anchored, to support the mental health of Australians recently unemployed due to COVID-19.",Other (psych),Psychological,Psychological,492,https://anzctr.org.au/ACTRN12620000555954.aspx,None
858,1600,ACTRN12620000557932,ANZCTR,2020-05-11,2020-05-18,False,Dr Karin Ried,Not Recruiting,Not Applicable,Interventional,"Australia, Germany, United States","International ALLIANCE Study of Therapies to prevent progression of COVID-19, a randomized trial",Drug,Hydroxychloroquine + Azithromycin + Zinc + Vitamin D + Vitamin B + Vitamin C vs. Hydroxychloroquine + Azithromycin + Zinc + Vitamin D + Vitamin B,Hydroxychloroquine; Azithromycin; Zinc; Vitamin D; Vitamin B; Vitamin C,200,https://anzctr.org.au/ACTRN12620000557932.aspx,None
859,1601,ACTRN12620000566932,ANZCTR,2020-05-14,2020-08-03,False,University of Sydney,Not Recruiting,Phase 3,Interventional,Australia,Randomised clinical trial of interventions for the treatment of COVID-19 in the community setting for high risk older people.,Drug,Hydroxychloroquine,Hydroxychloroquine,3000,https://anzctr.org.au/ACTRN12620000566932.aspx,None
860,1602,IRCT20200314046764N1,IRCT,2020-04-20,2020-04-26,False,Kermanshah University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Pirfenidine in SARS-COV2,Drug,"Interventional: Pirfenidine


Both Arms: Lopinavir/ritonavir + chloroquine + osiltamivir",Pirfenidine; Lopinavir/ritonavir; chloroquine; osiltamivir,40,http://en.irct.ir/trial/46533,None
861,1603,IRCT20150303021315N17,IRCT,2020-04-12,2020-03-15,True,Aryogen Pharmed,Recruiting,Phase 3,Interventional,Iran,Tocilizumab in severe COVID-19,Drug,Tocilizumab,Tocilizumab,85,http://en.irct.ir/trial/46550,None
862,1604,IRCT20200312046749N1,IRCT,2020-03-28,2020-03-27,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of Tumor Necrosis Factor alpha inhibitor in COVID-19,Drug,TNF-alpha inhibitor,TNF-alpha inhibitor,80,http://en.irct.ir/trial/46551,None
863,1605,IRCT20190727044343N2,IRCT,2020-04-19,2020-04-05,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Atorvastatin effect on COVID-19,Drug,Atorvastatin,Atorvastatin,100,http://en.irct.ir/trial/46639,None
864,1606,IRCT20171122037571N2,IRCT,2020-04-12,2020-03-20,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Remdesivir in treatment of COVID-19,Drug,Remdesivir + hydroxychloroquine or chloroquine + lopinavir/ritonavir or atazanavir,Remdesivir; hydroxychloroquine; chloroquine; lopinavir/ritonavir; atazanavir,120,http://en.irct.ir/trial/46660,None
865,1607,IRCT20200324046850N2,IRCT,2020-03-29,2020-03-18,True,Abadan University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Comparison of the effect of Sofosbuvir + Daclatasvir (Sovodac) and Ribavirin in Covid-19,Drug,Daclatasvir/sofosbuvir vs. Ribavirin,Daclatasvir/sofosbuvir; Ribavirin,62,http://en.irct.ir/trial/46713,None
866,1608,IRCT20200323046841N1,IRCT,2020-03-28,2020-03-28,False,Mashhad University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy evaluation of an herbal compound in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46715,None
867,1609,IRCT20200322046833N1,IRCT,2020-04-03,2020-03-28,True,Center for Progress and Development of Iran,Not Recruiting,Phase 3,Interventional,Iran,Umifenovir effectiveness in the treatment of COVID-19,Drug,"Umifenovir

All Arms: Hydroxychloroquine + Atazanavir/Ritonavir",Umifenovir; Hydroxychloroquine; Atazanavir/Ritonavir,100,http://en.irct.ir/trial/46731,None
868,1610,IRCT20160131026298N2,IRCT,2020-04-20,2020-03-10,True,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of PHR spray on patients with coronavirus-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,64,http://en.irct.ir/trial/46733,None
869,1611,IRCT20190804044429N1,IRCT,2020-04-11,2020-03-25,True,Mazandaran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon beta 1b in COVID-19,Drug,"Interventional: Interferon beta

Both Arms: Hydroxychloroquine + lopinavir/ritonavir",Interferon beta; Hydroxychloroquine; lopinavir/ritonavir,70,http://en.irct.ir/trial/46741,None
870,1612,IRCT20160313027033N2,IRCT,2020-04-16,2020-04-02,True,Kerman University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,The effect of MCT Oil on COVID-19,Drug,Medium-chain triglycerides,Medium-chain triglycerides,120,http://en.irct.ir/trial/46762,None
871,1613,IRCT20200204046369N1,IRCT,2020-04-08,2020-04-14,False,Shiraz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Methylprednisolone in treatment of COVID-19 patients,Drug,Corticosteroids,Methylprednisolone,48,http://en.irct.ir/trial/46776,None
872,1614,IRCT20180712040449N2,IRCT,2020-04-01,2020-03-23,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of oral multi-herbal preparation on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,68,http://en.irct.ir/trial/46782,None
873,1615,IRCT20130812014333N145,IRCT,2020-03-30,2020-04-08,False,Kermanshah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparative assessment of the efficacy and safety of add ontreatment with Sofosbuvir standard of care therapeutic regimenVelpatasvir to standard of caretherapeutic regimen in patients with COVID-19,Drug,Sofosbuvir/Velpatasvir with and without Hydroxychloroquine + lopinavir/ritonavir,Sofosbuvir/Velpatasvir; Hydroxychloroquine; lopinavir/ritonavir,80,http://en.irct.ir/trial/46790,None
874,1616,IRCT20200325046859N1,IRCT,2020-04-02,2020-04-04,False,Mashhad University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,The efficacy of intravenous immunoglobulin (IVIg) in patients with severe COVID-19 who have not responded to standard three-drug protocol,ATMP,Plasma,Plasma,50,http://en.irct.ir/trial/46811,None
875,1617,IRCT20161204031229N3,IRCT,2020-04-08,2020-03-30,True,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the Effect of Ticoplanin  in Patients With Coronavirus Disease,Drug,Teicoplanin with and without Hydroxychloroquine + lopinavir/ritonavir or atazanavir,Teicoplanin; Hydroxychloroquine; lopinavir/ritonavir; atazanavir,40,http://en.irct.ir/trial/46814,None
876,1618,IRCT20151228025732N51,IRCT,2020-04-08,2020-03-18,True,Semnan University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,"Effect of Algomed, Menta longifolia, Chamomile, Althaea rosea, Malva sylvestris, Lepidium sativum supplements on the Severity and Consequences of Coronavirus 19 disease (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46828,None
877,1619,IRCT20130917014693N10,IRCT,2020-04-08,2020-04-07,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Hydroxychloroquine administration for COVID-19 prophylaxis,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,100,http://en.irct.ir/trial/46849,None
878,1620,IRCT20180610040049N4,IRCT,2020-04-03,2020-04-07,False,Ghoum University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of Tanacetum parthenium (L) Sch syrup on clinical manifestations of patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46850,None
879,1621,IRCT20130812014333N147,IRCT,2020-04-22,2020-04-08,True,Kermanshah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Comparative assessment of the efficacy and safety of addon treatment with Sofosbuvir-Daclatasvir, Lithium,and Trifluoprazine to standard of care in three groups of patients with COVID-19",Drug,Hydroxychloroquine vs. Hydroxychloroquine + Sofosbuvir/Daclatasvir vs. Hydroxychloroquine + Lithium vs. Hydroxycholoquine + Trifluoprazine,Hydroxychloroquine; Sofosbuvir/Daclatasvir; Lithium; Trifluoprazine,80,http://en.irct.ir/trial/46853,None
880,1622,IRCT20081019001369N2,IRCT,2020-04-07,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of berberine on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/46868,None
881,1623,IRCT20200402046923N1,IRCT,2020-04-09,2020-04-05,True,Tehran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,"Effect of herbal capsule, Viroherb, and herbal syrup, Fenugreek in treatment of COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,110,http://en.irct.ir/trial/46879,None
882,1624,IRCT20200328046886N1,IRCT,2020-04-12,2020-03-05,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effectiveness of Sovodak (sofosbuvir+daclatasvir) in Covid-19 patients,Drug,Daclatasvir/sofosbuvir,Daclatasvir/sofosbuvir,48,http://en.irct.ir/trial/46885,None
883,1625,IRCT20131215015805N2,IRCT,2020-05-04,2020-05-04,False,Shiraz University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Assessment of effect of levamisole on pneumonia caused by COVID-19,Drug,Levamisole,Levamisole,50,http://en.irct.ir/trial/46887,None
884,1626,IRCT20200404046933N1,IRCT,2020-04-12,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation the effect of licorice for treatment of coronavirus,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/46893,None
885,1627,IRCT20200404046937N1,IRCT,2020-04-09,2020-04-09,False,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluating the effect of Marshmallow and Licorice on COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46903,None
886,1628,IRCT20080901001157N16,IRCT,2020-04-08,2020-03-30,True,HomaPharmed  Company,Recruiting,Phase 1/Phase 2,Interventional,Iran,Effect of IMFLUNA herbal compound on covid-19 pneumonia symptoms,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46907,None
887,1629,IRCT20200404046934N1,IRCT,2020-04-13,2020-03-10,True,Qom University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Investigation of the effect of Zufa syrup on clinical symptoms in the with suspected Corona (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,130,http://en.irct.ir/trial/46913,None
888,1630,IRCT20200403046926N1,IRCT,2020-04-11,2020-04-08,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of SOVODAK in the treatment of COVID-19 patients,Drug,Daclatasvir/sofosbuvir + hydroxychloroquine vs. hydroxychloroquine,Daclatasvir/sofosbuvir; hydroxychloroquine,60,http://en.irct.ir/trial/46926,None
889,1631,IRCT20151228025732N53,IRCT,2020-04-10,2020-04-20,False,Semnan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Therapeutic effects of plasma of recovered people from COVID-19 on hospitalized patients with this disease,ATMP,Plasma,Plasma,12,http://en.irct.ir/trial/46931,None
890,1632,IRCT20130306012728N8,IRCT,2020-04-12,2020-04-20,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Post-exposure hydroxycloroquine prophylaxis for Covid 19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,500,http://en.irct.ir/trial/46932,None
891,1633,IRCT20180429039463N2,IRCT,2020-04-10,2020-03-20,True,Torbate-Heidaria University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,"The Impact of Family-Based Empowerment Model on Stress, Anxiety and Satisfaction",Other (psych),Psychological,Psychological,30,http://en.irct.ir/trial/46933,None
892,1634,IRCT20200404046935N1,IRCT,2020-04-20,2020-04-18,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Effect of herbal medicine containing Saatar, Hofarigon and Fennel on COVID-19 patients",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/46940,None
893,1635,IRCT20151227025726N14,IRCT,2020-04-10,2020-04-05,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Favipiravir in COVID-19 patients,Drug,Favipiravir vs. Lopinavir/ritonavir,Favipiravir; Lopinavir/ritonavir,84,http://en.irct.ir/trial/46942,None
894,1636,IRCT20200405046958N1,IRCT,2020-04-14,2020-04-13,True,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Prevention of Novel Coronavirus Disease by Hydroxychloroquine in cancer patients.,Drug,Hydroxychloroquine,Hydroxychloroquine,60,http://en.irct.ir/trial/46946,None
895,1637,IRCT20200406046965N1,IRCT,2020-04-12,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The effect of elderberry syrup against COVID-19 symptoms,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/46958,None
896,1638,IRCT20200405046960N1,IRCT,2020-04-08,2020-04-09,False,Ardabil University of Medical Sciences,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of Kelofan syrup on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,15,http://en.irct.ir/trial/46961,None
897,1639,IRCT20200318046812N2,IRCT,2020-04-08,2020-04-10,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,evaluation of Safety and efficacy of anti inflammatory regimens in COVID-19,Drug,Corticosteroids + naproxen + azithromycin + hydroxychloroquine vs. naproxen + azithromycin + hydroxychloroquine vs. hydroxychloroquine + Lopinavit/ritonavir,Prednisolone; naproxen; azithromycin; hydroxychloroquine; Lopinavit/ritonavir,906,http://en.irct.ir/trial/46968,None
898,1640,IRCT20200317046797N4,IRCT,2020-04-14,2020-04-18,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Bromhexine Hydrochloride on patients with COVID-19,Drug,Bromhexine,Bromhexine,60,http://en.irct.ir/trial/46969,None
899,1641,IRCT20200404046948N1,IRCT,2020-04-15,2020-04-13,True,Artesh University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Efficacy and safety of convalescent plasma in the treatment of COVID-19,ATMP,Plasma,Plasma,60,http://en.irct.ir/trial/46973,None
900,1642,IRCT20180520039738N2,IRCT,2020-04-10,2020-04-07,True,Saveh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation and comparison of the effectiveness of standard treatment with stand treatment plus Vitamin A in treatment in covid19 patients,Drug,Vitamin A,Vitamin A,140,http://en.irct.ir/trial/46974,None
901,1643,IRCT20081019001369N4,IRCT,2020-04-11,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of minocycline on COVID-19,Drug,Minocycline,Minocycline,40,http://en.irct.ir/trial/46977,None
902,1644,IRCT20081019001369N3,IRCT,2020-04-11,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of crocetin on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/46978,None
903,1645,IRCT20200408046992N1,IRCT,2020-04-14,2020-04-16,False,Birjand University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Trifluoperazine in treatment of COVID-19,Drug,Trifluoprazine + Hydroxychloroquine vs. Hydroxychloroquine,Trifluoprazine; hydroxychloroquine,70,http://en.irct.ir/trial/47006,None
904,1646,IRCT20200408046987N1,IRCT,2020-04-27,2020-05-04,False,Chistasazan Notash Fartak Company Limited.,Recruiting,Phase 3,Interventional,Iran,Dose-Finding Study of Ivermectin in the Treatment of COVID-19,Drug,Ivermectin,Ivermectin,100,http://en.irct.ir/trial/47012,None
905,1647,IRCT20180129038542N1,IRCT,2020-04-13,2020-04-06,True,University of Baqiyatallah,Not Recruiting,Not Applicable,Interventional,Iran,Early tracheostomy in COVID-19,Other (physical),Mechanical ventilation,Mechanical ventilation,30,http://en.irct.ir/trial/47013,None
906,1648,IRCT20200317046797N3,IRCT,2020-04-11,2020-04-20,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Intravenous immunoglobulin (IVIG) in the treatment of COVID-19-induced cytokine storm,ATMP,"Interventional: Immunoglobulin

Both Arms: hydroxychloroquine + ribavirin + lopinavir/ritonavir",Immunoglobulin; hydroxychloroquine; ribavirin; lopinavir/ritonavir,100,http://en.irct.ir/trial/47014,None
907,1649,IRCT20200317046797N5,IRCT,2020-04-19,2020-04-20,False,Tabriz University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Treatment of COVID-19-induced cytokine storm by hemoperfusion,Other (device),Hemoperfusion,Hemoperfusion,10,http://en.irct.ir/trial/47015,None
908,1650,IRCT20200404046937N2,IRCT,2020-04-13,2020-04-13,False,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluating the effect of Phyllanthus Emblica on COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47016,None
909,1651,IRCT20180923041093N5,IRCT,2020-04-10,2020-04-15,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation the efficacy of hot foot-bath on COVID-19,Procedure,Foot bath,Foot bath,60,http://en.irct.ir/trial/47018,None
910,1652,IRCT20160131026298N3,IRCT,2020-04-30,2020-05-04,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Evaluation of the effect of Iranian medicine product, Algro, on patients with coronavirus 19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/47019,None
911,1653,IRCT20200406046968N1,IRCT,2020-04-14,2020-04-21,False,Tabriz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,The  effect of IL-6 inhibitor (Tocilizumab) on the prognosis of covid-19 patients with acute respiratory failure hospitalized in Imam Reza Hospital in Tabriz,Drug,Tocilizumab,Tocilizumab,10,http://en.irct.ir/trial/47021,None
912,1654,IRCT20150808023559N20,IRCT,2020-04-11,2020-04-29,False,Ardabil University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra in  hospitalized patients with COVID-19,Drug,Favipravir + hydroxychloroquine vs. lopinavir/ritonavir + hydroxychloroquine,Favipravir; hydroxychloroquine; lopinavir/ritonavir,100,http://en.irct.ir/trial/47022,None
913,1655,IRCT20130616013690N7,IRCT,2020-05-01,2020-05-02,False,Shiraz University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of interactive psycho-educational interventions on patients infected with COVID-19,Other (psych),Psychological,Psychological,50,http://en.irct.ir/trial/47034,None
914,1656,IRCT20200410047009N1,IRCT,2020-04-26,2020-04-13,True,Iran University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,The effect of Naproxen in recovery and reducing mortality in patients with COVID-19,Drug,"Naproxen w/ and w/o Hydroxychloroquine, Oseltamivir, Lopinavir/ritonavir, chloroquine, ribavirin",Naproxen; Hydroxychloroquine; Oseltamivir; Lopinavir/ritonavir; chloroquine; ribavirin,101,http://en.irct.ir/trial/47052,None
915,1657,IRCT20200409047007N1,IRCT,2020-04-12,2020-04-13,False,Mashhad University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of COVID 19 survivors plasma in COVID 19 patients with ARDS,ATMP,Plasma,Plasma,32,http://en.irct.ir/trial/47058,None
916,1658,IRCT20200408046990N1,IRCT,2020-04-18,2020-05-19,False,Mashhad University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of SinaCurcumin capsule efficacy as an supplement therapy for mild to moderate COVID-19 in Mashhad,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47061,None
917,1659,IRCT20200411047025N1,IRCT,2020-04-14,2020-04-18,False,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Intravenous vitamin c in Patients with COVID-19,Drug,Vitamin C + Hydroxychloroquine + Atazanavir/ritonavir vs. Hydroxychloroquine + Atazanavir/ritonavir,Vitamin C; Hydroxychloroquine; Atazanavir/ritonavir,110,http://en.irct.ir/trial/47078,None
918,1660,IRCT20080901001165N46,IRCT,2020-04-15,2020-03-30,True,Center for Progress and Development of Iran,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Umifenovir in controlling the symptoms of patients with COVID-19,Drug,Umifenovir,Umifenovir,200,http://en.irct.ir/trial/47087,None
919,1661,IRCT20200406046963N1,IRCT,2020-04-22,2020-03-30,True,Artesh University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of methylprednisolone pulse therapy in treatment of Covid-19 patients with Acute respiratory distress syndrome,Drug,Hydroxychloroquine + Corticosteroids vs. Hydroxychloroquine,Methylprednisolone; Hydroxychloroquine,40,http://en.irct.ir/trial/47088,None
920,1662,IRCT20190122042450N4,IRCT,2020-04-16,2020-04-20,False,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of hydroxychloroquine to prevent coronavirus disease,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1000,http://en.irct.ir/trial/47090,None
921,1663,IRCT20200411047030N1,IRCT,2020-04-17,2020-04-14,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of melatonin on the quality of sleep in COVID-19 patients,Drug,Melatonin + Hydroxychloroquine + Azithormycin vs. Hydroxychloroquine + Azithormycin,Melatonin; Hydroxychloroquine; azithormycin,82,http://en.irct.ir/trial/47099,None
922,1664,IRCT20200406046968N2,IRCT,2020-04-22,2020-05-04,False,Tabriz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of convalescent plasma transfusion of COVID-19 survivors on the treatment of respiratory failure of these patients,ATMP,Plasma,Plasma,30,http://en.irct.ir/trial/47115,None
923,1665,IRCT20200413047053N1,IRCT,2020-04-15,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation the effect of asafoetida in the treatment of coronavirus infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47139,None
924,1666,IRCT20081019001369N5,IRCT,2020-04-26,2020-05-02,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of lithium carbonate  on COVID-19,Drug,Lithium,Lithium,40,http://en.irct.ir/trial/47141,None
925,1667,IRCT20200408046988N1,IRCT,2020-04-29,2020-04-14,True,Gonabad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the efficacy of melatonin tablets as auxiliary medication in accelerating the improvement of the COVID-19 symptoms and clinical findings,Drug,Melatonin + Hydroxychloroquine vs. Hydroxychloroquine,Melatonin; Hydroxychloroquine,60,http://en.irct.ir/trial/47142,None
926,1668,IRCT20200413047062N1,IRCT,2020-05-04,2020-04-13,True,Islamic Azad University,Not Recruiting,Phase 3,Interventional,Iran,Effect of Atorvastatin in treatment of COVID-19 infection,Drug,Atorvastatin,Atorvastatin,76,http://en.irct.ir/trial/47146,None
927,1669,IRCT20191125045492N2,IRCT,2020-04-18,2020-04-23,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Ozone therapy in treatment of COVID-19,Drug,Ozone,Ozone,80,http://en.irct.ir/trial/47149,None
928,1670,IRCT20200406046968N3,IRCT,2020-05-08,2020-04-29,True,Zist Daru Danesh Company,Recruiting,Phase 2,Interventional,Iran,effect of Interfron-beta1(zifron) on clinical improvement and prognosis of COVID-19 in Tabriz Imam-Reza hospital,Drug,Interferon beta + Hydroxycholoquine + Lopinavir/ritonavir vs. Hydroxycholoquine + Lopinavir/ritonavir,Interferon beta; Hydroxycholoquine; Lopinavir/ritonavir,60,http://en.irct.ir/trial/47152,None
929,1671,IRCT20200413047063N1,IRCT,2020-05-04,2020-03-20,True,National Institute for Medical Research Development,Recruiting,Phase 1/Phase 2,Interventional,Iran,Placental Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection: A Phase 1-2 Clinical Trial,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://en.irct.ir/trial/47156,None
930,1672,IRCT20200413047052N1,IRCT,2020-05-07,2020-05-04,True,Esfahan University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,"The effectiveness of educational-treatment package based on psychological flexibility in burnout, quality of working life, work-family conflict and mental health",Other (psych),Psychological,Psychological,60,http://en.irct.ir/trial/47160,None
931,1673,IRCT20200414047072N1,IRCT,2020-04-28,2020-04-14,True,Hilton Pharma Pvt. Ltd.,Recruiting,Not Applicable,Interventional,Pakistan,Use of Convalescent Plasma in the treatment of COVID-19,ATMP,Plasma,Plasma,357,http://en.irct.ir/trial/47163,None
932,1674,IRCT20200414047070N1,IRCT,2020-04-21,2020-05-04,False,Fasa University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of ppd on recovery of covid disease 19,Drug,Tuberculin w/ and w/o Chloroquine + Lopinavir/ritonavir,Tuberculin; Chloroquine; Lopinavir/ritonavir,50,http://en.irct.ir/trial/47169,None
933,1675,IRCT20170210032478N3,IRCT,2020-04-29,2020-04-18,True,National Research Institute of Tuberculosis and Lung Diseases,Recruiting,Phase 3,Interventional,Iran,Effect of  Formoterol in treatment of covid19,Drug,Formoterol,Formoterol,50,http://en.irct.ir/trial/47173,None
934,1676,IRCT20200415047082N1,IRCT,2020-04-21,2020-05-04,False,Jahrom University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Effect evaluation of herbal supplementation from the combination of sugarcane, black myrobalan and mastic along with the treatment protocol of the Ministry of Health on the course of coronavirus disease",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,10,http://en.irct.ir/trial/47193,None
935,1677,IRCT20200413047056N1,IRCT,2020-04-17,2020-04-18,False,Birjand University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparison between the efficacy of intravenous immunoglobulin and convalescent plasma in COVID-19,ATMP,Plasma vs. Immunoglobulin,Plasma; Immunoglobulin,15,http://en.irct.ir/trial/47212,None
936,1678,IRCT20200418047116N1,IRCT,2020-05-04,2020-03-10,True,Gonabad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The effect of Intravenous immunoglobulin on COVID-19 infection,ATMP,Immunoglobulin,Immunoglobulin,20,http://en.irct.ir/trial/47219,None
937,1679,IRCT20200415047089N1,IRCT,2020-04-19,2020-04-18,True,Saveh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of herbal drugs (Echinacea and Ginger) on Improvement of clinical symptoms and hospitalizations in suspected COVID-19 outpatient cases,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/47234,None
938,1680,IRCT20200415047092N1,IRCT,2020-04-20,2020-04-24,False,Tehran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of azithromycin in treatment of COVID19,Drug,Azithromycin +  Oseltamivir + Lopinavir/ritonavir or Atazanavir + Hydroxychloroquine vs. Oseltamivir + Lopinavir/ritonavir or Atazanavir + Hydroxychloroquine,Azithromycin; oseltamivir; lopinavir/ritonavir; atazanavir; hydroxychloroquine,110,http://en.irct.ir/trial/47244,None
939,1681,IRCT20200416047104N1,IRCT,2020-04-23,2020-04-20,True,Shahre-kord University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of pomegranate tea on symptom relief of COVID-19 patients,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,66,http://en.irct.ir/trial/47251,None
940,1682,IRCT20200417047113N1,IRCT,2020-04-24,2020-04-27,False,Middle East Gene Therapy Corporation,Recruiting,Phase 1/Phase 2,Interventional,Iran,Effect of NK cell therapy in COVID-19,ATMP,Cells (NK),Cells (NK),70,http://en.irct.ir/trial/47264,None
941,1683,IRCT20200416047099N1,IRCT,2020-04-21,2020-04-05,True,Shahid Beheshti University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Plasma therapy in patient with COVID-19,ATMP,Plasma,Plasma,10,http://en.irct.ir/trial/47266,None
942,1684,IRCT20200418047122N1,IRCT,2020-05-03,2020-04-25,True,Esfahan University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Evaluation of the therapeutic effect of a combination drug including Apocynin, Niacin, and Tannin on COVID-19",Drug,Apocynin + Niacin + Tannin,Apocynin; Niacin; Tannin,80,http://en.irct.ir/trial/47268,None
943,1685,IRCT20200418047121N2,IRCT,2020-05-05,2020-05-09,False,Kermanshah University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Stem cell therapy in COVID-19,ATMP,Cells (stem cells),Cells (stem cells),6,http://en.irct.ir/trial/47275,None
944,1686,IRCT20140407017169N2,IRCT,2020-04-28,2020-04-30,False,Social Development and Health Promotion Research Center,Recruiting,Not Applicable,Interventional,Iran,Effect of natural from Tahini oil product on corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/47295,None
945,1687,IRCT20200329046892N1,IRCT,2020-05-02,2020-05-04,False,Rasht University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Trifluoperazine Effectiveness in Treatment of Coronavirus,Drug,Trifluoperazine,Trifluoperazine,70,http://en.irct.ir/trial/47300,None
946,1688,IRCT20080901001165N48,IRCT,2020-04-22,2020-03-30,True,Niak Pharmaceutical Company,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy of Zofa (a herbal medicine) in symptom management of patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/47318,None
947,1689,IRCT20151222025660N2,IRCT,2020-05-04,2020-04-13,True,Arak University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The prophylactic effect of Hydroxychloroquine on Novel Corona virus,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,140,http://en.irct.ir/trial/47319,None
948,1690,IRCT20200420047147N1,IRCT,2020-04-23,2020-05-04,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,?Evaluation the effects of Sitagliptin administration in patients with COVID-19,Drug,Sitagliptin + Hydroxychloroquine + Lopinavir/ritonavir vs. Hydroxychloroquine + Lopinavir/ritonavir,Sitagliptin; Hydroxychloroquine; Lopinavir/ritonavir,84,http://en.irct.ir/trial/47334,None
949,1691,IRCT20200421047155N1,IRCT,2020-04-25,2020-04-29,False,Ardabil University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Efficacy of tenofovir in covid-19,Drug,Tenofovir vs. Hydroxychloroquine,Tenofovir vs. Hydroxychloroquine,86,http://en.irct.ir/trial/47387,None
950,1692,IRCT20080901001165N49,IRCT,2020-04-25,2020-03-30,True,Andisheh Salamat Sabalan Medicinal Plants Company,Recruiting,Not Applicable,Interventional,Iran,"Evaluation efficacy of a herbal combination (contains Glycyrrhiza glabra, Mentha pulegium and Urtica) in controlling symptoms in patients with COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/47401,None
951,1693,IRCT20200422047168N1,IRCT,2020-04-29,2020-04-18,True,Ahvaz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Clinical trial study on the therapeutic effect of Tenofovir besides Kaletra and Chloroquinein in patients with Coronavirus disease 2019 (COVID-19),Drug,Tenofovir + Chloroquine + Lopinavir/ritonavir vs. Chloroquine + Lopinavir/ritonavir,Tenofovir; Chloroquine; Lopinavir/ritonavir,60,http://en.irct.ir/trial/47437,None
952,1694,IRCT20200408046990N2,IRCT,2020-04-25,2020-04-29,False,Mashhad University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the colchicine tablet efficacy as an adjuvant therapy for patients with mild to moderate COVID-19,Drug,Colchicine,Colchicine,40,http://en.irct.ir/trial/47468,None
953,1695,IRCT20180114038350N3,IRCT,2020-05-01,2020-05-04,False,Sanandaj University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Deferiprone on the improvement of symptoms of Coronavirus 2019 (COVID 19),Drug,Deferiprone,Deferiprone,80,http://en.irct.ir/trial/47475,None
954,1696,IRCT20200426047206N1,IRCT,2020-04-28,2020-05-09,False,Hamedan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of NBS powder in treatment of patients with  COVID-19,Supplement (+ Drug),NBS Powder vs. Hydroxychloroquine + Lopinavir/ritonavir,NBS Powder; Hydroxychloroquine; Lopinavir/ritonavir,46,http://en.irct.ir/trial/47495,None
955,1697,IRCT20120215009014N353,IRCT,2020-04-27,2020-05-14,False,Hamedan University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of plasma of patients recovered from covid-19 versus control group on treatment of covid-19,ATMP,Plasma,Plasma,100,http://en.irct.ir/trial/47501,None
956,1698,IRCT20140305016852N4,IRCT,2020-05-04,2020-04-20,True,Sabzevar University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of three methods of treatment in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with and without coronavirus positive test,Drug,Vitamin D vs. Vitamin C,Vitamin D; Vitamin C,30,http://en.irct.ir/trial/47508,None
957,1699,IRCT20180425039414N2,IRCT,2020-05-13,2020-04-20,True,Esfahan University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of zinc on the treatment and clinical course of patients with SARS-cov2 (COVID-19),Drug,Hydroxychloroqine + Zinc vs. Hydroxychloroquine,Hydroxychloroqine; Zinc,80,http://en.irct.ir/trial/47516,None
958,1700,IRCT20200427047215N1,IRCT,2020-05-05,2020-05-08,False,Isfahan University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation effect of Indomethacin for Covid19 infection,Drug,Indomethacin,Indomethacin,60,http://en.irct.ir/trial/47520,None
959,1701,IRCT20121216011763N46,IRCT,2020-05-04,2020-05-04,False,Esfahan University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of curcumin-piperine in patients with coronavirus(COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/47529,None
960,1702,IRCT20200426047212N1,IRCT,2020-05-02,2020-05-04,False,Shooshtar University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of of Inhalation of Thyme Oil in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,48,http://en.irct.ir/trial/47572,None
961,1703,IRCT20080901001165N50,IRCT,2020-05-01,2020-05-01,False,Sina Darou Laboratories Company,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Azithromycin inhaled spray in controlling the symptoms of patients with COVID-19,Drug,Azithromycin,Azithromycin,80,http://en.irct.ir/trial/47576,None
962,1704,IRCT20080901001165N51,IRCT,2020-05-01,2020-05-01,False,Sina Darou Laboratories Company,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Hydroxychloroquine nasal spray in controlling the symptoms of patients with COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,80,http://en.irct.ir/trial/47577,None
963,1705,IRCT20200418047121N1,IRCT,2020-05-01,2020-05-09,False,Kermanshah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Study the effectiveness of concomitant use of vitamin C, metformin, azithromycin and doxycycline on improving patients with COVID-19",Drug,Vitamin C + Metformin + Azithromycin + Doxycycline,Vitamin C; Metformin; Azithromycin; Doxycycline,40,http://en.irct.ir/trial/47578,None
964,1706,IRCT20150808023559N21,IRCT,2020-05-09,2020-05-12,False,Ardabil University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,The Effect of Convalescent Plasma Therapy on  Patients with 19-COVID,ATMP,Plasma,Plasma,60,http://en.irct.ir/trial/47594,None
965,1707,IRCT20200501047258N1,IRCT,2020-05-04,2020-05-04,False,Oroumia University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,effects of  convalescent plasma in COVID-19,ATMP,Plasma,Plasma,120,http://en.irct.ir/trial/47629,None
966,1708,IRCT20131129015584N2,IRCT,2020-05-08,2020-04-04,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of herbal syrup on patients with corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,152,http://en.irct.ir/trial/47639,None
967,1709,IRCT20080901001165N52,IRCT,2020-05-05,2020-04-20,True,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy of high dose of glucocorticoid in patients with moderate to severe pneumonia related to COVID-19,Drug,Corticosteroids,Methylprednisolone; Prednisone,50,http://en.irct.ir/trial/47641,None
968,1710,IRCT20160706028815N5,IRCT,2020-05-05,2020-05-20,False,Sabzevar University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,The effect of addition of selenium to treatment regimen of hospitalized patients with corona on the outcome of disease compared with control group,Drug,Selenium,Selenium,40,http://en.irct.ir/trial/47682,None
969,1711,IRCT20171213037866N2,IRCT,2020-05-07,2020-05-09,False,Semnan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of jujube product on Covid-19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,68,http://en.irct.ir/trial/47684,None
970,1712,IRCT20200326046868N1,IRCT,2020-05-09,2020-05-21,False,Abadan University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,effect of propolis  in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,88,http://en.irct.ir/trial/47934,None
971,1713,IRCT20200508047346N1,IRCT,2020-05-13,2020-05-21,False,Kowsar Biotechnology Co.,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of rabbit antibody against coronavirus in patients,ATMP,Antibodies,Antibodies,124,http://en.irct.ir/trial/47953,None
972,1714,IRCT20120215009014N354,IRCT,2020-05-12,2020-06-04,False,Hamedan University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,"Evaluating the effect of intravenous hydrocortisone, methylprednisolone, and dexamethasone in treatment of patients with moderate to severe acute respiratory distress syndrome caused by COVID-19",Drug,Corticosteroids,Hydrocortisone; Methylprednisolone; Dexamethasone,81,http://en.irct.ir/trial/48043,None
973,1716,KCT0005003,CRIS,2020-05-11,2020-05-25,False,Gyeongsang National University Hospital,Not Recruiting,Phase 2,Interventional,South Korea,Clinical efficacy of Nafamostat for COVID-19 pneumonia,Drug,Nafamostat w/ or w/o Lopinavir / ritonavir + Hydroxychloroquine + Oxygen,Nafamostat; Lopinavir/ritonavir; Hydroxychloroquine; Oxygen,84,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16635,None
974,1721,JPRN-UMIN000040235,JPRN,2020-04-25,2020-04-23,True,Yuri Kumiai General Hospital,Recruiting,Not Applicable,Interventional,Japan,Examination of test accuracy of COVID-19 rapid antibody kit,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,20,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045901,None
975,1724,JPRN-UMIN000040286,JPRN,2020-05-11,2020-05-12,False,University of Tokyo,Not Recruiting,Not Applicable,Interventional,Japan,Study on risk perception and behavioral change related to COVID-19,Other (psych),No Intervention,No Intervention,1980,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045966,None
976,1728,JPRN-UMIN000040401,JPRN,2020-05-15,2020-05-15,False,Tokyo Medical and Dental University,Recruiting,Not Applicable,Interventional,Japan,A feasibility study of remote rehabilitation using a wearable biological monitoring device in the patients with COVID-19,Other (device),Wearable,Wearable,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046104,None
977,1729,CTRI/2020/03/024402,CTRI,2020-03-31,2020-04-08,False,Dr. Remesh Bhasi,Not Recruiting,Phase 3,Interventional,India,"Hydroxy Chloroquine, in open labelled, Randomised intervention for prevention of new infection and adverse outcomes following COVID-19 infection -A Tertiary Hospital based study",Drug,Hydroxychloroquine,Hydroxychloroquine,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42638,None
978,1733,CTRI/2020/04/024479,CTRI,2020-04-07,2020-04-13,False,Command Hospital Airforce,Not Recruiting,Not Applicable,Interventional,India,Study of the effect of Chloroquine in addition to standard therapy in COVID-19 patients,Drug,Chloroquine,Chloroquine,32,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42713,None
979,1735,CTRI/2020/04/024659,CTRI,2020-04-15,2020-04-27,False,SSV Phytopharmaceuticals,Not Recruiting,Phase 3,Interventional,India,Study of Shreepad Shree Vallabh SSV Formulation to improve immunity in quarantine patients of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42967,None
980,1737,CTRI/2020/04/024731,CTRI,2020-04-20,2020-04-24,False,Parul University,Not Recruiting,Phase 3,Interventional,India,Study to Evaluate Preventive Effect of Ayurveda and Homeopathy Treatment in COVID 19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42912,None
981,1738,CTRI/2020/04/024729,CTRI,2020-04-20,2020-04-21,False,All India Institute of Medical Sciences,Not Recruiting,Phase 2,Interventional,India,"Topical Chloroquine Nasal Drops in Early Stage Covid 19-
Impact on Viral load and cure rates
",Drug,Chloroquine,Chloroquine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42933,None
982,1740,CTRI/2020/04/024747,CTRI,2020-04-21,2020-05-01,False,GSL Medical College,Not Recruiting,Not Applicable,Interventional,India,EFFECTIVENESS TO MANAGE COVID 19 PANDEMIC BY  TEACHING  VENTILATORY MANAGEMENT TO NON-ANAESTHESIOLOGY RESIDENTS,Other,Other,Other,26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43115,None
983,1741,CTRI/2020/04/024775,CTRI,2020-04-21,2020-04-22,False,Indian Council Of Medical Research,Not Recruiting,Phase 2,Interventional,India,Study to assess the efficacy and safety of convalescent plasma in moderate COVID-19 disease.,ATMP,Plasma,Plasma,452,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43149,None
984,1742,CTRI/2020/04/024749,CTRI,2020-04-21,2020-04-21,False,Serum Institute of India Pvt Ltd,Not Recruiting,Phase 3,Interventional,India,Study to Evaluate the Efficacy of Recombinant BCG VPM1002 in Reducing Infection Incidence and Disease Severity of SARS-COV-2/COVID-19 Among High-Risk Subjects,ATMP,Vaccine,Vaccine,5946,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42972,None
985,1743,CTRI/2020/04/024806,CTRI,2020-04-22,2020-04-26,False,All India Institute of Medical Sciences,Recruiting,Phase 2,Interventional,India,Imatinib in COVID-19 infection,Drug,Imatinib,Imatinib,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42843,None
986,1744,CTRI/2020/04/024804,CTRI,2020-04-22,2020-04-30,False,International Stemcell Services Ltd,Not Recruiting,Phase 1/Phase 2,Interventional,India,Evaluation of safety and efficacy of convalescent plasma in COVID-19 patients,ATMP,Plasma,Plasma,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42849,None
987,1745,CTRI/2020/04/024776,CTRI,2020-04-22,2020-04-23,False,Dr. Mahesh Mahich,Recruiting,Not Applicable,Interventional,India,"Novel Artificial Intelligence Algorithm to screen COVID-19 Patients from X-Ray , CT-Scan of Thorax and Voice Sampling through Android App and storage through Cloud",Other (software),eHealth,eHealth,1650,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43160,None
988,1748,CTRI/2020/04/024833,CTRI,2020-04-24,2020-05-01,False,Dr. Narayanan Parameswaran,Not Recruiting,Not Applicable,Interventional,India,BCG-Denmark versus no-BCG for COVID 19 prevention,ATMP,Vaccine,Vaccine,1826,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43105,None
989,1749,CTRI/2020/04/024846,CTRI,2020-04-24,2020-04-30,False,Cadila Pharnmaceuticals,Recruiting,Not Applicable,Interventional,India,A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients,Drug,Mycobacterium,Mycobacterium,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43004,None
990,1750,CTRI/2020/04/024857,CTRI,2020-04-25,2020-05-04,False,Welling Healthcare Private Limited,Not Recruiting,Phase 1/Phase 2,Interventional,India,Proving the efficacy of  Homeopathic treatment in prevention and cure of COVID-19.,Other,Homeopathy,Homeopathy,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43212,None
991,1752,CTRI/2020/04/024858,CTRI,2020-04-25,2020-04-25,False,Max Super Speciality Hospital (Devki Devi Foundation),Not Recruiting,Not Applicable,Interventional,India,"??To study the effectiveness of Ivermectin with standard of care treatment
versus standard of care treatment for COVID 19 cases. A Pilot Study",Drug,Ivermectin,Ivermectin,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43236,None
992,1753,CTRI/2020/04/024882,CTRI,2020-04-27,2020-04-28,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3,Interventional,India,A study to assess the effectiveness of Ayurvedic formulation in addition to standard of care in COVID-19 positive patients in a tertiary hospital.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42899,None
993,1754,CTRI/2020/04/024904,CTRI,2020-04-28,2020-05-11,False,Director General Armed Forces Medical Services,Not Recruiting,Phase 3,Interventional,India,Treatment of COVID19 : A randomised controlled trial,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43130,None
994,1755,CTRI/2020/04/024883,CTRI,2020-04-28,2020-04-29,False,Pankajakasthuri Herbal Research Foundation,Recruiting,Phase 4,Interventional,India,Clinical research on safety and efficacy of ZingiVir-H as an add on therapy in COVID-19 patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,112,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43168,None
995,1757,CTRI/2020/04/024915,CTRI,2020-04-29,2020-05-09,False,Max Super Speciality Hospital (Devki Devi Foundation),Not Recruiting,Phase 2,Interventional,India,"A Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications",ATMP,Plasma,Plasma,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43332,None
996,1758,CTRI/2020/04/024948,CTRI,2020-04-30,2020-05-15,False,Lady Hardinge Medical College,Not Recruiting,Phase 2,Interventional,India,"A clinical Trial to Study the Effects of Hydroxychloroquine, Ciclesonide and Ivermectin in treatment of moderate COVID-19 illness",Drug,Hydroxychloroquine vs. Ciclesonide vs. Ivermectin,Hydroxychloroquine; Ciclesonide; Ivermectin,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43364,None
997,1759,CTRI/2020/04/024949,CTRI,2020-04-30,2020-05-15,False,Lady Hardinge Medical College,Not Recruiting,Phase 2,Interventional,India,A study to evaluate the effect of Oral Niclosamide in mild and very mild COVID-19 cases,Drug,Niclosamide,Niclosamide,48,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43400,None
998,1760,CTRI/2020/04/024947,CTRI,2020-04-30,2020-05-08,False,Dr. Priti Katre,Not Recruiting,Phase 3,Interventional,India,Clinical trial on effects of homeopathic medicine made from cadamba on COVID-19,Other,Homeopathy,Homeopathy,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43259,None
999,1761,CTRI/2020/05/024967,CTRI,2020-05-01,2020-05-11,False,MiLab LifeSciences,Not Recruiting,Phase 4,Interventional,India,Clinical trial on Immunity and antiviral for quarantine patients of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43338,None
1000,1762,CTRI/2020/05/024959,CTRI,2020-05-01,2020-05-01,False,Biocon Limited,Recruiting,Phase 2,Interventional,India,Efficacy and Safety of Itolizumab in COVID-19 Complications,Drug,Itolizumab,Itolizumab,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42878,None
1001,1763,CTRI/2020/05/024969,CTRI,2020-05-01,2020-05-10,False,Naiminath Homoeopathic Medical College Hospital and Research Centre,Not Recruiting,Phase 2/Phase 3,Interventional,India,Homoeopathy as adjuvant in management of Covid-19 infection,Other,Homeopathy,Homeopathy,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43393,None
1002,1764,CTRI/2020/05/024962,CTRI,2020-05-01,2020-05-05,False,Win medicare,Not Recruiting,Not Applicable,Interventional,India,The use of topical Povidone Iodine (PVP-I) oropharyngeal and intranasal application during the current coronavirus pandemic as a potential measure to reduce viral transmission,Drug,Povidone Iodine,Povidone Iodine,96,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43237,None
1003,1765,CTRI/2020/05/024981,CTRI,2020-05-02,2020-05-15,False,Dabur India Ltd,Not Recruiting,Not Applicable,Interventional,India,Clinical study on Dabur Chyawanprash as a preventive remedy in pandemic of Covid-19.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43374,None
1004,1767,CTRI/2020/05/024983,CTRI,2020-05-02,2020-05-05,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,"Usage of topical lignocaine to decrease the gag reflex
while sampling for Covid-19: Does it affect the yield of

specimen?",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43204,None
1005,1771,CTRI/2020/05/024986,CTRI,2020-05-04,2020-05-13,False,Central Council for Research in Homoeopathy,Not Recruiting,Not Applicable,Interventional,India,HOMOEOPATHY IN PREVENTION OF COVID-19,Other,Homeopathy,Homeopathy,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43455,None
1006,1772,CTRI/2020/05/025013,CTRI,2020-05-05,2020-05-06,False,Haffkine Institute for Training Research and Testing,Not Recruiting,Phase 2,Interventional,India,Evaluation of BCG as potential therapy for COVID-19,ATMP,Vaccine,Vaccine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42858,None
1007,1773,CTRI/2020/05/025022,CTRI,2020-05-05,2020-05-06,False,All India Institute of Medical Sciences,Not Recruiting,Phase 2,Interventional,India,Hydroxychloroquine in patients with mild COVID-19 illness with risk factors for severe disease,Drug,Hydroxychloroquine,Hydroxychloroquine,166,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43183,None
1008,1774,CTRI/2020/05/025067,CTRI,2020-05-06,2020-06-15,False,George Institute for Global Health India,Not Recruiting,Not Applicable,Interventional,India,A randomized controlled trial of hydroxychloroquine prophylaxis for Healthcare Workers exposed to COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,10990,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43019,None
1009,1776,CTRI/2020/05/025049,CTRI,2020-05-06,2020-05-08,False,Sai Nidan Homeopathy Clinic,Not Recruiting,Phase 2/Phase 3,Interventional,India,A CLINICAL TRIAL TO STUDY THE EFFICACY OF HOMOEOPATHIC MEDICINE IN PREVENTION AND CURE OF CORONA VIRUS DISEASE 19,Other,Homeopathy,Homeopathy,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43313,None
1010,1777,CTRI/2020/05/025069,CTRI,2020-05-07,2020-05-16,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 3/Phase 4,Interventional,India,Ayurvedic Interventions in prevention of COVID-19 infection-A survey study,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1324,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43522,None
1011,1779,CTRI/2020/05/025068,CTRI,2020-05-07,2020-05-27,False,Christian Medical College Vellore,Not Recruiting,Phase 3,Interventional,India,Can a medicine help in curing viral infection,Drug,Ivermectin,Ivermectin,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43449,None
1012,1780,CTRI/2020/05/025071,CTRI,2020-05-08,2020-05-16,False,All India Institute of Medical Sciences,Not Recruiting,Phase 3,Interventional,India,Clinical trial evaluating two ventilator settings in Corona virus related severe lung diseases ( known as ARDS),Other (physical),Mechanical ventilation,Mechanical ventilation,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43447,None
1013,1781,CTRI/2020/05/025088,CTRI,2020-05-09,2020-05-20,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 1/Phase 2,Interventional,India,Study of GUDUCHI TABLET on healthy individuals to prevent covid 19.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43555,None
1014,1783,CTRI/2020/05/025093,CTRI,2020-05-11,2020-05-18,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 2/Phase 3,Interventional,India,Study of effect of Yashtimadhu tablet for the prevention of COVID -19 on healthy individuals.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43539,None
1015,1786,CTRI/2020/05/025114,CTRI,2020-05-12,2020-05-20,False,Glenmark Pharmaceuticals Ltd,Not Recruiting,Phase 3,Interventional,India,A Clinical Study on Favipiravir Compared to Standard Supportive Care in Patients With Mild to Moderate COVID-19.,Drug,Favipiravir,Favipiravir,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43504,None
1016,1787,CTRI/2020/05/025156,CTRI,2020-05-13,2020-05-18,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 3/Phase 4,Interventional,India,Effect of Ayurveda intervention AYUSH-64 add-on therapy for patients with COVID-19 infection (Stage I),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43590,None
1017,1788,CTRI/2020/05/025162,CTRI,2020-05-13,2020-05-26,False,Jawaharlal Institute of Postgraduate Medical Education and Research,Not Recruiting,Not Applicable,Interventional,India,Effect of pranayama and meditation on psychological well-being of healthcare workers during COVID-19 pandemic.,Other (psych),Psychological,Psychological,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43650,None
1018,1789,CTRI/2020/05/025161,CTRI,2020-05-13,2020-05-16,False,Ms Shukla Ashar Impex Pvt Ltd,Not Recruiting,Phase 2,Interventional,India,To study the Effectiveness of herbal formulation - Aayudh Advance as a supplementary treatment for the Corona Virus 2019 (Covid-19) infected patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43442,None
1019,1790,CTRI/2020/05/025166,CTRI,2020-05-14,2020-05-19,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 2/Phase 3,Interventional,India,Study of ASHWAGANDHA TABLET on healthy individuals to prevent covid 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43553,None
1020,1791,CTRI/2020/05/025178,CTRI,2020-05-14,2020-05-18,False,All India Institute of Ayurveda,Not Recruiting,Phase 2,Interventional,India,Evaluation of the Immuno-Stimulatory Potential (Shareera Bala) of an Ayurveda Management Protocol in Cohort of Quarantined Delhi Police under Covid-19 Care Centers- An Exploratory Clinical Study,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43557,None
1021,1792,CTRI/2020/05/025167,CTRI,2020-05-14,2020-05-17,False,Intas Pharmaceuticals Ltd,Not Recruiting,Phase 2,Interventional,India,Evaluation of Efficacy and Safety of Thymoquinone compared to Best supportive care in Patients with COVID-19,Drug,Thymoquinone,Thymoquinone,32,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43378,None
1022,1793,CTRI/2020/05/025171,CTRI,2020-05-14,2020-05-16,False,All India Institute of Ayurveda,Not Recruiting,Phase 2,Interventional,India,Ayurveda protocol & COVID-19 exposed individuals: Clinical trial of an Ayurveda Intervention,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43487,None
1023,1794,NCT04273321,ClinicalTrials.gov,2020-02-15,2020-02-14,True,"Beijing Chaoyang Hospital, Capital Medical University",Not Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Corticosteroids in COVID-19,Drug,Corticosteroids,Methylprednisolone,86,https://clinicaltrials.gov/show/NCT04273321,None
1024,1795,NCT04278963,ClinicalTrials.gov,2020-02-19,2020-02-27,False,China Academy of Chinese Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,China,Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,https://clinicaltrials.gov/show/NCT04278963,None
1025,1796,NCT04310865,ClinicalTrials.gov,2020-03-15,2020-11-01,False,Zhong Wang,Not Recruiting,Phase 2/Phase 3,Interventional,China,Yinhu Qingwen Granula for the Treatment of Severe CoVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,116,https://clinicaltrials.gov/show/NCT04310865,None
1026,1797,NCT04322396,ClinicalTrials.gov,2020-03-23,2020-04-06,False,Chronic Obstructive Pulmonary Disease Trial Network,Recruiting,Phase 2,Interventional,Denmark,Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine + Azithromycin,Hydroxychloroquine; azithromycin,226,https://clinicaltrials.gov/show/NCT04322396,None
1027,1798,NCT04334512,ClinicalTrials.gov,2020-04-02,2020-05-01,False,ProgenaBiome,Not Recruiting,Phase 2,Interventional,United States,A Study of Quintuple Therapy to Treat COVID-19 Infection,Drug,Hydroxychloroquine + azithromycin + vitamin C + vitamin D + zinc,Hydroxychloroquine; azithromycin; vitamin C; vitamin D; zinc,600,https://clinicaltrials.gov/show/NCT04334512,None
1028,1799,NCT04335084,ClinicalTrials.gov,2020-04-02,2020-05-01,False,ProgenaBiome,Not Recruiting,Phase 2,Interventional,United States,"A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection",Drug,Hydroxychloroquine + vitamin C + vitamin D + zinc,Hydroxychloroquine; vitamin C; vitamin D; zinc,600,https://clinicaltrials.gov/show/NCT04335084,None
1029,1801,NCT04340544,ClinicalTrials.gov,2020-04-03,2020-04-22,True,"University Hospital, Tbingen",Recruiting,Phase 3,Interventional,Germany,Hydroxychloroquine for the Treatment of Mild COVID-19 Disease,Drug,Hydroxychloroquine,Hydroxychloroquine,2700,https://clinicaltrials.gov/show/NCT04340544,EUCTR2020-001512-26
1030,1802,NCT04344015,ClinicalTrials.gov,2020-04-09,2020-04-13,False,Thomas Jefferson University,Recruiting,Not Applicable,Interventional,United States,COVID-19 Plasma Collection,ATMP,Plasma,Plasma,2000,https://clinicaltrials.gov/show/NCT04344015,None
1031,1803,NCT04346147,ClinicalTrials.gov,2020-04-07,2020-04-13,False,Hospital Universitario de Fuenlabrada,Recruiting,Phase 2,Interventional,Spain,Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19,Drug,"Lopinavir/ritonavir vs. Imatinib vs. Baricitinib

All in comibination with Hydroxychloroquine ",Hydroxychloroquine; Lopinavir/ritonavir; Imatinib; Baricitinib,165,https://clinicaltrials.gov/show/NCT04346147,None
1032,1804,NCT04346199,ClinicalTrials.gov,2020-04-09,2020-05-11,True,AstraZeneca,Not Recruiting,Phase 2,Interventional,"Italy, Spain, France",Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.,Drug,Acalabrutinib,Acalabrutinib,140,https://clinicaltrials.gov/show/NCT04346199,PER-018-20; EUCTR2020-001644-25
1033,1805,NCT04347915,ClinicalTrials.gov,2020-04-14,2020-05-06,False,Bukwang Pharmaceutical,Recruiting,Phase 2,Interventional,South Korea,The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19,Drug,Clevudine vs. Hydroxychloroquine,Clevudine; Hydroxychloroquine,60,https://clinicaltrials.gov/show/NCT04347915,None
1034,1807,NCT04354389,ClinicalTrials.gov,2020-04-15,2020-05-25,False,"Ansun Biopharma, Inc.",Not Recruiting,Phase 2/Phase 3,Interventional,Italy,DAS181 for STOP COVID-19,Drug,DAS181,DAS181,82,https://clinicaltrials.gov/show/NCT04354389,None
1035,1809,NCT04356690,ClinicalTrials.gov,2020-04-17,2020-05-08,False,Boston Medical Center,Recruiting,Phase 2,Interventional,United States,Etoposide in Patients With COVID-19 Infection,Drug,Etoposide,Etoposide,64,https://clinicaltrials.gov/show/NCT04356690,None
1036,1810,NCT04365985,ClinicalTrials.gov,2020-04-26,2020-04-29,False,William Beaumont Hospitals,Recruiting,Phase 2,Interventional,United States,Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19,Drug,"Ketamine, Naltrexone",Ketamine; Naltrexone,500,https://clinicaltrials.gov/show/NCT04365985,None
1037,1811,NCT04366271,ClinicalTrials.gov,2020-04-23,2020-05-07,True,Hospital Infantil Universitario Nio Jess,Recruiting,Phase 2,Interventional,Spain,Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),106,https://clinicaltrials.gov/show/NCT04366271,EUCTR2020-001450-22
1038,1814,NCT04373135,ClinicalTrials.gov,2020-04-30,2020-05-08,False,"University of California, Los Angeles",Recruiting,Not Applicable,Interventional,United States,"Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19",Other,Other,Other,1000,https://clinicaltrials.gov/show/NCT04373135,None
1039,1815,NCT04375046,ClinicalTrials.gov,2020-05-01,2020-08-01,False,Kafrelsheikh University,Not Recruiting,Phase 1,Interventional,No Country Given,Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2,Drug,ACE enzyme,ACE enzyme,24,https://clinicaltrials.gov/show/NCT04375046,None
1040,1817,NCT04376476,ClinicalTrials.gov,2020-04-28,2020-05-05,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Interventional,France,Host-pathogen Interactions During SARS-CoV-2 Infection,Clinical Presentation,No Intervention,No Intervention,450,https://clinicaltrials.gov/show/NCT04376476,None
1041,1821,NCT04379271,ClinicalTrials.gov,2020-05-01,2020-05-01,True,Immunic AG,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)",Drug,Vidofludimus calcium,Vidofludimus calcium,230,https://clinicaltrials.gov/show/NCT04379271,EUCTR2020-001264-28
1042,1822,NCT04379453,ClinicalTrials.gov,2020-04-27,2020-04-27,False,Hospital Israelita Albert Einstein,Recruiting,Not Applicable,Interventional,Brazil,Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses,Procedure,Percutaneous Cardiovascular Intervention,Percutaneous Cardiovascular Intervention,10,https://clinicaltrials.gov/show/NCT04379453,None
1043,1823,NCT04379492,ClinicalTrials.gov,2020-05-05,2020-05-05,False,Memorial Sloan Kettering Cancer Center,Recruiting,Phase 2,Interventional,United States,A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,120,https://clinicaltrials.gov/show/NCT04379492,None
1044,1825,NCT04380376,ClinicalTrials.gov,2020-05-06,2020-04-30,True,"Federal State Budgetary Institution, Pulmonology Scientific Research Institute",Recruiting,Phase 2,Interventional,Russian Federation,Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia,Drug,Melphalan,Melphalan,60,https://clinicaltrials.gov/show/NCT04380376,None
1045,1826,NCT04380688,ClinicalTrials.gov,2020-05-07,2020-05-12,False,AstraZeneca,Not Recruiting,Phase 2,Interventional,United States,Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.,Drug,Acalabrutinib,Acalabrutinib,60,https://clinicaltrials.gov/show/NCT04380688,None
1046,1832,NCT04380909,ClinicalTrials.gov,2020-05-07,2020-05-06,True,University of Bern,Recruiting,Not Applicable,Interventional,Switzerland,ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation,Other (psych),Psychological,Psychological,80,https://clinicaltrials.gov/show/NCT04380909,None
1047,1833,NCT04380935,ClinicalTrials.gov,2020-05-04,2020-05-11,False,Indonesia University,Not Recruiting,Phase 2/Phase 3,Interventional,Indonesia,Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04380935,None
1048,1835,NCT04381000,ClinicalTrials.gov,2020-05-07,2020-04-01,True,Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory,Recruiting,Not Applicable,Interventional,Greece,Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic.,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,170,https://clinicaltrials.gov/show/NCT04381000,None
1049,1836,NCT04381052,ClinicalTrials.gov,2020-05-06,2020-05-01,True,Columbia University,Not Recruiting,Phase 2,Interventional,United States,Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug,Clazakizumab,Clazakizumab,30,https://clinicaltrials.gov/show/NCT04381052,None
1050,1840,NCT04381338,ClinicalTrials.gov,2020-05-04,2020-05-10,False,University of Padova,Not Recruiting,Not Applicable,Interventional,Italy,Rehabilitation for People With COVID-19 in ICU,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,92,https://clinicaltrials.gov/show/NCT04381338,None
1051,1841,NCT04381364,ClinicalTrials.gov,2020-05-07,2020-05-15,True,Dr. Ola Blennow,Not Recruiting,Phase 2,Interventional,Sweden,Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19),Drug,Ciclesonide,Ciclesonide,446,https://clinicaltrials.gov/show/NCT04381364,EUCTR2020-001928-34
1052,1842,NCT04381377,ClinicalTrials.gov,2020-05-07,2020-04-29,True,NPO Petrovax,Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,Efficacy and Safety of Polyoxidonium in Hospitalized Patients With Coronavirus Disease COVID-19,Drug,Azoximer bromide,Azoximer bromide,394,https://clinicaltrials.gov/show/NCT04381377,None
1053,1844,NCT04381858,ClinicalTrials.gov,2020-05-06,2020-05-06,False,Centenario Hospital Miguel Hidalgo,Recruiting,Phase 3,Interventional,Mexico,Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia,ATMP,Plasma vs. Immunoglobulin,Plasma; Immunoglobulin,500,https://clinicaltrials.gov/show/NCT04381858,None
1054,1845,NCT04381871,ClinicalTrials.gov,2020-05-08,2020-06-01,False,Al-Neelain University,Not Recruiting,Phase 2/Phase 3,Interventional,Sudan,Potential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 Patients,Drug,Gum Arabic,Gum Arabic,110,https://clinicaltrials.gov/show/NCT04381871,None
1055,1846,NCT04382092,ClinicalTrials.gov,2020-05-06,2020-03-23,True,"University Clinic, UCLouvain",Not Recruiting,Not Applicable,Interventional,Belgium,Co-infection Management in COVID-19 Critically Ill,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,32,https://clinicaltrials.gov/show/NCT04382092,None
1056,1847,NCT04382131,ClinicalTrials.gov,2020-05-08,2020-05-01,True,University of Edinburgh,Not Recruiting,Not Applicable,Interventional,United Kingdom,Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19,Procedure,Nasal irrigation,Nasal irrigation,405,https://clinicaltrials.gov/show/NCT04382131,None
1057,1852,NCT04382560,ClinicalTrials.gov,2020-05-05,2020-05-02,True,University of Parma,Recruiting,Not Applicable,Interventional,Italy,Coping Strategies and Responsiveness to a Brief Online Intervention During COVID-19 Pandemic,Other (psych),Psychological,Psychological,100,https://clinicaltrials.gov/show/NCT04382560,None
1058,1853,NCT04382625,ClinicalTrials.gov,2020-04-14,2020-05-01,False,Kootenai Health,Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial,Drug,Hydroxychloroquine,Hydroxychloroquine,120,https://clinicaltrials.gov/show/NCT04382625,None
1059,1854,NCT04382729,ClinicalTrials.gov,2020-05-08,2020-04-17,True,University of Turin,Recruiting,Not Applicable,Interventional,Italy,Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,80,https://clinicaltrials.gov/show/NCT04382729,None
1060,1855,NCT04382755,ClinicalTrials.gov,2020-05-07,2020-05-01,True,"University Hospital, Ghent",Not Recruiting,Phase 2,Interventional,Belgium,Zilucoplan in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure,Drug,Zilucoplan,Zilucoplan,81,https://clinicaltrials.gov/show/NCT04382755,None
1061,1857,NCT04382846,ClinicalTrials.gov,2020-05-07,2020-05-08,False,Tanta University,Not Recruiting,Phase 3,Interventional,No Country Given,Novel Regimens in COVID-19 Treatment,Drug,Nitazoxanide + Azithromycin vs. Ivermectin + Chloroquine vs. Ivermectin + Nitazoxanide vs. Nitazoxanide + Ivermectin + Azithromycin,Nitazoxanide + Ivermectin + Azithromycin + Chloroquine,80,https://clinicaltrials.gov/show/NCT04382846,None
1062,1858,NCT04382924,ClinicalTrials.gov,2020-05-08,2020-07-01,False,Algernon Pharmaceuticals,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Confirmed COVID-19 Infected Hospitalized Patients,Drug,Ifenprodil,Ifenprodil,462,https://clinicaltrials.gov/show/NCT04382924,None
1063,1859,NCT04383002,ClinicalTrials.gov,2020-05-01,2020-05-01,False,"University Health Network, Toronto",Not Recruiting,Phase 1,Interventional,No Country Given,High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients),Drug,Nitric Oxide,Nitric Oxide,20,https://clinicaltrials.gov/show/NCT04383002,None
1064,1860,NCT04383574,ClinicalTrials.gov,2020-05-09,2020-05-20,False,"Sinovac Research and Development Co., Ltd.",Not Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19),ATMP,Vaccine,Vaccine,422,https://clinicaltrials.gov/show/NCT04383574,None
1065,1861,NCT04383587,ClinicalTrials.gov,2020-05-07,2020-05-06,True,Mayo Clinic,Recruiting,Not Applicable,Interventional,United States,Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04383587,None
1066,1867,NCT04384380,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Taoyuan General Hospital,Recruiting,Phase 4,Interventional,Taiwan,Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,45,https://clinicaltrials.gov/show/NCT04384380,None
1067,1870,NCT04384549,ClinicalTrials.gov,2020-05-06,2020-05-11,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 3,Interventional,France,Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers,ATMP,Vaccine,Vaccine,1120,https://clinicaltrials.gov/show/NCT04384549,EUCTR2020-001678-31
1068,1871,NCT04384588,ClinicalTrials.gov,2020-04-29,2020-04-07,True,Fundacion Arturo Lopez Perez,Recruiting,Phase 2/Phase 3,Interventional,Chile,COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID),ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04384588,None
1069,1873,NCT04385576,ClinicalTrials.gov,2020-04-28,2020-05-15,False,University of Malaya,Recruiting,Not Applicable,Interventional,Malaysia,"Taiwan ""Aerosol Box"" Versus UMMC ""Intubation Box""",Other (physical),Mechanical ventilation,Mechanical ventilation,30,https://clinicaltrials.gov/show/NCT04385576,None
1070,1879,NCT04328961,ClinicalTrials.gov,2020-03-23,2020-03-31,False,University of Washington,Recruiting,Phase 2/Phase 3,Interventional,United States,Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP),Drug (Chemoprophylaxis),Hydroxychloroquine vs. Vitamin C,Hydroxychloroquine; Vitamin C,2000,https://clinicaltrials.gov/show/NCT04328961,None
1071,1881,NCT04334148,ClinicalTrials.gov,2020-04-02,2020-04-22,False,Adrian Hernandez,Recruiting,Phase 3,Interventional,United States,Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,15000,https://clinicaltrials.gov/show/NCT04334148,None
1072,1882,NCT04335097,ClinicalTrials.gov,2020-04-01,2020-04-22,False,Lars Wik,Recruiting,Not Applicable,Interventional,Norway,Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation,Other (device),Biosensors,Biosensors,214,https://clinicaltrials.gov/show/NCT04335097,None
1073,1885,NCT04340050,ClinicalTrials.gov,2020-04-07,2020-04-10,False,University of Chicago,Not Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04340050,None
1074,1886,NCT04340349,ClinicalTrials.gov,2020-04-02,2020-05-11,False,Instituto Nacional de Rehabilitacion,Recruiting,Phase 1,Interventional,Mexico,Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals,Drug (Chemoprophylaxis),Hydroxychloroquine + bromhexine vs. bromhexine,Hydroxychloroquine; bromhexine,140,https://clinicaltrials.gov/show/NCT04340349,None
1075,1887,NCT04341415,ClinicalTrials.gov,2020-04-07,2020-04-09,False,Fondation Ophtalmologique Adolphe de Rothschild,Recruiting,Not Applicable,Interventional,France,Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome,Procedure,Auricular neuromodulation,Auricular neuromodulation,60,https://clinicaltrials.gov/show/NCT04341415,None
1076,1888,NCT04342728,ClinicalTrials.gov,2020-04-08,2020-04-08,False,The Cleveland Clinic,Recruiting,Not Applicable,Interventional,United States,Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation,Drug,Zinc + Vitamin C vs Zinc vs. Vitamin C,Zinc; vitamin C,520,https://clinicaltrials.gov/show/NCT04342728,None
1077,1892,NCT04347538,ClinicalTrials.gov,2020-04-11,2020-05-01,False,Vanderbilt University,Recruiting,Not Applicable,Interventional,United States,Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19,Procedure,Saline Nasal Irrigation,Saline Nasal Irrigation,90,https://clinicaltrials.gov/show/NCT04347538,None
1078,1893,NCT04350476,ClinicalTrials.gov,2020-04-14,2020-07-01,False,Vivek Reddy,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Remote Monitoring,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04350476,None
1079,1894,NCT04352348,ClinicalTrials.gov,2020-03-31,2020-03-31,False,Assistance Publique  Hpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being,Prognosis,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04352348,None
1080,1895,NCT04352751,ClinicalTrials.gov,2020-04-16,2020-05-01,False,Hilton Pharma,Recruiting,Not Applicable,Interventional,Pakistan,Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020,ATMP,Plasma,Plasma,2000,https://clinicaltrials.gov/show/NCT04352751,None
1081,1896,NCT04352933,ClinicalTrials.gov,2020-04-07,2020-05-11,True,Cambridge University Hospitals NHS Foundation Trust,Recruiting,Phase 3,Interventional,United Kingdom,PROLIFIC ChemoprophylaxisTrial (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1000,https://clinicaltrials.gov/show/NCT04352933,EUCTR2020-001331-26
1082,1897,NCT04353206,ClinicalTrials.gov,2020-04-16,2020-05-01,False,Noah Merin,Recruiting,Phase 1,Interventional,United States,Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04353206,None
1083,1898,NCT04354259,ClinicalTrials.gov,2020-04-16,2020-05-13,False,"University Health Network, Toronto",Recruiting,Phase 2,Interventional,Canada,Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19,Drug,Interferon lambda,Interferon lambda,140,https://clinicaltrials.gov/show/NCT04354259,None
1084,1899,NCT04354831,ClinicalTrials.gov,2020-04-14,2020-05-11,False,Medical College of Wisconsin,Recruiting,Phase 2,Interventional,United States,A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection,ATMP,Plasma,Plasma,131,https://clinicaltrials.gov/show/NCT04354831,None
1085,1902,NCT04357457,ClinicalTrials.gov,2020-04-20,2020-05-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 3,Interventional,France,Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia,Drug,Almitrine,Almitrine,212,https://clinicaltrials.gov/show/NCT04357457,EUCTR2020-001909-22
1086,1905,NCT04362085,ClinicalTrials.gov,2020-04-20,2020-05-11,False,"St. Michael's Hospital, Toronto",Recruiting,Phase 3,Interventional,Canada,Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care,Drug,Heparin,Heparin,462,https://clinicaltrials.gov/show/NCT04362085,None
1087,1908,NCT04364009,ClinicalTrials.gov,2020-04-17,2020-04-27,True,CHU de Tours,Recruiting,Phase 3,Interventional,France,Anakinra for COVID-19 Respiratory Symptoms,Drug,Anakinra,Anakinra,240,https://clinicaltrials.gov/show/NCT04364009,EUCTR2020-001734-36
1088,1910,NCT04364802,ClinicalTrials.gov,2020-04-25,2020-04-29,False,Alexandra Kejner,Recruiting,Phase 2,Interventional,United States,COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients,Drug,Povidone Iodine,Povidone Iodine,250,https://clinicaltrials.gov/show/NCT04364802,None
1089,1912,NCT04365257,ClinicalTrials.gov,2020-04-24,2020-05-13,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Prazosin to Prevent COVID-19 (PREVENT-COVID Trial),Drug,Prazosin,Prazosin,220,https://clinicaltrials.gov/show/NCT04365257,None
1090,1914,NCT04365517,ClinicalTrials.gov,2020-04-14,2020-05-29,False,University of Milan,Not Recruiting,Phase 3,Interventional,Italy,The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients,Drug,Sitagliptin,Sitagliptin,170,https://clinicaltrials.gov/show/NCT04365517,None
1091,1916,NCT04367077,ClinicalTrials.gov,2020-04-27,2020-04-28,False,"Athersys, Inc",Recruiting,Phase 2/Phase 3,Interventional,United States,MultiStem Administration for COVID-19 Induced ARDS (MACoVIA),ATMP,Cells (stem cells),Cells (stem cells),400,https://clinicaltrials.gov/show/NCT04367077,None
1092,1918,NCT04378712,ClinicalTrials.gov,2020-04-29,2020-01-21,True,Guangzhou Institute of Respiratory Disease,Not Recruiting,Not Applicable,Interventional,China,Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19),Drug,Hydrogen + Oxygen,Hydrogen; Oxygen,90,https://clinicaltrials.gov/show/NCT04378712,None
1093,1920,NCT04378920,ClinicalTrials.gov,2020-05-05,2020-04-14,True,Institut de Cancrologie Strasbourg Europe (ICANS),Recruiting,Phase 1/Phase 2,Interventional,France,A Study of Trans Crocetin in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Disease (LEAF-4L7520/4L6715),Drug,Trans Crocetin,Trans Crocetin,180,https://clinicaltrials.gov/show/NCT04378920,None
1094,1921,NCT04379076,ClinicalTrials.gov,2020-05-05,2020-05-14,False,Revimmune,Recruiting,Phase 2,Interventional,United Kingdom,InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort,Drug,CYT107,CYT107,48,https://clinicaltrials.gov/show/NCT04379076,None
1095,1924,NCT04381988,ClinicalTrials.gov,2020-05-08,2020-05-07,True,Memorial Sloan Kettering Cancer Center,Recruiting,Phase 2,Interventional,United States,A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy,Drug,Hydroxychloroquine,Hydroxychloroquine,132,https://clinicaltrials.gov/show/NCT04381988,None
1096,1925,NCT04382391,ClinicalTrials.gov,2020-04-14,2020-05-08,False,Allegheny Singer Research Institute,Recruiting,Not Applicable,Interventional,United States,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,Other (device),Vagus nerve stimulation,Vagus nerve stimulation,20,https://clinicaltrials.gov/show/NCT04382391,None
1097,1929,NCT04384731,ClinicalTrials.gov,2020-05-07,2020-05-27,False,Dr. Christophe Lenclud,Not Recruiting,Phase 2,Interventional,No Country Given,Curosurf in Adult Acute Respiratory Distress Syndrome Due to COVID-19,Drug,Poractant alfa,Poractant alfa,20,https://clinicaltrials.gov/show/NCT04384731,None
1098,1931,NCT04384900,ClinicalTrials.gov,2020-05-11,2020-05-11,False,"Copenhagen University Hospital, North Zealand",Recruiting,Not Applicable,Interventional,Denmark,Accelerated Prone Position Ventilation of Patients With COVID-19,Procedure,Positioning,Positioning,150,https://clinicaltrials.gov/show/NCT04384900,None
1099,1933,NCT04385017,ClinicalTrials.gov,2020-05-10,2020-05-11,False,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Role of Inflammasomes in COVID-19 Disease,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04385017,None
1100,1934,NCT04385043,ClinicalTrials.gov,2020-05-04,2020-05-01,True,University of Catanzaro,Recruiting,Phase 2/Phase 3,Interventional,Italy,Hyperimmune Plasma in Patients With COVID-19 Severe Infection,ATMP,Plasma,Plasma,400,https://clinicaltrials.gov/show/NCT04385043,None
1101,1936,NCT04385095,ClinicalTrials.gov,2020-04-24,2020-03-16,False,Synairgen Research Limited,Recruiting,Phase 2,Interventional,United Kingdom,Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection,Drug,Interferon beta,Interferon beta,400,https://clinicaltrials.gov/show/NCT04385095,EUCTR2020-001023-14; ISRCTN14241621
1102,1937,NCT04385108,ClinicalTrials.gov,2020-05-05,2020-05-12,False,"University Hospital, Toulouse",Not Recruiting,Not Applicable,Interventional,France,Predictive Immune Biomarkers for COVID-19 Pathogenesis,Clinical Presentation,No Intervention,No Intervention,170,https://clinicaltrials.gov/show/NCT04385108,None
1103,1939,NCT04385199,ClinicalTrials.gov,2020-05-09,2020-05-04,True,Henry Ford Health System,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for Patients With COVID-19,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04385199,None
1104,1940,NCT04385264,ClinicalTrials.gov,2020-04-21,2020-05-12,False,University of Lausanne,Not Recruiting,Phase 2/Phase 3,Interventional,Switzerland,#StayHome: Early Hydroxychloroquine to Reduce Secondary Hospitalisation and Household Transmission in COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,800,https://clinicaltrials.gov/show/NCT04385264,None
1105,1941,NCT04385771,ClinicalTrials.gov,2020-04-19,2020-06-01,False,Dr. Alexander Supady,Not Recruiting,Not Applicable,Interventional,Germany,Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,Other (device),Cytokine Adsorber,Cytokine Adsorber,80,https://clinicaltrials.gov/show/NCT04385771,None
1106,1946,NCT04386070,ClinicalTrials.gov,2020-04-30,2020-05-15,True,University of Birmingham,Not Recruiting,Phase 3,Interventional,No Country Given,Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,Drug,Lopinavir/ritonavir vs. Hydroxychloroquine vs. Lopinavir/ritonavir + Hydroxychloroquine,Lopinavir/ritonavir; Hydroxychloroquine,6400,https://clinicaltrials.gov/show/NCT04386070,EUCTR2020-001448-24
1107,1949,NCT04386239,ClinicalTrials.gov,2020-05-07,2020-05-01,True,ASST Fatebenefratelli Sacco,Not Recruiting,Phase 1,Interventional,No Country Given,Study on the Use of Sarilumab in Patients With COVID-19 Infection,Drug,Sarilumab,Sarilumab,40,https://clinicaltrials.gov/show/NCT04386239,None
1108,1957,NCT04387292,ClinicalTrials.gov,2020-05-12,2020-06-01,False,Fondation Ophtalmologique Adolphe de Rothschild,Recruiting,Not Applicable,Interventional,France,Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04387292,None
1109,1961,NCT04387955,ClinicalTrials.gov,2020-04-29,2020-05-01,False,Poitiers University Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Analysis of Chilblains pROfile During coVID-19 Epidemic (ACROVID),Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04387955,None
1110,1963,NCT04388410,ClinicalTrials.gov,2020-05-12,2020-06-01,False,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19,ATMP,Plasma,Plasma,250,https://clinicaltrials.gov/show/NCT04388410,None
1111,1969,NCT04389294,ClinicalTrials.gov,2020-05-08,2020-05-05,True,"Hospital for Special Surgery, New York",Recruiting,Not Applicable,Interventional,United States,HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists,Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04389294,None
1112,1971,NCT04389359,ClinicalTrials.gov,2020-05-12,2020-05-01,True,Cambridge University Hospitals NHS Foundation Trust,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,PROphylaxis for paTiEnts at Risk of COVID-19 infecTion,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1500,https://clinicaltrials.gov/show/NCT04389359,None
1113,1972,NCT04389671,ClinicalTrials.gov,2020-05-13,2020-06-01,False,Windtree Therapeutics,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,The Safety and Preliminary Efficacy of Lucinactant in Adults With COVID-19,Drug,Lucinactant,Lucinactant,30,https://clinicaltrials.gov/show/NCT04389671,None
1114,1973,NCT04390139,ClinicalTrials.gov,2020-05-07,2020-05-13,False,Banc de Sang i Teixits,Recruiting,Phase 1/Phase 2,Interventional,Spain,Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04390139,None
1115,1975,NCT04390178,ClinicalTrials.gov,2020-04-10,2020-04-10,False,Joakim Dillner,Not Recruiting,Phase 1/Phase 2,Interventional,Sweden,Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19),ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04390178,None
1116,1976,NCT04390191,ClinicalTrials.gov,2020-05-12,2020-05-07,True,Icahn School of Medicine at Mount Sinai,Recruiting,Not Applicable,Interventional,United States,Early CPAP in COVID-19 Confirmed or Suspected Patients,Other (device),CPAP,CPAP,200,https://clinicaltrials.gov/show/NCT04390191,None
1117,1977,NCT04394039,ClinicalTrials.gov,2020-05-13,2020-06-01,False,"National University, Singapore",Not Recruiting,Not Applicable,Interventional,Singapore,Post-Pandemic Perception of Public Space in Singapore,Other,No Intervention,No Intervention,34,https://clinicaltrials.gov/show/NCT04394039,None
1118,1978,ACTRN12620000445976,ANZCTR,2020-04-06,2020-04-10,False,University of Melbourne,Recruiting,Phase 3,Interventional,"New Zealand, Australia","To compare the effectiveness of two drugs (hydroxychloroquine and lopinavir/ritonavir alone or combined in treating hospitalized patients with confirmed COVID-19 compared to standard of care

",Drug,Lopinavir/ritonavir + hydroxychloroquine vs. lopinavir/ritonavir vs. hydroxychloroquine,Lopinavir/ritonavir; hydroxychloroquine,2500,https://anzctr.org.au/ACTRN12620000445976.aspx,None
1119,1979,ACTRN12620000580976,ANZCTR,2020-05-19,2020-05-26,False,QIMR Berghofer Medical Research Institute,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,Tocilizumab for tReatment Of COVID-19 in intensive cARe patients (TROCAR),Drug,Tocilizumab,Tocilizumab,150,https://anzctr.org.au/ACTRN12620000580976.aspx,None
1120,1980,ACTRN12620000588998,ANZCTR,2020-05-21,2020-05-29,False,Grand Medical Pty Ltd,Not Recruiting,Phase 2,Interventional,Australia,The safety and efficacy of STC3141 in patient with COVID-19 Acute Respiratory Distress Syndrome,Drug,STC3141,STC3141,160,https://anzctr.org.au/ACTRN12620000588998.aspx,None
1121,1981,ACTRN12620000571976,ANZCTR,2020-05-15,2020-05-20,False,UNSW Sydney,Not Recruiting,Phase 1,Interventional,Australia,"Evaluation of Shift, a smartphone application for Junior Medical Officers in New South Wales during the COVID-19 epidemic.",Other (psych),Psychological,Psychological,75,https://anzctr.org.au/ACTRN12620000571976.aspx,None
1122,1983,ACTRN12620000579998,ANZCTR,2020-05-19,2020-05-20,False,Mackay Hospital and Health Service,Not Recruiting,Not Applicable,Interventional,Australia,"In a simulation environment, is there a difference in time taken for consultant anaesthetists to perform spinal anaesthesia as compared to general anaesthesia on women, with suspected or confirmed COVID-19, who require emergency caesarean delivery?",Other,No Intervention,No Intervention,10,https://anzctr.org.au/ACTRN12620000579998.aspx,None
1123,1985,ISRCTN40580903,ISRCTN,2020-05-15,2020-05-16,True,University of Birmingham,Recruiting,Phase 2,Interventional,United Kingdom,Which treatment could lessen the severity of a coronavirus infection when compared with usual care in an NHS setting?,Drug,Gemtuzumab Ozogamicin,Gemtuzumab Ozogamicin,588,http://isrctn.com/ISRCTN40580903,EUCTR2020-001684-89
1124,1986,ISRCTN85216856,ISRCTN,2020-05-11,2020-05-10,True,Universidad Tecnolgica Equinoccial,Recruiting,Phase 2/Phase 3,Interventional,Ecuador,Using blood plasma to develop passive immunity to coronavirus in Ecuador,ATMP,Plasma,Plasma,200,http://isrctn.com/ISRCTN85216856,None
1125,1987,ISRCTN44152751,ISRCTN,2020-05-04,2020-05-11,False,Norwegian Institute of Public Health,Not Recruiting,Not Applicable,Interventional,Norway,School opening in Norway during the COVID-19 pandemic,Other,Other,Other,116750,http://isrctn.com/ISRCTN44152751,None
1126,1993,ChiCTR2000033133,ChiCTR,2020-05-21,2020-02-12,True,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Shuang-Huang-Lian oral solution in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=53925,None
1127,1998,ChiCTR2000033057,ChiCTR,2020-05-19,2020-02-25,True,The First Hospital of China Medical University,Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for determination of the clinical effect of Internet-assisted pulmonary rehabilitation on patients with novel coronavirus pneumonia (COVID-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,160,http://www.chictr.org.cn/showproj.aspx?proj=53529,None
1128,1999,ChiCTR2000033056,ChiCTR,2020-05-19,2020-01-29,True,Guizhou Provincial Jiangjunshan Hospital,Not Recruiting,Not Applicable,Interventional,China,Convalescent Plasma in the treatment of 6 COVID-19 Patients,ATMP,Plasma,Plasma,6,http://www.chictr.org.cn/showproj.aspx?proj=53859,None
1129,2005,ChiCTR2000033049,ChiCTR,2020-05-18,2020-05-19,False,Hongqi Hospital Affiliated to Mudangjiang Medical University,Recruiting,Phase 4,Interventional,China,A clinical study for the efficacy and safety of artemisinin-pipequine tablets in the treatment of the untreated mild or common type novel coronavirus pneumonia (COVID-19) patients,Drug,Artemisinin/pipequine,Artemisinin/pipequine,160,http://www.chictr.org.cn/showproj.aspx?proj=53840,None
1130,2006,EUCTR2020-001805-21-GB,EU Clinical Trials Register,2020-05-07,2020-05-15,False,University Hospitals Coventry and Warwickshire NHS Trust,Authorised,Phase 2,Interventional,United Kingdom,IMU-838 and Oseltamivir in treatment of Novel Coronavirus (COVID-19),Drug,IMU-838 + Oseltamivir,IMU-838; Oseltamivir,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001805-21,None
1131,2007,EUCTR2020-001614-38-BE,EU Clinical Trials Register,2020-04-06,2020-04-22,False,UZ Leuven,Authorised,Phase 2,Interventional,Belgium,"Covid-19: A randomized, open-label, adaptive, proof-of- concept clinical trial of new antiviral drug candidates against SARS-CoV-2.",Drug,Azithromycin,Azithromycin,282,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001614-38,None
1132,2008,EUCTR2020-001770-30-BE,EU Clinical Trials Register,2020-04-15,2020-04-21,False,CHU Ambroise Par,Authorised,Phase 2,Interventional,Belgium,Experimental use of tocilizumab in COVID-19 related pneumonia.,Drug,Tocilizumab,Tocilizumab,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001770-30,None
1133,2009,EUCTR2020-001995-13-ES,EU Clinical Trials Register,2020-05-21,2020-05-15,True,Fundacin SEIMC-GESIDA,Authorised,Phase 2,Interventional,Spain,Clinical trial to evaluate the efficacy and safety of tocilizumab for treating patients with COVID-19 pneumonia: the BREATH-19 Study,Drug,Tocilizumab,Tocilizumab,500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001995-13,None
1134,2010,EUCTR2020-002274-28-ES,EU Clinical Trials Register,2020-05-21,2020-05-19,True,Fundacin para la Investigacin y la Innovacin Biosanitaria del Principado de Asturias (FINBA),Authorised,Phase 4,Interventional,Spain,Evaluation of the likely beneficial effects of vitamin D on infection with coronavirus.,Drug,Vitamin D,Vitamin D,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002274-28,None
1135,2011,EUCTR2020-001704-42-ES,EU Clinical Trials Register,2020-05-21,2020-05-15,True,Instituto de Investigacin Marqus de Valdecilla (IDIVAL),Authorised,Phase 4,Interventional,Spain,Controlled and randomised trial to assess the safety and efficacy of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in hospital healthcare personnel (Sanitarios sin COVID-19).,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001704-42,None
1136,2013,NCT04313127,ClinicalTrials.gov,2020-03-15,2020-03-16,False,CanSino Biologics Inc.,Not Recruiting,Phase 1,Interventional,China,Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults,ATMP,Adenovirus vector,Adenovirus vector,108,https://clinicaltrials.gov/show/NCT04313127,None
1137,2014,NCT04321993,ClinicalTrials.gov,2020-03-24,2020-04-17,False,Lisa Barrett,Recruiting,Phase 2,Interventional,Canada,Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients,Drug,Lopinavir/ritonavir vs. hydroxychloroquine vs. baricitinib vs. sarilumab,lopinavir/ritonavir; hydroxychloroquine; sarilumab,1000,https://clinicaltrials.gov/show/NCT04321993,None
1138,2015,NCT04322565,ClinicalTrials.gov,2020-03-24,2020-04-20,False,AOU di Parma,Recruiting,Phase 2,Interventional,Italy,Colchicine Counteracting Inflammation in COVID-19 Pneumonia,Drug,Colchicine,Colchicine,310,https://clinicaltrials.gov/show/NCT04322565,None
1139,2016,NCT04325893,ClinicalTrials.gov,2020-03-25,2020-04-01,False,"University Hospital, Angers",Recruiting,Phase 3,Interventional,"France, Monaco",Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease,Drug,Hydroxychloroquine,Hydroxychloroquine,1300,https://clinicaltrials.gov/show/NCT04325893,None
1140,2018,NCT04328129,ClinicalTrials.gov,2020-03-23,2020-03-23,False,Institut Pasteur,Recruiting,Not Applicable,Interventional,French Guiana,Household Transmission Investigation Study for COVID-19 in French Guiana,Clinical Presentation (Epidemiology),No Intervention,No Intervention,450,https://clinicaltrials.gov/show/NCT04328129,None
1141,2022,NCT04341389,ClinicalTrials.gov,2020-04-07,2020-04-12,False,"Insitute of Biotechnology, Academy of Military Medical Sciences, PLA of China",Not Recruiting,Phase 2,Interventional,China,A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector),ATMP,Vaccine,Vaccine,508,https://clinicaltrials.gov/show/NCT04341389,None
1142,2023,NCT04341935,ClinicalTrials.gov,2020-04-06,2020-06-30,False,University of Miami,Not Recruiting,Phase 4,Interventional,United States,Effects of DPP4 Inhibition on COVID-19,Drug,Linagliptin,Linagliptin,20,https://clinicaltrials.gov/show/NCT04341935,None
1143,2024,NCT04342182,ClinicalTrials.gov,2020-03-31,2020-04-08,False,Erasmus Medical Center,Recruiting,Phase 2/Phase 3,Interventional,Netherlands,Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study),ATMP,Plasma,Plasma,426,https://clinicaltrials.gov/show/NCT04342182,None
1144,2027,NCT04358783,ClinicalTrials.gov,2020-04-21,2020-04-27,False,Hospital Universitario Dr. Jose E. Gonzalez,Recruiting,Phase 2,Interventional,Mexico,Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04358783,None
1145,2028,NCT04359537,ClinicalTrials.gov,2020-04-20,2020-05-01,False,Shaheed Zulfiqar Ali Bhutto Medical University,Recruiting,Phase 2,Interventional,Pakistan,Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,200,https://clinicaltrials.gov/show/NCT04359537,None
1146,2029,NCT04361253,ClinicalTrials.gov,2020-04-23,2020-04-30,False,Brigham and Women's Hospital,Recruiting,Phase 3,Interventional,United States,Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy,ATMP,Plasma,Plasma,220,https://clinicaltrials.gov/show/NCT04361253,None
1147,2030,NCT04363346,ClinicalTrials.gov,2020-04-23,2020-05-14,False,University of Minnesota,Recruiting,Phase 1,Interventional,United States,Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia,Drug,FT516,FT516,12,https://clinicaltrials.gov/show/NCT04363346,None
1148,2031,NCT04363502,ClinicalTrials.gov,2020-04-23,2020-05-07,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug,Clazakizumab,Clazakizumab,30,https://clinicaltrials.gov/show/NCT04363502,None
1149,2032,NCT04366960,ClinicalTrials.gov,2020-04-24,2020-05-14,True,Niguarda Hospital,Recruiting,Phase 3,Interventional,Italy,Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients,Drug,Enoxaparin,Enoxaparin,2712,https://clinicaltrials.gov/show/NCT04366960,EUCTR2020-001708-41
1150,2033,NCT04367831,ClinicalTrials.gov,2020-04-27,2020-05-02,False,Columbia University,Recruiting,Phase 4,Interventional,United States,Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19,Drug,Enoxaparin,Enoxaparin,100,https://clinicaltrials.gov/show/NCT04367831,None
1151,2034,NCT04370782,ClinicalTrials.gov,2020-04-26,2020-04-28,False,"St. Francis Hospital, New York",Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting,Drug,Hydroxychloroquine + Azithromycin + Zinc vs. Hydroxychloroquine + Doxycycline + Zinc,Hydroxychloroquine; Azithromycin; Zinc; Doxycycline,750,https://clinicaltrials.gov/show/NCT04370782,None
1152,2036,NCT04371952,ClinicalTrials.gov,2020-04-27,2020-06-01,False,Nantes University Hospital,Not Recruiting,Phase 3,Interventional,France,DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19),Drug,Doxycycline,Doxycycline,330,https://clinicaltrials.gov/show/NCT04371952,None
1153,2037,NCT04372979,ClinicalTrials.gov,2020-04-24,2020-05-01,False,Direction Centrale du Service de Sant des Armes,Not Recruiting,Phase 3,Interventional,France,Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients.,ATMP,Plasma,Plasma,80,https://clinicaltrials.gov/show/NCT04372979,None
1154,2039,NCT04375124,ClinicalTrials.gov,2020-05-01,2020-04-25,True,Kanuni Sultan Suleyman Training and Research Hospital,Recruiting,Not Applicable,Interventional,Turkey,Treatment of Angiotensin Peptide (1-7) for COVID-19,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04375124,None
1155,2042,NCT04377789,ClinicalTrials.gov,2020-05-01,2020-03-20,True,Kanuni Sultan Suleyman Training and Research Hospital,Recruiting,Not Applicable,Interventional,Turkey,Effect of Quercetin on Prophylaxis and Treatment of COVID-19,Drug (Chemoprophylaxis),Quercetin,Quercetin,50,https://clinicaltrials.gov/show/NCT04377789,None
1156,2045,NCT04388683,ClinicalTrials.gov,2020-05-13,2020-05-12,True,Tufts Medical Center,Recruiting,Phase 2,Interventional,United States,Inhaled Nitric Oxide for Preventing Progression in COVID-19,Drug,Nitric Oxide,Nitric Oxide,42,https://clinicaltrials.gov/show/NCT04388683,None
1157,2046,NCT04389333,ClinicalTrials.gov,2020-05-09,2020-03-26,True,Changhai Hospital,Recruiting,Not Applicable,Interventional,China,Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic,Other,Other,Other,40,https://clinicaltrials.gov/show/NCT04389333,None
1158,2047,NCT04389372,ClinicalTrials.gov,2020-05-05,2020-03-15,True,Fondazione IRCCS Istituto Neurologico Carlo Besta,Recruiting,Not Applicable,Interventional,Italy,"Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse",Other (psych),Psychological,Psychological,50,https://clinicaltrials.gov/show/NCT04389372,None
1159,2048,NCT04389385,ClinicalTrials.gov,2020-05-12,2020-05-01,True,TC Erciyes University,Not Recruiting,Phase 1,Interventional,Turkey,COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo),ATMP,Exosomes,Exosomes,60,https://clinicaltrials.gov/show/NCT04389385,None
1160,2053,NCT04389801,ClinicalTrials.gov,2020-05-13,2020-06-01,False,Hesham Al-Inany,Not Recruiting,Phase 4,Interventional,No Country Given,Use of Desferal for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection,Drug,Deferoxamine,Deferoxamine,200,https://clinicaltrials.gov/show/NCT04389801,None
1161,2054,NCT04389944,ClinicalTrials.gov,2020-05-12,2020-03-31,True,"University Hospital, Basel",Recruiting,Not Applicable,Interventional,Switzerland,Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19,ATMP,Plasma,Plasma,15,https://clinicaltrials.gov/show/NCT04389944,None
1162,2055,NCT04390061,ClinicalTrials.gov,2020-05-13,2020-06-01,True,Universit Politecnica delle Marche,Not Recruiting,Phase 2,Interventional,No Country Given,TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia,Drug,Tofacitinib + Hydroxycloroquine vs. Hydroxycloroquine,Tofacitinib; Hydroxycloroquine,116,https://clinicaltrials.gov/show/NCT04390061,EUCTR2020-002035-30
1163,2056,NCT04390152,ClinicalTrials.gov,2020-05-12,2020-06-01,False,BioXcellerator,Not Recruiting,Phase 1/Phase 2,Interventional,Colombia,Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19,ATMP,Cells (mesenchymal),Cells (mesenchymal),40,https://clinicaltrials.gov/show/NCT04390152,None
1164,2057,NCT04390217,ClinicalTrials.gov,2020-05-13,2020-06-30,False,"Leading BioSciences, Inc",Not Recruiting,Phase 2,Interventional,No Country Given,LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia,Drug,LB1148,LB1148,120,https://clinicaltrials.gov/show/NCT04390217,None
1165,2059,NCT04390412,ClinicalTrials.gov,2020-05-13,2020-05-04,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Low Dose Radiotherapy in COVID-19 Pneumonia,Other,Radiation,Radiation,5,https://clinicaltrials.gov/show/NCT04390412,IRCT20200509047366N1
1166,2060,NCT04390464,ClinicalTrials.gov,2020-05-08,2020-05-08,True,Cambridge University Hospitals NHS Foundation Trust,Recruiting,Phase 4,Interventional,United Kingdom,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R),Drug,Ravulizumab vs. Baricitinib,Ravulizumab; Baricitinib,1167,https://clinicaltrials.gov/show/NCT04390464,EUCTR2020-001354-22; ISRCTN11188345
1167,2061,NCT04390477,ClinicalTrials.gov,2020-05-07,2020-05-04,True,Bioithas SL,Recruiting,Not Applicable,Interventional,Spain,Study to Evaluate the Effect of a Probiotic in COVID-19,Supplement,Probiotics,Probiotics,40,https://clinicaltrials.gov/show/NCT04390477,None
1168,2062,NCT04390503,ClinicalTrials.gov,2020-05-14,2020-05-01,True,Columbia University,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for COVID-19 Close Contacts,ATMP,Plasma,Plasma,200,https://clinicaltrials.gov/show/NCT04390503,None
1169,2066,NCT04391712,ClinicalTrials.gov,2020-05-04,2020-04-30,True,Lowell General Hospital,Recruiting,Phase 2,Interventional,United States,Cold Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease,Other (device),Cold Laser Therapy,Cold Laser Therapy,20,https://clinicaltrials.gov/show/NCT04391712,None
1170,2067,NCT04391829,ClinicalTrials.gov,2020-05-13,2020-05-12,True,UZ Brussel,Not Recruiting,Not Applicable,Interventional,No Country Given,Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04391829,None
1171,2072,NCT04392141,ClinicalTrials.gov,2020-05-15,2020-04-01,True,Kermanshah University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Colchicine Plus Phenolic Monoterpenes to Treat COVID-19,Drug,Colchicine + Phenolic Monoterpenes,Colchicine; Phenolic Monoterpenes,200,https://clinicaltrials.gov/show/NCT04392141,None
1172,2074,NCT04392323,ClinicalTrials.gov,2020-05-15,2020-05-13,True,Northwell Health,Recruiting,Not Applicable,Interventional,United States,Incidence of COVID-19 Test Conversion in Post-surgical Patients,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04392323,None
1173,2077,NCT04392427,ClinicalTrials.gov,2020-05-12,2020-05-01,True,Mansoura University,Not Recruiting,Phase 3,Interventional,Egypt,New Antiviral Drugs for Treatment of COVID-19,Drug,Nitazoxanide + Ribavirin + Ivermectin,Nitazoxanide; Ribavirin; Ivermectin,100,https://clinicaltrials.gov/show/NCT04392427,None
1174,2078,NCT04392453,ClinicalTrials.gov,2020-05-15,2020-05-01,True,Fondazione Don Carlo Gnocchi Onlus,Not Recruiting,Not Applicable,Interventional,No Country Given,Upper Limb Robotic Rehabilitation During COVID-19 Outbreak,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,40,https://clinicaltrials.gov/show/NCT04392453,None
1175,2079,NCT04392713,ClinicalTrials.gov,2020-05-05,2020-04-15,True,"Combined Military Hospital, Pakistan",Recruiting,Not Applicable,Interventional,Pakistan,Efficacy of Ivermectin in COVID-19,Drug,Ivermectin,Ivermectin,100,https://clinicaltrials.gov/show/NCT04392713,None
1176,2080,NCT04392778,ClinicalTrials.gov,2020-04-25,2020-04-01,True,SBu Dr. Sadi Konuk Egitim ve Arastirma Hastanesi,Recruiting,Phase 1/Phase 2,Interventional,Turkey,Clinical Use of Stem Cells for the Treatment of Covid-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04392778,None
1177,2081,NCT04393961,ClinicalTrials.gov,2020-04-24,2020-04-05,True,ProofPilot,Recruiting,Not Applicable,Interventional,United States,At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,600,https://clinicaltrials.gov/show/NCT04393961,None
1178,2084,NCT04394169,ClinicalTrials.gov,2020-05-13,2020-05-25,False,Hospital Clinic of Barcelona,Not Recruiting,Not Applicable,Interventional,No Country Given,Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection.,Other,Other,Other,102,https://clinicaltrials.gov/show/NCT04394169,None
1179,2085,NCT04394182,ClinicalTrials.gov,2020-05-15,2020-04-21,True,Fundacin Genesiscare,Recruiting,Not Applicable,Interventional,Spain,Ultra Low Doses of Therapy With Radiation Applicated to COVID-19,Other,"Radiation (with Lopinavir/ritonavir, Hydroxychloroquine, Azithromycin, Piperacillin/tazobactam, Heparin, Corticosteroids, Tocilizumab)",Radiation; Lopinavir/ritonavir; Hydroxychloroquine; Azithromycin; Piperacillin/tazobactam; Heparin; Methylprednisolone; Tocilizumab,15,https://clinicaltrials.gov/show/NCT04394182,None
1180,2087,NCT04394208,ClinicalTrials.gov,2020-05-15,2020-06-01,False,Cairo University,Not Recruiting,Phase 3,Interventional,Egypt,Silymarin in COVID-19 Pneumonia,Drug,Silymarin,Silymarin,50,https://clinicaltrials.gov/show/NCT04394208,None
1181,2090,NCT04306393,ClinicalTrials.gov,2020-03-10,2020-03-21,True,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19,Drug,Nitric oxide,Nitric oxide,200,https://clinicaltrials.gov/show/NCT04306393,EUCTR2020-001490-68
1182,2094,NCT04338828,ClinicalTrials.gov,2020-04-05,2020-04-18,False,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED,Drug,Nitric oxide,Nitric oxide,260,https://clinicaltrials.gov/show/NCT04338828,None
1183,2096,NCT04341675,ClinicalTrials.gov,2020-04-05,2020-04-24,False,University of Cincinnati,Recruiting,Phase 2,Interventional,United States,Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia,Drug,Sirolimus,Sirolimus,30,https://clinicaltrials.gov/show/NCT04341675,None
1184,2098,NCT04342663,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Washington University in St. Louis,Recruiting,Phase 2,Interventional,United States,"A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection",Drug,Fluvoxamine,Fluvoxamine,152,https://clinicaltrials.gov/show/NCT04342663,None
1185,2099,NCT04347681,ClinicalTrials.gov,2020-04-08,2020-04-18,False,King Fahad Specialist Hospital,Recruiting,Phase 2,Interventional,Saudi Arabia,Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19,ATMP,Plasma,Plasma,40,https://clinicaltrials.gov/show/NCT04347681,None
1186,2102,NCT04350736,ClinicalTrials.gov,2020-04-14,2020-04-23,False,Theravance Biopharma,Recruiting,Phase 1,Interventional,United Kingdom,"First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19",Drug,TD-0903,TD-0903,54,https://clinicaltrials.gov/show/NCT04350736,None
1187,2106,NCT04354714,ClinicalTrials.gov,2020-04-16,2020-06-30,False,Washington University in St. Louis,Not Recruiting,Phase 2,Interventional,United States,Ruxolitinib to Combat COVID-19,Drug,Ruxolitinib,Ruxolitinib,0,https://clinicaltrials.gov/show/NCT04354714,None
1188,2107,NCT04355143,ClinicalTrials.gov,2020-04-14,2020-05-01,False,"University of California, Los Angeles",Recruiting,Phase 2,Interventional,United States,Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19),Drug,Colchicine,Colchicine,150,https://clinicaltrials.gov/show/NCT04355143,None
1189,2108,NCT04355533,ClinicalTrials.gov,2020-04-17,2020-06-01,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1920,https://clinicaltrials.gov/show/NCT04355533,None
1190,2109,NCT04355897,ClinicalTrials.gov,2020-04-15,2020-04-28,False,The Christ Hospital,Recruiting,Phase 1,Interventional,United States,CoVID-19 Plasma in Treatment of COVID-19 Patients,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04355897,None
1191,2110,NCT04358081,ClinicalTrials.gov,2020-04-08,2020-05-01,False,Novartis Pharmaceuticals,Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Azithromycin; Hydroxychloroquine,444,https://clinicaltrials.gov/show/NCT04358081,None
1192,2111,NCT04360837,ClinicalTrials.gov,2020-04-22,2020-05-06,False,Szeged University,Recruiting,Not Applicable,Interventional,Hungary,PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10,https://clinicaltrials.gov/show/NCT04360837,None
1193,2112,NCT04361214,ClinicalTrials.gov,2020-04-22,2020-05-05,False,University of Chicago,Recruiting,Phase 1,Interventional,United States,Leflunomide in Mild COVID-19 Patients,Drug,Leflunomide,Leflunomide,20,https://clinicaltrials.gov/show/NCT04361214,None
1194,2113,NCT04361344,ClinicalTrials.gov,2020-04-16,2020-05-19,False,Centre Hospitalier de Pau,Recruiting,Not Applicable,Interventional,France,Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04361344,None
1195,2114,NCT04362189,ClinicalTrials.gov,2020-04-21,2020-05-15,False,Hope Biosciences,Not Recruiting,Phase 2,Interventional,United States,Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),100,https://clinicaltrials.gov/show/NCT04362189,None
1196,2115,NCT04365153,ClinicalTrials.gov,2020-04-24,2020-04-24,False,The Cleveland Clinic,Recruiting,Phase 2,Interventional,United States,Canakinumab to Reduce Deterioration of Cardiac and Respiratory Function Due to COVID-19,Drug,Canakinumab,Canakinumab,45,https://clinicaltrials.gov/show/NCT04365153,None
1197,2119,NCT04368000,ClinicalTrials.gov,2020-04-24,2020-04-29,False,University of Utah,Recruiting,Not Applicable,Interventional,United States,Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization,Procedure,Positioning,Positioning,60,https://clinicaltrials.gov/show/NCT04368000,None
1198,2120,NCT04368845,ClinicalTrials.gov,2020-04-20,2020-05-11,False,Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory,Recruiting,Not Applicable,Interventional,Greece,Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,100,https://clinicaltrials.gov/show/NCT04368845,None
1199,2121,NCT04372628,ClinicalTrials.gov,2020-04-30,2020-05-31,False,Vanderbilt University,Not Recruiting,Phase 2,Interventional,United States,Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19,Drug,Hydroxychloroquein vs. Lopinavir/ritonavir,Hydroxychloroquein; Lopinavir/ritonavir,900,https://clinicaltrials.gov/show/NCT04372628,None
1200,2122,NCT04373096,ClinicalTrials.gov,2020-04-30,2020-06-01,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,No Country Given,Enhanced Hood PPE to Minimize COVID-19 Transmission to Front-line Health Care Workers,Other (device),Hood,Hood,42,https://clinicaltrials.gov/show/NCT04373096,None
1201,2126,NCT04380402,ClinicalTrials.gov,2020-05-01,2020-05-20,False,Mount Auburn Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Atorvastatin as Adjunctive Therapy in COVID-19,Drug,Atorvastatin,Atorvastatin,300,https://clinicaltrials.gov/show/NCT04380402,None
1202,2129,NCT04384445,ClinicalTrials.gov,2020-05-09,2020-05-01,True,Organicell Regenerative Medicine,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Organicell Flow for Patients With COVID-19,ATMP,Exosomes,Exosomes,20,https://clinicaltrials.gov/show/NCT04384445,None
1203,2132,NCT04386447,ClinicalTrials.gov,2020-05-12,2020-06-03,False,AOU di Parma,Not Recruiting,Phase 2,Interventional,"Italy, France",Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19,Drug,Oxytocin,Oxytocin,145,https://clinicaltrials.gov/show/NCT04386447,None
1204,2133,NCT04387240,ClinicalTrials.gov,2020-05-12,2020-06-01,False,Princess Nourah Bint Abdulrahman University,Not Recruiting,Phase 2,Interventional,Saudi Arabia,Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19,Drug,Artesunate,Artesunate,22,https://clinicaltrials.gov/show/NCT04387240,None
1205,2135,NCT04390022,ClinicalTrials.gov,2020-05-07,2020-05-14,False,Clnica Universidad de Navarra,Recruiting,Phase 2,Interventional,Spain,Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial,Drug,Ivermectin,Ivermectin,24,https://clinicaltrials.gov/show/NCT04390022,None
1206,2137,NCT04391101,ClinicalTrials.gov,2020-05-08,2020-06-01,False,Hospital San Vicente Fundacin,Not Recruiting,Phase 3,Interventional,Colombia,Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19),ATMP,Plasma,Plasma,231,https://clinicaltrials.gov/show/NCT04391101,None
1207,2139,NCT04392128,ClinicalTrials.gov,2020-05-15,2020-05-12,True,Institut de Cancrologie Strasbourg Europe (ICANS),Not Recruiting,Phase 2,Interventional,France,Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE),Drug,Hydroxychloroquine vs. Azithromycin,Hydroxychloroquine; Azithromycin,114,https://clinicaltrials.gov/show/NCT04392128,None
1208,2140,NCT04392232,ClinicalTrials.gov,2020-05-15,2020-05-05,True,TriHealth Inc.,Recruiting,Phase 2,Interventional,United States,A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04392232,None
1209,2141,NCT04393038,ClinicalTrials.gov,2020-05-18,2020-05-01,True,Abivax S.A.,Recruiting,Phase 2/Phase 3,Interventional,France,ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19,Drug,ABX464,ABX464,1034,https://clinicaltrials.gov/show/NCT04393038,None
1210,2142,NCT04393051,ClinicalTrials.gov,2020-05-16,2020-05-20,False,AOU Pisana,Not Recruiting,Phase 2,Interventional,Italy,Baricitinib Compared to Standard Therapy in Patients With COVID-19,Drug,Baricitinib,Baricitinib,126,https://clinicaltrials.gov/show/NCT04393051,None
1211,2147,NCT04393727,ClinicalTrials.gov,2020-05-16,2020-05-01,True,AOU Pisana,Recruiting,Phase 2,Interventional,Italy,Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19,ATMP,Plasma,Plasma,126,https://clinicaltrials.gov/show/NCT04393727,None
1212,2148,NCT04393792,ClinicalTrials.gov,2020-05-18,2020-05-01,True,Hampshire Hospitals NHS Foundation Trust,Recruiting,Phase 1,Interventional,United Kingdom,SINUS WASH Pilot Study in Adults Testing Positive for COVID-19,Drug,Povidone Iodine,Povidone Iodine,40,https://clinicaltrials.gov/show/NCT04393792,EUCTR2020-001721-31
1213,2150,NCT04393818,ClinicalTrials.gov,2020-05-18,2020-05-01,True,Fundaci d'investigaci Sanitria de les Illes Balears,Not Recruiting,Phase 3,Interventional,No Country Given,Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19,Other (psych),Psychological,Psychological,560,https://clinicaltrials.gov/show/NCT04393818,None
1214,2152,NCT04394013,ClinicalTrials.gov,2020-05-18,2020-06-01,False,Monash University Malaysia,Not Recruiting,Not Applicable,Interventional,Malaysia,A Web-Based Gentle Body Stretching to Alleviate Loneliness and Improve Mental Fitness During COVID-19 Isolation Period,Other (psych),Psychological,Psychological,70,https://clinicaltrials.gov/show/NCT04394013,None
1215,2154,NCT04394403,ClinicalTrials.gov,2020-05-13,2020-05-14,False,Hebrew University of Jerusalem,Recruiting,Not Applicable,Interventional,Israel,Pilot Internet-based Self-Help Program for Managing Corona (COVID-19) Stress,Other (psych),Psychological,Psychological,120,https://clinicaltrials.gov/show/NCT04394403,None
1216,2156,NCT04394442,ClinicalTrials.gov,2020-05-17,2020-03-21,True,Samah Lutfy,Recruiting,Phase 2,Interventional,Saudi Arabia,Hydroxychloroquine in COVID-19 Patients,Drug,Hydroxychloroquine,Hydroxychloroquine,200,https://clinicaltrials.gov/show/NCT04394442,None
1217,2157,NCT04395144,ClinicalTrials.gov,2020-05-15,2020-05-15,False,Hpital de Verdun,Recruiting,Not Applicable,Interventional,Canada,COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss,Procedure,Positioning,Positioning,346,https://clinicaltrials.gov/show/NCT04395144,None
1218,2158,NCT04395456,ClinicalTrials.gov,2020-05-19,2020-07-01,False,Amyndas Pharmaceuticals S.A.,Not Recruiting,Phase 2,Interventional,No Country Given,A Phase 2 Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE),Drug,AMY-101,AMY-101,144,https://clinicaltrials.gov/show/NCT04395456,None
1219,2162,NCT04395768,ClinicalTrials.gov,2020-05-18,2020-05-25,False,"National Institute of Integrative Medicine, Australia",Not Recruiting,Phase 2,Interventional,No Country Given,International ALLIANCE Study of Therapies to Prevent Progression of COVID-19,Drug,Vitamin C + Hydroxychloroquine + Azithromycin + Zinc + Vitamin D + Vitamin B vs. Hydroxychloroquine + Azithromycin + Zinc + Vitamin D + Vitamin B,Vitamin C; Hydroxychloroquine; Azithromycin; Zinc; Vitamin D; Vitamin B,200,https://clinicaltrials.gov/show/NCT04395768,None
1220,2165,NCT04395911,ClinicalTrials.gov,2020-05-17,2020-06-01,False,SeaStar Medical,Not Recruiting,Not Applicable,Interventional,No Country Given,Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections,Other (device),Selective Cytopheretic Device,Selective Cytopheretic Device,35,https://clinicaltrials.gov/show/NCT04395911,None
1221,2166,NCT04395976,ClinicalTrials.gov,2020-05-19,2020-06-10,False,British Ayurvedic Medical Council,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda as Prophylaxis for Suspected COVID-19 Patients,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,120,https://clinicaltrials.gov/show/NCT04395976,None
1222,2167,NCT04396106,ClinicalTrials.gov,2020-05-16,2020-05-01,True,"Atea Pharmaceuticals, Inc.",Not Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19),Drug,AT-527,AT-527,180,https://clinicaltrials.gov/show/NCT04396106,None
1223,2170,NCT04396314,ClinicalTrials.gov,2020-05-15,2020-09-01,False,University of Lleida,Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness of Basic Body Awareness Therapy in Survivors of Covid-19 and Health Workers Regarding Post-traumatic Stress Disorders,Other (psych),Psychological,Psychological,54,https://clinicaltrials.gov/show/NCT04396314,None
1224,2174,NCT04397328,ClinicalTrials.gov,2020-05-13,2020-05-19,False,Lawson Health Research Institute,Not Recruiting,Phase 3,Interventional,No Country Given,COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,336,https://clinicaltrials.gov/show/NCT04397328,None
1225,2176,NCT04397523,ClinicalTrials.gov,2020-05-20,2020-04-30,True,Institute for Transfusion Medicine of RNM,Recruiting,Not Applicable,Interventional,North Macedonia,Efficacy and Safety of COVID-19 Convalescent Plasma,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04397523,None
1226,2179,NCT04397666,ClinicalTrials.gov,2020-05-20,2020-05-15,True,Versailles Hospital,Recruiting,Not Applicable,Interventional,France,RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,68,https://clinicaltrials.gov/show/NCT04397666,None
1227,2180,NCT04397705,ClinicalTrials.gov,2020-05-20,2020-06-01,False,The Christie NHS Foundation Trust,Not Recruiting,Phase 1,Interventional,United Kingdom,Remote Monitoring of Cancer Patients With Suspected Covid-19,Other (device),Biosensors,Biosensors,30,https://clinicaltrials.gov/show/NCT04397705,None
1228,2185,NCT04398277,ClinicalTrials.gov,2020-05-20,2020-05-01,True,Kent State University,Recruiting,Not Applicable,Interventional,United States,A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic,Other (psych),Psychological,Psychological,1000,https://clinicaltrials.gov/show/NCT04398277,None
1229,2186,NCT04398290,ClinicalTrials.gov,2020-05-20,2020-07-01,False,Roger Alvarez,Not Recruiting,Phase 2,Interventional,United States,iNOPulse for COVID-19,Drug,Nitric Oxide,Nitric Oxide,30,https://clinicaltrials.gov/show/NCT04398290,None
1230,2187,NCT04398303,ClinicalTrials.gov,2020-05-20,2020-05-01,True,Aspire Health Science,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,ACT-20 in Patients With Severe COVID-19 Pneumonia,Drug,ACT-20,ACT-20,70,https://clinicaltrials.gov/show/NCT04398303,None
1231,2188,NCT04399746,ClinicalTrials.gov,2020-05-19,2020-03-15,True,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,Recruiting,Not Applicable,Interventional,Mexico,Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19,Drug,Ivermectin + Azithromycin + Cholecalciferol,Ivermectin; Azithromycin; Cholecalciferol,30,https://clinicaltrials.gov/show/NCT04399746,None
1232,2189,NCT04400032,ClinicalTrials.gov,2020-04-27,2020-05-01,False,Ottawa Hospital Research Institute,Not Recruiting,Phase 1,Interventional,Canada,Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome - Vanguard,ATMP,Cells (mesenchymal),Cells (mesenchymal),9,https://clinicaltrials.gov/show/NCT04400032,None
1233,2190,NCT04404634,ClinicalTrials.gov,2020-05-22,2020-05-01,True,Yale University,Not Recruiting,Phase 2,Interventional,No Country Given,Convalescent Plasma To Limit COVID-19 Associated Complications,ATMP,Plasma,Plasma,300,https://clinicaltrials.gov/show/NCT04404634,None
1234,2195,ACTRN12620000612910,ANZCTR,2020-05-25,2020-06-01,False,Cynata Therapeutics Limited,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,The MEND (MEseNchymal coviD-19) Trial: a pilot study to investigate early efficacy of mesenchymal stem cells in adults with COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://anzctr.org.au/ACTRN12620000612910.aspx,None
1235,2196,ChiCTR2000033433,ChiCTR,2020-05-31,2020-06-18,False,"International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University",Not Recruiting,Not Applicable,Interventional,China,Study for the Effect of Internet-based Cognitive Behavior Intervention on Perinatal Depression and Anxiety during the novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),Psychological,Psychological,300,http://www.chictr.org.cn/showproj.aspx?proj=54482,None
1236,2197,ChiCTR2000033372,ChiCTR,2020-05-29,2020-03-12,True,Shandong University Qilu Hospital,Not Recruiting,Not Applicable,Interventional,China,Efficacy and safety of leflunomide for Refractory novel coronavirus pneumonia (COVID-19): A non-Randomized Controlled Study,Drug,Leflunomide,Leflunomide,30,http://www.chictr.org.cn/showproj.aspx?proj=54408,None
1237,2203,ChiCTR2000033323,ChiCTR,2020-05-28,2020-05-11,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,Iraq,Severe Reluctant COVID-19 Patients Responding to Convalescent  Plasma; A case series,Drug,Plasma,Plasma,24,http://www.chictr.org.cn/showproj.aspx?proj=54346,None
1238,2204,ChiCTR2000033320,ChiCTR,2020-05-27,2020-01-21,True,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Study for Traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=54321,None
1239,2206,ChiCTR2000033318,ChiCTR,2020-05-27,2020-02-18,True,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Recruiting,Not Applicable,Interventional,China,Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19):  a randomized controlled trial,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,104,http://www.chictr.org.cn/showproj.aspx?proj=54326,None
1240,2208,ChiCTR2000033286,ChiCTR,2020-05-26,2020-02-15,True,Xiangyang Central Hospital,Not Recruiting,Not Applicable,Interventional,China,"A Randomized, Double-blind, Placebo-controlled trial for determination of the Efficacy and Safety of Baicalein in Hospitalized Adult  Mild and Moderate Patients of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Tradtional Medicine,Tradtional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=54176,None
1241,2209,ChiCTR2000033284,ChiCTR,2020-05-26,2020-06-01,False,Guangzhou Women and Children's Medical Center,Not Recruiting,Not Applicable,Interventional,China,Study for the improvement of the quality of life of severe patients of novel coronavirus pneumonia (COVID-19) by the integrated Chinese medicine and Western medicine therapy,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,150,http://www.chictr.org.cn/showproj.aspx?proj=49590,None
1242,2210,ChiCTR2000033261,ChiCTR,2020-05-25,2020-02-15,True,Jiangsu People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Usefulness of abdominal massage and ST-36 (Zusanli) acupressure in improving appetite of novel coronavirus pneumonia (COVID-19) patients treated in makeshift hospital,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=54185,None
1243,2212,ChiCTR2000029479,ChiCTR,2020-02-02,2020-01-30,True,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Research for Traditional Chinese Medicine Technology Prevention and Control of Novel Coronavirus Pneumonia  (COVID-19) in the Community Population,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,20000,http://www.chictr.org.cn/showproj.aspx?proj=48773,None
1244,2213,ISRCTN15254871,ISRCTN,2020-05-23,2020-05-18,True,Heim Pl National Pediatric Institute LaTRA Foundation,Recruiting,Not Applicable,Interventional,Hungary,Online parent training for reducing parenting stress during the coronavirus pandemic,Other (psych),Psychological,Psychological,300,http://isrctn.com/ISRCTN15254871,None
1245,2214,ISRCTN13447477,ISRCTN,2020-05-22,2020-06-01,False,Royal Surrey County Hospital NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,A pilot study of the ability of povidone-iodine (PVP-I) 0.5% aqueous solution oral/nasal spray and mouthwash to kill the SARS-CoV-2 virus in people with COVID-19,Drug,Povidone Iodine,Povidone Iodine,25,http://isrctn.com/ISRCTN13447477,None
1246,2216,ISRCTN30564012,ISRCTN,2020-05-20,2020-05-20,True,University of Dundee,Recruiting,Phase 3,Interventional,United Kingdom,STOP-COVID19: Superiority Trial Of Protease inhibition in COVID-19 (coronavirus infection),Drug,Brensocatib,Brensocatib,300,http://isrctn.com/ISRCTN30564012,EUCTR2020-001643-13
1247,2217,ISRCTN50212645,ISRCTN,2020-05-20,2020-06-01,False,"University College, London",Recruiting,Not Applicable,Interventional,United Kingdom,How effective are infection prevention and control measures that are informed by genetic analysis of coronavirus (rapid and standard) at preventing COVID-19 in NHS hospitals?,Genomics,Infection control,Infection control,2000,http://isrctn.com/ISRCTN50212645,None
1248,2219,ISRCTN88057279,ISRCTN,2020-05-14,2020-05-18,False,Cambridge University Hospitals NHS Foundation Trust,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,Preventative treatment for patients at risk of COVID-19 infection (PROTECT),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,500,http://isrctn.com/ISRCTN88057279,None
1249,2221,EUCTR2020-001644-25-FR,EU Clinical Trials Register,2020-04-11,2020-05-06,False,Acerta Pharma B.V.,Authorised,Phase 2,Interventional,"United States, Italy, Spain, France",A Phase 2 Randomized Study of the Efficacy and Safety of Acalabrutinib with Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized with COVID-19,Drug,Acalabrutinib,Acalabrutinib,428,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001644-25,None
1250,2222,EUCTR2020-001573-78-FR,EU Clinical Trials Register,2020-04-14,2020-05-06,False,Revimmune,Authorised,Phase 2,Interventional,"United States, France",Recombinant InterLeukin-7 (CYT107) to Improve clinical outcomes in lymphopenic pAtients with COVID-19 infection,Drug,Interleukin-7,Interleukin-7,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001573-78,None
1251,2223,EUCTR2020-001754-21-FR,EU Clinical Trials Register,2020-04-17,2020-05-19,False,Assistance Publique  Hpitaux de Marseille,Authorised,Phase 3,Interventional,France,An open prospective randomized therapeutic trial using ANAKINRA or TOCILIZUMAB alone or in combination with RUXOLITINIB in severe stage 2b and 3 COVID-19 disease,Drug,"Anakinra, Tocilizumab, Ruxolitinib",Anakinra; Tocilizumab; Ruxolitinib,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001754-21,None
1252,2224,EUCTR2020-001536-98-ES,EU Clinical Trials Register,2020-04-20,2020-04-18,True,Mtua Terrassa University Hospital,Not Recruiting,Phase 3,Interventional,Spain,"Prophylaxis of COVID-19 infection with hydroxychloroquine in healthcare
personnel with high risk of infection.",Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001536-98,None
1253,2225,EUCTR2020-001673-75-FR,EU Clinical Trials Register,2020-04-17,2020-05-06,False,ABIVAX,Authorised,Phase 2/Phase 3,Interventional,France,"Phase 2/3 study of ABX464, once daily oral capsule, in high risk patients infected by SARS-CoV-2 prior to COVID-19 associated respiratory distress.",Drug,ABX464,ABX464,1034,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001673-75,None
1254,2226,EUCTR2020-001497-30-FR,EU Clinical Trials Register,2020-04-28,2020-05-12,False,Alexion Pharmaceuticals,Authorised,Phase 3,Interventional,"United States, United Kingdom, Italy, France, Germany, Spain",ravulizumab for the treatment of patients with Coronavirus Disease 2019,Drug,Ravulizumab,Ravulizumab,270,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001497-30,None
1255,2227,EUCTR2020-001739-28-BE,EU Clinical Trials Register,2020-04-10,2020-05-20,False,UZ Leuven,Authorised,Phase 2,Interventional,Belgium,"A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19.

",Drug,"Aprotinin, Heparin, Anakinra, Nadroparin",Aprotinin; Heparin; Anakinra; Nadroparin,210,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001739-28,None
1256,2228,EUCTR2020-001870-32-DK,EU Clinical Trials Register,2020-05-05,2020-05-15,False,Novartis Pharmaceuticals,Authorised,Phase 2,Interventional,"Denmark, Hungary","Study to assess efficacy and safety of DFV890 in patients with COVID-19 pneumonia and impaired respiratory function
",Drug,DFV890,DFV890,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001870-32,None
1257,2229,EUCTR2020-001623-13-GR,EU Clinical Trials Register,2020-04-22,2020-05-20,False,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Authorised,Phase 2,Interventional,Greece,Triiodothyronine for the treatment of critically ill patients with COVID-19 infection (Thy-Support Study),Drug,Triiodothyronine,Triiodothyronine,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001623-13,None
1258,2230,EUCTR2020-002287-31-ES,EU Clinical Trials Register,2020-05-25,2020-05-22,True,Fundacin Pblica Andaluza para la Investigacin de Mlaga en Biomedicina y Salud (FIMABIS),Authorised,Phase 3,Interventional,Spain,COVID 19 prevention in nursing homes,Drug,Hydroxychloroquine,Hydroxychloroquine,1930,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002287-31,None
1259,2231,EUCTR2020-002037-15-ES,EU Clinical Trials Register,2020-05-26,2020-05-25,True,Cristina Avendao-Sol,Authorised,Phase 2,Interventional,Spain,"Multicenter, randomized, open-label study to evaluate the efficacy and safety of SOC + Sarilumab versus Standard of Care for the Early Treatment of COVID-19-pneumonia in Hospitalized Patients",Drug,Sarilumab,Sarilumab,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002037-15,None
1260,2232,EUCTR2020-001960-28-ES,EU Clinical Trials Register,2020-05-26,2020-05-25,True,Investigation Institute Bioaraba,Authorised,Phase 4,Interventional,Spain,Efficacy of vitamin D treatment in patients diagnosed with pneumonia who require hospital admission and have vitamin D deficiency and a positive diagnosis for SARS-Cov-2 (COVID-19),Drug,Vitamin D,Vitamin D,108,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001960-28,None
1261,2233,EUCTR2020-001841-38-ES,EU Clinical Trials Register,2020-05-26,2020-05-25,True,Sociedad Espaola de Cardiologa,Authorised,Phase 3,Interventional,Spain,"Colchicine for the Treatment of Hyperinflammation associated with Pneumonia due to COVID-19
",Drug,Colchicine,Colchicine,240,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001841-38,None
1262,2234,EUCTR2020-001420-34-DK,EU Clinical Trials Register,2020-04-01,2020-04-14,False,Aarhus University,Authorised,Phase 2,Interventional,Denmark,Senicapoc treatment of COVID-19 positive patients in intensive care,Drug,Senicapoc,Senicapoc,46,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001420-34,None
1263,2235,EUCTR2020-001732-10-DE,EU Clinical Trials Register,2020-04-27,2020-05-28,False,Philipps University Marburg,Authorised,Phase 2,Interventional,Germany,"Ruxolitinib for treatment of Covid-19 Patienten with acute respiratory
distress syndrome",Drug,Ruxolitinib,Ruxolitinib,15,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001732-10,None
1264,2236,EUCTR2020-001605-23-ES,EU Clinical Trials Register,2020-05-31,2020-05-29,True,Basque Health Service,Authorised,Phase 4,Interventional,Spain,Effectiveness of the combined treatment with hydroxycloroquine and azithromycin vs lopinavir/ritonavir + hydroxycloroquine in hospitalized patients with confirmed COVID-19 infection,Drug,Hydroxychloroquine + Azithromycin vs. Lopinavir/ritonavir + Hydroxychloroquine,Hydroxychloroquine; Azithromycin; Lopinavir/ritonavir,108,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001605-23,None
1265,2237,EUCTR2020-002312-43-ES,EU Clinical Trials Register,2020-05-31,2020-05-28,True,Hospital Universitario Severo Ochoa,Authorised,Phase 3,Interventional,Spain,"Clinical trial,  randomized, open-label, to evaluate the efficacy of  high-dose vitamin D  in patients with COVID-19 pneumonia",Drug,Vitamin D,Vitamin D,82,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002312-43,None
1266,2238,EUCTR2020-001671-32-ES,EU Clinical Trials Register,2020-05-31,2020-05-28,True,"Staidson (Beijing) Biopharmaceuticals Co., Ltd; Beijing Defengrui Biological Technology Co., Ltd.",Authorised,Phase 2,Interventional,Spain,"A clinical trial to investigate the efficacy and safety of a new compound for the treatment of COVID-19, called BDB-001. Patients in the trial will be randomly allocated to either the new treatment or the conventional treatment and will be aware of which treatment they are receiving",Drug,BDB-001,BDB-001,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001671-32,None
1267,2241,NCT04305457,ClinicalTrials.gov,2020-03-09,2020-03-21,False,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19,Drug,Nitric oxide,Nitric oxide,240,https://clinicaltrials.gov/show/NCT04305457,None
1268,2243,NCT04321278,ClinicalTrials.gov,2020-03-23,2020-03-28,False,Hospital Israelita Albert Einstein,Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II),Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; azithromycin,440,https://clinicaltrials.gov/show/NCT04321278,None
1269,2244,NCT04331600,ClinicalTrials.gov,2020-03-30,2020-04-16,True,Wroclaw Medical University,Recruiting,Phase 4,Interventional,Poland,Chloroquine as Antiviral Treatment in Coronavirus Infection 2020,Drug,Chloroquine,Chloroquine,400,https://clinicaltrials.gov/show/NCT04331600,EUCTR2020-001469-35
1270,2245,NCT04332107,ClinicalTrials.gov,2020-03-30,2020-05-22,False,Thomas M. Lietman,Recruiting,Phase 3,Interventional,United States,Azithromycin for COVID-19 Treatment in Outpatients Nationwide,Drug,Azithromycin,Azithromycin,2271,https://clinicaltrials.gov/show/NCT04332107,None
1271,2250,NCT04346693,ClinicalTrials.gov,2020-04-08,2020-04-08,False,Burnasyan Federal Medical Biophysical Center,Not Recruiting,Phase 3,Interventional,Russian Federation,An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19,Drug,Dalargin + Hydroxychloroquine + azithromycin + / - tocilizumab vs. Hydroxychloroquine + azithromycin + / - tocilizumab,Dalargin; Hydroxychloroquine; azithromycin; tocilizumab,320,https://clinicaltrials.gov/show/NCT04346693,None
1272,2251,NCT04348370,ClinicalTrials.gov,2020-03-30,2020-04-20,False,Texas A&M University,Recruiting,Phase 4,Interventional,United States,BCG Vaccine for Health Care Workers as Defense Against COVID 19,ATMP,Vaccine,Vaccine,1800,https://clinicaltrials.gov/show/NCT04348370,None
1273,2252,NCT04350450,ClinicalTrials.gov,2020-04-14,2020-04-01,True,Montefiore Medical Center,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore,Drug,Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04350450,None
1274,2255,NCT04363814,ClinicalTrials.gov,2020-04-19,2020-06-10,False,Inmunotek S.L.,Not Recruiting,Phase 3,Interventional,No Country Given,Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection,Drug,Bactek-R,Bactek-R,100,https://clinicaltrials.gov/show/NCT04363814,None
1275,2257,NCT04374591,ClinicalTrials.gov,2020-05-02,2020-04-01,True,Mansoura University,Not Recruiting,Phase 1,Interventional,Egypt,Home-based Treatment of Computed Tomography and Clinically Suspected Novel COVID-19 With Adjuvant Inhalable Sodium Bicarbonate: A Preliminary Case Series,Drug,Sodium Bicarbonate,Sodium Bicarbonate,40,https://clinicaltrials.gov/show/NCT04374591,None
1276,2259,NCT04377737,ClinicalTrials.gov,2020-05-04,2020-05-15,False,Fondation Lenval,Not Recruiting,Not Applicable,Interventional,France,Incidence of Covid-19 in School Children,Clinical Presentation (Epidemiology),No Intervention,No Intervention,0,https://clinicaltrials.gov/show/NCT04377737,None
1277,2260,NCT04379375,ClinicalTrials.gov,2020-05-04,2020-06-01,False,Medical College of Wisconsin,Not Recruiting,Not Applicable,Interventional,No Country Given,Nudges to Improve Health Behaviors That Limit COVID-19 Spread,Other,Other,Other,300,https://clinicaltrials.gov/show/NCT04379375,None
1278,2261,NCT04380532,ClinicalTrials.gov,2020-04-29,2020-05-15,False,Immunitor LLC,Not Recruiting,Phase 1/Phase 2,Interventional,"Mongolia, Canada",Tableted COVID-19 Therapeutic Vaccine,ATMP,Vaccine,Vaccine,20,https://clinicaltrials.gov/show/NCT04380532,None
1279,2263,NCT04381884,ClinicalTrials.gov,2020-05-05,2020-05-18,False,Laboratorio Elea,Recruiting,Phase 2,Interventional,Argentina,Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19,Drug,Ivermectin,Ivermectin,45,https://clinicaltrials.gov/show/NCT04381884,None
1280,2265,NCT04390594,ClinicalTrials.gov,2020-05-14,2020-06-01,False,Institut Pasteur,Not Recruiting,Phase 3,Interventional,Senegal,Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal,Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,258,https://clinicaltrials.gov/show/NCT04390594,None
1281,2266,NCT04392869,ClinicalTrials.gov,2020-05-09,2019-10-23,True,University of Granada,Not Recruiting,Not Applicable,Interventional,Spain,The Effects of Mindfulness-based Training in Undergraduate Students of Translation and Interpreting,Other (psych),Psychological,Psychological,75,https://clinicaltrials.gov/show/NCT04392869,None
1282,2267,NCT04393415,ClinicalTrials.gov,2020-05-15,2020-05-25,False,Aljazeera Hospital,Not Recruiting,Not Applicable,Interventional,Egypt,Using PRP and Cord Blood in Treatment of Covid -19,ATMP,Cells (stem cells),Cells (stem cells),100,https://clinicaltrials.gov/show/NCT04393415,None
1283,2268,NCT04395105,ClinicalTrials.gov,2020-05-16,2020-05-21,False,Centro de Educacin Medica e Investigaciones Clnicas Norberto Quirno,Recruiting,Phase 3,Interventional,Argentina,"Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial",Drug,Corticosteroids,Dexamethasone,284,https://clinicaltrials.gov/show/NCT04395105,None
1284,2272,NCT04397497,ClinicalTrials.gov,2020-05-20,2020-05-22,False,IRCCS Ospedale San Raffaele,Not Recruiting,Phase 2,Interventional,Italy,Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19),Drug,Mavrilimumab,Mavrilimumab,50,https://clinicaltrials.gov/show/NCT04397497,None
1285,2274,NCT04398004,ClinicalTrials.gov,2020-05-17,2020-05-06,True,Hellenic Institute for the Study of Sepsis,Recruiting,Phase 2,Interventional,Greece,Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early,Drug,Clarithromycin,Clarithromycin,90,https://clinicaltrials.gov/show/NCT04398004,EUCTR2020-001882-36
1286,2275,NCT04398147,ClinicalTrials.gov,2020-05-18,2020-05-01,True,CanSino Biologics Inc.,Not Recruiting,Phase 1/Phase 2,Interventional,Canada,Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada,ATMP,Vaccine,Vaccine,696,https://clinicaltrials.gov/show/NCT04398147,None
1287,2276,NCT04399109,ClinicalTrials.gov,2020-05-21,2020-05-20,True,Dr. Sze-Yuan Ooi,Recruiting,Not Applicable,Interventional,Australia,Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER),Other (software),eHealth,eHealth,2000,https://clinicaltrials.gov/show/NCT04399109,None
1288,2277,NCT04399252,ClinicalTrials.gov,2020-05-19,2020-05-25,False,Duke University,Not Recruiting,Not Applicable,Interventional,United States,Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19,Supplement,Lactobaciltus rhamnosus,Lactobaciltus rhamnosus,1000,https://clinicaltrials.gov/show/NCT04399252,None
1289,2278,NCT04399356,ClinicalTrials.gov,2020-05-19,2020-06-01,False,Tufts Medical Center,Not Recruiting,Phase 2,Interventional,No Country Given,Niclosamide for Mild to Moderate COVID-19,Drug,Niclosamide,Niclosamide,100,https://clinicaltrials.gov/show/NCT04399356,None
1290,2280,NCT04399681,ClinicalTrials.gov,2020-05-21,2020-05-10,True,Kanuni Sultan Suleyman Training and Research Hospital,Recruiting,Not Applicable,Interventional,Turkey,The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04399681,None
1291,2281,NCT04399798,ClinicalTrials.gov,2020-05-13,2020-05-15,False,IRCCS Policlinico San Matteo,Not Recruiting,Phase 2,Interventional,No Country Given,Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic Trial,Drug,Baricitinib,Baricitinib,13,https://clinicaltrials.gov/show/NCT04399798,None
1292,2283,NCT04400058,ClinicalTrials.gov,2020-05-21,2020-06-01,False,Octapharma,Not Recruiting,Phase 3,Interventional,No Country Given,OCTAGAM 10% THERAPY IN COVID-19 PATIENTS WITH SEVERE DISEASE PROGRESSION,ATMP,Immunoglobulin,Immunoglobulin,54,https://clinicaltrials.gov/show/NCT04400058,None
1293,2284,NCT04400305,ClinicalTrials.gov,2020-05-21,2020-05-20,True,University of Victoria,Recruiting,Not Applicable,Interventional,Canada,"""Increasing Physical Activity in Canadian Adults Who Have Been Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention""",Other (software),eHealth,eHealth,40,https://clinicaltrials.gov/show/NCT04400305,None
1294,2286,NCT04400799,ClinicalTrials.gov,2020-05-15,2020-06-01,False,University of Zurich,Not Recruiting,Phase 3,Interventional,No Country Given,Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19,Drug,Heparin,Heparin,1000,https://clinicaltrials.gov/show/NCT04400799,None
1295,2288,NCT04400838,ClinicalTrials.gov,2020-05-12,2020-05-01,True,University of Oxford,Not Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,Investigating a Vaccine Against COVID-19,ATMP,Vaccine,Vaccine,10260,https://clinicaltrials.gov/show/NCT04400838,EUCTR2020-001228-32
1296,2289,NCT04400890,ClinicalTrials.gov,2020-05-22,2020-06-01,False,Dr. Marvin McCreary,Not Recruiting,Phase 2,Interventional,No Country Given,Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol for COVID-19,Drug,Resveratrol,Resveratrol,200,https://clinicaltrials.gov/show/NCT04400890,None
1297,2290,NCT04400929,ClinicalTrials.gov,2020-05-08,2020-06-01,False,Singapore General Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Using GM-CSF as a Host Directed Therapeutic Against COVID-19,Drug,Sargramostim,Sargramostim,30,https://clinicaltrials.gov/show/NCT04400929,None
1298,2295,NCT04401150,ClinicalTrials.gov,2020-05-21,2020-06-01,False,University of Sherbrooke,Not Recruiting,Phase 3,Interventional,Canada,Lessening Organ Dysfunction With VITamin C - COVID-19,Drug,Vitamin C,Vitamin C,800,https://clinicaltrials.gov/show/NCT04401150,None
1299,2296,NCT04401202,ClinicalTrials.gov,2020-05-21,2020-05-21,False,King Abdulaziz University,Recruiting,Phase 2,Interventional,Saudi Arabia,Nigella Sativa in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,https://clinicaltrials.gov/show/NCT04401202,None
1300,2301,NCT04401410,ClinicalTrials.gov,2020-05-21,2020-07-30,False,Baylor University,Not Recruiting,Phase 1,Interventional,United States,Anti-SARS Cov-2 T Cell Infusions for COVID 19,ATMP,Cells (T),Cells (T),20,https://clinicaltrials.gov/show/NCT04401410,None
1301,2302,NCT04401423,ClinicalTrials.gov,2020-05-21,2020-06-01,False,Columbia University,Not Recruiting,Phase 2,Interventional,No Country Given,TXA COVID-19 Clinical Trial,Drug,TXA127,TXA127,100,https://clinicaltrials.gov/show/NCT04401423,None
1302,2303,NCT04401527,ClinicalTrials.gov,2020-05-21,2020-06-01,False,Hope Pharmaceuticals,Not Recruiting,Phase 2,Interventional,No Country Given,Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite,Drug,Sodium Nitrite,Sodium Nitrite,200,https://clinicaltrials.gov/show/NCT04401527,None
1303,2305,NCT04401644,ClinicalTrials.gov,2020-05-15,2020-06-01,False,Somerset NHS Foundation Trust,Not Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19: Laser Interferometry for Rapid Single Coronavirus Detection,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,250,https://clinicaltrials.gov/show/NCT04401644,None
1304,2306,NCT04402203,ClinicalTrials.gov,2020-05-19,2020-05-01,True,Bangladesh Medical Research Council (BMRC),Recruiting,Phase 2/Phase 3,Interventional,Bangladesh,Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh,Drug,Favipiravir,Favipiravir,50,https://clinicaltrials.gov/show/NCT04402203,None
1305,2309,NCT04402840,ClinicalTrials.gov,2020-05-22,2020-04-24,True,West Virginia University,Recruiting,Not Applicable,Interventional,United States,Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS),Procedure,Stellate Ganglion Block,Stellate Ganglion Block,5,https://clinicaltrials.gov/show/NCT04402840,None
1306,2310,NCT04402983,ClinicalTrials.gov,2020-05-22,2020-05-20,True,Istanbul Medipol University Hospital,Recruiting,Not Applicable,Interventional,Turkey,The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,34,https://clinicaltrials.gov/show/NCT04402983,None
1307,2313,NCT04403269,ClinicalTrials.gov,2020-05-18,2020-05-05,True,Versailles Hospital,Recruiting,Phase 2,Interventional,France,"NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE",ATMP,Immunoglobulin,Immunoglobulin,35,https://clinicaltrials.gov/show/NCT04403269,None
1308,2315,NCT04403477,ClinicalTrials.gov,2020-05-20,2020-05-20,False,Bangabandhu Sheikh Mujib Medical University,Recruiting,Phase 2,Interventional,Bangladesh,Convalescent Plasma Therapy in Severe COVID-19 Infection,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04403477,None
1309,2316,NCT04403555,ClinicalTrials.gov,2020-05-23,2020-06-01,False,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,Ivermectin and Doxycycine in COVID-19 Treatment,Drug,Ivermectin + Doxycycine vs. Chloroquine,Ivermectin; Doxycycline; Chloroquine,40,https://clinicaltrials.gov/show/NCT04403555,None
1310,2318,NCT04403906,ClinicalTrials.gov,2020-05-21,2020-06-01,False,Somerset NHS Foundation Trust,Not Recruiting,Not Applicable,Interventional,United Kingdom,Somerset and South Essex Coronavirus Antigen Testing,Clinical Presentation (Epidemiology),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04403906,None
1311,2319,NCT04404192,ClinicalTrials.gov,2020-05-21,2020-11-01,False,"VistaGen Therapeutics, Inc.",Not Recruiting,Phase 2,Interventional,United States,PH94B in the Treatment of Adjustment Disorder With Anxiety,Other (psych),PH94B,PH94B,30,https://clinicaltrials.gov/show/NCT04404192,None
1312,2320,NCT04404218,ClinicalTrials.gov,2020-05-24,2020-05-01,True,"University Health Network, Toronto",Not Recruiting,Phase 2,Interventional,No Country Given,The Aa Berry COVID-19 Anti-Inflammation Trial,Supplement,Acai Berry,Acai Berry,480,https://clinicaltrials.gov/show/NCT04404218,None
1313,2321,NCT04307693,ClinicalTrials.gov,2020-03-10,2020-03-11,False,Asan Medical Center,Not Recruiting,Phase 2,Interventional,South Korea,Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19),Drug,Lopinavir/ritonavir vs. hydroxychloroquine,Lopinavir/ritonavir; Hydroxychloroquine,65,https://clinicaltrials.gov/show/NCT04307693,None
1314,2322,NCT04317040,ClinicalTrials.gov,2020-03-19,2020-04-08,False,"OncoImmune, Inc.",Recruiting,Phase 3,Interventional,United States,CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment,ATMP,Gene-derived protein,Gene-derived protein,230,https://clinicaltrials.gov/show/NCT04317040,None
1315,2323,NCT04321421,ClinicalTrials.gov,2020-03-23,2020-03-17,True,Foundation IRCCS San Matteo Hospital,Not Recruiting,Not Applicable,Interventional,Italy,Hyperimmune Plasma for Critical Patients With COVID-19,ATMP,Plasma,Plasma,49,https://clinicaltrials.gov/show/NCT04321421,None
1316,2324,NCT04327206,ClinicalTrials.gov,2020-03-25,2020-03-30,False,Murdoch Childrens Research Institute,Recruiting,Phase 3,Interventional,Australia,BCG Vaccination to Protect Healthcare Workers Against COVID-19,ATMP,Vaccine,Vaccine,10078,https://clinicaltrials.gov/show/NCT04327206,None
1317,2326,NCT04328467,ClinicalTrials.gov,2020-03-27,2020-04-06,False,University of Minnesota,Not Recruiting,Phase 3,Interventional,United States,Pre-exposure Prophylaxis for SARS-Coronavirus-2,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1500,https://clinicaltrials.gov/show/NCT04328467,None
1318,2327,NCT04328493,ClinicalTrials.gov,2020-03-27,2020-04-07,False,University of Oxford,Recruiting,Phase 2,Interventional,Vietnam,The Vietnam Chloroquine Treatment on COVID-19,Drug,Chloroquine,Chloroquine,250,https://clinicaltrials.gov/show/NCT04328493,None
1319,2328,NCT04334629,ClinicalTrials.gov,2020-04-02,2020-05-26,False,King's College London,Recruiting,Phase 4,Interventional,United Kingdom,LIBERATE Trial in COVID-19,Drug,Ibuprofen,Ibuprofen,230,https://clinicaltrials.gov/show/NCT04334629,None
1320,2329,NCT04334850,ClinicalTrials.gov,2020-04-02,2020-04-20,True,Assistance Publique  Hpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia,Other,Other,Other,194,https://clinicaltrials.gov/show/NCT04334850,EUCTR2020-001324-33
1321,2330,NCT04341610,ClinicalTrials.gov,2020-04-07,2020-04-20,False,"Rigshospitalet, Denmark",Not Recruiting,Phase 1/Phase 2,Interventional,Denmark,ASC Therapy for Patients With Severe Respiratory COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),0,https://clinicaltrials.gov/show/NCT04341610,None
1322,2332,NCT04345289,ClinicalTrials.gov,2020-04-10,2020-05-01,True,Thomas Benfield,Recruiting,Phase 3,Interventional,Denmark,Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia,Drug (+ ATMP),Plamsa vs. Sarilumab vs. Hydroxychloroquine vs. Baricitinib,Plamsa; Sarilumab; Hydroxychloroquine; Baricitinib,1500,https://clinicaltrials.gov/show/NCT04345289,EUCTR2020-001367-88
1323,2333,NCT04351516,ClinicalTrials.gov,2020-04-15,2020-04-21,True,"University Hospital, Tbingen",Recruiting,Phase 2/Phase 3,Interventional,Germany,Test and Treat COVID 65plus+,Drug,Hydroxychloroquine,Hydroxychloroquine,350,https://clinicaltrials.gov/show/NCT04351516,EUCTR2020-001482-37
1324,2334,NCT04354428,ClinicalTrials.gov,2020-04-16,2020-04-16,False,University of Washington,Recruiting,Phase 2/Phase 3,Interventional,United States,Treatment for COVID-19 in High-Risk Adult Outpatients,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine vs. Vitamin C + Folic Acid,Azithromycin; Hydroxychloroquine; Vitamin C; Folic Acid,630,https://clinicaltrials.gov/show/NCT04354428,None
1325,2335,NCT04359264,ClinicalTrials.gov,2020-04-16,2020-04-20,False,"St. Michael's Hospital, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial,Other,Other,Other,392,https://clinicaltrials.gov/show/NCT04359264,None
1326,2337,NCT04362059,ClinicalTrials.gov,2020-04-20,2020-06-27,True,University Hospital Southampton NHS Foundation Trust,Not Recruiting,Not Applicable,Interventional,No Country Given,A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19,Drug,Bovactant,Bovactant,24,https://clinicaltrials.gov/show/NCT04362059,EUCTR2020-001886-35
1327,2340,NCT04364594,ClinicalTrials.gov,2020-04-22,2020-03-26,True,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Not Recruiting,Not Applicable,Interventional,Italy,COVID-19 Search in Conjunctival Cells,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04364594,None
1328,2341,NCT04366115,ClinicalTrials.gov,2020-04-26,2020-06-01,False,AVM Biotechnology LLC,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Evaluating AVM0703 for Treatment of COVID-19,Drug,AVM0703,AVM0703,126,https://clinicaltrials.gov/show/NCT04366115,None
1329,2342,NCT04366141,ClinicalTrials.gov,2020-04-24,2020-05-01,False,University of British Columbia,Recruiting,Not Applicable,Interventional,Canada,COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box,Other (device),Barrier,Barrier,120,https://clinicaltrials.gov/show/NCT04366141,None
1330,2344,NCT04368988,ClinicalTrials.gov,2020-04-24,2020-05-25,False,Novavax,Recruiting,Phase 1,Interventional,Australia,Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant,ATMP,Vaccine,Vaccine,131,https://clinicaltrials.gov/show/NCT04368988,None
1331,2345,NCT04373200,ClinicalTrials.gov,2020-04-22,2020-05-25,False,Rennes University Hospital,Recruiting,Not Applicable,Interventional,France,Human Ab Response & immunoMONItoring of COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,75,https://clinicaltrials.gov/show/NCT04373200,None
1332,2346,NCT04374526,ClinicalTrials.gov,2020-05-02,2020-05-27,False,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Recruiting,Phase 2/Phase 3,Interventional,Italy,Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression.,ATMP,Plasma,Plasma,182,https://clinicaltrials.gov/show/NCT04374526,None
1333,2348,NCT04377659,ClinicalTrials.gov,2020-05-04,2020-05-01,True,Memorial Sloan Kettering Cancer Center,Recruiting,Phase 2,Interventional,United States,Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection,Drug,Tocilizumab,Tocilizumab,40,https://clinicaltrials.gov/show/NCT04377659,None
1334,2350,NCT04378803,ClinicalTrials.gov,2020-05-04,2020-05-13,False,University of Miami,Not Recruiting,Not Applicable,Interventional,United States,Mindfulness Training for Seniors,Other (psych),Psychological,Psychological,53,https://clinicaltrials.gov/show/NCT04378803,None
1335,2354,NCT04382547,ClinicalTrials.gov,2020-05-08,2020-05-11,False,Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus,Recruiting,Phase 1/Phase 2,Interventional,Belarus,Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells,ATMP,Cells (mesenchymal),Cells (mesenchymal),40,https://clinicaltrials.gov/show/NCT04382547,None
1336,2355,NCT04384497,ClinicalTrials.gov,2020-05-07,2020-05-07,False,Joakim Dillner,Recruiting,Phase 1/Phase 2,Interventional,Sweden,Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study,ATMP,Plasma,Plasma,50,https://clinicaltrials.gov/show/NCT04384497,None
1337,2357,NCT04386291,ClinicalTrials.gov,2020-05-11,2020-05-25,False,"Research Foundation for Mental Hygiene, Inc.",Recruiting,Not Applicable,Interventional,United States,Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,360,https://clinicaltrials.gov/show/NCT04386291,None
1338,2360,NCT04388527,ClinicalTrials.gov,2020-05-04,2020-04-30,True,University of Pennsylvania,Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma for Mechanically Ventilated Population,ATMP,Plasma,Plasma,50,https://clinicaltrials.gov/show/NCT04388527,None
1339,2364,NCT04397692,ClinicalTrials.gov,2020-05-19,2020-05-18,True,Beyond Air Ltd,Not Recruiting,Not Applicable,Interventional,United States,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial),Drug,Nitric Oxide,Nitric Oxide,20,https://clinicaltrials.gov/show/NCT04397692,None
1340,2366,NCT04401046,ClinicalTrials.gov,2020-05-22,2020-05-30,False,Institut Paoli-Calmettes,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 and Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder,Other (psych),No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04401046,None
1341,2367,NCT04402892,ClinicalTrials.gov,2020-05-19,2020-06-01,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19: SARS-CoV-2 Specific Memory B and T-CD4+ Cells,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04402892,None
1342,2369,NCT04402918,ClinicalTrials.gov,2020-05-18,2020-05-17,True,CHU de Besanon,Recruiting,Not Applicable,Interventional,France,Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy,Clinical Presentation,No Intervention,No Intervention,160,https://clinicaltrials.gov/show/NCT04402918,None
1343,2371,NCT04403243,ClinicalTrials.gov,2020-05-20,2020-05-08,True,Lomonosov Moscow State University Medical Research and Educational Center,Recruiting,Phase 2,Interventional,Russian Federation,COLchicine Versus Ruxolitinib and Secukinumab In Open Prospective Randomized Trial,Drug,Colchicine vs. Ruxolitinib vs. Secukinumab,Colchicine; Ruxolitinib; Secukinumab,70,https://clinicaltrials.gov/show/NCT04403243,None
1344,2372,NCT04403646,ClinicalTrials.gov,2020-05-22,2020-06-01,False,Hospital de Clnicas Jos de San Martn,Not Recruiting,Not Applicable,Interventional,No Country Given,Tannin Specific Natural Extract for COVID-19 Infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,140,https://clinicaltrials.gov/show/NCT04403646,None
1345,2374,NCT04403685,ClinicalTrials.gov,2020-05-24,2020-05-08,True,Beneficncia Portuguesa de So Paulo,Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers,Drug,Tocilizumab,Tocilizumab,150,https://clinicaltrials.gov/show/NCT04403685,None
1346,2378,NCT04404426,ClinicalTrials.gov,2020-05-22,2020-06-15,False,Rennes University Hospital,Not Recruiting,Not Applicable,Interventional,France,CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome,Drug,Citrulline,Citrulline,100,https://clinicaltrials.gov/show/NCT04404426,None
1347,2379,NCT04405102,ClinicalTrials.gov,2020-05-26,2020-07-06,False,Francois Lellouche,Not Recruiting,Phase 2,Interventional,No Country Given,COVID-19 Ozanimod Intervention Study,Drug,Ozanimod,Ozanimod,48,https://clinicaltrials.gov/show/NCT04405102,None
1348,2380,NCT04405271,ClinicalTrials.gov,2020-05-26,2020-06-15,False,Hospital Italiano de Buenos Aires,Not Recruiting,Phase 3,Interventional,Argentina,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),Drug (Chemoprophylaxis),Emtricitabine + Tenofovir alafenamide,Emtricitabine; Tenofovir alafenamide,1378,https://clinicaltrials.gov/show/NCT04405271,None
1349,2381,NCT04405310,ClinicalTrials.gov,2020-05-26,2020-05-20,True,Grupo Mexicano para el Estudio de la Medicina Intensiva,Recruiting,Phase 2,Interventional,Mexico,Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial,ATMP,Plasma,Plasma,80,https://clinicaltrials.gov/show/NCT04405310,None
1350,2383,NCT04405492,ClinicalTrials.gov,2020-05-19,2020-05-25,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,"Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1210,https://clinicaltrials.gov/show/NCT04405492,None
1351,2384,NCT04405843,ClinicalTrials.gov,2020-05-23,2020-06-01,False,Centro de Estudios en Infectologa Peditrica,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19,Drug,Ivermectin,Ivermectin,400,https://clinicaltrials.gov/show/NCT04405843,None
1352,2386,NCT04405999,ClinicalTrials.gov,2020-05-18,2020-05-14,True,"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health",Recruiting,Phase 4,Interventional,Russian Federation,Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease,Drug (Chemoprophylaxis),Bromhexine hydrochloride,Bromhexine hydrochloride,140,https://clinicaltrials.gov/show/NCT04405999,None
1353,2388,NCT04406064,ClinicalTrials.gov,2020-05-26,2020-06-01,False,"Children's Hospital Medical Center, Cincinnati",Not Recruiting,Phase 2,Interventional,United States,Viral Specific T-cells for Treatment of COVID-19,ATMP,Cells (T),Cells (T),100,https://clinicaltrials.gov/show/NCT04406064,None
1354,2391,NCT04406246,ClinicalTrials.gov,2020-05-24,2020-05-21,True,Materno-Perinatal Hospital of the State of Mexico,Recruiting,Phase 4,Interventional,Mexico,Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide,Drug,Nitazoxanide,Nitazoxanide,150,https://clinicaltrials.gov/show/NCT04406246,None
1355,2393,NCT04406389,ClinicalTrials.gov,2020-05-26,2020-06-01,False,Weill Medical College of Cornell University,Not Recruiting,Phase 4,Interventional,United States,Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial),Drug,"Heparin, Fondapariniux, Argatroban",Heparin; Fondapariniux; Argatroban,186,https://clinicaltrials.gov/show/NCT04406389,None
1356,2394,NCT04406493,ClinicalTrials.gov,2020-05-23,2020-04-28,True,Hillel Yaffe Medical Center,Recruiting,Not Applicable,Interventional,Israel,Monitoring COVID-19 Patients' Lung Fluid Using Impedance Technique,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04406493,None
1357,2395,NCT04406532,ClinicalTrials.gov,2020-05-22,2020-07-01,False,Albert Einstein College of Medicine,Not Recruiting,Not Applicable,Interventional,No Country Given,Home-Based Covid-19 Rehabilitation Program,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,100,https://clinicaltrials.gov/show/NCT04406532,None
1358,2401,NCT04407286,ClinicalTrials.gov,2020-05-19,2020-05-19,False,Arizona State University,Recruiting,Phase 1,Interventional,United States,Vitamin D Testing and Treatment for COVID 19,Drug,Vitamin D,Vitamin D,100,https://clinicaltrials.gov/show/NCT04407286,None
1359,2405,NCT04407507,ClinicalTrials.gov,2020-05-27,2020-06-01,False,Investigacion Biomedica para el Desarrollo de Farmacos S.A. de C.V.,Not Recruiting,Phase 2,Interventional,No Country Given,"Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms",Drug,Ivermectin,Ivermectin,66,https://clinicaltrials.gov/show/NCT04407507,None
1360,2409,NCT04408027,ClinicalTrials.gov,2020-05-26,2020-06-01,False,The Hospital for Sick Children,Not Recruiting,Not Applicable,Interventional,Canada,Mental Health Support for SickKids Children and Families During COVID-19 Using Established eHealth Interventions,Other (psych),Psychological,Psychological,20,https://clinicaltrials.gov/show/NCT04408027,None
1361,2410,NCT04408040,ClinicalTrials.gov,2020-05-15,2020-06-01,False,"Northside Hospital, Inc.",Not Recruiting,Phase 2,Interventional,United States,Use of Convalescent Plasma for COVID-19,ATMP,Plasma,Plasma,700,https://clinicaltrials.gov/show/NCT04408040,None
1362,2412,NCT04408235,ClinicalTrials.gov,2020-05-26,2020-06-01,True,AOU di Modena,Not Recruiting,Phase 3,Interventional,Italy,High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy,Drug,Heparin,Heparin,300,https://clinicaltrials.gov/show/NCT04408235,EUCTR2020-001972-13
1363,2415,ACTRN12620000640909,ANZCTR,2020-06-01,2020-06-08,False,University of Melbourne,Not Recruiting,Not Applicable,Interventional,Australia,"A phase II, open label non-randomised clinical trial of the safety and efficacy of the CovidCare app to support self-monitoring for COVID-19 symptoms in self-isolation and to determine the impacts on mental health",Other (software),eHealth,eHealth,200,https://anzctr.org.au/ACTRN12620000640909.aspx,None
1364,2416,ACTRN12620000635965,ANZCTR,2020-05-29,2020-06-05,False,South Western Sydney Local Health District,Not Recruiting,Not Applicable,Interventional,Australia,"Open label, prospective study for the Biofourmis Everion armband telemonitoring solution for patients during COVID-19 home isolation within South Western Sydney",Other (software),eHealth,eHealth,50,https://anzctr.org.au/ACTRN12620000635965.aspx,None
1365,2418,ACTRN12620000636954,ANZCTR,2020-05-29,2020-06-05,False,South Western Sydney Local Health District,Not Recruiting,Not Applicable,Interventional,Australia,COACHING FOR COVID-19: A Pilot Study Investigating the Effectiveness of Coaching on Psychological Outcomes in Hospital-Based Senior Doctors,Other (psych),Psychological,Psychological,35,https://anzctr.org.au/ACTRN12620000636954.aspx,None
1366,2419,ACTRN12620000634976,ANZCTR,2020-05-29,2020-06-08,False,University of Auckland,Not Recruiting,Not Applicable,Interventional,New Zealand,Testing an Online Coping Skills Intervention for People Living with Chronic Illness During the Covid-19 Pandemic,Other (psych),Psychological,Psychological,46,https://anzctr.org.au/ACTRN12620000634976.aspx,None
1367,2421,ChiCTR2000033627,ChiCTR,2020-06-07,2020-06-10,False,Rayak Hospital,Not Recruiting,Not Applicable,Interventional,Iraq,In vivo use of ivermectin (IVR) for treatment for corona virus infected patients: a randomized controlled trial,Drug,Ivermectin,Ivermectin,60,http://www.chictr.org.cn/showproj.aspx?proj=54707,None
1368,2426,ChiCTR2000033491,ChiCTR,2020-06-02,2020-02-11,True,Huo-Shen-Shan Hospital,Not Recruiting,Phase 4,Interventional,China,Oral Favipiravir for Patients with Delayed SARS-Cov-2 viral RNA Clearance,Drug,Favipiravir,Favipiravir,9,http://www.chictr.org.cn/showproj.aspx?proj=54278,None
1369,2427,ISRCTN99248812,ISRCTN,2020-05-29,2020-05-30,False,University of Oxford,Recruiting,Not Applicable,Interventional,United Kingdom,Peer support training for adolescents during the COVID-19 outbreak,Other (psych),Psychological,Psychological,100,http://isrctn.com/ISRCTN99248812,None
1370,2429,ISRCTN12107048,ISRCTN,2020-05-28,2020-06-08,False,University of Cambridge,Recruiting,Not Applicable,Interventional,United Kingdom,Supporting weight management during COVID-19,Other (exercise),Exercise,Exercise,360,http://isrctn.com/ISRCTN12107048,None
1371,2430,ISRCTN11384058,ISRCTN,2020-05-26,2020-04-01,True,Policlinico San Martino Genoa,Recruiting,Not Applicable,Interventional,Italy,"A collaborative pilot study to monitor and optimise access to urgent surgery during the period of reduced resources in Genoa, Italy caused by the COVID-19 pandemic, using a bespoke referral process and the SWALIS 2020 model to prioritise surgery by clinical urgency and waiting time",Health System,No Intervention,No Intervention,300,http://isrctn.com/ISRCTN11384058,None
1372,2432,ISRCTN43900695,ISRCTN,2020-04-08,2020-05-04,False,Northumbria University,Not Recruiting,Not Applicable,Interventional,United Kingdom,Testing an early online intervention for the treatment of disturbed sleep during the COVID-19 pandemic,Other,Sleep aids,Sleep aids,75,http://isrctn.com/ISRCTN43900695,None
1373,2434,EUCTR2020-001597-30-GB,EU Clinical Trials Register,2020-04-09,2020-05-29,False,4D Pharma,Authorised,Phase 2,Interventional,"Ireland, United States, United Kingdom, Italy",A study to test the effectiveness and safety of bacteria called Bifidobacterium breve in patients with COVID-19 infections,Drug,Bifidobacterium,Bifidobacterium,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001597-30,None
1374,2435,EUCTR2020-001546-19-BE,EU Clinical Trials Register,2020-04-09,2020-04-21,False,Argenx BV,Authorised,Phase 1/Phase 2,Interventional,Belgium,A First-in-Human Study in Adult Subjects Hospitalized with Covid-19 to Investigate a new product called ARGX-117,Drug,ARGX-117,ARGX-117,6,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001546-19,None
1375,2436,EUCTR2020-002111-22-PL,EU Clinical Trials Register,2020-04-29,2020-06-26,False,University of Rzeszw,Authorised,Phase 3,Interventional,Poland,Study evaluating the impact of BCG vaccination on the incidence and course of SARS-CoV-2 infection among health care workers in Poland during the COVID-19 pandemic,Drug,Vaccine,Vaccine,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002111-22,None
1376,2437,EUCTR2020-001904-41-GB,EU Clinical Trials Register,2020-04-30,2020-05-20,False,NHS Greater Glasgow and Clyde,Authorised,Phase 2,Interventional,United Kingdom,A study comparing favipiravir versus standard of care management as an early treatment arm in COVID-19 Hospitalized patients,Drug,Favipiravir,Favipiravir,302,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001904-41,None
1377,2438,EUCTR2020-002091-12-BG,EU Clinical Trials Register,2020-05-05,2020-05-15,False,Huvepharma EOOD,Authorised,Phase 2,Interventional,Bulgaria,Study of ivermectin against COVID-19,Drug,Ivermectin,Ivermectin,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002091-12,None
1378,2439,EUCTR2020-001849-39-SE,EU Clinical Trials Register,2020-04-28,2020-05-18,False,Region Skne,Authorised,Phase 2,Interventional,Sweden,Treatment of COVID-19 with the inhalation drug pulmozyme,Drug,Dornase alfa,Dornase alfa,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001849-39,None
1379,2440,EUCTR2020-001951-42-PL,EU Clinical Trials Register,2020-04-29,2020-05-08,False,Nicolaus Copernicus University,Authorised,Phase 3,Interventional,"Italy, Canada, Spain, Poland",Amiodarone or Verapamil in COVID-19 hospitalized patients with symptoms: Randomized clinical trial,Drug,Amiodarone vs. Verapamil,Amiodarone; Verapamil,804,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001951-42,None
1380,2442,EUCTR2020-001038-36-DE,EU Clinical Trials Register,2020-04-14,2020-04-20,False,Biontech SE,Authorised,Phase 1/Phase 2,Interventional,Germany,Study to investigate the safety and effects of vaccines in healthy adults.,ATMP,Vaccine,Vaccine,196,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001038-36,None
1381,2443,EUCTR2020-002130-33-BE,EU Clinical Trials Register,2020-05-06,2020-05-26,False,"University Hospital, Ghent",Authorised,Phase 2,Interventional,Belgium,Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19,Drug,Zilucoplan,Zilucoplan,81,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002130-33,None
1382,2444,NCT04283461,ClinicalTrials.gov,2020-02-21,2020-03-16,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Phase 1,Interventional,United States,Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19),ATMP,Vaccine,Vaccine,155,https://clinicaltrials.gov/show/NCT04283461,None
1383,2445,NCT04292730,ClinicalTrials.gov,2020-02-28,2020-03-15,True,Gilead Sciences,Not Recruiting,Phase 3,Interventional,"Hong Kong, United States, Netherlands, Singapore, Sweden, France, Germany, Italy, Japan, Switzerland, Taiwan, China, United Kingdom, Iran, South Korea, Spain",Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment,Drug,Remdesivir,Remdesivir,1600,https://clinicaltrials.gov/show/NCT04292730,EUCTR2020-000842-32
1384,2446,NCT04292899,ClinicalTrials.gov,2020-02-28,2020-03-06,True,Gilead Sciences,Not Recruiting,Phase 3,Interventional,"Hong Kong, United States, Netherlands, Singapore, Sweden, France, Germany, Italy, Japan, Switzerland, Taiwan, China, United Kingdom, South Korea, Spain",Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734) in Participants With Severe Coronavirus Disease (COVID-19),Drug,Remdesivir,Remdesivir,6000,https://clinicaltrials.gov/show/NCT04292899,EUCTR2020-000841-15
1385,2447,NCT04320615,ClinicalTrials.gov,2020-03-23,2020-04-03,True,Roche,Not Recruiting,Phase 3,Interventional,"Denmark, United States, Netherlands, United Kingdom, France, Germany, Italy, Canada, Spain",A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia,Drug,Tocilizumab,Tocilizumab,450,https://clinicaltrials.gov/show/NCT04320615,EUCTR2020-001154-22
1386,2448,NCT04322123,ClinicalTrials.gov,2020-03-24,2020-04-01,False,Hospital do Corao,Not Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19),Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; azithromycin,630,https://clinicaltrials.gov/show/NCT04322123,None
1387,2450,NCT04323228,ClinicalTrials.gov,2020-03-23,2020-07-01,False,King Saud University,Not Recruiting,Phase 4,Interventional,No Country Given,Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19,Supplement,Oral nutrition supplement,Oral nutrition supplement,30,https://clinicaltrials.gov/show/NCT04323228,None
1388,2451,NCT04329832,ClinicalTrials.gov,2020-03-30,2020-03-30,False,"Intermountain Health Care, Inc.",Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19,Drug,Hydroxychloroquine vs. Azithromycin,Hydroxychloroquine; azithromycin,300,https://clinicaltrials.gov/show/NCT04329832,None
1389,2452,NCT04334967,ClinicalTrials.gov,2020-04-02,2020-03-30,True,Providence Health & Services,Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care,Drug,Hydroxychloroquine vs. Vitamin C,Hydroxychloroquine; Vitamin C,13,https://clinicaltrials.gov/show/NCT04334967,None
1390,2455,NCT04337788,ClinicalTrials.gov,2020-04-03,2020-05-01,False,"University Hospital, Limoges",Not Recruiting,Not Applicable,Interventional,No Country Given,Gerontological Telemonitoring of Older Adults Living in Nursing Homes With COVID-19 Disease,Telehealth,Telehealth,Telehealth,200,https://clinicaltrials.gov/show/NCT04337788,None
1391,2457,NCT04344600,ClinicalTrials.gov,2020-04-10,2020-05-29,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection,Drug,Interferon lambda,Interferon lambda,164,https://clinicaltrials.gov/show/NCT04344600,None
1392,2458,NCT04344951,ClinicalTrials.gov,2020-04-06,2020-04-06,False,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Recruiting,Phase 2,Interventional,Greece,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",Drug,Chloroquine,Chloroquine,60,https://clinicaltrials.gov/show/NCT04344951,None
1393,2461,NCT04348513,ClinicalTrials.gov,2020-04-09,2020-05-29,False,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Recruiting,Phase 2,Interventional,Greece,Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection,Drug,Triiodothyronine,Triiodothyronine,60,https://clinicaltrials.gov/show/NCT04348513,None
1394,2462,NCT04351243,ClinicalTrials.gov,2020-04-15,2020-04-12,True,Kinevant Sciences GmbH,Recruiting,Phase 2,Interventional,United States,A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE).,Drug,Grimsilumab,Grimsilumab,270,https://clinicaltrials.gov/show/NCT04351243,None
1395,2463,NCT04355364,ClinicalTrials.gov,2020-04-15,2020-04-21,False,Fondation Ophtalmologique Adolphe de Rothschild,Recruiting,Phase 3,Interventional,France,Efficacy and Safety of Aerosolized Intra-tracheal Dornase Alfa Administration in Patients With COVID19-induced ARDS (COVIDORNASE),Drug,Dornase alfa,Dornase alfa,100,https://clinicaltrials.gov/show/NCT04355364,None
1396,2465,NCT04357340,ClinicalTrials.gov,2020-04-13,2020-04-02,True,Tehran University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,40,https://clinicaltrials.gov/show/NCT04357340,None
1397,2467,NCT04363736,ClinicalTrials.gov,2020-04-21,2020-05-05,False,Roche,Recruiting,Phase 2,Interventional,United States,A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia,Drug,Tocilizumab,Tocilizumab,100,https://clinicaltrials.gov/show/NCT04363736,None
1398,2468,NCT04363827,ClinicalTrials.gov,2020-04-24,2020-05-14,False,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori,Recruiting,Phase 2,Interventional,Italy,Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19),Drug (+ Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,2300,https://clinicaltrials.gov/show/NCT04363827,None
1399,2471,NCT04370236,ClinicalTrials.gov,2020-04-29,2020-07-01,False,"Inmune Bio, Inc.",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,XPro1595 for the Treatment of Pulmonary Complications From COVID-19,Drug,XPro1595,XPro1595,366,https://clinicaltrials.gov/show/NCT04370236,None
1400,2472,NCT04370886,ClinicalTrials.gov,2020-04-28,2020-04-30,False,Guangzhou Blood Center,Not Recruiting,Not Applicable,Interventional,China,Recruit Blood Donors Via SMS During Epidemic of COVID-19,Other,No Intervention,No Intervention,456517,https://clinicaltrials.gov/show/NCT04370886,None
1401,2473,NCT04373044,ClinicalTrials.gov,2020-04-17,2020-05-01,False,University of Southern California,Recruiting,Phase 2,Interventional,United States,"Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19",Drug,Baricitinib + one of Hydroxychloroquine or Lopinavir/ritonavir or Remdesivir,Baricitinib; Hydroxychloroquine; Lopinavir/ritonavir; Remdesivir,144,https://clinicaltrials.gov/show/NCT04373044,None
1402,2474,NCT04374461,ClinicalTrials.gov,2020-05-01,2020-05-01,False,Memorial Sloan Kettering Cancer Center,Recruiting,Phase 2,Interventional,United States,A Study of N-acetylcysteine in Patients With COVID-19 Infection,Drug,N-acetylcysteine,N-acetylcysteine,86,https://clinicaltrials.gov/show/NCT04374461,None
1403,2475,NCT04377672,ClinicalTrials.gov,2020-05-04,2020-05-28,False,Johns Hopkins University,Recruiting,Phase 1,Interventional,United States,Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19),ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04377672,None
1404,2476,NCT04384965,ClinicalTrials.gov,2020-05-08,2020-05-12,False,Centre for Addiction and Mental Health,Recruiting,Not Applicable,Interventional,Canada,Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic,Other (psych),Electroconvulsive Therapy,Electroconvulsive Therapy,200,https://clinicaltrials.gov/show/NCT04384965,None
1405,2477,NCT04385186,ClinicalTrials.gov,2020-05-06,2020-06-20,False,"National Blood Center Foundation, Hemolife",Not Recruiting,Phase 2,Interventional,Colombia,Inactivated Convalescent Plasma as a Therapeutic Alternative in Patients CoViD-19,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04385186,None
1406,2478,NCT04385849,ClinicalTrials.gov,2020-05-07,2020-06-01,False,"ImmunityBio, Inc.",Not Recruiting,Phase 1,Interventional,No Country Given,Study of the Safety of Therapeutic Treatment With an Immunomodulatory Agent (N-803) in Adults With COVID-19,Drug,N-803,N-803,30,https://clinicaltrials.gov/show/NCT04385849,None
1407,2480,NCT04391179,ClinicalTrials.gov,2020-05-15,2020-05-31,False,Yogendra Kanthi,Recruiting,Phase 2,Interventional,United States,Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19,Drug,Dipyridamole,Dipyridamole,80,https://clinicaltrials.gov/show/NCT04391179,None
1408,2482,NCT04396067,ClinicalTrials.gov,2020-05-18,2020-06-01,False,Kafrelsheikh University,Not Recruiting,Phase 2,Interventional,No Country Given,Combination With Inhibitor of Neutrophil Elastase (All-trans Retinoic Acid ) and Isotretinoin May Enhances Neutralizing Antibodies in COVID -19 Infected Patients Better Than COVID-19 Inactivated Vaccines,Drug,Retinoic acid,Retinoic acid,360,https://clinicaltrials.gov/show/NCT04396067,None
1409,2483,NCT04397757,ClinicalTrials.gov,2020-05-19,2020-05-13,True,University of Pennsylvania,Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.,ATMP,Plasma,Plasma,80,https://clinicaltrials.gov/show/NCT04397757,None
1410,2484,NCT04397796,ClinicalTrials.gov,2020-05-18,2020-06-01,False,"NantKwest, Inc.",Not Recruiting,Phase 1,Interventional,No Country Given,Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation,ATMP,Cells (mesenchymal),Cells (mesenchymal),45,https://clinicaltrials.gov/show/NCT04397796,None
1411,2486,NCT04401475,ClinicalTrials.gov,2020-05-21,2020-08-01,False,Edesa Biotech Inc.,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With Moderate to Severe COVID-19 Pneumonia",Drug,EB05,EB05,865,https://clinicaltrials.gov/show/NCT04401475,None
1412,2488,NCT04402879,ClinicalTrials.gov,2020-05-22,2020-05-25,False,University of Calgary,Recruiting,Not Applicable,Interventional,Canada,CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals,Procedure,Positioning,Positioning,596,https://clinicaltrials.gov/show/NCT04402879,None
1413,2490,NCT04405544,ClinicalTrials.gov,2020-05-26,2020-05-22,True,Ministry of Health of Russia,Recruiting,Not Applicable,Interventional,Russian Federation,Determination of Acute Encephalopathy Predictors in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04405544,None
1414,2492,NCT04405986,ClinicalTrials.gov,2020-05-08,2020-05-19,False,"University Hospital, Bordeaux",Recruiting,Not Applicable,Interventional,France,Exploring Brain Damages After COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,38,https://clinicaltrials.gov/show/NCT04405986,None
1415,2493,NCT04406181,ClinicalTrials.gov,2020-04-28,2020-05-18,False,UZ Brussel,Recruiting,Not Applicable,Interventional,Belgium,Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04406181,None
1416,2497,NCT04407182,ClinicalTrials.gov,2020-05-25,2020-05-04,True,Catalysis SL,Recruiting,Phase 2,Interventional,Ecuador,Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19,Supplement,Viusid + Asbrip,Viusid + Asbrip,60,https://clinicaltrials.gov/show/NCT04407182,None
1417,2499,NCT04407208,ClinicalTrials.gov,2020-05-16,2020-05-01,True,Biofarma,Recruiting,Phase 1,Interventional,Indonesia,Convalescent Plasma Therapy in Patients With COVID-19,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04407208,None
1418,2501,NCT04407390,ClinicalTrials.gov,2020-05-22,2020-06-01,False,University of Copenhagen,Recruiting,Phase 2,Interventional,Denmark,Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly,Supplement,Nicotinamide riboside,Nicotinamide riboside,100,https://clinicaltrials.gov/show/NCT04407390,None
1419,2506,NCT04408131,ClinicalTrials.gov,2020-05-28,2020-05-28,False,Assistance Publique  Hpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04408131,None
1420,2507,NCT04408157,ClinicalTrials.gov,2020-05-26,2020-05-20,True,King's College London,Not Recruiting,Not Applicable,Interventional,No Country Given,A Research Study to Evaluate the Benefits of a Self-management Booklet to Promote Wellbeing During the COVID-19 Pandemic,Other (psych),Psychological,Psychological,548,https://clinicaltrials.gov/show/NCT04408157,None
1421,2510,NCT04408209,ClinicalTrials.gov,2020-05-25,2020-04-23,True,National and Kapodistrian University of Athens,Recruiting,Not Applicable,Interventional,Greece,Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04408209,None
1422,2511,NCT04408287,ClinicalTrials.gov,2020-05-20,2020-06-01,False,Lawson Health Research Institute,Not Recruiting,Not Applicable,Interventional,Canada,Improving Activity Engagement Among Persons With SCI During COVID-19,Other (exercise),Exercise,Exercise,50,https://clinicaltrials.gov/show/NCT04408287,None
1423,2513,NCT04408456,ClinicalTrials.gov,2020-05-24,2020-03-01,True,Postgraduate Institute of Medical Education and Research,Recruiting,Phase 3,Interventional,India,Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,200,https://clinicaltrials.gov/show/NCT04408456,None
1424,2516,NCT04409327,ClinicalTrials.gov,2020-05-28,2020-05-01,True,Restorbio Inc.,Recruiting,Phase 3,Interventional,United States,Phase 3 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes,Drug,RTB101,RTB101,550,https://clinicaltrials.gov/show/NCT04409327,None
1425,2517,NCT04409483,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Epicentre,Not Recruiting,Phase 3,Interventional,No Country Given,Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger,Drug,Lopinavir/ritonavir,Lopinavir/ritonavir,928,https://clinicaltrials.gov/show/NCT04409483,None
1426,2518,NCT04409509,ClinicalTrials.gov,2020-05-28,2020-06-01,False,CSL Behring,Not Recruiting,Phase 2,Interventional,No Country Given,Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19),Drug,Garadacimab,Garadacimab,124,https://clinicaltrials.gov/show/NCT04409509,None
1427,2519,NCT04409522,ClinicalTrials.gov,2020-05-28,2020-05-12,True,Mohammad Sadegh Bagheri Baghdasht,Recruiting,Not Applicable,Interventional,Iran,Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients,Drug,Melatonin,Melatonin,55,https://clinicaltrials.gov/show/NCT04409522,None
1428,2521,NCT04409743,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Stanford University,Recruiting,Not Applicable,Interventional,United States,Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic,Telehealth,Telehealth,Telehealth,100,https://clinicaltrials.gov/show/NCT04409743,None
1429,2522,NCT04409821,ClinicalTrials.gov,2020-05-22,2020-06-01,False,"Rigshospitalet, Denmark",Not Recruiting,Not Applicable,Interventional,No Country Given,Tele-based Psychological Emotional Support for Informal CARegivers of COVID-19 Patients in Intensive Care,Telehealth,Telehealth,Telehealth,50,https://clinicaltrials.gov/show/NCT04409821,None
1430,2524,NCT04409873,ClinicalTrials.gov,2020-05-28,2020-07-01,False,"University of California, San Francisco",Not Recruiting,Phase 2,Interventional,United States,Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19),Drug,Mouthwash,Mouthwash,120,https://clinicaltrials.gov/show/NCT04409873,None
1431,2529,NCT04410328,ClinicalTrials.gov,2020-05-28,2020-06-21,False,Rutgers University,Not Recruiting,Phase 3,Interventional,No Country Given,Aggrenox To Treat Acute Covid-19,Drug,Dipyridamole,Dipyridamole,132,https://clinicaltrials.gov/show/NCT04410328,None
1432,2530,NCT04410458,ClinicalTrials.gov,2020-05-29,2020-05-31,False,Guangzhou Blood Center,Recruiting,Not Applicable,Interventional,China,Recruit Blood Donors Via SMS During Epidemic of COVID-19 (Repeat Trial),Other,Other,Other,506517,https://clinicaltrials.gov/show/NCT04410458,None
1433,2532,NCT04410510,ClinicalTrials.gov,2020-05-27,2020-06-01,False,Hospital Universitario San Ignacio,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19,Drug,P2Et,P2Et,100,https://clinicaltrials.gov/show/NCT04410510,None
1434,2533,NCT04410536,ClinicalTrials.gov,2020-05-25,2020-06-01,False,Fondazione IRCCS Istituto Neurologico Carlo Besta,Not Recruiting,Not Applicable,Interventional,Italy,Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency,Other,Other,Other,25,https://clinicaltrials.gov/show/NCT04410536,None
1435,2534,NCT04410549,ClinicalTrials.gov,2020-05-21,2020-05-27,False,IRCCS Ospedale San Raffaele,Recruiting,Not Applicable,Interventional,Italy,Pulmonary Optical Coherence Tomography in COVID-19 Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10,https://clinicaltrials.gov/show/NCT04410549,None
1436,2535,NCT04410562,ClinicalTrials.gov,2020-05-26,2020-05-13,True,Barcelona Institute for Global Health,Recruiting,Phase 3,Interventional,Spain,Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy,Drug,Hydroxychloroquine,Hydroxychloroquine,714,https://clinicaltrials.gov/show/NCT04410562,None
1437,2536,NCT04410692,ClinicalTrials.gov,2020-05-27,2020-05-15,True,"National University, Singapore",Not Recruiting,Not Applicable,Interventional,Singapore,Can the Prediction Market Improve Predictions of COVID-19?,Other,Other,Other,560,https://clinicaltrials.gov/show/NCT04410692,None
1438,2539,NCT04411433,ClinicalTrials.gov,2020-05-23,2020-05-08,True,"Ministry of Health, Turkey",Recruiting,Phase 3,Interventional,Turkey,Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19,Drug,Favipiravir vs. Favipiravir + Hydroxychloroquine vs. Favipiravir + Azithromycin vs. Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Favipiravir; Azithromycin; Hydroxychloroquine,1000,https://clinicaltrials.gov/show/NCT04411433,None
1439,2542,NCT04411602,ClinicalTrials.gov,2020-05-22,2020-04-07,True,Ascension South East Michigan,Recruiting,Phase 1,Interventional,United States,Feasibility Study of Anti-SARS-CoV-2 Plasma Transfusions in COVID-19 Patients With SRD,ATMP,Plasma,Plasma,90,https://clinicaltrials.gov/show/NCT04411602,None
1440,2543,NCT04411680,ClinicalTrials.gov,2020-05-29,2020-06-01,False,"Partner Therapeutics, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,Study of Sargramostim in Patients With COVID-19,Drug,Sargramostim,Sargramostim,60,https://clinicaltrials.gov/show/NCT04411680,None
1441,2545,NCT04412239,ClinicalTrials.gov,2020-05-30,2020-04-20,True,Health Science Center of Xi'an Jiaotong University,Recruiting,Not Applicable,Interventional,Pakistan,To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic,Telehealth,Telehealth,Telehealth,200,https://clinicaltrials.gov/show/NCT04412239,None
1442,2546,NCT04412343,ClinicalTrials.gov,2020-05-29,2020-05-30,False,University of British Columbia,Recruiting,Not Applicable,Interventional,Canada,The Seniors COvid-19 Pandemic and Exercise Study,Other (exercise),Exercise,Exercise,600,https://clinicaltrials.gov/show/NCT04412343,None
1443,2549,NCT04412395,ClinicalTrials.gov,2020-05-15,2020-06-01,False,"National Research Center, Egypt",Not Recruiting,Phase 2,Interventional,Egypt,Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease,Supplement,Lactoferrin,Lactoferrin,516,https://clinicaltrials.gov/show/NCT04412395,None
1444,2552,NCT04412486,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Dr. Gailen D. Marshall Jr.,Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma (CCP) Transfusion,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04412486,None
1445,2556,NCT04311697,ClinicalTrials.gov,2020-03-14,2020-05-15,False,"NeuroRx, Inc.",Recruiting,Phase 2,Interventional,"United States, Israel",Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure,Drug,Aviptadil,Aviptadil,144,https://clinicaltrials.gov/show/NCT04311697,None
1446,2557,NCT04315948,ClinicalTrials.gov,2020-03-13,2020-03-22,True,INSERM,Recruiting,Phase 3,Interventional,"Luxembourg, France",Trial of Treatments for COVID-19 in Hospitalized Adults,Drug,Remdesivir vs. Lopinavir/ritonavir vs. Lopinavir/ritonavir + Interferon beta vs. Hydroxychloroquine,Remdesivir; Lopinavir/ritonavir; Interferon beta; Hydroxychloroquine,3100,https://clinicaltrials.gov/show/NCT04315948,EUCTR2020-000936-23
1447,2558,NCT04326114,ClinicalTrials.gov,2020-03-26,2020-07-26,False,Complutense University of Madrid,Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness and Safety of Respiratory Training in the Prevention and Severity of COVID-19,Other (training),Other,Other,240,https://clinicaltrials.gov/show/NCT04326114,None
1448,2559,NCT04327401,ClinicalTrials.gov,2020-03-26,2020-04-13,False,Hospital Srio-Libans,Recruiting,Phase 3,Interventional,Brazil,COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III,Drug,Dexamethasone,Dexamethasone,350,https://clinicaltrials.gov/show/NCT04327401,None
1449,2560,NCT04327505,ClinicalTrials.gov,2020-03-25,2020-06-03,True,Karolinska Institutet,Recruiting,Phase 2/Phase 3,Interventional,"Sweden, Germany",Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19,Drug,Oxygen,Oxygen,200,https://clinicaltrials.gov/show/NCT04327505,EUCTR2020-001349-37; DRKS00021626
1450,2562,NCT04332081,ClinicalTrials.gov,2020-03-30,2020-04-06,False,NYU Langone Health,Not Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen for COVID-19 Patients,Drug,Oxygen,Oxygen,20,https://clinicaltrials.gov/show/NCT04332081,None
1451,2563,NCT04333654,ClinicalTrials.gov,2020-04-01,2020-04-12,False,Sanofi,Not Recruiting,Phase 1,Interventional,"United States, Netherlands, Belgium, France",Hydroxychloroquine in Outpatient Adults With COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,210,https://clinicaltrials.gov/show/NCT04333654,None
1452,2564,NCT04336410,ClinicalTrials.gov,2020-04-03,2020-04-03,False,Inovio Pharmaceuticals,Recruiting,Phase 1,Interventional,United States,"Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers",Drug,INO-4800,INO-4800,120,https://clinicaltrials.gov/show/NCT04336410,None
1453,2565,NCT04339816,ClinicalTrials.gov,2020-04-06,2020-05-13,True,Frantisek Duska,Recruiting,Phase 3,Interventional,Czech Republic,Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial,Drug,Hydroxychloroquine + azithromycin vs. hydroxychloroquine,Hydroxychloroquine; azithromycin,240,https://clinicaltrials.gov/show/NCT04339816,EUCTR2020-001456-18
1454,2567,NCT04341142,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Interventional,France,Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,130,https://clinicaltrials.gov/show/NCT04341142,None
1455,2568,NCT04343092,ClinicalTrials.gov,2020-04-05,2020-04-18,False,University of Baghdad,Not Recruiting,Phase 1,Interventional,Iraq,Efficacy of Ivermectin as Add on Therapy in COVID19 Patients,Drug,Ivermectin + hydroxychloroquine vs. hydroxychloroquine,Ivermectin; hydroxychloroquine,100,https://clinicaltrials.gov/show/NCT04343092,None
1456,2569,NCT04343248,ClinicalTrials.gov,2020-04-08,2020-05-12,False,Romark Laboratories L.C.,Recruiting,Phase 3,Interventional,United States,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF),Drug (Chemoprophylaxis),Nitazoxanide,Nitazoxanide,800,https://clinicaltrials.gov/show/NCT04343248,None
1457,2570,NCT04345276,ClinicalTrials.gov,2020-04-10,2020-03-18,True,Huo-Shen-Shan Hospital,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,Drug,Danoprevir + Ritonavir,Danoprevir; Ritonavir,10,https://clinicaltrials.gov/show/NCT04345276,None
1458,2571,NCT04345692,ClinicalTrials.gov,2020-04-09,2020-03-26,True,Queen's Medical Centre,Recruiting,Phase 3,Interventional,United States,A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients,Drug,Hydroxychloroquine,Hydroxychloroquine,350,https://clinicaltrials.gov/show/NCT04345692,None
1459,2572,NCT04347512,ClinicalTrials.gov,2020-04-11,2020-06-02,False,"University Hospital, Strasbourg",Not Recruiting,Phase 3,Interventional,No Country Given,EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Azithromycin; Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04347512,None
1460,2575,NCT04348500,ClinicalTrials.gov,2020-04-13,2020-04-24,False,Cedars-Sinai Medical Center,Recruiting,Phase 2,Interventional,United States,Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease,Drug,Clazakizumab,Clazakizumab,60,https://clinicaltrials.gov/show/NCT04348500,None
1461,2577,NCT04355936,ClinicalTrials.gov,2020-04-17,2020-05-19,False,Laboratorio Elea,Recruiting,Phase 2,Interventional,Argentina,Telmisartan for Treatment of COVID-19 Patients,Drug,Telmisartan,Telmisartan,400,https://clinicaltrials.gov/show/NCT04355936,None
1462,2578,NCT04356482,ClinicalTrials.gov,2020-04-17,2020-05-20,False,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,Recruiting,Phase 1/Phase 2,Interventional,Mexico,CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19,ATMP,Plasma,Plasma,90,https://clinicaltrials.gov/show/NCT04356482,None
1463,2579,NCT04358003,ClinicalTrials.gov,2020-04-20,2020-05-20,False,Marker Therapeutics AG,Recruiting,Not Applicable,Interventional,United States,Plasma Adsorption in Patients With Confirmed COVID-19,Other (device),Plasma Adsorption Cartridge,Plasma Adsorption Cartridge,2000,https://clinicaltrials.gov/show/NCT04358003,None
1464,2580,NCT04359511,ClinicalTrials.gov,2020-04-20,2020-06-01,False,CHU de Tours,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,Drug,Corticosteroids,Prednisone; Hydrocortisone,210,https://clinicaltrials.gov/show/NCT04359511,None
1465,2581,NCT04359680,ClinicalTrials.gov,2020-04-20,2020-05-13,False,Romark Laboratories L.C.,Recruiting,Phase 3,Interventional,United States,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers,Drug (Chemoprophylaxis),Nitazoxanide,Nitazoxanide,800,https://clinicaltrials.gov/show/NCT04359680,None
1466,2582,NCT04359901,ClinicalTrials.gov,2020-04-20,2020-04-10,True,Westyn Branch-Elliman,Recruiting,Phase 2,Interventional,United States,Sarilumab for Patients With Moderate COVID-19 Disease,Drug,Sarilumab,Sarilumab,120,https://clinicaltrials.gov/show/NCT04359901,None
1467,2583,NCT04361838,ClinicalTrials.gov,2020-04-16,2020-06-01,False,Kansas City Heart Rhythm Institute,Recruiting,Not Applicable,Interventional,United States,The COVID-19 ICU PRAYER Study,Other,Other,Other,1000,https://clinicaltrials.gov/show/NCT04361838,None
1468,2585,NCT04371926,ClinicalTrials.gov,2020-04-29,2020-06-01,False,Texas Cardiac Arrhythmia Research Foundation,Not Recruiting,Not Applicable,Interventional,No Country Given,Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04371926,None
1469,2586,NCT04372589,ClinicalTrials.gov,2020-04-24,2020-05-20,False,University of Manitoba,Recruiting,Phase 2/Phase 3,Interventional,"Canada, United States, Mexico, Brazil",Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC ),Drug,Heparin,Heparin,3000,https://clinicaltrials.gov/show/NCT04372589,None
1470,2587,NCT04374084,ClinicalTrials.gov,2020-04-20,2020-05-10,False,"Guang'anmen Hospital, China Academy of Chinese Medical Sciences",Recruiting,Not Applicable,Interventional,China,Moxibustion Plus Cupping in Convalescent Patients With COVID-19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,https://clinicaltrials.gov/show/NCT04374084,None
1471,2588,NCT04374786,ClinicalTrials.gov,2020-05-01,2020-05-15,False,University of Arizona,Recruiting,Not Applicable,Interventional,United States,Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic,Other (psych),Psychological,Psychological,328,https://clinicaltrials.gov/show/NCT04374786,None
1472,2589,NCT04382040,ClinicalTrials.gov,2020-05-07,2020-05-08,False,MGC Pharmaceuticals,Recruiting,Phase 2,Interventional,Israel,"A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19",Drug,Artemisinin + Curcumin + Frankincense + Vitamin C,Artemisinin; Curcumin; Frankincense; Vitamin C,50,https://clinicaltrials.gov/show/NCT04382040,None
1473,2590,NCT04382066,ClinicalTrials.gov,2020-05-07,2020-05-12,False,PharmaMar,Recruiting,Phase 1,Interventional,Spain,Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19,Drug,Plitidepsin,Plitidepsin,27,https://clinicaltrials.gov/show/NCT04382066,None
1474,2591,NCT04382950,ClinicalTrials.gov,2020-05-08,2020-07-01,False,Kafrelsheikh University,Not Recruiting,Phase 1,Interventional,No Country Given,Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2,Drug,ACE enzyme + retonic acid,ACE enzyme + retonic acid,24,https://clinicaltrials.gov/show/NCT04382950,None
1475,2592,NCT04384458,ClinicalTrials.gov,2020-05-08,2020-06-01,False,Federal University of Ceara,Not Recruiting,Not Applicable,Interventional,Brazil,COVID-19 Prophylaxis With Hydroxychloroquine Associated With Zinc For High-Risk Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine + Zinc,Hydroxychloroquine; Zinc,400,https://clinicaltrials.gov/show/NCT04384458,None
1476,2594,NCT04385901,ClinicalTrials.gov,2020-05-06,2020-05-19,False,University of Missouri-Columbia,Recruiting,Not Applicable,Interventional,United States,Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,72,https://clinicaltrials.gov/show/NCT04385901,None
1477,2595,NCT04385940,ClinicalTrials.gov,2020-05-08,2020-06-01,False,University of Alberta,Not Recruiting,Phase 3,Interventional,No Country Given,Vitamin D and COVID-19 Management,Drug,Vitamin D,Vitamin D,64,https://clinicaltrials.gov/show/NCT04385940,None
1478,2597,NCT04389580,ClinicalTrials.gov,2020-05-12,2020-06-01,False,Kafrelsheikh University,Not Recruiting,Phase 2,Interventional,No Country Given,Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus,Drug,Isotretinoin + Tamoxifen,Isotretinoin; Tamoxifen,160,https://clinicaltrials.gov/show/NCT04389580,None
1479,2598,NCT04392414,ClinicalTrials.gov,2020-05-13,2020-05-01,True,"Federal Research Clinical Center of Federal Medical & Biological Agency, Russia",Recruiting,Phase 2,Interventional,Russian Federation,Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04392414,None
1480,2599,NCT04393246,ClinicalTrials.gov,2020-05-16,2020-06-15,False,Cambridge University Hospitals NHS Foundation Trust,Not Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms,Drug,EDP1815 vs. Ambrisentan + Dapagliflozin,EDP1815; Ambrisentan; Dapagliflozin,1407,https://clinicaltrials.gov/show/NCT04393246,None
1481,2600,NCT04394416,ClinicalTrials.gov,2020-05-08,2020-06-02,False,"University of Maryland, Baltimore",Recruiting,Phase 3,Interventional,United States,Trial of Imatinib for Hospitalized Adults With COVID-19,Drug,Imatinib,Imatinib,204,https://clinicaltrials.gov/show/NCT04394416,None
1482,2603,NCT04400279,ClinicalTrials.gov,2020-05-21,2020-06-01,False,University of British Columbia,Not Recruiting,Not Applicable,Interventional,No Country Given,The COVID-19 Pandemic and Exercise Study,Other (exercise),Exercise,Exercise,490,https://clinicaltrials.gov/show/NCT04400279,None
1483,2605,NCT04408066,ClinicalTrials.gov,2020-04-30,2020-04-30,False,LumiraDx UK Limited,Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19: A POC Test Under Research & Evaluation,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,2000,https://clinicaltrials.gov/show/NCT04408066,None
1484,2606,NCT04408183,ClinicalTrials.gov,2020-05-22,2020-06-01,False,"GeneOne Life Science, Inc.",Recruiting,Phase 2,Interventional,United States,GLS-1200Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) in Health Care Personnel,Drug (Chemoprophylaxis),GLS-1200,GLS-1200,225,https://clinicaltrials.gov/show/NCT04408183,None
1485,2608,NCT04409496,ClinicalTrials.gov,2020-05-26,2020-06-01,False,University of Hong Kong,Recruiting,Not Applicable,Interventional,Hong Kong,Chat-based Support for Preveting Smoking Relapse,Other,Other,Other,100,https://clinicaltrials.gov/show/NCT04409496,None
1486,2610,NCT04409834,ClinicalTrials.gov,2020-05-28,2020-06-01,False,The TIMI Study Group,Not Recruiting,Phase 4,Interventional,No Country Given,Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial,Drug,Heparin,Heparin,750,https://clinicaltrials.gov/show/NCT04409834,None
1487,2612,NCT04411446,ClinicalTrials.gov,2020-05-26,2020-06-15,False,Vitamin D Study Group,Not Recruiting,Phase 4,Interventional,Argentina,Cholecalciferol to Improve the Outcomes of COVID-19 Patients,Drug,Vitamin D,Vitamin D,1265,https://clinicaltrials.gov/show/NCT04411446,None
1488,2615,NCT04411667,ClinicalTrials.gov,2020-05-29,2020-04-28,True,Dr. George Sakoulas,Recruiting,Phase 4,Interventional,United States,Study of Standard of Care Plus Intravenous Immunoglobulin (IVIG) Compared to Standard of Care Alone in the Treatment of COVID-19 Infection,ATMP,Immunoglobulin,Immunoglobulin,40,https://clinicaltrials.gov/show/NCT04411667,None
1489,2617,NCT04412018,ClinicalTrials.gov,2020-05-29,2020-06-01,False,Canadian Medical and Surgical Knowledge Translation Research Group,Recruiting,Phase 2,Interventional,Canada,An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19,Drug,Icosapent ethyl,Icosapent ethyl,100,https://clinicaltrials.gov/show/NCT04412018,None
1490,2619,NCT04412538,ClinicalTrials.gov,2020-05-21,2020-05-15,True,Chinese Academy of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19,ATMP,Vaccine,Vaccine,942,https://clinicaltrials.gov/show/NCT04412538,None
1491,2622,NCT04412772,ClinicalTrials.gov,2020-06-01,2020-06-01,False,Queen's Medical Centre,Recruiting,Phase 3,Interventional,United States,A RCT - Safety & Efficacy of Tocilizumab - Tx of Severe COVID-19: ARCHITECTS,Drug,Tocilizumab,Tocilizumab,300,https://clinicaltrials.gov/show/NCT04412772,None
1492,2623,NCT04412785,ClinicalTrials.gov,2020-06-01,2020-06-01,False,University of Pennsylvania,Not Recruiting,Phase 1,Interventional,United States,Cyclosporine in Patients With Moderate COVID-19,Drug,Cyclosporine,Cyclosporine,20,https://clinicaltrials.gov/show/NCT04412785,None
1493,2624,NCT04413006,ClinicalTrials.gov,2020-05-21,2020-05-25,False,University of Manitoba,Recruiting,Not Applicable,Interventional,Canada,Self-compassion for Chronic Pain Virtual Group Treatment Program,Other (psych),Psychological,Psychological,28,https://clinicaltrials.gov/show/NCT04413006,None
1494,2626,NCT04413838,ClinicalTrials.gov,2020-06-02,2020-06-15,False,Hospices Civils de Lyon,Not Recruiting,Phase 2,Interventional,France,Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) Infection,Drug,Nivolumab,Nivolumab,120,https://clinicaltrials.gov/show/NCT04413838,None
1495,2627,NCT04413864,ClinicalTrials.gov,2020-04-21,2020-04-24,False,Assistance Publique  Hpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19,Drug,Dexmedetomidine,Dexmedetomidine,50,https://clinicaltrials.gov/show/NCT04413864,None
1496,2629,NCT04413968,ClinicalTrials.gov,2020-06-02,2020-06-02,False,Assistance Publique  Hpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,"COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants",Clinical Presentation (Epidemiology),No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04413968,None
1497,2631,NCT04414098,ClinicalTrials.gov,2020-05-29,2020-06-01,False,Marcelo Iastrebner,Not Recruiting,Phase 2,Interventional,No Country Given,Ruxolitinib in the Treatment of Covid-19,Drug,Ruxolitinib,Ruxolitinib,100,https://clinicaltrials.gov/show/NCT04414098,None
1498,2632,NCT04414124,ClinicalTrials.gov,2020-06-01,2020-06-01,False,Kaleido Biosciences,Recruiting,Not Applicable,Interventional,United States,A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19,Drug,KB109,KB109,400,https://clinicaltrials.gov/show/NCT04414124,None
1499,2633,NCT04414371,ClinicalTrials.gov,2020-05-31,2020-05-20,True,Rutgers University,Recruiting,Not Applicable,Interventional,United States,Tools for Wellbeing COVID-19 National Study of Undergraduate Students,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,200,https://clinicaltrials.gov/show/NCT04414371,None
1500,2635,NCT04414631,ClinicalTrials.gov,2020-05-19,2020-06-01,False,"University Hospital, Basel",Not Recruiting,Phase 2,Interventional,Switzerland,Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19,Drug,Conestat alfa,Conestat alfa,120,https://clinicaltrials.gov/show/NCT04414631,None
1501,2637,NCT04415073,ClinicalTrials.gov,2020-05-29,2020-05-30,False,Syndax Pharmaceuticals,Recruiting,Phase 2,Interventional,United States,A Phase 2 Study to Evaluate Axatilimab for Hospitalized Patients With Respiratory Involvement Secondary to COVID-19,Drug,Axatilimab,Axatilimab,186,https://clinicaltrials.gov/show/NCT04415073,None
1502,2638,NCT04415151,ClinicalTrials.gov,2020-06-02,2020-06-30,False,Yale University,Not Recruiting,Phase 2,Interventional,No Country Given,Tofacitinib for Treatment of Moderate COVID-19,Drug,Tofacitinib,Tofacitinib,60,https://clinicaltrials.gov/show/NCT04415151,None
1503,2640,NCT04416048,ClinicalTrials.gov,2020-06-02,2020-06-15,False,Charit University,Not Recruiting,Phase 3,Interventional,Germany,Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19,Drug,Rivaroxaban,Rivaroxaban,400,https://clinicaltrials.gov/show/NCT04416048,None
1504,2643,NCT04416113,ClinicalTrials.gov,2020-05-24,2020-08-01,False,Cairo University,Not Recruiting,Not Applicable,Interventional,No Country Given,Photodynamic Therapy for the Treatment of COVID-19,Other,Photodynamic Therapy,Photodynamic Therapy,60,https://clinicaltrials.gov/show/NCT04416113,None
1505,2644,NCT04416139,ClinicalTrials.gov,2020-05-30,2020-05-01,True,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Recruiting,Phase 2,Interventional,Mexico,Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),10,https://clinicaltrials.gov/show/NCT04416139,None
1506,2646,NCT04416308,ClinicalTrials.gov,2020-05-27,2020-05-29,False,Rennes University Hospital,Recruiting,Not Applicable,Interventional,France,COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB),Clinical Presentation (Epidemiology),No Intervention,No Intervention,13000,https://clinicaltrials.gov/show/NCT04416308,None
1507,2647,NCT04416360,ClinicalTrials.gov,2020-05-19,2020-05-05,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak,Other (psych),No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04416360,None
1508,2650,NCT04416919,ClinicalTrials.gov,2020-05-13,2020-06-15,False,University of Oklahoma,Not Recruiting,Not Applicable,Interventional,United States,Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment,Other (device),Masks,Masks,20,https://clinicaltrials.gov/show/NCT04416919,None
1509,2651,NCT04417270,ClinicalTrials.gov,2020-06-01,2020-06-08,False,Northwell Health,Not Recruiting,Not Applicable,Interventional,No Country Given,Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge,Other (device),Biosensors,Biosensors,50,https://clinicaltrials.gov/show/NCT04417270,None
1510,2652,NCT04417335,ClinicalTrials.gov,2020-05-25,2020-04-16,True,Radboud University,Not Recruiting,Phase 4,Interventional,Netherlands,Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination,ATMP,Vaccine,Vaccine,2014,https://clinicaltrials.gov/show/NCT04417335,EUCTR2020-001591-15
1511,2654,NCT04418947,ClinicalTrials.gov,2020-05-29,2020-06-01,False,University of Pennsylvania,Not Recruiting,Not Applicable,Interventional,United States,Project Resurgence Communication Trial,Other,Other,Other,10000,https://clinicaltrials.gov/show/NCT04418947,None
1512,2655,NCT04419025,ClinicalTrials.gov,2020-06-03,2020-06-15,False,Cambridge Health Alliance,Not Recruiting,Phase 4,Interventional,No Country Given,Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease,Drug,N-acetylcysteine,N-acetylcysteine,200,https://clinicaltrials.gov/show/NCT04419025,None
1513,2657,ISRCTN59048638,ISRCTN,2020-06-04,2020-06-15,False,CLINEDEM,Recruiting,Not Applicable,Interventional,Mexico,Sulodexide in the treatment of COVID-19,Drug,Sulodexide,Sulodexide,600,http://isrctn.com/ISRCTN59048638,None
1514,2666,ChiCTR2000033774,ChiCTR,2020-06-11,2020-03-02,True,Children's Hospital Affiliated to Zhejiang University School of Medicine,Not Recruiting,Phase 4,Interventional,China,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets in Treating Pediatric novel coronavirus pneumonia (COVID-19),Drug,Bromhexine Hydrochloride,Bromhexine Hydrochloride,30,http://www.chictr.org.cn/showproj.aspx?proj=55097,None
1515,2672,EUCTR2020-001257-51-DK,EU Clinical Trials Register,2020-03-26,2020-04-15,False,"Rigshospitalet, Denmark",Not Recruiting,Phase 3,Interventional,Denmark,Hydroxychloroquine for prevention of COVID-19 in patients on chronic dialysis,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,568,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001257-51,None
1516,2673,EUCTR2020-001363-85-DK,EU Clinical Trials Register,2020-04-17,2020-04-23,False,Odense University Hospital,Not Recruiting,Phase 3,Interventional,Denmark,Medication for prevention of Corona-virus for Danish nursing home residents,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,206,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001363-85,None
1517,2674,EUCTR2020-001270-29-GB,EU Clinical Trials Register,2020-03-30,2020-04-02,False,Sanofi,Not Recruiting,Phase 2/Phase 3,Interventional,"Czech Republic, Denmark, Hungary, United Kingdom, France, Germany",Hydroxychloroquine for COVID 19 in moderately to severely ill hospitalized patients,Drug,Hydroxychloroquine,Hydroxychloroquine,350,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001270-29,None
1518,2675,EUCTR2020-001376-15-DE,EU Clinical Trials Register,2020-04-06,2020-05-13,False,Vakzine Projekt Management GmbH,Authorised,Phase 3,Interventional,Germany,A study to investigate whether vaccination with VPM1002 can reduce the sick days of healthcare professionals during the SARS-CoV-2 pandemic,ATMP,Vaccine,Vaccine,1200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001376-15,None
1519,2676,EUCTR2020-001411-25-GB,EU Clinical Trials Register,2020-04-06,2020-04-24,False,Karyopharm Therapeutics Inc,Authorised,Phase 2,Interventional,"Canada, Belgium, Australia, United States, United Kingdom, Italy, France, Germany, Malaysia, Austria, Israel, Spain, India",Low Dose Oral Selinexor in Patients with Severe COVID-19 Infection,Drug,Selinexor,Selinexor,300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25,None
1520,2677,EUCTR2020-001498-63-BE,EU Clinical Trials Register,2020-05-03,2020-05-18,False,Biophytis S.A.,Authorised,Phase 2,Interventional,"United States, United Kingdom, Belgium, France","Testing the Efficacy and Safety of BIO101, for the Prevention of Respiratory Deterioration, in Patients with COVID-19 Pneumonia (COVA study)",Drug,BIO101,BIO101,310,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001498-63,None
1521,2678,EUCTR2020-001264-28-HU,EU Clinical Trials Register,2020-05-14,2020-05-28,False,Immunic AG,Authorised,Phase 2/Phase 3,Interventional,"Bulgaria, United States, Hungary, Germany, Romania, Greece, Serbia",A study to investigate whether the experimental medication IMU-838 is safe and effective when it is given to Covid-19 patients in addition to their normal treatment,Drug,Vidofludimus calcium,Vidofludimus calcium,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001264-28,None
1522,2679,EUCTR2020-001937-11-GB,EU Clinical Trials Register,2020-06-08,2020-04-30,True,"University College, London",Authorised,Phase 2,Interventional,United Kingdom,"The COVASE study:
Investigation of an approved nebulised human Dnase enzyme (Pulmozyme) to reduce hyperinflammation in hospitalised people with COVID-19",Drug,Dornase alfa,Dornase alfa,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001937-11,None
1523,2680,EUCTR2020-001244-26-AT,EU Clinical Trials Register,2020-03-31,2020-04-11,False,Medical University of Vienna,Authorised,Phase 2,Interventional,Austria,COVID-19: Efficacy of solnatide to treat pulmonary permeability oedema in SARS-Cov-2 positive patients with moderate-to-severe ARDS - a pilot-trial.,Drug,Solnatide,Solnatide,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001244-26,None
1524,2683,DRKS00021447,German Clinical Trials Register,2020-04-27,2020-05-01,False,Charit University,Not Recruiting,Phase 2,Interventional,Germany,CytoResc - CytoSorb Rescue for COVID-19 Cytokine Storm,Other (device),Cytokine Adsorber,Cytokine Adsorber,100,http://www.drks.de/DRKS00021447,None
1525,2685,DRKS00021420,German Clinical Trials Register,2020-04-16,2020-04-01,True,Technische Universitt Mnchen,Recruiting,Phase 1,Interventional,Germany,Observational clinical trial for the evaluation of an automated nasal and pharyngeal swab exam to test COVID-19 patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,http://www.drks.de/DRKS00021420,None
1526,2695,DRKS00021527,German Clinical Trials Register,2020-04-24,2020-04-14,True,"University Hospital, Leipzig",Not Recruiting,Not Applicable,Interventional,Germany,Evaluation of online support during the coronavirus (COVID-19) pandemic: a group chat program in the psychiatric outpatient clinic of the Leipzig University Hospital,Other (psych),Psychological,Psychological,100,http://www.drks.de/DRKS00021527,None
1527,2699,DRKS00021573,German Clinical Trials Register,2020-04-27,2020-04-30,False,"University Hospital, Heidelberg",Recruiting,Phase 1,Interventional,Germany,"Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Covid-19",Drug,Proton pump inhibitor + Hydoxychloroquine + Midazolam + Yohimbine vs. Hydoxychloroquine + Midazolam + Yohimbine,Proton pump inhibitor; Hydoxychloroquine; Midazolam; Yohimbine,24,http://www.drks.de/DRKS00021573,None
1528,2703,DRKS00021585,German Clinical Trials Register,2020-04-29,2020-04-24,True,Vivantes Humboldt Klinikum,Recruiting,Not Applicable,Interventional,Germany,Lung Ultrasound in Covid-19 Pneumonia,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,220,http://www.drks.de/DRKS00021585,None
1529,2704,DRKS00021588,German Clinical Trials Register,2020-05-04,2020-05-08,False,University of Erlangen-Nuremberg,Recruiting,Not Applicable,Interventional,Germany,Naturalistic evaluation of an Internet-based psychological training program for mental strain associated with the coronavirus / COVID-19 pandemic,Other (psych),Psychological,Psychological,1000,http://www.drks.de/DRKS00021588,None
1530,2706,DRKS00021582,German Clinical Trials Register,2020-05-12,2020-05-31,False,Heidelberg University,Not Recruiting,Not Applicable,Interventional,"United States, United Kingdom, France, Germany, Mexico, Spain","A short, animated video to improve COVID-19 hygiene uptake: an online randomized experiment with 20,000 participants",Other,Other,Other,20000,http://www.drks.de/DRKS00021582,None
1531,2710,DRKS00021214,German Clinical Trials Register,2020-04-01,2020-04-07,False,"University Hospital, Schleswig-Holstein",Recruiting,Not Applicable,Interventional,Germany,Improvement of the nutritional status regarding nicotinamide (vitamin B3) and the course of COVID-19 disease,Drug,Vitamin B3,Vitamin B3,1300,http://www.drks.de/DRKS00021214,None
1532,2722,DRKS00021153,German Clinical Trials Register,2020-04-06,2020-04-07,False,Leuphana Universitt Lneburg,Recruiting,Not Applicable,Interventional,Germany,get.calm and move.on  tackling worries and finding strength for the crisis (COVID-19) in 10 steps,Other (psych),Psychological,Psychological,352,http://www.drks.de/DRKS00021153,None
1533,2724,DRKS00021301,German Clinical Trials Register,2020-04-16,2020-06-04,False,Universitt Duisburg-Essen,Not Recruiting,Not Applicable,Interventional,Germany,An e-Mental Health Intervention to Support burdened People in Times of the COVID-19 pandemic: CoPE It,Other (psych),Psychological,Psychological,90,http://www.drks.de/DRKS00021301,None
1534,2732,DRKS00021273,German Clinical Trials Register,2020-04-20,2020-04-25,False,Goethe University Frankfurt,Recruiting,Not Applicable,Interventional,"Brazil, Singapore, Chile, Italy, France, Germany, Austria, Argentina, Spain",Effects of digital home exercise programs on physical and mental well-being during the COVID-19 pandemic: a multi-center trial,Other (exercise),Exercise,Exercise,544,http://www.drks.de/DRKS00021273,None
1535,2736,DRKS00022067,German Clinical Trials Register,2020-06-12,2020-06-25,False,MSB Medical School Berlin,Not Recruiting,Not Applicable,Interventional,Germany,An intensive longitudinal study on habit formation of hand washing behavior during the COVID-19 pandemic,Procedure,Hand washing,Hand washing,134,http://www.drks.de/DRKS00022067,None
1536,2738,DRKS00022083,German Clinical Trials Register,2020-06-09,2020-05-20,True,Landesklinikum Neunkirchen,Recruiting,Not Applicable,Interventional,Austria,Evaluation of three commercially available rapid assays for detection of IgG and/or IGM antibodies to SARS-CoV-2 (COVID-19) for assessment of contact persons immune status and termination of quarantine and self-isolation  a prospective pilot study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,70,http://www.drks.de/DRKS00022083,None
1537,2761,DRKS00021732,German Clinical Trials Register,2020-06-10,2020-06-14,True,Klinikum St. Georg gGmbH,Not Recruiting,Not Applicable,Interventional,Germany,"Treatment of Sars-CoV2 infections (Covid-19) with valsartan vs placebo, a three-armed randomized, partly blinded trial",Drug,Valsartan,Valsartan,300,http://www.drks.de/DRKS00021732,EUCTR2020-001431-27
1538,2762,DRKS00021706,German Clinical Trials Register,2020-05-15,2020-05-25,False,"University Hospital, Leipzig",Not Recruiting,Not Applicable,Interventional,Germany,Evaluation of online support during the coronavirus (COVID-19) pandemic: Online cognitive behavioral therapy for obsessive-compulsive disorder (OCD NET program),Other (psych),Psychological,Psychological,40,http://www.drks.de/DRKS00021706,None
1539,2771,SLCTR/2020/011,SLCTR,2020-05-04,2020-05-04,False,University of Kelaniya,Not Recruiting,Phase 4,Interventional,Sri Lanka,"Hydroxychloroquine for Post-Exposure Prophylaxis of COVID-19 among naval personnel: a placebo-controlled, randomized, clinical trial",Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,0,https://slctr.lk/trials/slctr-2020-011,None
1540,2772,IRCT20200128046294N2,IRCT,2020-03-14,2020-03-26,False,Digestive Disease Research Institute,Not Recruiting,Phase 3,Interventional,Iran,Study to Evaluate the Safety and Efficacy of Sofosbuvir/Daclatasvir in Participants with Moderate to Severe Coronavirus Disease (COVID-19),Drug,Sofosbuvir + Daclatasvir,Sofosbuvir; Daclatasvir,70,http://en.irct.ir/trial/46463,None
1541,2773,IRCT20200314046774N1,IRCT,2020-06-12,2020-05-04,True,Ghoum University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,treatment of COVID-19 whit vitamin A,Drug,Vitamin A,Vitamin A,94,http://en.irct.ir/trial/46519,None
1542,2774,IRCT20200324046850N3,IRCT,2020-03-30,2020-04-20,False,Abadan University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of naproxen on the healing process of patients with COVID-19,Drug,"Investigational: Naproxen

All Arms: Hydroxychloroquine + Lopinavir/Ritonavir",Naproxen; Hydroxychloroquine; Lopinavir/Ritonavi,80,http://en.irct.ir/trial/46718,None
1543,2775,IRCT20180923041093N3,IRCT,2020-03-28,2020-04-02,False,Kerman University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Efficacy of the myrtle syrup in the treatment of novel corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,70,http://en.irct.ir/trial/46721,None
1544,2776,IRCT20180923041093N4,IRCT,2020-03-28,2020-04-02,False,Kerman University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Efficacy of the barley-based remedy in the treatment of novel corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,70,http://en.irct.ir/trial/46728,None
1545,2777,IRCT20200324046850N1,IRCT,2020-03-29,2020-06-06,False,Abadan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparison of vitamin D3 and N-acetylcysteine prescription in COVID-19 patients   and their effect on recovery process,Drug,Vitamin D vs. N-acetylcysteine vs. Vitamin D + N-acetylcysteine,Vitamin D; N-acetylcysteine,100,http://en.irct.ir/trial/46732,None
1546,2778,IRCT20200318046812N1,IRCT,2020-04-01,2020-04-01,False,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Comparison of the safety and efficacy of Favipiravir and kaletra in COVID-19,Drug,Favipiravir + hydroxychloroquine vs. Lopinavir/ritonavir + hydroxychloroquine,Favipiravir; hydroxychloroquine; Lopinavir/ritonavir,324,http://en.irct.ir/trial/46783,None
1547,2779,IRCT20190810044500N5,IRCT,2020-05-18,2020-04-04,True,Yazd University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of colchicine in treatment of COVID-19,Drug,Colchicine,Colchicine,200,http://en.irct.ir/trial/46867,None
1548,2780,IRCT20180725040596N2,IRCT,2020-04-18,2020-04-29,False,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Arbidol in treatment of COVID-19,Drug,Umifenovir + Hydroxychloroquine vs. Lopinavir/ritonavir vs. Hydroxychloroquine,Umifenovir; Hydroxychloroquine; Lopinavir/ritonavir,100,http://en.irct.ir/trial/46897,None
1549,2781,IRCT20200404046947N1,IRCT,2020-04-15,2020-03-28,True,Tehran University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Effect of Methylprednisolone on treatment of COVID-19,Drug,Corticosteroids,Methylprednisolone,68,http://en.irct.ir/trial/46904,None
1550,2782,IRCT20151228025732N52,IRCT,2020-04-09,2020-04-07,True,Semnan University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,A study on melatonin and Vitamin C and zinc efficacy in patients with COVID19,Drug,Melatonin + Vitamin C + Zinc,Melatonin; Vitamin C; Zinc,30,http://en.irct.ir/trial/46963,None
1551,2783,IRCT20081027001411N3,IRCT,2020-06-01,2020-03-29,True,Tehran University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of Prednisolone on treatment of COVID-19,Drug,Corticosteroids,Prednisolone,60,http://en.irct.ir/trial/46975,None
1552,2784,IRCT20091201002804N12,IRCT,2020-06-01,2020-04-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of surfactant on clinical outcome of patients with COVID-19,Drug,Surfactant,Surfactant,60,http://en.irct.ir/trial/46983,None
1553,2785,IRCT20200217046526N1,IRCT,2020-04-13,2020-03-15,True,Iranian Academic Center for Education Culture and Research,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection,ATMP,Cells (mesenchymal),Cells (mesenchymal),6,http://en.irct.ir/trial/47030,None
1554,2786,IRCT20200411047016N1,IRCT,2020-05-31,2020-04-05,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of Stopcivir syrup in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,http://en.irct.ir/trial/47044,None
1555,2787,IRCT20190727044343N3,IRCT,2020-06-12,2020-06-09,True,Mazandaran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,ANIF1 effect on COVID-19,Drug,ANIF1,ANIF1,60,http://en.irct.ir/trial/47062,None
1556,2788,IRCT20200223046586N2,IRCT,2020-05-30,2020-05-18,True,Shahroud University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,web- based communication between nurse and family member,Telehealth,Telehealth,Telehealth,74,http://en.irct.ir/trial/47091,None
1557,2789,IRCT20081019001369N6,IRCT,2020-05-17,2020-06-21,False,Mashhad University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Clinical trial of trans sodium crocetinate  against COVID-19,Drug,Trans Sodium Crocetinate,Trans Sodium Crocetinate,30,http://en.irct.ir/trial/47188,None
1558,2790,IRCT20091012002582N21,IRCT,2020-05-18,2019-05-05,True,Tabriz University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Effect of intrapulmonary injection of processed serum derived from covid-19 patients in reduction of pulmonary complications,ATMP,Plasma,Plasma,30,http://en.irct.ir/trial/47197,None
1559,2791,IRCT20200325046859N2,IRCT,2020-04-26,2020-04-22,True,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,effects of the 2-drug diet (hydroxychloroquine + umifenovir(Arbidol)) compared with Hydroxy chlorquine on the of mortality rate in patients with moderate symptoms of COVID-19 infections,Drug,Umifenovir + Hydroxycholoquine vs. Hydroxychloroquine,Umifenovir; Hydroxycholoquine,100,http://en.irct.ir/trial/47200,None
1560,2792,IRCT20190418043307N1,IRCT,2020-05-17,2020-04-26,True,Ilam University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of selenium on covid-19 disease,Drug,Selenium,Selenium,100,http://en.irct.ir/trial/47209,None
1561,2793,IRCT20200411047019N1,IRCT,2020-05-18,2020-06-04,False,Shiraz University of Mdical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of BCG Vaccine on Preventing COVID-19,ATMP,Vaccine,Vaccine,500,http://en.irct.ir/trial/47279,None
1562,2794,IRCT20150303021315N19,IRCT,2020-05-27,2020-06-06,False,CinnaGen Company,Recruiting,Phase 2,Interventional,Iran,"Pembrolizumab (CinnaGen Co, Iran) in COVID-19",Drug,Pembrolizumab,Pembrolizumab,62,http://en.irct.ir/trial/47335,None
1563,2795,IRCT20080901001165N59,IRCT,2020-05-27,2020-05-25,True,Niwasha Company,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Niwasha mouthwash in controlling the symptoms of patients with COVID-19,Drug,Mouthwash,Mouthwash,80,http://en.irct.ir/trial/47477,None
1564,2796,IRCT20200209046427N1,IRCT,2020-06-07,2020-05-30,True,Shahid Beheshti University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of bee products on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47504,None
1565,2797,IRCT20200428047228N1,IRCT,2020-05-16,2020-05-19,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficiency and safety of favipiravir + hydroxychloroquine drug regimen in comparison with hydroxychloroquine in hospitalized patients with covid-19,Drug,Favipiravir + Hydroxychloroquine vs. Hydroxychloroquine,Favipiravir; Hydroxychloroquine,50,http://en.irct.ir/trial/47559,None
1566,2798,IRCT20200501047259N1,IRCT,2020-05-17,2020-05-09,True,Oroumia University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,IVIG and COVID19,ATMP,Immunoglobulin,Immunoglobulin,40,http://en.irct.ir/trial/47609,None
1567,2799,IRCT20200115046144N2,IRCT,2020-05-21,2020-05-31,False,Semnan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effects of nokhod-ab on fatigue,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/47645,None
1568,2800,IRCT20131129015584N3,IRCT,2020-05-20,2020-05-04,True,Mazandaran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,The effect of hot cupping on corona symptoms,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,68,http://en.irct.ir/trial/47665,None
1569,2801,IRCT20150107020592N25,IRCT,2020-06-13,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Prone position effectiveness in Non invasive ventilation of covid-19 patients undergoing respiratory failure,Procedure,Positioning,Positioning,30,http://en.irct.ir/trial/47666,None
1570,2802,IRCT20200502047268N1,IRCT,2020-05-16,2020-05-21,False,Semnan University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Evaluation of the effect of GCSF injection in treatment of COVID-19 patients with lymphopenia,Drug,Granulocyte colony-stimulating factor,Granulocyte colony-stimulating factor,10,http://en.irct.ir/trial/47692,None
1571,2803,IRCT20200503047280N1,IRCT,2020-06-02,2020-05-09,True,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Laris-Teucrium Polium L.and Laris-Hyssop combined herbal medicine on the prevention of covid-19 disease,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://en.irct.ir/trial/47704,None
1572,2804,IRCT20200418047126N1,IRCT,2020-05-14,2020-05-04,True,Ardabil University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of colchicine  in treatment of coronavirus,Drug,Colchicine,Colchicine,100,http://en.irct.ir/trial/47707,None
1573,2805,IRCT20200405046951N1,IRCT,2020-06-11,2020-05-21,True,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Vitamin A and COVID-19,Drug,Vitamin A,Vitamin A,120,http://en.irct.ir/trial/47722,None
1574,2806,IRCT20170211032494N3,IRCT,2020-05-25,2020-05-27,False,Tehran University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Low dose whole lung irradiation for treatment of COVID-19 pneumonia,Other,Radiation,Radiation,10,http://en.irct.ir/trial/47735,None
1575,2807,IRCT20081011001323N25,IRCT,2020-05-17,2020-05-21,False,Yasouj University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy  of  extract of  of Zingiber  cinnamomum  and  zataria multiflora    in covid-19 disease,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/47935,None
1576,2808,IRCT20200421047150N1,IRCT,2020-05-14,2020-05-12,True,DEY Company,Recruiting,Phase 2/Phase 3,Interventional,Iran,Stem cell treatment for COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),90,http://en.irct.ir/trial/47964,None
1577,2809,IRCT20180923041093N6,IRCT,2020-06-11,2020-05-13,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The efficacy of  barely-based traditional remedy on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47974,None
1578,2810,IRCT20200509047360N1,IRCT,2020-05-16,2020-05-03,True,Tehran University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,"The effect of cognitive-behavioral  intervention on improving COVID-19 fear symptoms, improving quality of life and improving mental health in patients with corona",Other (psych),Psychological,Psychological,60,http://en.irct.ir/trial/47979,None
1579,2811,IRCT20140428017469N1,IRCT,2020-05-23,2020-06-13,False,Petroleum Industry Health Organization,Recruiting,Phase 3,Interventional,Iran,Polio Vaccine and COVID-19,ATMP,Vaccine,Vaccine,130000,http://en.irct.ir/trial/47989,None
1580,2812,IRCT20200506047323N2,IRCT,2020-05-31,2020-05-21,True,Bandare-abbas University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effects of Licorice in treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47990,None
1581,2813,IRCT20200509047373N1,IRCT,2020-05-23,2020-06-03,False,Health Medicine Chemistry Company,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation effect of Dinvl for Covid19 infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48001,None
1582,2814,IRCT20151227025726N15,IRCT,2020-05-18,2020-04-08,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluating the effects of Umifenovir (Arbidol) in COVID-19,Drug,Umifenovir,Umifenovir,100,http://en.irct.ir/trial/48018,None
1583,2815,IRCT20150716023235N15,IRCT,2020-05-29,2020-05-21,True,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,sex hormones in coronavirus,Drug,Hormones,Hormones,80,http://en.irct.ir/trial/48019,None
1584,2816,IRCT20200510047383N1,IRCT,2020-05-15,2020-05-21,False,Arak University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Tocilizumab on outcomes of the severe COVID-19 patients,Drug,Tocilizumab,Tocilizumab,100,http://en.irct.ir/trial/48024,None
1585,2817,IRCT20120215009014N355,IRCT,2020-05-18,2020-06-04,False,Hamedan University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluating the effect of intravenous N-acetyl cysteine versus placebo in the treatment of patients with mild and moderate acute respiratory distress syndrome caused by COVID-19,Drug,N-acetylcysteine,N-acetylcysteine,92,http://en.irct.ir/trial/48039,None
1586,2818,IRCT20200511047396N1,IRCT,2020-05-16,2020-05-21,False,CinnaGen Company,Recruiting,Phase 3,Interventional,Iran,Efficacy evaluation of inhalation therapy (nasal spray) of Interferon Beta-1a in Mild to Moderate cases of Covid-19 at Baqiyatallal Hospital,Drug,Interferon beta,Interferon beta,100,http://en.irct.ir/trial/48048,None
1587,2819,IRCT20170731035423N2,IRCT,2020-06-12,2020-05-21,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of the combination of BCc1 & Hep-S on hospitalized COVID-19 patients,Drug,BCc1 vs. Hep-S vs. BCc1 + Hep-S,BCc1; Hep-S,120,http://en.irct.ir/trial/48049,None
1588,2820,IRCT20090609002017N35,IRCT,2020-05-17,2020-05-19,False,Tabriz University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Assessment of boron-containing compounds  and Oleoylethanolamid  supplementation in the treatment of COVID-19,Drug,Boron vs. Oleoylethanolamid vs. Boron + Oleoylethanolamid,Boron; Oleoylethanolamid,40,http://en.irct.ir/trial/48058,None
1589,2821,IRCT20080901001165N55,IRCT,2020-05-23,2020-05-13,True,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of N-Acetyl Cysteine (NAC) inhalation spray in controlling the symptoms of patients with COVID-19,Drug,N-acetylcysteine,N-acetylcysteine,72,http://en.irct.ir/trial/48061,None
1590,2822,IRCT20080901001165N53,IRCT,2020-05-14,2020-05-14,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Interferon Beta1a nasal spray in controlling the symptoms of patients with COVID-19,Drug,Interferon beta,Interferon beta,100,http://en.irct.ir/trial/48066,None
1591,2823,IRCT20200428047228N2,IRCT,2020-06-10,2020-05-19,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Hydroxychloroquine in comparison with hydroxychloroquine + azithromycin in  patients with covid-19,Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,40,http://en.irct.ir/trial/48096,None
1592,2824,IRCT20080901001165N60,IRCT,2020-05-28,2020-05-14,True,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy of Provita Capsule in controlling the symptoms of patients with COVID-19,Supplement,Nutritional Supplement,Nutritional Supplement,30,http://en.irct.ir/trial/48102,None
1593,2825,IRCT20200506047323N1,IRCT,2020-05-23,2020-05-21,True,Bandare-abbas University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effects of Ginger in treatment COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,84,http://en.irct.ir/trial/48114,None
1594,2826,IRCT20080901001165N56,IRCT,2020-05-23,2020-05-16,True,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Evaluation efficacy of ""Curcumin and Resveratrol"" capsule  in controlling symptoms in patients with COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48116,None
1595,2827,IRCT20200405046960N2,IRCT,2020-05-19,2020-05-17,True,Ardabil University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of Kelofan syrup on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48126,None
1596,2828,IRCT20200516047462N1,IRCT,2020-05-17,2020-05-06,True,Kashan University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Intervention,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://en.irct.ir/trial/48141,None
1597,2829,IRCT20151227025726N17,IRCT,2020-05-31,2020-04-24,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evolution of the efficacy and safety of Dexamethasone administration in COVID-19,Drug,Corticosteroids vs. Lopinavir/ritonavir,Dexamethasone; Lopinavir/ritonavir,48,http://en.irct.ir/trial/48153,None
1598,2830,IRCT20200516047468N1,IRCT,2020-05-19,2020-04-08,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Investigation of the effect of intravenous vitamin C on definite patients with coronavirus pneumonia,Drug,Vitamin C,Vitamin C,50,http://en.irct.ir/trial/48176,None
1599,2831,IRCT20150107020592N23,IRCT,2020-05-31,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Plasmapheresis and plasma exchanges;usefulness in covid-19 critically ill patients,ATMP,Plasma,Plasma,15,http://en.irct.ir/trial/48185,None
1600,2832,IRCT20160809029275N1,IRCT,2020-05-30,2020-06-14,False,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,stem cell therapy in Covid-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://en.irct.ir/trial/48187,None
1601,2833,IRCT20151226025699N3,IRCT,2020-05-20,2020-06-04,False,Sabzevar University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,The effect of omega-3 supplementation in COVID-19,Drug,Omega 3,Omega 3,50,http://en.irct.ir/trial/48213,None
1602,2834,IRCT20180608040007N2,IRCT,2020-06-13,2020-04-28,True,Yazd University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of Auriculotherapy  in treatment of Covid 19,Other,Auriculotherapy,Auriculotherapy,70,http://en.irct.ir/trial/48218,None
1603,2835,IRCT20200517047485N1,IRCT,2020-05-29,2020-06-20,False,Arak University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Comparison of combination therapies of COVID_19,Drug,Hydroxychloroquine + Atazanavir/ritonavir vs. Hydroxychloroquine + Lopinavir/ritonavir,Atazanavir/ritonavir; Hydroxychloroquine; Lopinavir/ritonavir,108,http://en.irct.ir/trial/48226,None
1604,2836,IRCT20150107020592N22,IRCT,2020-05-25,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Cyclosporin for the Prevention and Treatment of COVID-19 Disease,Drug,Cyclosporine,Cyclosporine,60,http://en.irct.ir/trial/48262,None
1605,2837,IRCT20200518047497N1,IRCT,2020-05-21,2020-05-25,False,Tabriz University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of Laris - Hyssop combined herbal distilled on the improving clinical and paraclinical symptoms in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/48289,None
1606,2838,IRCT20200519047510N1,IRCT,2020-05-28,2020-06-05,False,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the anti-inflammatory effects of curcumin in the treatment of patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48292,None
1607,2839,IRCT20151227025726N18,IRCT,2020-06-10,2020-06-22,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Pentaglobin effect in critically ill patients with COVID-19,Drug,Cyclosporine vs. Lopinavir/ritonavir,Cyclosporine; Lopinavir/ritonavir,30,http://en.irct.ir/trial/48312,None
1608,2840,IRCT20161206031256N3,IRCT,2020-06-02,2020-05-23,True,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Using interferon to treat COVID-19,Drug,Interferon beta,Interferon beta,76,http://en.irct.ir/trial/48329,None
1609,2841,IRCT20080901001165N58,IRCT,2020-05-27,2020-04-29,True,Bagheiat-allah University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Investigating the efficacy and safety of Plasmapheresis in patients with Moderate to severe COVID-19,ATMP,Plasma,Plasma,100,http://en.irct.ir/trial/48394,None
1610,2842,IRCT20160126026217N4,IRCT,2020-06-08,2020-06-21,False,Khoram-Abad University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Investigation of the effects of prone position on  cardiac and respiratory status in patients with Coronavirus,Procedure,Positioning,Positioning,74,http://en.irct.ir/trial/48403,None
1611,2843,IRCT20200422047168N2,IRCT,2020-05-30,2020-05-30,False,Ahvaz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Clinical trial study of the therapeutic effect of Ivermectin, besides Kaletra and Chloroquinein in patients with Coronavirus disease 2019 (COVID-19)",Drug,Ivermectin + Lopinavir/ritonavir + Chloriquine vs. Lopinavir/ritonavir + Chloriquine,Ivermectin; Lopinavir/ritonavir; Chloriquine,60,http://en.irct.ir/trial/48444,None
1612,2844,IRCT20200525047562N1,IRCT,2020-06-14,2020-05-25,True,High Educational and Research Institute of Transfusion Medicine,Recruiting,Phase 3,Interventional,Iran,Treatment of Covid-19 patients with convalescent plasma,ATMP,Plasma,Plasma,100,http://en.irct.ir/trial/48493,None
1613,2845,IRCT20200523047550N1,IRCT,2020-06-06,2020-04-20,True,Tehran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of Umifenovir in treatment of covid-19,Drug,Umifenovir + Hydroxychloroquine vs Hydroxychloroquine,Umifenovir; Hydroxychloroquine,50,http://en.irct.ir/trial/48495,None
1614,2846,IRCT20150107020592N24,IRCT,2020-06-08,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Oxycodone administration on pain control in patients with COVID-19,Drug,Oxycodone,Oxycodone,60,http://en.irct.ir/trial/48534,None
1615,2847,IRCT20200518047497N2,IRCT,2020-06-06,2020-06-20,False,Zahravi Pharmaceutical Company,Not Recruiting,Phase 3,Interventional,Iran,Effect of Dinvl on improving of clinical and paraclinical symptoms in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/48644,None
1616,2848,IRCT20120703010178N20,IRCT,2020-06-13,2020-06-21,False,Persisgen Par Pharmaceutical Company,Not Recruiting,Phase 3,Interventional,Iran,effect of anakinra in treatment of COVID-19,Drug,Anakinra,Anakinra,30,http://en.irct.ir/trial/48702,None
1617,2849,IRCT20200412047042N1,IRCT,2020-06-11,2020-06-19,False,Jahrom University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,"Evaluation the effect of raltegravir, and raltegravir/interferon beta combination on covid 19 patients",Drug,Hydroxychloroquine + Raltagravir vs. Hydroxychloroquine + Raltagravir + Interferon beta vs. Hydroxychloroquine,Raltagravir; Interferon beta; Hydroxychloroquine,60,http://en.irct.ir/trial/48749,None
1618,2850,KCT0005105,CRIS,2020-06-10,2020-04-08,True,Koera University Guro Hospital,Recruiting,Phase 2,Interventional,South Korea,A Trial of Ciclesonide in Adults with Mild COVID-19,Drug,Ciclesonide,Ciclesonide,141,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16795,None
1619,2852,JPRN-JapicCTI-205270,JPRN,2020-04-23,2020-05-25,False,"Chugai Pharmaceutical Co., Ltd.",Recruiting,Phase 3,Interventional,Japan,A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia in Japan,Drug,Tocilizumab,Tocilizumab,10,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205270,None
1620,2854,JPRN-jRCTs031190227,JPRN,2020-02-27,2020-04-01,False,Tokue Yutaka,Not Recruiting,Phase 2,Interventional,Japan,Triple combination therapy in patients infected with COVID-19,Drug,Lopinavir/ritonavir + hydroxychloroquine (w/ and w/o oseltamivir),Lopinavir/Ritonavir; Hydroxychloroquine; Oseltamivir,50,https://jrct.niph.go.jp/latest-detail/jRCTs031190227,None
1621,2855,JPRN-jRCTs031190269,JPRN,2020-03-27,2020-04-03,False,Sugiyama Haruhito,Recruiting,Phase 2,Interventional,Japan,"A multicenter, open-label, randomized controlled trial to evaluate the efficacy and safety of inhaled ciclesonide for asymptomatic and mild patients with COVID-19",Drug,Ciclesonide,Ciclesonide,90,https://jrct.niph.go.jp/latest-detail/jRCTs031190269,None
1622,2856,JPRN-jRCTs031200026,JPRN,2020-05-01,2020-05-01,False,Kyoji Moriya,Recruiting,Phase 3,Interventional,Japan,Combination therapy of Favipiravir and Nafamostat Mesilate in Patients with COVID-19 Pneumonia,Drug,Favipiravir + Nafamostat Mesilate,Favipiravir; Nafamostat Mesilate,160,https://jrct.niph.go.jp/latest-detail/jRCTs031200026,None
1623,2857,JPRN-jRCTs032200044,JPRN,2020-06-03,2020-06-03,False,Wakabayashi Kenji,Recruiting,Phase 1/Phase 2,Interventional,Japan,Clinical safety and usefulness of the simple ventilator,Other (physical),Mechanical ventilation,Mechanical ventilation,10,https://jrct.niph.go.jp/latest-detail/jRCTs032200044,None
1624,2858,JPRN-jRCTs041190120,JPRN,2020-03-02,2020-03-02,False,Doi Yohei,Not Recruiting,Phase 2,Interventional,Japan,Favipiravir for SARS-CoV-infected patients,Drug,Favipiravir,Favipiravir,86,https://jrct.niph.go.jp/latest-detail/jRCTs041190120,None
1625,2859,JPRN-jRCTs061200002,JPRN,2020-05-20,2020-05-20,False,Eiki Ichihara,Recruiting,Phase 2,Interventional,Japan,Teprenone for preventing aggravation of COVID-19,Drug,Teprenone,Teprenone,100,https://jrct.niph.go.jp/latest-detail/jRCTs061200002,None
1626,2863,JPRN-UMIN000040341,JPRN,2020-05-09,2020-05-09,False,Takanawa Clinic,Not Recruiting,Not Applicable,Interventional,Japan,Immunological efficacy of Qing Fei Pai Du Tang for COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,15,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046023,None
1627,2866,JPRN-UMIN000040407,JPRN,2020-05-15,2020-05-15,False,Takanawa Clinic,Not Recruiting,Not Applicable,Interventional,Japan,Immunological efficacy of Jinhua Qinggan Granule for COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,15,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046108,None
1628,2869,JPRN-UMIN000040479,JPRN,2020-05-22,2020-05-22,False,Takanawa Clinic,Recruiting,Not Applicable,Interventional,Japan,Immunological efficacy of lactic acid bacteria for COVID-19,Drug,Lactic acid bacteria,Lactic acid bacteria,30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046202,None
1629,2875,JPRN-UMIN000040602,JPRN,2020-06-01,2020-06-15,False,Federal University of So Carlos,Not Recruiting,Phase 2,Interventional,South America,Homeopathy for Covid-19 in primary care,Other,Homeopathy,Homeopathy,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046338,None
1630,2881,JPRN-UMIN000040694,JPRN,2020-06-09,2020-06-10,False,Kinki Health Administration Center,Not Recruiting,Not Applicable,Interventional,Japan,SUrveillance of SARS-CoV-2 Virus Antibody in Health CarE and CloSe-Contact WorkerS,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046448,None
1631,2882,PACTR202004801273802,PACTR,2020-04-02,2020-04-17,False,Lagos State Government,Not Recruiting,Phase 3,Interventional,Nigeria,"Lagos COVID-19 Chloroquine Treatment Trial (LACCTT)
",Drug,Chloroquine vs. Hydroxychloroquine,Chloroquine; Hydroxychloroquine,600,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10928,None
1632,2883,PACTR202004693933092,PACTR,2020-04-12,2020-04-15,False,Misr University for Science and Technology,Not Recruiting,Not Applicable,Interventional,Egypt,Effectiveness of Measles Vaccine in Health Care Professionals During COVID-19 Outbreak (Randomized Controlled Trial),ATMP,Vaccine,Vaccine,200,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10953,None
1633,2884,PACTR202004761408382,PACTR,2020-04-13,2020-05-01,False,International Centre for Ethnomedicine and Drug Development and Neimeth International Pharmaceuticals Plc.,Not Recruiting,Not Applicable,Interventional,Nigeria,"Efficacy and safety of IHP Detox Tea (a special blend of Andrographis paniculata, Garcinia kola and Psidium guajava) for treatment of Corona virus disease 2019 (COVID-19): a pilot randomized trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,72,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10957,None
1634,2885,PACTR202005599385499,PACTR,2020-04-16,2020-04-20,False,Cairo University,Not Recruiting,Phase 2,Interventional,Egypt,Folic acid: A new suggested prevention and treatment of COVID-19 infection.,Drug,Folic Acid,Folic Acid,60,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10971,None
1635,2886,PACTR202004893013257,PACTR,2020-04-21,2020-04-25,False,Dr. Birgit Whitman,Not Recruiting,Phase 3,Interventional,Ghana,Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,Drug,Hydroxychloroquine + Lopinavir/ritonavir vs. Hydroxychloroquine vs. Lopinavir/ritonavir,Hydroxychloroquine; Lopinavir/ritonavir,6400,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10981,None
1636,2887,PACTR202005681895696,PACTR,2020-04-26,2020-05-31,False,University of Oxford,Not Recruiting,Phase 1,Interventional,Kenya,A study to determine if a new COVID-19 vaccine safely generates protective immune responses in adults in Kenya,ATMP,Vaccine,Vaccine,400,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10988,None
1637,2888,PACTR202005622389003,PACTR,2020-05-14,2020-06-01,False,Universite Cheikh Anta Diop ,Not Recruiting,Phase 3,Interventional,Senegal,"Hydroxychloroquine, Azithromycine and Zinc for the treatment of SARS-Cov2 infection in Senegal. COVID-19",Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,384,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11053,None
1638,2889,PACTR202006717277937,PACTR,2020-05-25,2020-10-01,False,Awolola Eniola Oladejo,Not Recruiting,Not Applicable,Interventional,Nigeria,Effect of Interferential Therapy on SARS-CoV-2. COVID-19,Other,Inferential Therapy,Inferential Therapy,48,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11088,None
1639,2890,PACTR202006899597082,PACTR,2020-05-29,2020-04-29,True,Malagasy Government,Not Recruiting,Phase 2,Interventional,Madagascar,Efficacy of a new COVID-19 treatment,Drug,Artesunate vs. Artesunate + Vitamin C,Artesunate; Vitamin C,60,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11103,None
1640,2891,RBR-6m69fc,REBEC,2020-04-02,2020-04-01,True,University of Sevilla,Recruiting,Not Applicable,Interventional,Spain,"Therapeutic Pulmonary Telerehabilitation Protocol in patients affected by COVID-19, confined in their homes",Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,99,http://www.ensaiosclinicos.gov.br/rg/RBR-6m69fc/,None
1641,2893,RBR-8969zg,REBEC,2020-04-13,2020-04-14,False,University de So Paulo,Not Recruiting,Not Applicable,Interventional,Brazil,Treatment of 2019-nCoV Pneumonia with N-acetylcysteine,Drug,N-acetylcysteine,N-acetylcysteine,200,http://www.ensaiosclinicos.gov.br/rg/RBR-8969zg/,None
1642,2894,RBR-658khm,REBEC,2020-04-22,2020-04-01,True,Centro Medico Mazzei,Recruiting,Not Applicable,Interventional,Brazil,"Telemedicine in the Covid-19 pandemic in Brazil
in a medical clinic in the supplementary health sector in So Paulo, Brazil",Telehealth,Telehealth,Telehealth,90,http://www.ensaiosclinicos.gov.br/rg/RBR-658khm/,None
1643,2895,RBR-6w5tbk,REBEC,2020-04-29,2020-04-30,False,Hospital Universitrio de Braslia,Not Recruiting,Not Applicable,Interventional,Brazil,Effects of tests for covid-19 on the preservation of the healthcare workforce during pandemia in Brazil,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,250,http://www.ensaiosclinicos.gov.br/rg/RBR-6w5tbk/,None
1644,2896,RBR-3k4wxb,REBEC,2020-05-05,2020-05-01,True,Hospital Santo Antnio,Not Recruiting,Phase 2,Interventional,Brazil,"Evaluation of the use of Hydroxychlorochine in Chinese flu
",Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,45,http://www.ensaiosclinicos.gov.br/rg/RBR-3k4wxb/,None
1645,2897,RBR-3rdhgm,REBEC,2020-05-14,2020-05-01,True,Faculdade de Medicina de Botucatu,Recruiting,Not Applicable,Interventional,Brazil,The role of early dialysis in the evolution of patients with COVID19,Other (device),Dialysis,Dialysis,118,http://www.ensaiosclinicos.gov.br/rg/RBR-3rdhgm/,None
1646,2898,RBR-4vm3yy,REBEC,2020-05-15,2020-04-19,True,Instituto Estadual de Hematologia Arthur Siqueira Cavalcanti,Recruiting,Not Applicable,Interventional,Brazil,Effect of convalescent plasma in patients with severe COVI-19,ATMP,Plasma,Plasma,20,http://www.ensaiosclinicos.gov.br/rg/RBR-4vm3yy/,None
1647,2900,RBR-9y32yy,REBEC,2020-05-24,2020-07-01,False,Sao Paulo State University (Universidade Estadual Paulista),Not Recruiting,Not Applicable,Interventional,Brazil,Acute and chronic cardiovascular and respiratory changes in COVID-19 hospitalized patients and the effect of physical rehabilitation supervised by telecommunication,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,100,http://www.ensaiosclinicos.gov.br/rg/RBR-9y32yy/,None
1648,2901,RBR-9d8z6m,REBEC,2020-03-27,2020-03-30,False,Hospital do Corao,Not Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azythromycin in SARS-Cov-2 Virus,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine ,Hydroxychloroquine; Azithromycin,630,http://www.ensaiosclinicos.gov.br/rg/RBR-9d8z6m/,None
1649,2902,RBR-2dxyx4,REBEC,2020-06-02,2020-06-04,False,Hospital Universitrio Clementino Fraga Filho,Not Recruiting,Not Applicable,Interventional,Brazil,Mechanical ventilator for use in patients with respiratory failure due to Covid-19 (VExCO),Other (physical),Mechanical ventilation,Mechanical ventilation,5,http://www.ensaiosclinicos.gov.br/rg/RBR-2dxyx4/,None
1650,2904,RBR-949z6v,REBEC,2020-05-06,2020-05-30,False,Faculdade de Medicina de Ribeiro Preto,Recruiting,Phase 2,Interventional,Brazil,Full versus prophylactic anticoagulation for the treatment of severe forms of Covid-19:,Drug,Heparin,Heparin,30,http://www.ensaiosclinicos.gov.br/rg/RBR-949z6v/,None
1651,2905,RBR-876qb5,REBEC,2020-06-08,2020-05-27,True,University de So Paulo,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Treatment of severe cases of Covid-19 with Eculizumab,Drug,Eculizumab,Eculizumab,10,http://www.ensaiosclinicos.gov.br/rg/RBR-876qb5/,None
1652,2907,RPCEC00000306,RPCEC,2020-04-13,2020-03-27,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Recruiting,Phase 1/Phase 2,Interventional,Cuba,CIGB 2020 in contacts and SARS-CoV-2 infection suspects,ATMP,Vaccine,Vaccine,80,https://rpcec.sld.cu/en/trials/RPCEC00000306-En,None
1653,2908,RPCEC00000307,RPCEC,2020-04-14,2020-04-10,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Recruiting,Phase 2,Interventional,Cuba,ESPERANZA study,Drug,Interferon alpha,Interferon alpha,120,https://rpcec.sld.cu/en/trials/RPCEC00000307-En,None
1654,2909,RPCEC00000308,RPCEC,2020-05-03,2020-05-04,False,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Phase 1,Interventional,Cuba,Pharmacodynamics of the Nasalferon in healthy volunteers.,Drug,Nasalferon,Nasalferon,30,https://rpcec.sld.cu/en/trials/RPCEC00000308-En,None
1655,2910,RPCEC00000309,RPCEC,2020-05-05,2020-05-20,False,Colima State Health Service ,Not Recruiting,Phase 1/Phase 2,Interventional,Mexico,Therapy for COVID-19-Phase I-II,Drug,Homeostec + Paracetamol,Homeostec; Paracetamol,50,https://rpcec.sld.cu/en/trials/RPCEC00000309-En,None
1656,2912,RPCEC00000311,RPCEC,2020-05-12,2020-03-28,True,Center of Molecular Immunology (CIM),Recruiting,Not Applicable,Interventional,Cuba,Treatment of SARS CoV-2 pneumonia with the anti-CD6 monoclonal antibody itolizumab,Drug,Itolizumab,Itolizumab,80,https://rpcec.sld.cu/en/trials/RPCEC00000311-En,None
1657,2914,RPCEC00000313,RPCEC,2020-05-14,2020-03-31,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Not Applicable,Interventional,Cuba,CIGB-258 at COVID-19,Drug,CIGB-258,CIGB-258,16,https://rpcec.sld.cu/en/trials/RPCEC00000313-En,None
1658,2915,RPCEC00000314,RPCEC,2020-05-22,2020-04-24,True,Finlay Vaccine Institute (IFV),Recruiting,Not Applicable,Interventional,Cuba,VA-MENGOC-BC to stimulate the innate response against SARS-CoV-2,ATMP,Vaccine,Vaccine,115000,https://rpcec.sld.cu/en/trials/RPCEC00000314-En,None
1659,2916,RPCEC00000315,RPCEC,2020-05-22,2020-05-19,True,Finlay Vaccine Institute (IFV),Recruiting,Not Applicable,Interventional,Cuba,Evaluation of the synergistic effect of  sequential administration of two immunostimulant products: Immuno-1 and Immuno-2 for the stimulation of the immune response in older adults. Exploratory study,Drug,Immunostimulants,Immunostimulants,60,https://rpcec.sld.cu/en/trials/RPCEC00000315-En,None
1660,2917,RPCEC00000316,RPCEC,2020-05-28,2020-06-01,False,Centro Nacional de Biopreparados (BioCen),Not Recruiting,Not Applicable,Interventional,Cuba,Exploratory study of BMT IM to stimulate immune response in patients with CKD-5 on iterated hemodialysis,Drug,Biomodulin T,Biomodulin T,20,https://rpcec.sld.cu/en/trials/RPCEC00000316-En,None
1661,2918,RPCEC00000317,RPCEC,2020-05-28,2020-06-01,False,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Phase 1/Phase 2,Interventional,Cuba,ATENEA-Co-300 study,Drug,CIGB-300,CIGB-300,20,https://rpcec.sld.cu/en/trials/RPCEC00000317-En,None
1662,2921,RPCEC00000320,RPCEC,2020-06-05,2020-06-08,False,National Center for Scientific Research (CNIC),Not Recruiting,Not Applicable,Interventional,Cuba,Rectal Ozone in the COVID-19 treatment,Drug,Ozone,Ozone,32,https://rpcec.sld.cu/en/trials/RPCEC00000320-En,None
1663,2922,TCTR20200601002,TCTR,2020-05-28,2020-06-01,False,Self-sponsored,Recruiting,Not Applicable,Interventional,Malaysia,"A Randomized Controlled Trial on Effectiveness of Mental Health & Psychosocial Support Module (MHPSS) in Reduction of Depression, Anxiety and Stress among Healthcare Workers during COVID-19 Pandemic in Jerantut, Pahang",Other (psych),Psychological,Psychological,110,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6322,None
1664,2924,TCTR20200514001,TCTR,2020-05-12,2020-06-01,False,Siriraj Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,Thailand,An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients without Pneumonia ?? An open-label randomized controlled study ??,Drug,Favipiravir,Favipiravir,96,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6236,None
1665,2927,TCTR20200409006,TCTR,2020-04-03,2020-05-01,False,King Chulalongkorn Memorial Hospital,Not Recruiting,Not Applicable,Interventional,Thailand,Efficacy of HA330 Hemoperfusion in Critically Ill Patients with Severe COVID-19,Other (device),HA330,HA330,206,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6016,None
1666,2929,TCTR20200404004,TCTR,2020-03-31,2020-04-27,False,Health Systems Research Institute (HSRI),Not Recruiting,Phase 4,Interventional,Thailand,Comparative effectiveness of Chloroquine and Vitamin C prophylaxis in household contacts of confirmed COVID-19 patients,Drug,Chloroquine + Vitamin C,Chloroquine; Vitamin C,400,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5995,None
1667,2933,NCT04315298,ClinicalTrials.gov,2020-03-15,2020-03-18,False,Regeneron Pharmaceuticals,Recruiting,Phase 2/Phase 3,Interventional,United States,Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19,Drug,Sarilumab,Sarilumab,2500,https://clinicaltrials.gov/show/NCT04315298,None
1668,2934,NCT04316377,ClinicalTrials.gov,2020-03-13,2020-03-25,False,"University Hospital, Akershus",Not Recruiting,Phase 4,Interventional,Norway,Norwegian Coronavirus Disease 2019 Study,Drug,Hydroxychloroquine,Hydroxychloroquine,53,https://clinicaltrials.gov/show/NCT04316377,None
1669,2935,NCT04321928,ClinicalTrials.gov,2020-03-20,2020-04-01,False,University of Pecs,Recruiting,Not Applicable,Interventional,Hungary,Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary,Other,Health Education,Health Education,7576,https://clinicaltrials.gov/show/NCT04321928,None
1670,2936,NCT04335279,ClinicalTrials.gov,2020-04-01,2020-04-09,False,Lady Davis Institute,Recruiting,Not Applicable,Interventional,Canada,Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program,Other (psych),Psychological,Psychological,195,https://clinicaltrials.gov/show/NCT04335279,None
1671,2937,NCT04335305,ClinicalTrials.gov,2020-03-31,2020-07-01,False,MedSIR,Recruiting,Phase 2,Interventional,Spain,Checkpoint Blockade in COVID-19 Pandemic,Drug,Tocilizumab + Pembrolizumab,Tocilizumab; pembrolizumab,24,https://clinicaltrials.gov/show/NCT04335305,None
1672,2938,NCT04335851,ClinicalTrials.gov,2020-04-02,2020-04-06,False,Biruni University,Not Recruiting,Not Applicable,Interventional,Turkey,Video-Based Exercises and Well-Being During Social Isolation,Other (exercise),Exercise,Exercise,68,https://clinicaltrials.gov/show/NCT04335851,None
1673,2939,NCT04339426,ClinicalTrials.gov,2020-04-07,2020-04-20,False,HonorHealth Research Institute,Recruiting,Phase 2,Interventional,United States,Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection,Drug,Atovaquone + azithromycin,Atovaquone; azithromycin,25,https://clinicaltrials.gov/show/NCT04339426,None
1674,2940,NCT04345653,ClinicalTrials.gov,2020-04-08,2020-04-14,False,Hackensack Meridian Health,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,44,https://clinicaltrials.gov/show/NCT04345653,None
1675,2941,NCT04346420,ClinicalTrials.gov,2020-04-08,2020-04-09,False,"University Clinic, UCLouvain",Not Recruiting,Not Applicable,Interventional,Belgium,Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19,Other (device),Masks,Masks,12,https://clinicaltrials.gov/show/NCT04346420,None
1676,2942,NCT04346589,ClinicalTrials.gov,2020-04-09,2020-04-15,False,A.O. Ospedale Papa Giovanni XXIII,Recruiting,Not Applicable,Interventional,Italy,Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04346589,None
1677,2943,NCT04347382,ClinicalTrials.gov,2020-04-11,2020-04-30,False,Sohaib Ashraf,Recruiting,Phase 3,Interventional,Pakistan,Honey & Nigella Sativa Trial Against COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,https://clinicaltrials.gov/show/NCT04347382,None
1678,2944,NCT04348656,ClinicalTrials.gov,2020-04-13,2020-05-14,False,Hamilton Health Sciences Corporation,Recruiting,Phase 3,Interventional,"United States, Canada",CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1),ATMP,Plasma,Plasma,1200,https://clinicaltrials.gov/show/NCT04348656,None
1679,2948,NCT04351581,ClinicalTrials.gov,2020-04-14,2020-05-18,True,"Copenhagen University Hospital, Gentofte",Recruiting,Not Applicable,Interventional,Denmark,Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,215,https://clinicaltrials.gov/show/NCT04351581,EUCTR2020-001544-26
1680,2951,NCT04357444,ClinicalTrials.gov,2020-04-10,2020-06-01,True,Assistance Publique  Hpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19,Drug,ILT101,ILT101,30,https://clinicaltrials.gov/show/NCT04357444,EUCTR2020-001571-32
1681,2953,NCT04366323,ClinicalTrials.gov,2020-04-22,2020-04-27,True,Andalusian Network for Design and Translation of Advanced Therapies,Recruiting,Phase 1/Phase 2,Interventional,Spain,Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),26,https://clinicaltrials.gov/show/NCT04366323,EUCTR2020-001364-29
1682,2954,NCT04367545,ClinicalTrials.gov,2020-04-27,2020-04-16,True,"University Hospital, Rouen",Recruiting,Not Applicable,Interventional,France,Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04367545,None
1683,2955,NCT04367662,ClinicalTrials.gov,2020-04-16,2020-04-09,True,"University Hospital, Rouen",Not Recruiting,Not Applicable,Interventional,France,Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19,Clinical Presentation,No Intervention,No Intervention,99,https://clinicaltrials.gov/show/NCT04367662,None
1684,2956,NCT04368728,ClinicalTrials.gov,2020-04-27,2020-04-29,False,Biontech SE,Recruiting,Phase 1,Interventional,United States,"Study to Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults",ATMP,Vaccine,Vaccine,7600,https://clinicaltrials.gov/show/NCT04368728,None
1685,2957,NCT04370223,ClinicalTrials.gov,2020-04-27,2020-05-25,False,Institut d'Investigaci Biomdica de Girona Dr. Josep Trueta,Not Recruiting,Phase 3,Interventional,Spain,Ozone Auto-hemotherapy for COVID-19 Pneumonia,Drug,Ozone,Ozone,208,https://clinicaltrials.gov/show/NCT04370223,None
1686,2960,NCT04372017,ClinicalTrials.gov,2020-04-25,2020-05-14,False,Sanford Health,Not Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1,https://clinicaltrials.gov/show/NCT04372017,None
1687,2961,NCT04374565,ClinicalTrials.gov,2020-04-27,2020-05-05,False,University of Virginia,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia,ATMP,Plasma,Plasma,29,https://clinicaltrials.gov/show/NCT04374565,None
1688,2963,NCT04381923,ClinicalTrials.gov,2020-05-07,2020-06-01,False,University of Pennsylvania,Not Recruiting,Not Applicable,Interventional,No Country Given,COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia,Drug,Oxygen,Oxygen,200,https://clinicaltrials.gov/show/NCT04381923,None
1689,2964,NCT04381962,ClinicalTrials.gov,2020-05-07,2020-05-29,True,University of Oxford,Recruiting,Phase 3,Interventional,United Kingdom,A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2),Drug,Azithromycin,Azithromycin,800,https://clinicaltrials.gov/show/NCT04381962,EUCTR2020-001740-26
1690,2967,NCT04393636,ClinicalTrials.gov,2020-05-11,2020-06-05,False,Academic Hospital Maastricht,Recruiting,Not Applicable,Interventional,Netherlands,Digital Cardiac Counseling Trial: DCC Trial,Other (software),eHealth,eHealth,394,https://clinicaltrials.gov/show/NCT04393636,None
1691,2968,NCT04395807,ClinicalTrials.gov,2020-05-18,2020-06-03,False,Lund University,Recruiting,Not Applicable,Interventional,Sweden,Helmet CPAP Versus HFNC in COVID-19,Other (device),CPAP vs. Nasal cannula,CPAP; Nasal cannula,120,https://clinicaltrials.gov/show/NCT04395807,None
1692,2969,NCT04397510,ClinicalTrials.gov,2020-05-19,2020-06-01,False,Frederick Health,Recruiting,Phase 4,Interventional,United States,Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury,Drug,Heparin,Heparin,50,https://clinicaltrials.gov/show/NCT04397510,None
1693,2970,NCT04401293,ClinicalTrials.gov,2020-05-20,2020-04-26,True,Northwell Health,Recruiting,Phase 3,Interventional,United States,Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients,Drug,Heparin,Heparin,308,https://clinicaltrials.gov/show/NCT04401293,None
1694,2972,NCT04402060,ClinicalTrials.gov,2020-05-22,2020-05-26,False,"Apellis Pharmaceuticals, Inc.",Recruiting,Phase 1/Phase 2,Interventional,United States,A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19,Drug,APL-9,APL-9,66,https://clinicaltrials.gov/show/NCT04402060,None
1695,2973,NCT04403100,ClinicalTrials.gov,2020-05-23,2020-06-03,False,Cardresearch,Recruiting,Phase 3,Interventional,Brazil,"Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: ""The Hope Coalition - 1""",Drug,Hydroxychloroquine + Lopinavir/ritonavir vs. Hydroxychloroquine vs. Lopinavir/ritonavir,Hydroxychloroquine; Lopinavir/ritonavir,1968,https://clinicaltrials.gov/show/NCT04403100,None
1696,2978,NCT04412356,ClinicalTrials.gov,2020-05-24,2020-06-04,False,Sahlgrenska University Hospital,Recruiting,Not Applicable,Interventional,Sweden,Timing of Tracheotomy in Covid-19 Patients,Other,No Intervention,No Intervention,180,https://clinicaltrials.gov/show/NCT04412356,None
1697,2979,NCT04413747,ClinicalTrials.gov,2020-05-29,2020-06-01,False,Health Ricerca E Sviluppo S.r.l.,Not Recruiting,Not Applicable,Interventional,Italy,Yoga Pranayama Adjuvant to Treat Burden COVID -19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,1000,https://clinicaltrials.gov/show/NCT04413747,None
1698,2980,NCT04415086,ClinicalTrials.gov,2020-06-01,2020-06-01,False,University of So Paulo General Hospital,Recruiting,Phase 2,Interventional,Brazil,Treatment of Patients With COVID-19 With Convalescent Plasma,ATMP,Plasma,Plasma,120,https://clinicaltrials.gov/show/NCT04415086,None
1699,2981,NCT04415879,ClinicalTrials.gov,2020-06-01,2020-06-01,False,The Cleveland Clinic,Recruiting,Not Applicable,Interventional,United States,Effects of a N95 Respirator vs Cloth Mask on Exercise Capacity During Treadmill Exercise.,Other (device),Masks,Masks,20,https://clinicaltrials.gov/show/NCT04415879,None
1700,2982,NCT04416399,ClinicalTrials.gov,2020-06-03,2020-06-11,False,University of Oxford,Not Recruiting,Phase 2,Interventional,No Country Given,STerOids in COVID-19 Study,Drug,Corticosteroids,Budesonide,478,https://clinicaltrials.gov/show/NCT04416399,None
1701,2984,NCT04418128,ClinicalTrials.gov,2020-06-03,2020-06-10,False,Gyeongsang National University Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia,Drug,Nafamostat Mesylate,Nafamostat Mesylate,84,https://clinicaltrials.gov/show/NCT04418128,None
1702,2986,NCT04418206,ClinicalTrials.gov,2020-05-18,2020-06-01,False,CHU de Nice,Not Recruiting,Not Applicable,Interventional,France,Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04418206,None
1703,2989,NCT04418505,ClinicalTrials.gov,2020-06-03,2020-07-01,False,Vielight Inc.,Not Recruiting,Not Applicable,Interventional,Canada,Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms,Other,Photobiomodulation,Photobiomodulation,280,https://clinicaltrials.gov/show/NCT04418505,None
1704,2990,NCT04418518,ClinicalTrials.gov,2020-06-03,2020-06-01,True,Weill Medical College of Cornell University,Not Recruiting,Phase 3,Interventional,United States,A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness,ATMP,Plasma,Plasma,1200,https://clinicaltrials.gov/show/NCT04418518,None
1705,2991,NCT04418531,ClinicalTrials.gov,2020-06-03,2020-06-01,True,Piero Luigi Ruggenenti,Not Recruiting,Not Applicable,Interventional,Italy,Convalescent Antibodies Infusion in COVID 19 Patients,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04418531,None
1706,2995,NCT04419623,ClinicalTrials.gov,2020-06-03,2020-06-01,True,"Telios Pharma, Inc.",Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer,Drug,TL-895,TL-895,146,https://clinicaltrials.gov/show/NCT04419623,None
1707,2996,NCT04420182,ClinicalTrials.gov,2020-05-29,2020-06-08,False,Lawson Health Research Institute,Not Recruiting,Not Applicable,Interventional,Canada,COVID-19 Virtual Care at Home,Other (software),eHealth,eHealth,2000,https://clinicaltrials.gov/show/NCT04420182,None
1708,2997,NCT04420260,ClinicalTrials.gov,2020-05-25,2020-07-01,False,Unidad de Investigacin Gentica Molecular,Not Recruiting,Not Applicable,Interventional,No Country Given,Primary Prevention of Infection by COVID-19 in Health Providers,Drug (Chemoprophylaxis),"Oropharygeal spray, Immunostimulant",Oropharygeal spray; Immunostimulant,300,https://clinicaltrials.gov/show/NCT04420260,None
1709,2998,NCT04420273,ClinicalTrials.gov,2020-06-03,2020-06-15,False,Northwestern University,Not Recruiting,Not Applicable,Interventional,United States,Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician Access,Other,Other,Other,1000,https://clinicaltrials.gov/show/NCT04420273,None
1710,3000,NCT04420364,ClinicalTrials.gov,2020-06-04,2020-07-01,False,Brigham and Women's Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease,Other,Immunosupression,Immunosupression,50,https://clinicaltrials.gov/show/NCT04420364,None
1711,3001,NCT04420390,ClinicalTrials.gov,2020-05-14,2020-05-01,True,"Hospital San Carlos, Madrid",Recruiting,Not Applicable,Interventional,Spain,Low Dose Radiotherapy for COVID-19 Pneumonitis,Other,Radiation,Radiation,41,https://clinicaltrials.gov/show/NCT04420390,None
1712,3005,NCT04420676,ClinicalTrials.gov,2020-06-04,2020-08-01,False,Medical University of Graz,Not Recruiting,Not Applicable,Interventional,Austria,Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection,Supplement,Probiotics,Probiotics,108,https://clinicaltrials.gov/show/NCT04420676,None
1713,3006,NCT04420806,ClinicalTrials.gov,2020-06-05,2020-03-14,True,University of Erlangen-Nornberg Medical School,Not Recruiting,Not Applicable,Interventional,Germany,Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women,Other (exercise),Exercise,Exercise,21,https://clinicaltrials.gov/show/NCT04420806,None
1714,3008,NCT04421391,ClinicalTrials.gov,2020-06-04,2020-06-08,False,Therapeutic Solutions International,Recruiting,Not Applicable,Interventional,United States,QuadraMune(TM) for Prevention of COVID-19,Supplement,Nutritional Supplement,Nutritional Supplement,500,https://clinicaltrials.gov/show/NCT04421391,None
1715,3009,NCT04421534,ClinicalTrials.gov,2020-06-05,2020-06-01,True,Cairo University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19,Drug,Lactoferrin,Lactoferrin,150,https://clinicaltrials.gov/show/NCT04421534,None
1716,3010,NCT04421625,ClinicalTrials.gov,2020-05-18,2020-06-15,False,Institut de Cancrologie de l'Ouest,Not Recruiting,Not Applicable,Interventional,France,Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic,Clinical Presentation (Epidemiology),No Intervention,No Intervention,12000,https://clinicaltrials.gov/show/NCT04421625,None
1717,3011,NCT04421664,ClinicalTrials.gov,2020-06-05,2020-03-25,True,McGill University,Recruiting,Phase 3,Interventional,"United States, Canada",Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1500,https://clinicaltrials.gov/show/NCT04421664,None
1718,3017,NCT04423042,ClinicalTrials.gov,2020-06-05,2020-06-01,True,University of Calgary,Not Recruiting,Phase 3,Interventional,No Country Given,Tocilizumab in Coronavirus-19 Positive Patients,Drug,Tocilizumab,Tocilizumab,30,https://clinicaltrials.gov/show/NCT04423042,None
1719,3020,NCT04424134,ClinicalTrials.gov,2020-05-27,2020-05-16,True,Lomonosov Moscow State University Medical Research and Educational Center,Recruiting,Phase 3,Interventional,Russian Federation,BromhexIne And Spironolactone For Coron?VirUs Infection Requiring HospiTalization,Drug,Bromhexine + Spironolactone,Bromhexine; Spironolactone,80,https://clinicaltrials.gov/show/NCT04424134,None
1720,3021,NCT04425616,ClinicalTrials.gov,2020-06-03,2020-05-29,True,University Hospital Southampton NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer,Other,Welfare,Welfare,1100,https://clinicaltrials.gov/show/NCT04425616,None
1721,3024,NCT04303507,ClinicalTrials.gov,2020-03-06,2020-04-29,True,University of Oxford,Not Recruiting,Not Applicable,Interventional,"Thailand, United Kingdom",Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting,Drug,Chloroquine or Hydroxychloroquine,Chloroquine; hydroxychloroquine,40000,https://clinicaltrials.gov/show/NCT04303507,EUCTR2020-001441-39
1722,3025,NCT04315987,ClinicalTrials.gov,2020-03-18,2020-06-01,False,Azidus Brasil,Not Recruiting,Phase 2,Interventional,Brazil,NestaCell Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),90,https://clinicaltrials.gov/show/NCT04315987,None
1723,3026,NCT04322682,ClinicalTrials.gov,2020-03-23,2020-03-23,False,Montreal Heart Institute,Recruiting,Phase 3,Interventional,"United States, Canada, Spain",Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA),Drug,Colchicine,Colchicine,6000,https://clinicaltrials.gov/show/NCT04322682,None
1724,3027,NCT04325906,ClinicalTrials.gov,2020-03-26,2020-04-02,False,Rush University Medical Center,Recruiting,Not Applicable,Interventional,United States,Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS,Other (device),Nasal cannula,Nasal cannula,346,https://clinicaltrials.gov/show/NCT04325906,None
1725,3028,NCT04331795,ClinicalTrials.gov,2020-04-01,2020-04-04,False,University of Chicago,Not Recruiting,Phase 2,Interventional,United States,"Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis",Drug,Tocilizumab,Tocilizumab,32,https://clinicaltrials.gov/show/NCT04331795,None
1726,3029,NCT04334460,ClinicalTrials.gov,2020-04-02,2020-05-04,False,Blade Therapeutics,Recruiting,Phase 2,Interventional,United States,Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects,Drug,BLD-2660,BLD-2660,120,https://clinicaltrials.gov/show/NCT04334460,None
1727,3030,NCT04335786,ClinicalTrials.gov,2020-04-02,2020-04-17,True,Radboud University,Recruiting,Phase 4,Interventional,Netherlands,Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease,Drug,Valsartan,Valsartan,651,https://clinicaltrials.gov/show/NCT04335786,EUCTR2020-001320-34
1728,3032,NCT04337996,ClinicalTrials.gov,2020-04-01,2020-06-01,False,Tourcoing Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Dynamic Evaluation of COVID-19 Diagnostic Tests,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,165,https://clinicaltrials.gov/show/NCT04337996,None
1729,3033,NCT04338074,ClinicalTrials.gov,2020-04-06,2020-06-01,False,University of Alabama at Birmingham,Recruiting,Phase 2,Interventional,United States,TXA and Corona Virus 2019 (COVID19) in Outpatients,Drug,Tranexamic acid,Tranexamic acid,100,https://clinicaltrials.gov/show/NCT04338074,None
1730,3034,NCT04341116,ClinicalTrials.gov,2020-04-04,2020-04-11,False,I-Mab Biopharma Co. Ltd.,Recruiting,Phase 1/Phase 2,Interventional,United States,Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19),Drug,TJ003234,TJ003234,144,https://clinicaltrials.gov/show/NCT04341116,None
1731,3035,NCT04341922,ClinicalTrials.gov,2020-04-07,2020-05-09,False,Karolinska Institutet,Recruiting,Not Applicable,Interventional,Sweden,A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic,Other (psych),Psychological,Psychological,670,https://clinicaltrials.gov/show/NCT04341922,None
1732,3037,NCT04343651,ClinicalTrials.gov,2020-03-31,2020-04-01,False,"CytoDyn, Inc.",Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19,Drug,Leronlimab,Leronlimab,75,https://clinicaltrials.gov/show/NCT04343651,None
1733,3039,NCT04344288,ClinicalTrials.gov,2020-04-10,2020-04-21,True,Hospices Civils de Lyon,Recruiting,Phase 2,Interventional,France,Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection,Drug,Corticosteroids,Prednisone,304,https://clinicaltrials.gov/show/NCT04344288,EUCTR2020-001553-48
1734,3042,NCT04345861,ClinicalTrials.gov,2020-04-05,2020-04-11,False,"University Hospital, Montpellier",Not Recruiting,Phase 2/Phase 3,Interventional,France,Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial),Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; azithormycin,7,https://clinicaltrials.gov/show/NCT04345861,None
1735,3044,NCT04346628,ClinicalTrials.gov,2020-04-10,2020-06-01,False,Stanford University,Not Recruiting,Phase 2,Interventional,United States,Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19,Drug,Favipiravir,Favipiravir,120,https://clinicaltrials.gov/show/NCT04346628,None
1736,3045,NCT04347174,ClinicalTrials.gov,2020-03-31,2020-04-30,False,Cadila Pharnmaceuticals,Recruiting,Not Applicable,Interventional,India,A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients,Drug,Mycobacterium,Mycobacterium,40,https://clinicaltrials.gov/show/NCT04347174,None
1737,3046,NCT04347239,ClinicalTrials.gov,2020-04-13,2020-04-15,False,"CytoDyn, Inc.",Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19),Drug,Leronlimab,Leronlimab,390,https://clinicaltrials.gov/show/NCT04347239,None
1738,3047,NCT04348409,ClinicalTrials.gov,2020-04-03,2020-05-25,False,Azidus Brasil,Recruiting,Not Applicable,Interventional,Brazil,Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19,Drug,Nitazoxanide,Nitazoxanide,50,https://clinicaltrials.gov/show/NCT04348409,None
1739,3049,NCT04351152,ClinicalTrials.gov,2020-04-15,2020-04-30,False,"Humanigen, Inc.",Recruiting,Phase 3,Interventional,United States,Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Hospitalized Patients With COVID-19 Pneumonia,Drug,Lenzilumab,Lenzilumab,238,https://clinicaltrials.gov/show/NCT04351152,None
1740,3051,NCT04353596,ClinicalTrials.gov,2020-04-14,2020-04-15,True,Medical University Innsbruck,Recruiting,Phase 4,Interventional,"Austria, Germany",Stopping ACE-inhibitors in COVID-19,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,208,https://clinicaltrials.gov/show/NCT04353596,EUCTR2020-001206-35
1741,3052,NCT04355351,ClinicalTrials.gov,2020-04-17,2020-05-05,False,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Study of Immune Response During SARS-CoV-2 Infection - (COVID-19),Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04355351,None
1742,3053,NCT04356495,ClinicalTrials.gov,2020-04-11,2020-07-01,True,"University Hospital, Bordeaux",Recruiting,Phase 3,Interventional,France,Treatments to Decrease the Risk of Hospitalization or Death in Elderly Outpatients With Symptomatic SARS-CoV-2 Infection (COVID-19),Drug,Hydroxychloroquine vs. Imatinib vs. Favipiravir vs. Telmisartan vs. Vitamins,Hydroxychloroquine; Imatinib; Favipiravir; Telmisartan; Vitamins,1057,https://clinicaltrials.gov/show/NCT04356495,EUCTR2020-001435-27
1743,3056,NCT04361474,ClinicalTrials.gov,2020-04-22,2020-05-18,True,Fondation Ophtalmologique Adolphe de Rothschild,Recruiting,Phase 3,Interventional,France,Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity,Drug,Corticosteroids,Budesonide,120,https://clinicaltrials.gov/show/NCT04361474,EUCTR2020-001667-85
1744,3057,NCT04362813,ClinicalTrials.gov,2020-04-24,2020-04-30,True,Novartis Pharmaceuticals,Recruiting,Phase 3,Interventional,"United States, United Kingdom, Italy, France, Germany, Russian Federation, Spain",Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia,Drug,Canakinumab,Canakinumab,450,https://clinicaltrials.gov/show/NCT04362813,EUCTR2020-001370-30
1745,3058,NCT04363606,ClinicalTrials.gov,2020-04-24,2020-05-27,False,CHU de Saint Etienne,Recruiting,Not Applicable,Interventional,France,Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability,Clinical Presentation,No Intervention,No Intervention,52,https://clinicaltrials.gov/show/NCT04363606,None
1746,3060,NCT04366232,ClinicalTrials.gov,2020-04-27,2020-06-01,True,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,Not Recruiting,Phase 2,Interventional,France,Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation (JAKINCOV),Drug,Anakinra + Ruxolitinib vs. Anakinra,Anakinra; Ruxolitinib,54,https://clinicaltrials.gov/show/NCT04366232,EUCTR2020-001963-10
1747,3061,NCT04366245,ClinicalTrials.gov,2020-04-22,2020-04-23,False,Andalusian Network for Design and Translation of Advanced Therapies,Recruiting,Phase 1/Phase 2,Interventional,Spain,Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection,ATMP,Plasma,Plasma,72,https://clinicaltrials.gov/show/NCT04366245,None
1748,3063,NCT04369599,ClinicalTrials.gov,2020-04-28,2020-07-01,False,Emory University,Recruiting,Not Applicable,Interventional,United States,Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q Vest for COVID-19,Other (device),Thoracic Manipulation Vest,Thoracic Manipulation Vest,24,https://clinicaltrials.gov/show/NCT04369599,None
1749,3065,NCT04375098,ClinicalTrials.gov,2020-05-03,2020-05-04,False,Pontificia Universidad Catlica de Chile,Recruiting,Phase 2,Interventional,Chile,Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection,ATMP,Plasma,Plasma,58,https://clinicaltrials.gov/show/NCT04375098,None
1750,3066,NCT04375735,ClinicalTrials.gov,2020-04-22,2020-07-01,False,Lawson Health Research Institute,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,London's Exogenous Surfactant Study for COVID19,Drug,Bovine Lipid Extract Surfactant,Bovine Lipid Extract Surfactant,20,https://clinicaltrials.gov/show/NCT04375735,None
1751,3067,NCT04377711,ClinicalTrials.gov,2020-05-05,2020-06-08,False,Covis Pharma,Recruiting,Phase 3,Interventional,United States,A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients,Drug,Ciclesonide,Ciclesonide,400,https://clinicaltrials.gov/show/NCT04377711,None
1752,3068,NCT04379531,ClinicalTrials.gov,2020-04-30,2020-04-25,True,Department of Health Care of Moscow,Not Recruiting,Not Applicable,Interventional,Russian Federation,LDCT in COVID-19 Pneumonia: a Prospective Moscow Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,230,https://clinicaltrials.gov/show/NCT04379531,None
1753,3069,NCT04380961,ClinicalTrials.gov,2020-05-07,2020-04-24,True,Janssen Pharmaceutical,Recruiting,Phase 2,Interventional,United States,A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19,Drug,Sirukumab,Sirukumab,270,https://clinicaltrials.gov/show/NCT04380961,None
1754,3070,NCT04381013,ClinicalTrials.gov,2020-05-07,2020-06-01,False,Stanford University,Not Recruiting,Not Applicable,Interventional,United States,Emergency Ventilator Splitting Between Two or More Patients (COVID-19),Other (device),Other,Other,4,https://clinicaltrials.gov/show/NCT04381013,None
1755,3071,NCT04382768,ClinicalTrials.gov,2020-05-06,2020-05-01,True,Quimica Luar SRL,Recruiting,Not Applicable,Interventional,Argentina,Inhaled Ibuprofen to Treat COVID-19,Drug,Ibuprofen,Ibuprofen,40,https://clinicaltrials.gov/show/NCT04382768,None
1756,3074,NCT04386694,ClinicalTrials.gov,2020-05-08,2020-05-18,False,University of Nove de Julho,Recruiting,Not Applicable,Interventional,Brazil,Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19,Other,Photobiomodulation therapy + static magnetic field,Photobiomodulation therapy; static magnetic field,30,https://clinicaltrials.gov/show/NCT04386694,None
1757,3075,NCT04386850,ClinicalTrials.gov,2020-05-11,2020-04-14,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Oral 25-hydroxyvitamin D3 and COVID-19,Drug,Vitamin D,Vitamin D,1500,https://clinicaltrials.gov/show/NCT04386850,IRCT20200401046909N1; IRCT20200401046909N2
1758,3077,NCT04389450,ClinicalTrials.gov,2020-05-14,2020-06-04,False,Pluristem Ltd.,Recruiting,Phase 2,Interventional,"United States, Israel","Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19",ATMP,Cells (mesenchymal),Cells (mesenchymal),140,https://clinicaltrials.gov/show/NCT04389450,None
1759,3080,NCT04390516,ClinicalTrials.gov,2020-05-14,2020-03-24,True,Dascena,Not Recruiting,Not Applicable,Interventional,United States,Respiratory Decompensation and Model for the Triage of COVID-19 Patients,Prognosis,No Intervention,No Intervention,197,https://clinicaltrials.gov/show/NCT04390516,None
1760,3081,NCT04391127,ClinicalTrials.gov,2020-05-12,2020-05-04,True,Centenario Hospital Miguel Hidalgo,Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection,Drug,Hydroxychloroquine vs. Ivermectin,Hydroxychloroquine; Ivermectin,200,https://clinicaltrials.gov/show/NCT04391127,None
1761,3085,NCT04395170,ClinicalTrials.gov,2020-05-15,2020-06-01,False,Lifefactors Zona Franca,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,Convalescent Plasma Compared to Anti-COVID-19 Human Immunoglobulin and Standard Treatment (TE) in Hospitalized Patients,ATMP,Plasma vs. Immunoglobulin,Plasma; Immunoglobulin,75,https://clinicaltrials.gov/show/NCT04395170,None
1762,3086,NCT04399980,ClinicalTrials.gov,2020-05-21,2020-05-20,True,The Cleveland Clinic,Recruiting,Phase 2,Interventional,United States,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation,Drug,Mavrilimumab,Mavrilimumab,60,https://clinicaltrials.gov/show/NCT04399980,None
1763,3092,NCT04409886,ClinicalTrials.gov,2020-05-27,2020-06-01,False,Maimonides Medical Center,Not Recruiting,Not Applicable,Interventional,No Country Given,Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients,Drug,Oxygen,Oxygen,30,https://clinicaltrials.gov/show/NCT04409886,None
1764,3093,NCT04410016,ClinicalTrials.gov,2020-05-22,2020-05-25,False,University of Nottingham,Recruiting,Not Applicable,Interventional,United Kingdom,Evaluation of Staff COVID-19 Wellbeing Centres in a Healthcare Workplace: COVID-WELL Study,Other (psych),Psychological,Psychological,45,https://clinicaltrials.gov/show/NCT04410016,None
1765,3095,NCT04412252,ClinicalTrials.gov,2020-05-30,2020-06-04,False,Pfizer,Not Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy,Drug,Tofacitinib,Tofacitinib,240,https://clinicaltrials.gov/show/NCT04412252,None
1766,3098,NCT04414293,ClinicalTrials.gov,2020-06-01,2020-06-01,False,Hospital Provincial de Castelln,Not Recruiting,Not Applicable,Interventional,Spain,Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis,Other,Radiation,Radiation,41,https://clinicaltrials.gov/show/NCT04414293,None
1767,3099,NCT04414618,ClinicalTrials.gov,2020-05-26,2020-06-11,False,RedHill Biopharma Limited,Recruiting,Phase 2,Interventional,United States,A Study of Opaganib in Coronavirus Disease 2019 Pneumonia,Drug,Opaganib,Opaganib,40,https://clinicaltrials.gov/show/NCT04414618,None
1768,3101,NCT04416334,ClinicalTrials.gov,2020-06-03,2020-05-25,True,Instituto de Investigacin Marqus de Valdecilla,Recruiting,Phase 3,Interventional,Spain,PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 70 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS,Drug,Colchicine,Colchicine,1028,https://clinicaltrials.gov/show/NCT04416334,None
1769,3102,NCT04420299,ClinicalTrials.gov,2020-06-05,2020-06-04,True,La Fundacin de Investigacin HM,Recruiting,Phase 2,Interventional,Spain,Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19,Drug,Bemiparin,Bemiparin,120,https://clinicaltrials.gov/show/NCT04420299,None
1770,3103,NCT04422353,ClinicalTrials.gov,2020-06-07,2020-05-01,True,Federal University of Rio Grande do Sul,Recruiting,Not Applicable,Interventional,Brazil,Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson's Disease,Other (exercise),Exercise,Exercise,60,https://clinicaltrials.gov/show/NCT04422353,None
1771,3104,NCT04422509,ClinicalTrials.gov,2020-06-03,2020-06-25,False,Radboud University,Not Recruiting,Phase 1/Phase 2,Interventional,Netherlands,Lanadelumab for Treatment of COVID-19 Disease,Drug,Lanadelumab,Lanadelumab,80,https://clinicaltrials.gov/show/NCT04422509,None
1772,3108,NCT04422613,ClinicalTrials.gov,2020-06-05,2020-05-28,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04422613,None
1773,3110,NCT04422678,ClinicalTrials.gov,2020-06-05,2020-06-01,True,Alexandria University,Not Recruiting,Phase 3,Interventional,No Country Given,The Safety & Efficacy of Imatinib for the Treatment of SARS-COV-2 Induced Pneumonia,Drug,Imatinib,Imatinib,30,https://clinicaltrials.gov/show/NCT04422678,None
1774,3113,NCT04423289,ClinicalTrials.gov,2020-06-06,2020-03-31,True,Vall d'Hebron Research Institute (VHIR),Not Recruiting,Not Applicable,Interventional,Spain,Telematic Monitoring Through a Mobile Application of Patients With COVID-19,Other (software),eHealth,eHealth,150,https://clinicaltrials.gov/show/NCT04423289,None
1775,3116,NCT04423861,ClinicalTrials.gov,2020-06-08,2020-07-01,False,Azidus Brasil,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety of Nitazoxanide 600 mg TID for the Treatment of Hospitalized Patients With COVID-19,Drug,Nitazoxanide,Nitazoxanide,50,https://clinicaltrials.gov/show/NCT04423861,None
1776,3117,NCT04423991,ClinicalTrials.gov,2020-06-08,2020-03-10,True,Dascena,Not Recruiting,Not Applicable,Interventional,United States,Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning,Other (software),Machine Learning,Machine Learning,290,https://clinicaltrials.gov/show/NCT04423991,None
1777,3120,NCT04424082,ClinicalTrials.gov,2020-06-07,2020-06-07,False,Karolinska Institutet,Recruiting,Not Applicable,Interventional,Sweden,External Dead Space in Ventilated COVID-19 Patients,Other (physical),Mechanical ventilation,Mechanical ventilation,40,https://clinicaltrials.gov/show/NCT04424082,None
1778,3122,NCT04424797,ClinicalTrials.gov,2020-06-05,2020-06-01,True,Poudre Valley Health System,Recruiting,Not Applicable,Interventional,United States,Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol,Procedure,Positioning,Positioning,100,https://clinicaltrials.gov/show/NCT04424797,None
1779,3124,NCT04424901,ClinicalTrials.gov,2020-05-29,2020-05-03,True,UConn Health,Recruiting,Phase 2,Interventional,United States,Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19,Drug,Dipyridamole,Dipyridamole,100,https://clinicaltrials.gov/show/NCT04424901,None
1780,3126,NCT04425005,ClinicalTrials.gov,2020-06-08,2020-05-10,True,University of So Paulo,Recruiting,Not Applicable,Interventional,Brazil,Home-based Exercise Training During Covid-19 Pandemic in Post-bariatric,Other (exercise),Exercise,Exercise,70,https://clinicaltrials.gov/show/NCT04425005,None
1781,3128,NCT04425317,ClinicalTrials.gov,2020-05-27,2020-06-15,False,CRG UZ Brussel,Not Recruiting,Not Applicable,Interventional,No Country Given,Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,20,https://clinicaltrials.gov/show/NCT04425317,None
1782,3130,NCT04425460,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Zhejiang Hisun Pharmaceutical Co. Ltd.,Not Recruiting,Phase 3,Interventional,"Romania, China, Germany","A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19",Drug,Favipiravir,Favipiravir,256,https://clinicaltrials.gov/show/NCT04425460,None
1783,3131,NCT04425499,ClinicalTrials.gov,2020-06-08,2020-06-01,True,University of Montreal,Not Recruiting,Not Applicable,Interventional,No Country Given,A Gamified Network for Surgical Education During COVID-19: A Randomized Controlled Trial,Other,Other,Other,60,https://clinicaltrials.gov/show/NCT04425499,None
1784,3132,NCT04425538,ClinicalTrials.gov,2020-06-08,2020-06-01,True,Tufts Medical Center,Recruiting,Phase 2,Interventional,United States,A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).,Drug,Infliximab,Infliximab,17,https://clinicaltrials.gov/show/NCT04425538,None
1785,3133,NCT04425707,ClinicalTrials.gov,2020-06-08,2020-06-09,False,"Ministry of Health and Population, Egypt",Recruiting,Not Applicable,Interventional,Egypt,Ivermectin In Treatment of COVID 19 Patients,Drug,Ivermectin,Ivermectin,100,https://clinicaltrials.gov/show/NCT04425707,None
1786,3134,NCT04425733,ClinicalTrials.gov,2020-06-08,2020-07-07,False,Merck Sharp & Dohme Corp.,Not Recruiting,Phase 1,Interventional,No Country Given,MK-5475 in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009),Drug,MK-5475,MK-5475,64,https://clinicaltrials.gov/show/NCT04425733,None
1787,3135,NCT04425772,ClinicalTrials.gov,2020-05-09,2020-06-12,False,"HeNan Sincere Biotech Co., Ltd",Not Recruiting,Not Applicable,Interventional,No Country Given,A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Azvudine,Azvudine,342,https://clinicaltrials.gov/show/NCT04425772,None
1788,3136,NCT04425837,ClinicalTrials.gov,2020-05-29,2020-07-01,False,Fundacin Santa Fe de Bogot,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19,ATMP,Plasma,Plasma,236,https://clinicaltrials.gov/show/NCT04425837,None
1789,3138,NCT04425915,ClinicalTrials.gov,2020-06-07,2020-06-09,False,"Institute of Liver and Biliary Sciences, India",Recruiting,Phase 3,Interventional,India,Efficacy of Convalescent Plasma Therapy in Patients With COVID-19,ATMP,Plasma,Plasma,400,https://clinicaltrials.gov/show/NCT04425915,None
1790,3139,NCT04426006,ClinicalTrials.gov,2020-06-09,2020-06-01,True,Institut Bergoni,Not Recruiting,Not Applicable,Interventional,France,Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergoni in the Context of the COVID-19 Pandemic - PRO-SERO-COV,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04426006,None
1791,3142,NCT04426201,ClinicalTrials.gov,2020-06-09,2020-06-22,False,Revimmune,Not Recruiting,Phase 2,Interventional,No Country Given,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-O ),Drug,Interleukin-7,Interleukin-7,48,https://clinicaltrials.gov/show/NCT04426201,None
1792,3145,NCT04426292,ClinicalTrials.gov,2020-06-08,2020-05-12,True,UZ Brussel,Recruiting,Not Applicable,Interventional,Belgium,SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3500,https://clinicaltrials.gov/show/NCT04426292,None
1793,3146,NCT04426305,ClinicalTrials.gov,2020-06-03,2020-05-21,True,University of Ghent,Recruiting,Not Applicable,Interventional,Belgium,Community Health Workers Against COVID19,Other (psych),Psychological,Psychological,140,https://clinicaltrials.gov/show/NCT04426305,None
1794,3147,NCT04426318,ClinicalTrials.gov,2020-06-09,2020-06-10,False,"University of Wisconsin, Madison",Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 and the Healthy Minds Program for Educators,Other (psych),Psychological,Psychological,400,https://clinicaltrials.gov/show/NCT04426318,None
1795,3148,NCT04426344,ClinicalTrials.gov,2020-06-03,2020-06-01,True,Washington University in St. Louis,Not Recruiting,Not Applicable,Interventional,United States,Core Warming of COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04426344,None
1796,3154,NCT04427631,ClinicalTrials.gov,2020-06-03,2020-06-22,False,Cambridgeshire Community Services NHS Trust,Not Recruiting,Not Applicable,Interventional,United Kingdom,Exploring Interventions for Glue Ear During Covid-19,Other,Other,Other,20,https://clinicaltrials.gov/show/NCT04427631,None
1797,3156,NCT04428021,ClinicalTrials.gov,2020-06-07,2020-06-15,False,AOU Citt della Salute e della Scienza di Torino,Not Recruiting,Phase 2,Interventional,No Country Given,Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure,ATMP,Plasma,Plasma,180,https://clinicaltrials.gov/show/NCT04428021,None
1798,3157,NCT04428073,ClinicalTrials.gov,2020-06-08,2020-07-01,False,GeneCure Biotechnologies,Not Recruiting,Phase 1,Interventional,No Country Given,Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection,ATMP,Vaccine,Vaccine,32,https://clinicaltrials.gov/show/NCT04428073,None
1799,3158,NCT04428099,ClinicalTrials.gov,2020-06-09,2020-01-13,True,University of the Balearic Islands,Recruiting,Not Applicable,Interventional,Spain,Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression,Telehealth,Telehealth,Telehealth,186,https://clinicaltrials.gov/show/NCT04428099,None
1800,3159,NCT04428801,ClinicalTrials.gov,2020-04-08,2020-06-20,False,Celltex Therapeutics Corporation,Not Recruiting,Phase 2,Interventional,No Country Given,Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),200,https://clinicaltrials.gov/show/NCT04428801,None
1801,3161,NCT04429529,ClinicalTrials.gov,2020-06-09,2020-06-09,False,Tychan Pte Ltd.,Recruiting,Phase 1,Interventional,Singapore,"Safety of TY027, a Treatment for COVID-19, in Humans",Drug,TY027,TY027,25,https://clinicaltrials.gov/show/NCT04429529,None
1802,3162,NCT04429763,ClinicalTrials.gov,2020-06-10,2020-07-01,False,Trustem,Not Recruiting,Phase 2,Interventional,No Country Given,Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04429763,None
1803,3163,NCT04429854,ClinicalTrials.gov,2020-06-09,2020-05-02,True,UZ Leuven,Recruiting,Phase 2,Interventional,Belgium,Donated Antibodies Working Against nCoV,ATMP,Plasma,Plasma,483,https://clinicaltrials.gov/show/NCT04429854,None
1804,3164,ACTRN12620000501943,ANZCTR,2020-04-22,2020-05-20,False,Walter and Eliza Hall Institute of Medical Research,Recruiting,Phase 2/Phase 3,Interventional,Australia,COVID-19 prophylaxis with hydroxychloroquine in Front-line Health and Allied-Health Care Workers: The COVID-SHIELD Trial,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,2250,https://anzctr.org.au/ACTRN12620000501943.aspx,None
1805,3165,ACTRN12620000500954,ANZCTR,2020-04-22,2020-05-01,False,Western Health,Not Recruiting,Not Applicable,Interventional,Australia,A reusable personalised ventilation hood: A phase 1 safety study of a new device (McMonty) in patients with suspected or confirmed COVID-19.,Other (device),Hood,Hood,20,https://anzctr.org.au/ACTRN12620000500954.aspx,None
1806,3166,ACTRN12620000674932,ANZCTR,2020-06-12,2020-07-14,False,University of Queensland,Not Recruiting,Phase 1,Interventional,Australia,"An interventional study to evaluate the safety and immune response of a vaccine against Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2, the virus that causes COVID-19 infection) when given to healthy adult participants.",ATMP,Vaccine,Vaccine,120,https://anzctr.org.au/ACTRN12620000674932.aspx,None
1807,3167,ACTRN12620000676910,ANZCTR,2020-06-15,2020-06-29,False,Monash Health,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,Amnion cells for COVID-19 related respiratory failure,ATMP,Cells (amniotic epithelial),Cells (amniotic epithelial),40,https://anzctr.org.au/ACTRN12620000676910.aspx,None
1808,3168,ISRCTN89951424,ISRCTN,2020-06-11,2020-06-15,False,University of Oxford,Recruiting,Phase 3,Interventional,Brazil,A phase III study to investigate a vaccine against COVID-19,ATMP,Vaccine,Vaccine,2000,http://isrctn.com/ISRCTN89951424,None
1809,3170,ISRCTN94091479,ISRCTN,2020-06-09,2020-06-15,False,"Tees, Esk and Wear Valleys NHS Foundation Trust",Recruiting,Not Applicable,Interventional,United Kingdom,Behavioural Activation in Social IsoLation (BASIL): Benefiting from activities to improve your mood while you are socially isolating,Other (psych),Psychological,Psychological,100,http://isrctn.com/ISRCTN94091479,None
1810,3171,ISRCTN33578935,ISRCTN,2020-06-02,2020-06-01,True,Kimera Labs,Recruiting,Phase 2,Interventional,Germany,To study the treatment of COVID-19 with severe viral pneumonia by using purified stem cell exosomes,ATMP,Cells (mesenchymal),Cells (mesenchymal),64,http://isrctn.com/ISRCTN33578935,None
1811,3172,ISRCTN40302986,ISRCTN,2020-05-26,2020-06-22,False,Lagos University Teaching Hospital,Recruiting,Phase 3,Interventional,Nigeria,Does ivermectin cure and/or prevent COVID-19?,Drug (+ Chemoprophylaxis),Ivermectin,Ivermectin,45,http://isrctn.com/ISRCTN40302986,None
1812,3173,ISRCTN21363594,ISRCTN,2020-05-18,2020-05-01,True,King Saud Medical City,Recruiting,Not Applicable,Interventional,"Oman, United Arab Emirates, Saudi Arabia",Therapeutic plasma exchange (removal of the non-cell portion of blood) in critically ill adult patients with serious SARS CoV-2 disease (COVID-19),ATMP,Plasma,Plasma,80,http://isrctn.com/ISRCTN21363594,None
1813,3179,ChiCTR2000033936,ChiCTR,2020-06-17,2020-06-16,True,No Sponsor Name Given,Recruiting,Not Applicable,Prevention,China,Psychological Preparedness towards Novel Coronavirus Precautionary Measures  an online survey,Other (psych),No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=55291,None
1814,3183,EUCTR2020-001243-15-BE,EU Clinical Trials Register,2020-03-27,2020-03-26,True,UZ Leuven,Not Recruiting,Phase 2,Interventional,Belgium,"Covid-19: A randomized, open-label, adaptive, proof-of- concept clinical trial of new antiviral drug candidates against SARS-CoV-2.",Drug,Itraconazole,Itraconazole,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001243-15,None
1815,3184,EUCTR2020-001411-25-DE,EU Clinical Trials Register,2020-04-01,2020-05-18,False,Karyopharm Therapeutics Inc,Authorised,Phase 2,Interventional,"Canada, Belgium, Australia, United States, United Kingdom, Italy, France, Germany, Malaysia, Austria, Israel, Spain, India",A Phase 2 Randomized Single-Blind Study to Evaluate the Activity and Safety of Low Dose Oral Selinexor (KPT-330) in Patients with Severe COVID-19 Infection,Drug,Selinexor,Selinexor,230,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25,None
1816,3185,EUCTR2020-001636-95-GB,EU Clinical Trials Register,2020-05-04,2020-05-20,False,University of Manchester,Authorised,Phase 2,Interventional,United Kingdom,Does subcutaneously(SC) administered of anakinra achieve good penetration in blood and result in reduce inflammation in patients with SARS-CoV-19?,Drug,Anakinra,Anakinra,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001636-95,None
1817,3186,EUCTR2020-002293-28-SE,EU Clinical Trials Register,2020-05-13,2020-05-29,False,Karolinska University Hospital,Authorised,Phase 2,Interventional,Sweden,"Treatment with Omega-3 polyunsaturated fatty acids in COVID-19 patients.

A single-blind, randomized, placebo-controlled feasibility study.",Drug,Omega 3,Omega 3,20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002293-28,None
1818,3187,EUCTR2020-001889-10-GB,EU Clinical Trials Register,2020-05-15,2020-06-02,False,University of Oxford,Authorised,Phase 2,Interventional,United Kingdom,Treating COVID-19 infections with inhaled corticosteroids,Drug,Budesonide,Budesonide,478,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001889-10,None
1819,3188,EUCTR2020-002120-37-GB,EU Clinical Trials Register,2020-06-08,2020-06-16,False,Thirty Respiratory Limited,Authorised,Phase 2/Phase 3,Interventional,"United States, Netherlands, United Kingdom, France, Germany, Italy, Spain","An open-label, adaptive randomized, controlled multicenter study to evaluate the efficacy and safety of RESP301+SOC vs SOC in hospitalized participants with COVID-19 requiring supplemental oxygen",Drug,Sodium Nitrite,Sodium Nitrite,300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002120-37,None
1820,3189,EUCTR2020-002233-15-DE,EU Clinical Trials Register,2020-05-13,2020-06-17,False,Charit Research Organisation GmbH,Authorised,Phase 2,Interventional,Germany,"A study to investigate the safety and efficacy of two approved drugs, niclosamide and camostat, administered alone and in combination and compared to placebo in COVID-19 patients",Drug,Niclosamide vs. Camostat Mesilate vs. Niclosamide + Camostat Mesilate,Niclosamide; Camostat Mesilate,72,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002233-15,None
1821,3190,EUCTR2020-001784-88-FI,EU Clinical Trials Register,2020-04-17,2020-04-29,False,University of Helsinki,Authorised,Phase 3,Interventional,Finland,"A clinical study to evaluate the efficacy of different anti-viral drugs in
SARS-CoV-2 infected patients (COVID-19)",Drug,"Oxiklorin, Hydroxychloroquine, Remdesivir","Oxiklorin, Hydroxychloroquine, Remdesivir",582,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001784-88,None
1822,3191,EUCTR2020-001497-30-GB,EU Clinical Trials Register,2020-04-27,2020-05-07,False,Alexion Pharmaceuticals,Authorised,Phase 3,Interventional,"United States, United Kingdom, Italy, France, Germany, Spain",ravulizumab for the treatment of patients with Coronavirus Disease 2019,Drug,Ravulizumab,Ravulizumab,270,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001497-30,None
1823,3192,EUCTR2020-001736-95-GB,EU Clinical Trials Register,2020-04-23,2020-04-28,False,University Hospital Southampton NHS Foundation Trust,Authorised,Phase 2,Interventional,United Kingdom,A Phase 2 Study for the Treatment of COVID 19 in Hospitalised Patients,Drug (+ ATMP),"Bemcentinib, Immunoglobulin, Acalabrutinib, Zilucoplan, Heparin",Bemcentinib; Immunoglobulin; Acalabrutinib; Zilucoplan; Heparin,825,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001736-95,None
1824,3193,NCT04244591,ClinicalTrials.gov,2020-01-23,2020-01-26,False,Peking Union Medical College Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,China,Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure,Drug,Corticosteroids,Methylprednisolone,80,https://clinicaltrials.gov/show/NCT04244591,None
1825,3194,NCT04285190,ClinicalTrials.gov,2020-02-19,2020-02-26,False,"Tasly Pharmaceuticals, Inc.",Not Recruiting,Not Applicable,Interventional,No Country Given,The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,0,https://clinicaltrials.gov/show/NCT04285190,None
1826,3195,NCT04303299,ClinicalTrials.gov,2020-02-24,2020-07-15,False,Rajavithi Hospital,Not Recruiting,Phase 3,Interventional,Thailand,"Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Hydroxychloroquine for Treatment of COVID-19 : A Randomized Control Trial",Drug,"Various Combinations of: Oseltamivir, Chloroquine, Lopipinavir/Ritonavir, Darunavir/ritonavir, Favipiravir",Oseltamivir; Hydroxychloroquine; Lopinavir; Ritonavir; Darunavir; Favipiravir,320,https://clinicaltrials.gov/show/NCT04303299,None
1827,3196,NCT04311177,ClinicalTrials.gov,2020-03-13,2020-04-09,False,University of Minnesota,Recruiting,Phase 2,Interventional,United States,Losartan for Patients With COVID-19 Not Requiring Hospitalization,Drug,ARB (Losartan),ARB (Losartan),580,https://clinicaltrials.gov/show/NCT04311177,None
1828,3197,NCT04312009,ClinicalTrials.gov,2020-03-13,2020-04-13,False,University of Minnesota,Recruiting,Phase 2,Interventional,United States,Losartan for Patients With COVID-19 Requiring Hospitalization,Drug,ARB (Losartan),ARB (Losartan),200,https://clinicaltrials.gov/show/NCT04312009,None
1829,3198,NCT04312243,ClinicalTrials.gov,2020-03-15,2020-04-07,False,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,NO Prevention of COVID-19 for Healthcare Providers,Drug,Nitric oxide,Nitric oxide,470,https://clinicaltrials.gov/show/NCT04312243,None
1830,3199,NCT04333914,ClinicalTrials.gov,2020-04-01,2020-04-15,True,Centre Leon Berard,Not Recruiting,Phase 2,Interventional,France,Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection,Drug,Chloroquine + Nivolumab + Tocilizumab,Chloroquine; Nivolumab; Tocilizumab,384,https://clinicaltrials.gov/show/NCT04333914,EUCTR2020-001373-70
1831,3200,NCT04340414,ClinicalTrials.gov,2020-03-03,2020-02-20,True,Peking Union Medical College Hospital,Recruiting,Not Applicable,Interventional,China,Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP,Drug,Oxygen,Oxygen,10,https://clinicaltrials.gov/show/NCT04340414,None
1832,3202,NCT04346446,ClinicalTrials.gov,2020-04-14,2020-04-20,False,"Institute of Liver and Biliary Sciences, India",Not Recruiting,Phase 2,Interventional,India,Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients,ATMP,Plasma,Plasma,29,https://clinicaltrials.gov/show/NCT04346446,None
1833,3204,NCT04353128,ClinicalTrials.gov,2020-04-16,2020-04-20,False,Instituto de Investigacin Hospital Universitario La Paz,Recruiting,Phase 2/Phase 3,Interventional,Spain,Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.,Drug (Chemoprophylaxis),Melatonin,Melatonin,450,https://clinicaltrials.gov/show/NCT04353128,None
1834,3207,NCT04369066,ClinicalTrials.gov,2020-04-27,2020-04-28,False,Institut Curie,Recruiting,Not Applicable,Interventional,France,"COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie",Clinical Presentation,No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04369066,None
1835,3208,NCT04370262,ClinicalTrials.gov,2020-04-27,2020-04-07,True,Northwell Health,Recruiting,Phase 3,Interventional,United States,Multi-site Adaptive Trials for COVID-19,Drug,Hydroxychloroquine + Famotidine vs. Hydroxychloroquine,Hydroxychloroquine; Famotidine,942,https://clinicaltrials.gov/show/NCT04370262,None
1836,3209,NCT04371029,ClinicalTrials.gov,2020-04-28,2020-04-28,False,"University Hospital, Bordeaux",Recruiting,Not Applicable,Interventional,France,Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS,Other,Polysomnography,Polysomnography,25,https://clinicaltrials.gov/show/NCT04371029,None
1837,3211,NCT04376814,ClinicalTrials.gov,2020-05-03,2020-03-29,True,Baqiyatallah Medical Sciences University,Not Recruiting,Not Applicable,Interventional,Iran,Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19,Drug,Favipiravir + Hydroxychloroquine vs. Lopinavir/ritonavir + Hydroxychloroquine,Favipiravir; Hydroxychloroquine; Lopinavir/ritonavir,40,https://clinicaltrials.gov/show/NCT04376814,None
1838,3212,NCT04382053,ClinicalTrials.gov,2020-05-08,2020-05-27,True,Novartis Pharmaceuticals,Recruiting,Phase 2,Interventional,"Denmark, Hungary, Germany",Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia,Drug,DFV890,DFV890,120,https://clinicaltrials.gov/show/NCT04382053,EUCTR2020-001870-32
1839,3213,NCT04383535,ClinicalTrials.gov,2020-05-06,2020-05-15,False,Hospital Italiano de Buenos Aires,Recruiting,Not Applicable,Interventional,Argentina,Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia,ATMP,Plasma,Plasma,333,https://clinicaltrials.gov/show/NCT04383535,None
1840,3217,NCT04387409,ClinicalTrials.gov,2020-05-11,2020-05-25,False,Vakzine Projekt Management GmbH,Recruiting,Phase 3,Interventional,Germany,Study to Assess VPM1002 in Reducing Healthcare Professionals' Absenteeism in COVID-19 Pandemic,Drug,VPM1002,VPM1002,1200,https://clinicaltrials.gov/show/NCT04387409,None
1841,3218,NCT04388709,ClinicalTrials.gov,2020-05-12,2020-09-01,False,Icahn School of Medicine at Mount Sinai,Not Recruiting,Phase 2,Interventional,United States,Interferon Lambda Therapy for COVID-19,Drug,Interferon lambda,Interferon lambda,66,https://clinicaltrials.gov/show/NCT04388709,None
1842,3220,NCT04391140,ClinicalTrials.gov,2020-05-10,2020-05-13,False,Vall d'Hebron Research Institute (VHIR),Recruiting,Not Applicable,Interventional,Spain,Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS,Procedure,Positioning,Positioning,248,https://clinicaltrials.gov/show/NCT04391140,None
1843,3221,NCT04394455,ClinicalTrials.gov,2020-05-03,2020-06-15,False,Universidad Nacional Autnoma de Honduras,Not Recruiting,Not Applicable,Interventional,Honduras,Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms,Other (psych),Psychological,Psychological,236,https://clinicaltrials.gov/show/NCT04394455,None
1844,3222,NCT04395716,ClinicalTrials.gov,2020-05-19,2020-06-01,False,ProgenaBiome,Not Recruiting,Phase 1,Interventional,United States,A Study of ResCure to Treat COVID-19 Infection,Drug,Unspecified Therapy,Unspecified Therapy,50,https://clinicaltrials.gov/show/NCT04395716,None
1845,3223,NCT04397562,ClinicalTrials.gov,2020-05-19,2020-04-29,True,Biocad,Not Recruiting,Phase 3,Interventional,Russian Federation,A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19,Drug,Levilimab,Levilimab,204,https://clinicaltrials.gov/show/NCT04397562,None
1846,3227,NCT04402944,ClinicalTrials.gov,2020-05-12,2020-06-18,False,Boston Children's Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Pulmozyme to Improve COVID-19 ARDS Outcomes,Drug,Dornase alfa,Dornase alfa,60,https://clinicaltrials.gov/show/NCT04402944,None
1847,3228,NCT04402957,ClinicalTrials.gov,2020-05-12,2020-07-01,False,Arch Biopartners Inc.,Not Recruiting,Phase 2,Interventional,No Country Given,LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19),Drug,LSALT peptide,LSALT peptide,60,https://clinicaltrials.gov/show/NCT04402957,None
1848,3230,NCT04412057,ClinicalTrials.gov,2020-05-29,2020-06-09,False,Aevi Genomic Medicine,Recruiting,Phase 2,Interventional,United States,Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury,Drug,CERC-002,CERC-002,82,https://clinicaltrials.gov/show/NCT04412057,None
1849,3235,NCT04421404,ClinicalTrials.gov,2020-06-03,2020-06-08,False,Dr. Priscilla Hsue,Recruiting,Phase 2,Interventional,United States,Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04421404,None
1850,3241,NCT04425252,ClinicalTrials.gov,2020-06-09,2020-06-12,False,"Clear Creek Bio, Inc.",Not Recruiting,Phase 1/Phase 2,Interventional,United States,Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19,Drug,Brequinar,Brequinar,24,https://clinicaltrials.gov/show/NCT04425252,None
1851,3244,NCT04427865,ClinicalTrials.gov,2020-06-10,2020-07-01,False,Cairo University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Utility of Lactoferrin as a Preventive Agent for Healthcare Workers Exposed to COVID-19,Drug (Chemoprophylaxis),Lactoferrin,Lactoferrin,200,https://clinicaltrials.gov/show/NCT04427865,None
1852,3245,NCT04427878,ClinicalTrials.gov,2020-06-10,2020-07-01,False,CHU de Nice,Not Recruiting,Not Applicable,Interventional,France,Is Adipose Tissue a Reservoir for SARS-Cov2 Spread in Covid-19 Patients?,Clinical Presentation,No Intervention,No Intervention,5,https://clinicaltrials.gov/show/NCT04427878,None
1853,3246,NCT04428268,ClinicalTrials.gov,2020-04-26,2020-03-10,True,Hospital Universitario Dr. Jose E. Gonzalez,Recruiting,Phase 2,Interventional,Mexico,Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia,Drug,Chloroquine vs. Chloroquine + Losartan,Chloroquine; Losartan,20,https://clinicaltrials.gov/show/NCT04428268,None
1854,3247,NCT04429334,ClinicalTrials.gov,2020-05-29,2020-06-01,False,Inotrem,Not Recruiting,Phase 2,Interventional,France,"Safety, Tolerability and Efficacy of Nangibotide in Mechanically Ventilated Patients With COVID-19 and Features of Systemic Inflammation",Drug,Nangibotide,Nangibotide,60,https://clinicaltrials.gov/show/NCT04429334,None
1855,3248,NCT04429555,ClinicalTrials.gov,2020-06-09,2020-07-31,False,MediciNova,Not Recruiting,Phase 2,Interventional,No Country Given,"Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS",Drug,Ibudilast,Ibudilast,40,https://clinicaltrials.gov/show/NCT04429555,None
1856,3249,NCT04429711,ClinicalTrials.gov,2020-05-24,2020-05-12,True,Sheba Medical Center,Recruiting,Not Applicable,Interventional,Israel,Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19,Drug,Ivermectin,Ivermectin,100,https://clinicaltrials.gov/show/NCT04429711,None
1857,3250,NCT04429724,ClinicalTrials.gov,2020-06-10,2020-06-01,True,Tourcoing Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Health Professional Exposure Assessment to Covid-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,6000,https://clinicaltrials.gov/show/NCT04429724,None
1858,3252,NCT04429828,ClinicalTrials.gov,2020-06-11,2020-06-13,False,University of Nottingham,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Psychological Wellbeing for Healthcare Students,Other (psych),Psychological,Psychological,45,https://clinicaltrials.gov/show/NCT04429828,None
1859,3253,NCT04429867,ClinicalTrials.gov,2020-06-10,2020-05-07,True,WellStar Health System,Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease,Drug,Hydroxychloroquine,Hydroxychloroquine,700,https://clinicaltrials.gov/show/NCT04429867,None
1860,3255,NCT04430608,ClinicalTrials.gov,2020-05-26,2020-05-25,True,"Copenhagen University Hospital, North Zealand",Recruiting,Not Applicable,Interventional,Denmark,Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients,Other (device),Biosensors,Biosensors,72,https://clinicaltrials.gov/show/NCT04430608,None
1861,3256,NCT04431180,ClinicalTrials.gov,2020-06-12,2020-06-13,False,Guangzhou Blood Center,Recruiting,Not Applicable,Interventional,China,Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial#,Other,Other,Other,403535,https://clinicaltrials.gov/show/NCT04431180,None
1862,3258,NCT04431297,ClinicalTrials.gov,2020-06-12,2020-06-01,True,Icahn School of Medicine at Mount Sinai,Not Recruiting,Not Applicable,Interventional,United States,Virtual Mindfulness Rounds in the Time of COVID-19 Pandemic,Other (psych),Psychological,Psychological,30,https://clinicaltrials.gov/show/NCT04431297,None
1863,3260,NCT04431453,ClinicalTrials.gov,2020-06-08,2020-06-01,False,Gilead Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19)",Drug,Remdesivir,Remdesivir,52,https://clinicaltrials.gov/show/NCT04431453,EUCTR2020-001803-17
1864,3261,NCT04431466,ClinicalTrials.gov,2020-06-10,2020-07-01,False,Federal University of So Carlos,Not Recruiting,Phase 2,Interventional,Brazil,A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19,Drug,Ivermectin,Ivermectin,64,https://clinicaltrials.gov/show/NCT04431466,None
1865,3262,NCT04431856,ClinicalTrials.gov,2020-06-12,2020-05-15,True,University of Miami,Recruiting,Not Applicable,Interventional,United States,CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment,Other (psych),Psychological,Psychological,68,https://clinicaltrials.gov/show/NCT04431856,None
1866,3264,NCT04432272,ClinicalTrials.gov,2020-06-12,2020-06-01,True,William Beaumont Hospitals,Not Recruiting,Phase 2,Interventional,United States,ANTIBODY-LEVEL BASED ANALYSIS OF COVID CONVALESCENT SERUM (ABACCuS),ATMP,Plasma,Plasma,500,https://clinicaltrials.gov/show/NCT04432272,None
1867,3265,NCT04432324,ClinicalTrials.gov,2020-06-12,2020-06-01,True,"Grifols, S.A.",Not Recruiting,Phase 2,Interventional,Spain,Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19),ATMP,Immunoglobulin,Immunoglobulin,100,https://clinicaltrials.gov/show/NCT04432324,EUCTR2020-001696-32
1868,3270,NCT04434131,ClinicalTrials.gov,2020-06-09,2020-04-28,True,University of New Mexico,Recruiting,Phase 2,Interventional,United States,Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04434131,None
1869,3274,NCT04269525,ClinicalTrials.gov,2020-02-07,2020-02-06,True,ZhiYong Peng,Recruiting,Phase 2,Interventional,China,Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),16,https://clinicaltrials.gov/show/NCT04269525,None
1870,3275,NCT04288102,ClinicalTrials.gov,2020-02-24,2020-03-05,False,Beijing 302 Hospital,Not Recruiting,Phase 2,Interventional,China,Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),100,https://clinicaltrials.gov/show/NCT04288102,None
1871,3276,NCT04304053,ClinicalTrials.gov,2020-03-05,2020-03-18,True,Fundaci Lluita contra la SIDA,Not Recruiting,Phase 3,Interventional,Spain,Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention,Drug (Chemoprophylaxis),Darunavir + cobicistat + hydroxychloroquine,Darunavir; cobicistat; hydroxychloroquine,2250,https://clinicaltrials.gov/show/NCT04304053,EUCTR2020-001031-27
1872,3277,NCT04308668,ClinicalTrials.gov,2020-03-11,2020-03-17,False,University of Minnesota,Not Recruiting,Phase 3,Interventional,"United States, Canada",Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1309,https://clinicaltrials.gov/show/NCT04308668,None
1873,3278,NCT04312997,ClinicalTrials.gov,2020-03-16,2020-06-16,False,"Pulmotect, Inc.",Recruiting,Phase 2,Interventional,United States,The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection,Drug,"PUL-042, unspecified immunomodulatory drug",PUL-042 (unspecified immunomodulatory drug),100,https://clinicaltrials.gov/show/NCT04312997,None
1874,3279,NCT04313023,ClinicalTrials.gov,2020-03-16,2020-06-09,False,"Pulmotect, Inc.",Recruiting,Phase 2,Interventional,United States,The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2,Drug,"PUL-042, unspecified immunomodulatory drug",PUL-042 (unspecified immunomodulatory drug),200,https://clinicaltrials.gov/show/NCT04313023,None
1875,3286,NCT04323800,ClinicalTrials.gov,2020-03-24,2020-06-10,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Stem Coronavirus (CSSC-001),ATMP,Plasma,Plasma,487,https://clinicaltrials.gov/show/NCT04323800,None
1876,3287,NCT04324463,ClinicalTrials.gov,2020-03-25,2020-04-21,False,Population Health Research Institute,Recruiting,Phase 3,Interventional,Canada,Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial,Drug,Chloroquine + azithromycin,Chloroquine; azithromycin,4000,https://clinicaltrials.gov/show/NCT04324463,None
1877,3289,NCT04328285,ClinicalTrials.gov,2020-03-25,2020-04-14,True,CHU de Saint Etienne,Not Recruiting,Phase 3,Interventional,France,Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1200,https://clinicaltrials.gov/show/NCT04328285,EUCTR2020-001188-96
1878,3290,NCT04329533,ClinicalTrials.gov,2020-03-26,2020-04-13,False,University of Arizona,Recruiting,Not Applicable,Interventional,United States,Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic,Other (psych),Psychological,Psychological,150,https://clinicaltrials.gov/show/NCT04329533,None
1879,3291,NCT04329611,ClinicalTrials.gov,2020-03-29,2020-04-13,False,Dr. Michael Hill,Not Recruiting,Phase 3,Interventional,Canada,ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease,Drug,Hydroxychloroquine,Hydroxychloroquine,1660,https://clinicaltrials.gov/show/NCT04329611,None
1880,3292,NCT04331366,ClinicalTrials.gov,2020-03-31,2020-04-08,False,Emory University,Recruiting,Not Applicable,Interventional,United States,Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19,Other (device),Bidirectional Oxygenation Valve,Bidirectional Oxygenation Valve,5,https://clinicaltrials.gov/show/NCT04331366,None
1881,3293,NCT04331899,ClinicalTrials.gov,2020-03-27,2020-04-24,False,Stanford University,Recruiting,Phase 2,Interventional,United States,Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19,Drug,Interferon lambda,Interferon lambda,120,https://clinicaltrials.gov/show/NCT04331899,None
1882,3294,NCT04332991,ClinicalTrials.gov,2020-03-31,2020-04-02,False,Massachusetts General Hospital,Not Recruiting,Phase 3,Interventional,United States,Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease,Drug,Hydroxychloroquine,Hydroxychloroquine,479,https://clinicaltrials.gov/show/NCT04332991,None
1883,3295,NCT04335136,ClinicalTrials.gov,2020-04-01,2020-04-30,True,Apeiron Biologics,Recruiting,Phase 2,Interventional,"Denmark, Austria, Germany",Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,Drug,ACE enzyme,ACE enzyme,200,https://clinicaltrials.gov/show/NCT04335136,EUCTR2020-001172-15
1884,3296,NCT04337918,ClinicalTrials.gov,2020-04-06,2020-05-08,False,Sanotize Research and Development corp.,Recruiting,Phase 2,Interventional,Canada,Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection,Drug,Nitric oxide,Nitric oxide,200,https://clinicaltrials.gov/show/NCT04337918,None
1885,3298,NCT04341285,ClinicalTrials.gov,2020-03-30,2020-08-01,False,"University Hospital, Tbingen",Not Recruiting,Not Applicable,Interventional,Germany,Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID),Drug,Oxygen,Oxygen,200,https://clinicaltrials.gov/show/NCT04341285,None
1886,3299,NCT04341688,ClinicalTrials.gov,2020-04-06,2020-08-01,False,Aga Khan University,Not Recruiting,Not Applicable,Interventional,No Country Given,A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients,Drug,Mouthwash,Mouthwash,50,https://clinicaltrials.gov/show/NCT04341688,None
1887,3300,NCT04342689,ClinicalTrials.gov,2020-04-08,2020-06-03,False,Yale University,Recruiting,Phase 3,Interventional,United States,The Role of Resistant Starch in COVID-19 Infection,Supplement,Resistant Potato Starch,Resistant Potato Starch,1500,https://clinicaltrials.gov/show/NCT04342689,None
1888,3301,NCT04342897,ClinicalTrials.gov,2020-04-10,2020-04-20,False,Eli Lilly and Company,Recruiting,Phase 2,Interventional,United States,A Study of LY3127804 in Participants With COVID-19,Drug,LY3127804,LY3127804,200,https://clinicaltrials.gov/show/NCT04342897,None
1889,3302,NCT04343261,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Saint Francis Care,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma in the Treatment of COVID 19,ATMP,Plasma,Plasma,47,https://clinicaltrials.gov/show/NCT04343261,None
1890,3303,NCT04343729,ClinicalTrials.gov,2020-04-09,2020-04-18,False,Fundao de Medicina Tropical Dr. Heitor Vieira Dourado,Not Recruiting,Phase 2,Interventional,Brazil,Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19,Drug,Corticosteroids,Methylprednisolone,425,https://clinicaltrials.gov/show/NCT04343729,None
1891,3304,NCT04343976,ClinicalTrials.gov,2020-04-09,2020-06-22,False,Raymond Chung,Recruiting,Phase 2,Interventional,United States,Pegylated Interferon Lambda Treatment for COVID-19,Drug,Interferon lambda,Interferon lambda,20,https://clinicaltrials.gov/show/NCT04343976,None
1892,3305,NCT04344561,ClinicalTrials.gov,2020-04-10,2020-05-25,False,Johns Hopkins University,Recruiting,Not Applicable,Interventional,United States,Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation,Procedure,Positioning,Positioning,70,https://clinicaltrials.gov/show/NCT04344561,None
1893,3306,NCT04344587,ClinicalTrials.gov,2020-04-08,2020-04-23,False,Boston University,Recruiting,Not Applicable,Interventional,United States,Awake Prone Position for Early Hypoxemia in COVID-19,Procedure,Positioning,Positioning,560,https://clinicaltrials.gov/show/NCT04344587,None
1894,3307,NCT04345419,ClinicalTrials.gov,2020-04-11,2020-06-16,False,Tanta University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,A Real-life Experience on Treatment of Patients With COVID 19,Drug,Chloroquine vs. Favipiravir vs. Nitazoxanide vs. Ivermectin vs. Niclosamide,Chloroquine; Favipiravir; Nitazoxanide; Ivermectin; Niclosamide,120,https://clinicaltrials.gov/show/NCT04345419,None
1895,3309,NCT04346355,ClinicalTrials.gov,2020-04-12,2020-03-31,True,Azienda Unita Sanitaria Locale Reggio Emilia,Not Recruiting,Phase 2,Interventional,Italy,Efficacy of Early Administration of Tocilizumab in COVID-19 Patients,Drug,Tocilizumab,Tocilizumab,126,https://clinicaltrials.gov/show/NCT04346355,EUCTR2020-001386-37
1896,3310,NCT04346615,ClinicalTrials.gov,2020-04-09,2020-04-25,False,"Biohaven Pharmaceuticals, Inc.",Recruiting,Phase 2/Phase 3,Interventional,United States,Safety and Efficacy Trial of Vazegepant Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen,Drug,Vazegepant,Vazegepant,120,https://clinicaltrials.gov/show/NCT04346615,None
1897,3311,NCT04347954,ClinicalTrials.gov,2020-04-13,2020-06-11,False,Stanford University,Recruiting,Phase 1/Phase 2,Interventional,United States,PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19),Drug,Povidone Iodine,Povidone Iodine,45,https://clinicaltrials.gov/show/NCT04347954,None
1898,3312,NCT04349241,ClinicalTrials.gov,2020-04-13,2020-04-18,False,Ain Shams University,Not Recruiting,Phase 3,Interventional,Egypt,Efficacy and Safety of Favipiravir in Management of COVID-19,Drug,Favipiravir,Favipiravir,100,https://clinicaltrials.gov/show/NCT04349241,None
1899,3313,NCT04350593,ClinicalTrials.gov,2020-04-14,2020-04-22,False,Saint Luke's Health System,Recruiting,Phase 3,Interventional,United States,Dapagliflozin in Respiratory Failure in Patients With COVID-19,Drug,Dapagliflozin,Dapagliflozin,900,https://clinicaltrials.gov/show/NCT04350593,None
1900,3314,NCT04351347,ClinicalTrials.gov,2020-04-15,2020-06-16,False,Tanta University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,The Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment,Drug,Chloroquine + Nitazoxanide vs. Chloroquine + Ivermectin vs. Chloroquine ,Chloroquine; Nitazoxanide; Ivermectin,300,https://clinicaltrials.gov/show/NCT04351347,None
1901,3316,NCT04353180,ClinicalTrials.gov,2020-04-10,2020-06-01,False,Kafrelsheikh University,Not Recruiting,Phase 3,Interventional,Egypt,Assessment the Activity Value of 13- Cis-Retinoic Acid (Isotretinoin) in the Treatment of COVID-19 (Randomized),Drug,Isotretinoin,Isotretinoin,1000,https://clinicaltrials.gov/show/NCT04353180,None
1902,3317,NCT04353284,ClinicalTrials.gov,2020-04-16,2020-06-19,False,Yale University,Recruiting,Phase 2,Interventional,United States,Camostat Mesylate in COVID-19 Outpatients,Drug,Camostat Mesilate,Camostat Mesilate,114,https://clinicaltrials.gov/show/NCT04353284,None
1903,3318,NCT04353336,ClinicalTrials.gov,2020-04-15,2020-05-23,False,Tanta University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Efficacay of Chloroquine in COVID-19 Treatment,Drug,Chloroquine,Chloroquine,40,https://clinicaltrials.gov/show/NCT04353336,None
1904,3319,NCT04353674,ClinicalTrials.gov,2020-04-07,2020-04-28,False,Lawson Health Research Institute,Recruiting,Phase 1,Interventional,Canada,Modulation of Hyperinflammation in COVID-19,Other (device),Dialysis,Dialysis,40,https://clinicaltrials.gov/show/NCT04353674,None
1905,3320,NCT04354441,ClinicalTrials.gov,2020-04-14,2020-05-01,False,Sir Mortimer B. Davis - Jewish General Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women,Drug,Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04354441,None
1906,3323,NCT04354805,ClinicalTrials.gov,2020-04-17,2020-07-01,False,Cairo University,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,Administration of Chlorpromazine as a Treatment for COVID-19,Drug,Chlorpromazine,Chlorpromazine,100,https://clinicaltrials.gov/show/NCT04354805,None
1907,3324,NCT04355728,ClinicalTrials.gov,2020-04-13,2020-04-25,False,Camillo Ricordi,Recruiting,Phase 1/Phase 2,Interventional,United States,Use of UC-MSCs for COVID-19 Patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://clinicaltrials.gov/show/NCT04355728,None
1908,3325,NCT04355767,ClinicalTrials.gov,2020-04-17,2020-07-01,False,Stanford University,Not Recruiting,Phase 3,Interventional,United States,Convalescent Plasma in Outpatients With COVID-19,ATMP,Plasma,Plasma,600,https://clinicaltrials.gov/show/NCT04355767,None
1909,3326,NCT04356534,ClinicalTrials.gov,2020-04-15,2020-04-19,False,Royal College of Surgeons in Ireland - Medical University of Bahrain,Recruiting,Not Applicable,Interventional,Bahrain,Convalescent Plasma Trial in COVID -19 Patients,ATMP,Plasma,Plasma,40,https://clinicaltrials.gov/show/NCT04356534,None
1910,3327,NCT04356937,ClinicalTrials.gov,2020-04-19,2020-04-20,False,Massachusetts General Hospital,Recruiting,Phase 3,Interventional,United States,Efficacy of Tocilizumab on Patients With COVID-19,Drug,Tocilizumab,Tocilizumab,278,https://clinicaltrials.gov/show/NCT04356937,None
1911,3328,NCT04357028,ClinicalTrials.gov,2020-04-19,2020-06-16,False,Kasr El Aini Hospital,Recruiting,Phase 3,Interventional,Egypt,Measles Vaccine in HCW,ATMP,Vaccine,Vaccine,200,https://clinicaltrials.gov/show/NCT04357028,None
1912,3331,NCT04357730,ClinicalTrials.gov,2020-04-18,2020-05-14,False,Denver Health and Hospital Authority,Recruiting,Phase 2,Interventional,United States,Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection,Drug,Alteplase,Alteplase,60,https://clinicaltrials.gov/show/NCT04357730,None
1913,3332,NCT04358068,ClinicalTrials.gov,2020-04-20,2020-05-01,False,National Institute of Allergy and Infectious Diseases (NIAID),Not Recruiting,Phase 2,Interventional,"United States, Puerto Rico",Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,2000,https://clinicaltrials.gov/show/NCT04358068,None
1914,3334,NCT04358549,ClinicalTrials.gov,2020-04-16,2020-04-17,False,"Fujifilm Pharmaceuticals U.S.A., Inc.",Recruiting,Phase 2,Interventional,United States,Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19,Drug,Favipiravir,Favipiravir,50,https://clinicaltrials.gov/show/NCT04358549,None
1915,3335,NCT04358835,ClinicalTrials.gov,2020-04-16,2020-09-01,False,Johns Hopkins University,Not Recruiting,Not Applicable,Interventional,No Country Given,Keto-diet for Intubated Critical Care COVID-19,Other (nutrition),Nutrition,Nutrition,15,https://clinicaltrials.gov/show/NCT04358835,None
1916,3336,NCT04359277,ClinicalTrials.gov,2020-04-20,2020-04-21,False,NYU Langone Health,Recruiting,Phase 3,Interventional,United States,A Randomized Trial of Anticoagulation Strategies in COVID-19,Drug,"Enoxaparin, Heparin",Enoxaparin; Heparin,1000,https://clinicaltrials.gov/show/NCT04359277,None
1917,3337,NCT04360824,ClinicalTrials.gov,2020-04-13,2020-05-06,False,University of Iowa,Recruiting,Phase 4,Interventional,United States,Covid-19 Associated Coagulopathy,Drug,Enoxaparin,Enoxaparin,170,https://clinicaltrials.gov/show/NCT04360824,None
1918,3338,NCT04361396,ClinicalTrials.gov,2020-04-22,2020-07-01,False,Centre Hospitalier Ren Dubos,Recruiting,Not Applicable,Interventional,France,Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04361396,None
1919,3339,NCT04361552,ClinicalTrials.gov,2020-04-07,2020-04-07,False,Emory University,Not Recruiting,Phase 3,Interventional,United States,Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection),Drug,Tocilizumab,Tocilizumab,0,https://clinicaltrials.gov/show/NCT04361552,None
1920,3340,NCT04362137,ClinicalTrials.gov,2020-04-22,2020-03-31,False,Novartis Pharmaceuticals,Recruiting,Phase 3,Interventional,"United States, United Kingdom, Italy, Germany, Russian Federation, Spain","Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)",Drug,Ruxolitinib,Ruxolitinib,402,https://clinicaltrials.gov/show/NCT04362137,EUCTR2020-001662-11
1921,3341,NCT04362332,ClinicalTrials.gov,2020-04-20,2020-04-14,True,UMC Utrecht,Not Recruiting,Phase 4,Interventional,Netherlands,"Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19",Drug,Chloroquine vs. hydroxychloroquine,Chloroquine; hydroxychloroquine,25,https://clinicaltrials.gov/show/NCT04362332,None
1922,3343,NCT04363203,ClinicalTrials.gov,2020-04-23,2020-04-30,False,Dr. Salomeh Keyhani,Not Recruiting,Phase 3,Interventional,United States,VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL),Drug,Hydroxychloroquine vs. Azithromycin,Hydroxychloroquine; Azithromycin,300,https://clinicaltrials.gov/show/NCT04363203,None
1923,3344,NCT04363385,ClinicalTrials.gov,2020-04-21,2020-05-15,False,Centre Hospitalier Intercommunal Creteil,Recruiting,Not Applicable,Interventional,France,Collection of Biological Samples With Clinical Characterization of Covid-19 Patients,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04363385,None
1924,3345,NCT04363463,ClinicalTrials.gov,2020-04-22,2020-11-01,False,Centre Hospitalier Rgional d'Orleans,Not Recruiting,Not Applicable,Interventional,France,Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress,Procedure,Positioning,Positioning,400,https://clinicaltrials.gov/show/NCT04363463,None
1925,3346,NCT04363853,ClinicalTrials.gov,2020-04-17,2020-06-01,False,Instituto Nacional de Cancerologa,Recruiting,Phase 2,Interventional,Mexico,Tocilizumab Treatment in Patients With COVID-19,Drug,Tocilizumab,Tocilizumab,200,https://clinicaltrials.gov/show/NCT04363853,None
1926,3347,NCT04364737,ClinicalTrials.gov,2020-04-22,2020-04-17,True,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients,ATMP,Plasma,Plasma,300,https://clinicaltrials.gov/show/NCT04364737,None
1927,3348,NCT04364763,ClinicalTrials.gov,2020-04-20,2020-06-25,False,"Renibus Therapuetics, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study),Drug,Stannous protoporphyrin,Stannous protoporphyrin,252,https://clinicaltrials.gov/show/NCT04364763,None
1928,3349,NCT04364893,ClinicalTrials.gov,2020-04-07,2020-04-06,True,D'Or Institute for Research and Education,Recruiting,Not Applicable,Interventional,Brazil,Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,700,https://clinicaltrials.gov/show/NCT04364893,None
1929,3350,NCT04365101,ClinicalTrials.gov,2020-04-22,2020-05-13,False,Celularity Incorporated,Recruiting,Phase 1/Phase 2,Interventional,United States,Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 (CYNK-001-COVID-19),ATMP,Cells (NK),Cells (NK),86,https://clinicaltrials.gov/show/NCT04365101,None
1930,3351,NCT04365582,ClinicalTrials.gov,2020-04-23,2020-05-07,False,Groupe Hospitalier Paris Saint-Joseph,Recruiting,Phase 3,Interventional,France,OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome,Drug,Hydroxychloroquine vs. Azithromycin vs. Lopinavir/ritonavir,Hydroxychloroquine; Azithromycin; Lopinavir/ritonavir,640,https://clinicaltrials.gov/show/NCT04365582,None
1931,3353,NCT04366791,ClinicalTrials.gov,2020-04-24,2020-04-23,True,Emory University,Recruiting,Phase 1/Phase 2,Interventional,United States,Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19,Other,Radiation,Radiation,10,https://clinicaltrials.gov/show/NCT04366791,None
1932,3357,NCT04368923,ClinicalTrials.gov,2020-04-24,2020-03-15,True,Cairo University,Not Recruiting,Not Applicable,Interventional,Egypt,Management of Covid-19 Patients During Home Isolation,Drug,Oxygen,Oxygen,60,https://clinicaltrials.gov/show/NCT04368923,None
1933,3358,NCT04369742,ClinicalTrials.gov,2020-04-25,2020-04-15,True,NYU Langone Health,Not Recruiting,Phase 2,Interventional,United States,Treating COVID-19 With Hydroxychloroquine (TEACH),Drug,Hydroxychloroquine,Hydroxychloroquine,626,https://clinicaltrials.gov/show/NCT04369742,None
1934,3359,NCT04370834,ClinicalTrials.gov,2020-04-30,2020-05-28,False,National Cancer Institute (NCI),Recruiting,Phase 2,Interventional,United States,Tocilizumab for Patients With Cancer and COVID-19 Disease,Drug,Tocilizumab,Tocilizumab,217,https://clinicaltrials.gov/show/NCT04370834,None
1935,3361,NCT04371393,ClinicalTrials.gov,2020-04-28,2020-04-30,False,Icahn School of Medicine at Mount Sinai,Recruiting,Phase 3,Interventional,United States,MSCs in COVID-19 ARDS,ATMP,Cells (mesenchymal),Cells (mesenchymal),300,https://clinicaltrials.gov/show/NCT04371393,None
1936,3362,NCT04371419,ClinicalTrials.gov,2020-04-28,2020-05-13,False,"National Bureau of Economic Research, Inc.",Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Health Messaging to Underserved Communities,Other,Health Education,Health Education,15475,https://clinicaltrials.gov/show/NCT04371419,None
1937,3365,NCT04371822,ClinicalTrials.gov,2020-04-29,2020-08-01,False,Kafrelsheikh University,Not Recruiting,Phase 1,Interventional,Egypt,Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients,Drug,"SnPP Protoporphyrin, Porphyrin",SnPP Protoporphyrin; Porphyrin,56,https://clinicaltrials.gov/show/NCT04371822,None
1938,3366,NCT04372186,ClinicalTrials.gov,2020-04-29,2020-05-14,False,"Genentech, Inc.",Recruiting,Phase 3,Interventional,"United States, Kenya, Mexico, Peru, South Africa",A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia,Drug,Tocilizumab,Tocilizumab,379,https://clinicaltrials.gov/show/NCT04372186,None
1939,3367,NCT04373460,ClinicalTrials.gov,2020-04-30,2020-06-03,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Limit SARS-CoV-2 Associated Complications,ATMP,Plasma,Plasma,1344,https://clinicaltrials.gov/show/NCT04373460,None
1940,3368,NCT04373707,ClinicalTrials.gov,2020-05-01,2020-05-13,False,CHU de Nancy,Recruiting,Phase 4,Interventional,France,Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19,Drug,Heparin,Heparin,602,https://clinicaltrials.gov/show/NCT04373707,None
1941,3369,NCT04373733,ClinicalTrials.gov,2020-05-01,2020-05-01,True,Chelsea and Westminster Hospital NHS Foundation Trust,Recruiting,Phase 3,Interventional,United Kingdom,Early Intervention in COVID-19: Favipiravir Verses HydroxycholorquiNe & Azithromycin & Zinc vErsEs Standard CaRe,Drug,Favipiravir vs. Hydroxychloroquine + Azithromycin + Zinc,Favipiravir; Hydroxychloroquine; Azithromycin; Zinc,450,https://clinicaltrials.gov/show/NCT04373733,EUCTR2020-001449-38
1942,3371,NCT04375397,ClinicalTrials.gov,2020-05-04,2020-06-06,False,AbbVie,Recruiting,Phase 2,Interventional,United States,Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury,Drug,Ibrutinib,Ibrutinib,46,https://clinicaltrials.gov/show/NCT04375397,None
1943,3373,NCT04376684,ClinicalTrials.gov,2020-05-04,2020-05-28,True,GlaxoSmithKline,Recruiting,Phase 2,Interventional,"United States, United Kingdom, Spain",Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease,Drug,Otilimab,Otilimab,800,https://clinicaltrials.gov/show/NCT04376684,EUCTR2020-001759-42
1944,3375,NCT04377100,ClinicalTrials.gov,2020-05-05,2020-07-01,False,National Institute of Mental Health (NIMH),Not Recruiting,Not Applicable,Interventional,United States,Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses,Other (psych),No Intervention,No Intervention,750,https://clinicaltrials.gov/show/NCT04377100,None
1945,3376,NCT04377334,ClinicalTrials.gov,2020-04-16,2020-08-01,False,"University Hospital, Tbingen",Not Recruiting,Phase 2,Interventional,Germany,Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS),ATMP,Cells (mesenchymal),Cells (mesenchymal),40,https://clinicaltrials.gov/show/NCT04377334,None
1946,3377,NCT04377568,ClinicalTrials.gov,2020-04-30,2020-07-15,False,The Hospital for Sick Children,Not Recruiting,Phase 2,Interventional,Canada,Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04377568,None
1947,3378,NCT04377620,ClinicalTrials.gov,2020-05-04,2020-05-24,False,Incyte Corporation,Recruiting,Phase 3,Interventional,United States,Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT),Drug,Ruxolitinib,Ruxolitinib,500,https://clinicaltrials.gov/show/NCT04377620,None
1948,3380,NCT04380818,ClinicalTrials.gov,2020-05-04,2020-06-05,False,Grupo de Investigacin Clnica en Oncologa Radioterapia (GICOR),Recruiting,Not Applicable,Interventional,Spain,Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19,Other (+ Drug),"Radiation with or without hydroxychloroquine, lopinavir/ritonavir, azithromycin, cortocosteroids, Heparin, oxygen",Radiation; hydroxychloroquine; lopinavir/ritonavir; azithromycin; methylprednisolone; dexamethasone; prednisone; Heparin; oxygen,106,https://clinicaltrials.gov/show/NCT04380818,None
1949,3381,NCT04382586,ClinicalTrials.gov,2020-05-07,2020-06-01,False,BeiGene,Recruiting,Phase 2,Interventional,United States,Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants,Drug,Zanubrutinib,Zanubrutinib,52,https://clinicaltrials.gov/show/NCT04382586,None
1950,3382,NCT04382651,ClinicalTrials.gov,2020-05-08,2020-06-11,False,Novartis Pharmaceuticals,Recruiting,Phase 2,Interventional,United States,Study of Efficacy and Safety of MAS825 in Patients With COVID-19,Drug,MAS825,MAS825,120,https://clinicaltrials.gov/show/NCT04382651,None
1951,3386,NCT04383613,ClinicalTrials.gov,2020-05-05,2020-05-15,False,"St. Michael's Hospital, Toronto",Recruiting,Not Applicable,Interventional,Canada,Prone Positioning for Patients on General Medical Wards With COVID19,Procedure,Positioning,Positioning,350,https://clinicaltrials.gov/show/NCT04383613,None
1952,3389,NCT04386252,ClinicalTrials.gov,2020-05-11,2020-07-01,False,"Aivita Biomedical, Inc.",Not Recruiting,Phase 1/Phase 2,Interventional,United States,Phase Ib-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults,ATMP,Vaccine,Vaccine,180,https://clinicaltrials.gov/show/NCT04386252,None
1953,3390,NCT04386616,ClinicalTrials.gov,2020-05-11,2020-06-02,False,"Genentech, Inc.",Recruiting,Phase 2,Interventional,United States,A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia,Drug,Astegolimab vs. UTTR1147A,Astegolimab; UTTR1147A,300,https://clinicaltrials.gov/show/NCT04386616,None
1954,3392,NCT04387760,ClinicalTrials.gov,2020-05-09,2020-07-14,False,Royal College of Surgeons in Ireland - Medical University of Bahrain,Not Recruiting,Phase 2/Phase 3,Interventional,Bahrain,Favipiravir vs Hydroxychloroquine in COVID -19,Drug,Hydroxychloroquine vs. Favipiravir,Hydroxychloroquine; Favipiravir,150,https://clinicaltrials.gov/show/NCT04387760,None
1955,3394,NCT04388826,ClinicalTrials.gov,2020-05-13,2020-06-18,False,Veru Inc.,Recruiting,Phase 2,Interventional,United States,COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111,Drug,Veru-111,Veru-111,40,https://clinicaltrials.gov/show/NCT04388826,None
1956,3395,NCT04389411,ClinicalTrials.gov,2020-05-13,2020-07-01,False,McGill University,Not Recruiting,Phase 3,Interventional,No Country Given,The COvid-19 Symptom MOntelukast Trial,Drug,Montelukast,Montelukast,600,https://clinicaltrials.gov/show/NCT04389411,None
1957,3396,NCT04389710,ClinicalTrials.gov,2020-04-27,2020-04-15,True,Thomas Jefferson University,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for the Treatment of COVID-19,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04389710,None
1958,3397,NCT04389840,ClinicalTrials.gov,2020-05-13,2020-06-03,False,Chimerix,Recruiting,Phase 2/Phase 3,Interventional,United States,Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure,Drug,Heparin,Heparin,524,https://clinicaltrials.gov/show/NCT04389840,None
1959,3399,NCT04391309,ClinicalTrials.gov,2020-05-14,2020-07-01,False,Implicit Bioscience,Not Recruiting,Phase 2,Interventional,United States,IC14 (Anti-CD14) Treatment in Patients With SARS-CoV-2 (COVID-19),Drug,IC14,IC14,300,https://clinicaltrials.gov/show/NCT04391309,None
1960,3401,NCT04392219,ClinicalTrials.gov,2020-04-29,2020-04-10,True,Ridgeback Biotherapeutics,Recruiting,Phase 1,Interventional,"United States, United Kingdom","COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers",Drug,EIDD-2801,EIDD-2801,130,https://clinicaltrials.gov/show/NCT04392219,None
1961,3402,NCT04392973,ClinicalTrials.gov,2020-05-10,2020-05-21,False,King Abdullah International Medical Research Center,Recruiting,Not Applicable,Interventional,Saudi Arabia,FAvipiravir and HydroxyChloroquine Combination Therapy,Drug,Favipiravir + Hydroxychloroquine,Favipiravir; Hydroxychloroquine,520,https://clinicaltrials.gov/show/NCT04392973,None
1962,3403,NCT04393311,ClinicalTrials.gov,2020-05-15,2020-07-01,False,Stanford University,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients,Drug,Ulinastatin,Ulinastatin,150,https://clinicaltrials.gov/show/NCT04393311,None
1963,3404,NCT04393948,ClinicalTrials.gov,2020-05-15,2020-06-01,False,Brigham and Women's Hospital,Recruiting,Not Applicable,Interventional,United States,Lung Irradiation for COVID-19 Pneumonia,Other,Radiation,Radiation,48,https://clinicaltrials.gov/show/NCT04393948,None
1964,3405,NCT04394117,ClinicalTrials.gov,2020-05-18,2020-06-19,False,The George Institute for Global Health,Recruiting,Phase 4,Interventional,Australia,Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease,Drug,ARBs,ARBs,605,https://clinicaltrials.gov/show/NCT04394117,None
1965,3406,NCT04394377,ClinicalTrials.gov,2020-05-08,2020-06-21,False,Brazilian Clinical Research Institute,Recruiting,Phase 4,Interventional,Brazil,Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial,Drug,Rivaroxaban + Heparin,Rivaroxaban; Heparin,600,https://clinicaltrials.gov/show/NCT04394377,None
1966,3407,NCT04394793,ClinicalTrials.gov,2020-05-17,2020-06-13,False,All India Institute of Medical Sciences,Recruiting,Not Applicable,Interventional,India,Low Dose Radiation Therapy for Covid-19 Pneumonia,Other,Radiation,Radiation,10,https://clinicaltrials.gov/show/NCT04394793,None
1967,3412,NCT04397718,ClinicalTrials.gov,2020-05-14,2020-07-01,False,VA Office of Research and Development,Not Recruiting,Phase 2,Interventional,United States,Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization,Drug,Degarelix,Degarelix,198,https://clinicaltrials.gov/show/NCT04397718,None
1968,3413,NCT04399005,ClinicalTrials.gov,2020-05-19,2020-05-25,False,The First Affiliated Hospital of Zhejiang Chinese Medical University,Not Recruiting,Not Applicable,Interventional,China,The Efficacy Comparing Daily and After-each-case Room Disinfection.,Other,Other,Other,240,https://clinicaltrials.gov/show/NCT04399005,None
1969,3414,NCT04399317,ClinicalTrials.gov,2020-05-18,2020-05-28,False,Hamad Medical Corporation,Recruiting,Not Applicable,Interventional,Qatar,Flow Controlled Ventilation in ARDS Associated With COVID-19,Other (physical),Mechanical ventilation,Mechanical ventilation,20,https://clinicaltrials.gov/show/NCT04399317,None
1970,3415,NCT04399889,ClinicalTrials.gov,2020-05-21,2020-06-18,False,"Joanne Kurtzberg, MD",Recruiting,Phase 1/Phase 2,Interventional,United States,hCT-MSCs for COVID19 ARDS,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04399889,None
1971,3416,NCT04399967,ClinicalTrials.gov,2020-05-19,2020-06-13,False,University of Hong Kong,Recruiting,Not Applicable,Interventional,China,"COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via ""Quit to Win"" Contest 2020",Other,Other,Other,842,https://clinicaltrials.gov/show/NCT04399967,None
1972,3418,NCT04401579,ClinicalTrials.gov,2020-05-22,2020-05-08,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Phase 3,Interventional,"United States, Singapore, Japan, Mexico, South Korea",Adaptive COVID-19 Treatment Trial 2 (ACTT-II),Drug,Baricitinib + Remdesivir vs. Remdesivir,Baricitinib; Remdesivir,1032,https://clinicaltrials.gov/show/NCT04401579,JPRN-jRCT2031200035
1973,3419,NCT04402866,ClinicalTrials.gov,2020-05-22,2020-06-24,True,Theravance Biopharma,Recruiting,Phase 2,Interventional,United Kingdom,TD-0903 for ALI Associated With COVID-19,Drug,TD-0903,TD-0903,159,https://clinicaltrials.gov/show/NCT04402866,EUCTR2020-001807-18
1974,3421,NCT04404361,ClinicalTrials.gov,2020-05-22,2020-05-22,False,CTI BioPharma,Recruiting,Phase 3,Interventional,United States,PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer,Drug,Pacritinib,Pacritinib,358,https://clinicaltrials.gov/show/NCT04404361,None
1975,3422,NCT04405076,ClinicalTrials.gov,2020-05-13,2020-05-29,False,"ModernaTX, Inc.",Recruiting,Phase 2,Interventional,United States,"Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older",ATMP,Vaccine,Vaccine,600,https://clinicaltrials.gov/show/NCT04405076,None
1976,3423,NCT04405570,ClinicalTrials.gov,2020-05-26,2020-06-16,False,Ridgeback Biotherapeutics,Recruiting,Phase 2,Interventional,United States,"A Safety, Tolerability and Efficacy of EIDD-2801 to Eliminate Infectious Virus Detection in Persons With COVID-19",Drug,EIDD-2801,EIDD-2801,44,https://clinicaltrials.gov/show/NCT04405570,None
1977,3424,NCT04405739,ClinicalTrials.gov,2020-05-26,2020-06-16,False,Ridgeback Biotherapeutics,Recruiting,Phase 2,Interventional,United States,The Effect of EIDD-2801 on Viral Shedding of SARS-CoV-2 (COVID-19),Drug,EIDD-2801,EIDD-2801,60,https://clinicaltrials.gov/show/NCT04405739,None
1978,3425,NCT04405908,ClinicalTrials.gov,2020-05-25,2020-06-19,False,Clover Biopharmaceuticals,Recruiting,Phase 1,Interventional,Australia,SCB-2019 as COVID-19 Vaccine,ATMP,Vaccine,Vaccine,150,https://clinicaltrials.gov/show/NCT04405908,None
1979,3426,NCT04405921,ClinicalTrials.gov,2020-05-26,2020-07-01,False,Centre Hpital Universitaire Farhat Hached,Not Recruiting,Phase 3,Interventional,Tunisia,"Hydroxychloroquine, Azithromycin in the Treatment of Covid-19",Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin,200,https://clinicaltrials.gov/show/NCT04405921,None
1980,3427,NCT04405934,ClinicalTrials.gov,2020-05-07,2020-07-01,False,"University College, London",Not Recruiting,Not Applicable,Interventional,No Country Given,COG-UK Project Hospital-Onset COVID-19 Infections Study,Genomics,Genomics,Genomics,2000,https://clinicaltrials.gov/show/NCT04405934,None
1981,3429,NCT04407130,ClinicalTrials.gov,2020-05-17,2020-06-16,False,"International Centre for Diarrhoeal Disease Research, Bangladesh",Recruiting,Phase 2,Interventional,Bangladesh,Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.,Drug,Ivermectin + Doxycycline vs. Ivermectin,Ivermectin; Doxycycline,72,https://clinicaltrials.gov/show/NCT04407130,None
1982,3432,NCT04407689,ClinicalTrials.gov,2020-05-27,2020-06-08,False,Revimmune,Recruiting,Phase 2,Interventional,France,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort,Drug,Interleukin-7,Interleukin-7,48,https://clinicaltrials.gov/show/NCT04407689,None
1983,3434,NCT04409262,ClinicalTrials.gov,2020-05-28,2020-06-16,False,Roche,Recruiting,Phase 3,Interventional,"United States, Brazil",A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia,Drug,Tocilizumab + Remdesivir vs. Remdesivir,Tocilizumab; Remdesivir,450,https://clinicaltrials.gov/show/NCT04409262,None
1984,3435,NCT04409925,ClinicalTrials.gov,2020-05-13,2020-06-01,False,Exactis Innovation,Not Recruiting,Phase 1,Interventional,No Country Given,DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1),Drug,rhDNase I,rhDNase I,25,https://clinicaltrials.gov/show/NCT04409925,None
1985,3436,NCT04410159,ClinicalTrials.gov,2020-05-27,2020-06-22,False,Universiti Sains Islam Malaysia,Recruiting,Phase 2,Interventional,Malaysia,Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients,Drug,Povidone Iodine vs. Essential Oil,Povidone Iodine; Essential Oil,20,https://clinicaltrials.gov/show/NCT04410159,None
1986,3437,NCT04410354,ClinicalTrials.gov,2020-04-28,2020-06-16,False,"ViralClear Pharmaceuticals, Inc.",Recruiting,Phase 2,Interventional,United States,Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19,Drug,Merimepodib + Remdesivir vs. Remdesivir,Merimepodib; Remdesivir,40,https://clinicaltrials.gov/show/NCT04410354,None
1987,3439,NCT04411628,ClinicalTrials.gov,2020-05-29,2020-05-28,True,Eli Lilly and Company,Recruiting,Phase 1,Interventional,United States,A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19,Drug,LY3819253,LY3819253,40,https://clinicaltrials.gov/show/NCT04411628,None
1988,3440,NCT04412291,ClinicalTrials.gov,2020-06-01,2020-06-11,False,Karolinska University Hospital,Recruiting,Phase 2,Interventional,Sweden,"A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study",Drug,Anakinra vs. Tocilizumab,Anakinra; Tocilizumab,120,https://clinicaltrials.gov/show/NCT04412291,None
1989,3442,NCT04412330,ClinicalTrials.gov,2020-05-12,2020-05-01,True,University of Kentucky,Recruiting,Not Applicable,Interventional,United States,Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,20,https://clinicaltrials.gov/show/NCT04412330,None
1990,3443,NCT04412668,ClinicalTrials.gov,2020-06-01,2020-06-12,False,"aTyr Pharma, Inc.",Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19,Drug,ATYR1923,ATYR1923,30,https://clinicaltrials.gov/show/NCT04412668,None
1991,3444,NCT04414267,ClinicalTrials.gov,2020-06-01,2020-05-26,True,Hellenic Institute for the Study of Sepsis,Recruiting,Phase 4,Interventional,Greece,Bacillus Calmette-gurin Vaccination to Prevent COVID-19,ATMP,Vaccine,Vaccine,900,https://clinicaltrials.gov/show/NCT04414267,EUCTR2020-002448-21
1992,3445,NCT04415060,ClinicalTrials.gov,2020-06-02,2020-06-15,False,Sunnybrook Health Sciences Centre,Not Recruiting,Phase 3,Interventional,Canada,SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival,Drug,Isoflurane + Sevoflurane,Isoflurane; Sevoflurane,752,https://clinicaltrials.gov/show/NCT04415060,None
1993,3448,NCT04417257,ClinicalTrials.gov,2020-05-28,2020-06-29,False,Laurent Pharmaceuticals Inc.,Not Recruiting,Phase 2,Interventional,Canada,Study of LAU-7b for the Treatment of COVID-19 Disease in Adults,Drug,LAU-7b,LAU-7b,300,https://clinicaltrials.gov/show/NCT04417257,None
1994,3450,NCT04419610,ClinicalTrials.gov,2020-04-16,2020-07-01,False,Imperial College London,Not Recruiting,Phase 1,Interventional,No Country Given,RAS and Coagulopathy in COVID19,Drug,TRV027,TRV027,60,https://clinicaltrials.gov/show/NCT04419610,None
1995,3451,NCT04420247,ClinicalTrials.gov,2020-06-02,2020-04-16,True,Centro de Estudos e Pesquisa em Emergncias Mdicas e Terapia Intensiva (CEPETI),Recruiting,Phase 3,Interventional,Brazil,Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19,Drug,Chloroquine or Hydroxychloroquine,Chloroquine; Hydroxychloroquine,100,https://clinicaltrials.gov/show/NCT04420247,None
1996,3453,NCT04420338,ClinicalTrials.gov,2020-06-05,2020-06-05,False,Assistance Publique  Hpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,"SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study",Clinical Presentation (Epidemiology),No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04420338,None
1997,3454,NCT04420741,ClinicalTrials.gov,2020-06-04,2020-06-15,True,Par Johansson,Recruiting,Phase 2,Interventional,Denmark,Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure,Drug,Ilopros,Ilopros,80,https://clinicaltrials.gov/show/NCT04420741,EUCTR2020-001296-33
1998,3455,NCT04421027,ClinicalTrials.gov,2020-06-05,2020-06-12,True,Eli Lilly and Company,Recruiting,Phase 3,Interventional,"Brazil, United States, United Kingdom, Italy, Germany, Mexico, Russian Federation, Argentina, Spain",A Study of Baricitinib (LY3009104) in Participants With COVID-19,Drug,Baricitinib,Baricitinib,400,https://clinicaltrials.gov/show/NCT04421027,EUCTR2020-001517-21
1999,3456,NCT04421508,ClinicalTrials.gov,2020-06-05,2020-07-01,False,Bellerophon Pulse Technologies,Not Recruiting,Phase 3,Interventional,United States,A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19,Drug,Nitric Oxide,Nitric Oxide,500,https://clinicaltrials.gov/show/NCT04421508,None
2000,3458,NCT04422561,ClinicalTrials.gov,2020-06-06,2020-05-31,True,Zagazig University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Prophylactic Ivermectin in COVID-19 Contacts,Drug (Chemoprophylaxis),Ivermectin,Ivermectin,100,https://clinicaltrials.gov/show/NCT04422561,None
2001,3461,NCT04425031,ClinicalTrials.gov,2020-06-05,2020-08-01,False,Aalborg University Hospital,Not Recruiting,Phase 4,Interventional,Denmark,Handling Oxygenation Targets in COVID-19,Drug,Oxygen,Oxygen,780,https://clinicaltrials.gov/show/NCT04425031,None
2002,3462,NCT04425629,ClinicalTrials.gov,2020-06-08,2020-06-16,False,Regeneron Pharmaceuticals,Recruiting,Phase 1/Phase 2,Interventional,United States,"Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult Patients With COVID-19",Drug,REGN10933 + REGN10987,REGN10933; REGN10987,1054,https://clinicaltrials.gov/show/NCT04425629,None
2003,3463,NCT04425720,ClinicalTrials.gov,2020-06-02,2020-07-05,False,Montefiore Medical Center,Not Recruiting,Not Applicable,Interventional,United States,Use of Remote Monitoring for COVID-19 Patient,Other (device),Biosensors,Biosensors,300,https://clinicaltrials.gov/show/NCT04425720,None
2004,3467,NCT04426695,ClinicalTrials.gov,2020-06-08,2020-06-10,False,Regeneron Pharmaceuticals,Recruiting,Phase 1/Phase 2,Interventional,United States,"Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19",Drug,REGN10933 vs. REGN10987,REGN10933; REGN10987,1860,https://clinicaltrials.gov/show/NCT04426695,None
2005,3468,NCT04427098,ClinicalTrials.gov,2020-05-29,2020-05-22,False,AOU di Bologna Policlinico S.Orsola-Malpighi,Recruiting,Phase 2,Interventional,Italy,Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients,Drug,Enoxaparin,Enoxaparin,300,https://clinicaltrials.gov/show/NCT04427098,EUCTR2020-001308-40
2006,3469,NCT04427137,ClinicalTrials.gov,2020-06-10,2020-06-09,True,Centre for Addiction and Mental Health,Recruiting,Not Applicable,Interventional,Canada,Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic,Other (psych),Electroconvulsive Therapy,Electroconvulsive Therapy,50,https://clinicaltrials.gov/show/NCT04427137,None
2007,3470,NCT04427501,ClinicalTrials.gov,2020-06-09,2020-06-13,False,Eli Lilly and Company,Recruiting,Phase 2,Interventional,United States,A Study of LY3819253 (LY-CoV555) in Participants With Early Mild to Moderate COVID-19 Illness,Drug,LY3819253,LY3819253,400,https://clinicaltrials.gov/show/NCT04427501,None
2008,3471,NCT04427566,ClinicalTrials.gov,2020-06-05,2020-06-11,False,Ohio State University Comprehensive Cancer Center,Recruiting,Phase 2,Interventional,United States,Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise,Other,Radiation,Radiation,24,https://clinicaltrials.gov/show/NCT04427566,None
2009,3472,NCT04428008,ClinicalTrials.gov,2020-06-07,2020-06-01,True,Inova Health System,Not Recruiting,Phase 2,Interventional,No Country Given,Thymosin Alpha 1 to Prevent COVID-19 Infection in Elderly Renal Dialysis Patients,Drug,Thymalfasin,Thymalfasin,240,https://clinicaltrials.gov/show/NCT04428008,None
2010,3479,NCT04432051,ClinicalTrials.gov,2020-06-11,2020-05-26,True,Gaziosmanpasa Taksim Research and Education Hospital,Recruiting,Not Applicable,Interventional,Turkey,The Use of Lung Ultrasonography in COVID-19 Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04432051,None
2011,3480,NCT04432103,ClinicalTrials.gov,2020-06-12,2020-06-19,False,Centro Medico ABC,Not Recruiting,Phase 3,Interventional,No Country Given,Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma,ATMP,Plasma,Plasma,36,https://clinicaltrials.gov/show/NCT04432103,None
2012,3481,NCT04432298,ClinicalTrials.gov,2020-06-12,2020-06-20,False,FibroGen,Recruiting,Phase 2,Interventional,United States,"Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Patients With Acute COVID-19 Disease",Drug,Pamrevlumab,Pamrevlumab,130,https://clinicaltrials.gov/show/NCT04432298,None
2013,3482,NCT04432766,ClinicalTrials.gov,2020-06-12,2020-07-20,False,Bio-Thera Solutions,Not Recruiting,Phase 1,Interventional,No Country Given,A Phase 1 Study to Assess BAT2020 in Hospitalized Patients Infected With SARS-CoV-2 (COVID-19),Drug,BAT2020,BAT2020,174,https://clinicaltrials.gov/show/NCT04432766,None
2014,3484,NCT04432805,ClinicalTrials.gov,2020-06-15,2020-06-15,False,Assistance Publique  Hpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,160,https://clinicaltrials.gov/show/NCT04432805,None
2015,3488,NCT04432987,ClinicalTrials.gov,2020-06-15,2020-05-25,True,Acibadem University,Recruiting,Phase 2,Interventional,Turkey,Dornase Alpha for the Treatment of COVID-19,Drug,Dornase alfa,Dornase alfa,60,https://clinicaltrials.gov/show/NCT04432987,None
2016,3489,NCT04433013,ClinicalTrials.gov,2020-06-14,2020-07-01,False,Nanyang Technological University,Not Recruiting,Phase 3,Interventional,No Country Given,A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,https://clinicaltrials.gov/show/NCT04433013,None
2017,3491,NCT04433078,ClinicalTrials.gov,2020-06-10,2020-06-22,False,Temple University,Recruiting,Phase 2,Interventional,United States,RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM,Drug,Doxycycline,Doxycycline,20,https://clinicaltrials.gov/show/NCT04433078,None
2018,3496,NCT04433546,ClinicalTrials.gov,2020-05-28,2020-06-26,False,PhaseBio Pharmaceuticals Inc.,Not Recruiting,Phase 2,Interventional,No Country Given,"PB1046, a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).",Drug,PB1046,PB1046,210,https://clinicaltrials.gov/show/NCT04433546,None
2019,3499,NCT04433910,ClinicalTrials.gov,2020-05-06,2020-06-01,True,Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen,Recruiting,Phase 2,Interventional,Germany,A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19,ATMP,Plasma,Plasma,106,https://clinicaltrials.gov/show/NCT04433910,EUCTR2020-001310-38
2020,3500,NCT04433949,ClinicalTrials.gov,2020-06-12,2020-06-12,False,Emory University,Recruiting,Phase 3,Interventional,United States,Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19,Other,Radiation,Radiation,52,https://clinicaltrials.gov/show/NCT04433949,None
2021,3502,NCT04434248,ClinicalTrials.gov,2020-06-13,2020-04-23,True,Chromis LLC,Not Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19,Drug,Favipiravir,Favipiravir,330,https://clinicaltrials.gov/show/NCT04434248,None
2022,3505,NCT04435015,ClinicalTrials.gov,2020-06-16,2020-08-01,False,Yale University,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications,Drug,Camostat Mesilate,Camostat Mesilate,200,https://clinicaltrials.gov/show/NCT04435015,None
2023,3511,NCT04435184,ClinicalTrials.gov,2020-06-16,2020-06-01,True,Johns Hopkins University,Not Recruiting,Phase 2,Interventional,United States,Crizanlizumab for Treating COVID-19 Vasculopathy,Drug,Crizanlizumab,Crizanlizumab,40,https://clinicaltrials.gov/show/NCT04435184,None
2024,3513,NCT04435275,ClinicalTrials.gov,2020-06-09,2020-06-30,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,No Country Given,Virtual Assistant for COVID-19 PPE,Telehealth,Telehealth,Telehealth,50,https://clinicaltrials.gov/show/NCT04435275,None
2025,3514,NCT04435314,ClinicalTrials.gov,2020-06-08,2020-06-01,True,Azidus Brasil,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19,Drug,Nitazoxanide,Nitazoxanide,200,https://clinicaltrials.gov/show/NCT04435314,None
2026,3516,NCT04435353,ClinicalTrials.gov,2020-06-14,2020-03-22,True,Astana Medical University,Recruiting,Not Applicable,Interventional,Kazakhstan,Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19,Other,Vibroacoustic Therapy,Vibroacoustic Therapy,200,https://clinicaltrials.gov/show/NCT04435353,None
2027,3517,NCT04435379,ClinicalTrials.gov,2020-06-16,2020-06-01,True,Vakzine Projekt Management GmbH,Recruiting,Phase 3,Interventional,Germany,Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic,Drug,VPM1002,VPM1002,2038,https://clinicaltrials.gov/show/NCT04435379,EUCTR2020-001675-33
2028,3519,NCT04435587,ClinicalTrials.gov,2020-06-15,2020-07-01,False,Mahidol University,Not Recruiting,Phase 4,Interventional,Thailand,Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection,Drug,Ivermectin vs. Hydroxychloroquine + Darunavir/ritonavir,Ivermectin; Hydroxychloroquine; Darunavir/ritonavir,80,https://clinicaltrials.gov/show/NCT04435587,None
2029,3520,NCT04435717,ClinicalTrials.gov,2020-06-11,2020-05-04,True,Hospital Universitario Ramn y Cajal,Recruiting,Phase 2,Interventional,Spain,Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01),Drug,Tocilizumab,Tocilizumab,78,https://clinicaltrials.gov/show/NCT04435717,None
2030,3521,NCT04435795,ClinicalTrials.gov,2020-06-16,2020-06-25,False,McGill University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Inhaled Ciclesonide for Outpatients With COVID19,Drug,Ciclesonide,Ciclesonide,454,https://clinicaltrials.gov/show/NCT04435795,None
2031,3522,NCT04435808,ClinicalTrials.gov,2020-06-04,2020-04-14,True,University of New Mexico,Recruiting,Phase 1/Phase 2,Interventional,United States,Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,350,https://clinicaltrials.gov/show/NCT04435808,None
2032,3523,NCT04436276,ClinicalTrials.gov,2020-06-15,2020-07-13,False,Janssen Pharmaceutical,Not Recruiting,Phase 1/Phase 2,Interventional,"United States, Belgium",A Study of Ad26COVS1 in Adults,ATMP,Vaccine,Vaccine,1045,https://clinicaltrials.gov/show/NCT04436276,None
2033,3524,NCT04436458,ClinicalTrials.gov,2020-06-16,2020-08-01,False,"First Wave Bio, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,Niclosamide In Moderate COVID-19,Drug,Niclosamide,Niclosamide,100,https://clinicaltrials.gov/show/NCT04436458,None
2034,3525,NCT04436471,ClinicalTrials.gov,2020-06-16,2020-06-17,False,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,"An Open Study of the Safety, Tolerability and Immunogenicity of the Drug ""Gam-COVID-Vac"" Vaccine Against COVID-19",ATMP,Vaccine,Vaccine,38,https://clinicaltrials.gov/show/NCT04436471,None
2035,3529,NCT04437693,ClinicalTrials.gov,2020-06-17,2020-07-01,False,Hamad Medical Corporation,Not Recruiting,Phase 3,Interventional,No Country Given,Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,500,https://clinicaltrials.gov/show/NCT04437693,None
2036,3531,NCT04437719,ClinicalTrials.gov,2020-06-17,2020-06-30,False,Groupe Hospitalier Paris Saint-Joseph,Not Recruiting,Not Applicable,Interventional,France,"Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic",Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04437719,None
2037,3532,NCT04437823,ClinicalTrials.gov,2020-06-17,2020-06-01,True,Jinnah Hospital,Recruiting,Phase 2,Interventional,Pakistan,Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04437823,None
2038,3533,NCT04437875,ClinicalTrials.gov,2020-06-16,2020-06-17,False,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,"An Open Study of the Safety, Tolerability and Immunogenicity of ""Gam-COVID-Vac Lyo"" Vaccine Against COVID-19",ATMP,Vaccine,Vaccine,38,https://clinicaltrials.gov/show/NCT04437875,None
2039,3536,NCT04438057,ClinicalTrials.gov,2020-06-17,2020-07-06,False,Metro Infectious Disease Consultants,Not Recruiting,Phase 2,Interventional,United States,Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19,ATMP,Plasma,Plasma,150,https://clinicaltrials.gov/show/NCT04438057,None
2040,3537,NCT04438070,ClinicalTrials.gov,2020-06-17,2020-04-10,True,St. Joseph's Healthcare Hamilton,Recruiting,Not Applicable,Interventional,Canada,COVID Screening Strategies in Homeless Shelters,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,400,https://clinicaltrials.gov/show/NCT04438070,None
2041,3540,NCT04438694,ClinicalTrials.gov,2020-06-16,2020-06-01,True,Cairo University,Recruiting,Phase 1/Phase 2,Interventional,Egypt,Use of Convalescent Plasma for Treatment of Patients With COVID-19 Infection,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04438694,None
2042,3541,NCT04438837,ClinicalTrials.gov,2020-06-18,2020-06-01,True,Rambam Health Care Campus,Not Recruiting,Not Applicable,Interventional,Israel,Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,582,https://clinicaltrials.gov/show/NCT04438837,None
2043,3542,NCT04438850,ClinicalTrials.gov,2020-04-10,2020-06-01,False,IRCCS Don Calabria Ospedale Sacro Cuore,Not Recruiting,Phase 2,Interventional,"Spain, Italy",COVidIVERmectin: Ivermectin for Treatment of Covid-19,Drug,Ivermectin,Ivermectin,102,https://clinicaltrials.gov/show/NCT04438850,None
2044,3547,NCT04438980,ClinicalTrials.gov,2020-06-18,2020-05-15,True,Fundacin Miguel Servet,Recruiting,Phase 3,Interventional,Spain,Glucocorticoids in COVID-19 (CORTIVID),Drug,Corticosteroids,Methylprednisolone,72,https://clinicaltrials.gov/show/NCT04438980,EUCTR2020-001827-15
2045,3549,NCT04439006,ClinicalTrials.gov,2020-06-17,2020-06-15,True,Jennifer Woyach,Not Recruiting,Phase 2,Interventional,United States,Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization,Drug,Ibrutinib,Ibrutinib,72,https://clinicaltrials.gov/show/NCT04439006,None
2046,3550,NCT04439045,ClinicalTrials.gov,2020-06-03,2020-06-14,False,"University Health Network, Toronto",Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity,Drug,VPM1002,VPM1002,3626,https://clinicaltrials.gov/show/NCT04439045,None
2047,3551,NCT04439071,ClinicalTrials.gov,2020-06-17,2020-06-30,False,PTC Therapeutics,Not Recruiting,Phase 2/Phase 3,Interventional,"United States, Spain",A Study to Evaluate Efficacy and Safety of PTC299 in Hospitalized Participants With Coronavirus (COVID-19),Drug,PTC299,PTC299,380,https://clinicaltrials.gov/show/NCT04439071,None
2048,3553,NCT04440007,ClinicalTrials.gov,2020-06-17,2020-08-01,False,"Sorrento Therapeutics, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) With SOC Versus SOC in Subjects With COVID-19,Drug,Abivertinib,Abivertinib,80,https://clinicaltrials.gov/show/NCT04440007,None
2049,3556,NCT04441385,ClinicalTrials.gov,2020-06-18,2020-06-26,False,Hospital Universitario Infanta Leonor,Not Recruiting,Phase 2,Interventional,Spain,Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19).,Drug,Maraviroc,Maraviroc,200,https://clinicaltrials.gov/show/NCT04441385,None
2050,3557,NCT04441398,ClinicalTrials.gov,2020-06-18,2020-07-01,False,Azidus Brasil,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 Patients,Drug,Nitazoxanide,Nitazoxanide,300,https://clinicaltrials.gov/show/NCT04441398,None
2051,3558,NCT04441424,ClinicalTrials.gov,2020-06-12,2020-04-03,True,Alkarkh Health Directorate-Baghdad,Not Recruiting,Not Applicable,Interventional,Iraq,Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients,ATMP (+ Drug),Plasma + Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Azithromycin,Plasma; Hydroxychloroquine; Azithromycin,49,https://clinicaltrials.gov/show/NCT04441424,None
2052,3561,NCT04441632,ClinicalTrials.gov,2020-06-18,2020-06-15,True,Cedars-Sinai Medical Center,Recruiting,Not Applicable,Interventional,United States,Effect of Positive Attitudes on Behavior and Wellness,Other (psych),Psychological,Psychological,50,https://clinicaltrials.gov/show/NCT04441632,None
2053,3562,NCT04441684,ClinicalTrials.gov,2020-05-20,2020-04-17,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Interventional,France,"Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19)",Clinical Presentation (Epidemiology),No Intervention,No Intervention,1800,https://clinicaltrials.gov/show/NCT04441684,None
2054,3564,NCT04441918,ClinicalTrials.gov,2020-06-06,2020-06-05,True,"Shanghai Junshi Bioscience Co., Ltd.",Recruiting,Phase 1,Interventional,China,"Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects",Drug,JS016,JS016,40,https://clinicaltrials.gov/show/NCT04441918,None
2055,3565,NCT04441996,ClinicalTrials.gov,2020-06-19,2020-07-01,False,Emory University,Not Recruiting,Phase 4,Interventional,United States,Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04441996,None
2056,3566,NCT04442048,ClinicalTrials.gov,2020-06-19,2020-07-01,False,Canadian Cancer Trials Group,Not Recruiting,Phase 3,Interventional,No Country Given,Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure,Drug,IMM-101,IMM-101,1500,https://clinicaltrials.gov/show/NCT04442048,None
2057,3567,NCT04442152,ClinicalTrials.gov,2020-06-19,2020-06-01,True,Promundo,Recruiting,Not Applicable,Interventional,Rwanda,Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants,Other,Other,Other,1000,https://clinicaltrials.gov/show/NCT04442152,None
2058,3569,NCT04442178,ClinicalTrials.gov,2020-06-19,2020-06-30,False,Revimmune,Not Recruiting,Phase 2,Interventional,No Country Given,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ),Drug,Interleukin-7,Interleukin-7,48,https://clinicaltrials.gov/show/NCT04442178,None
2059,3570,NCT04442191,ClinicalTrials.gov,2020-05-11,2020-05-05,True,"University of Illinois, Chicago",Recruiting,Phase 2,Interventional,United States,Convalescent Plasma as a Possible Treatment for COVID-19,ATMP,Plasma,Plasma,50,https://clinicaltrials.gov/show/NCT04442191,None
2060,3573,NCT04442230,ClinicalTrials.gov,2020-06-17,2020-06-01,True,"Altimmune, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19),ATMP,Vaccine,Vaccine,96,https://clinicaltrials.gov/show/NCT04442230,None
2061,3579,NCT04442958,ClinicalTrials.gov,2020-06-17,2020-05-15,True,Bagcilar Training and Research Hospital,Not Recruiting,Not Applicable,Interventional,Turkey,Effectiveness of Convalescent Immune Plasma Therapy,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04442958,None
2062,3583,NCT04443270,ClinicalTrials.gov,2020-06-17,2020-06-22,False,Centro Mdico Nacional 20 de Noviembre,Not Recruiting,Phase 1,Interventional,Mexico,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Other (Chemoprophylaxis),Chloroquine,Chloroquine,200,https://clinicaltrials.gov/show/NCT04443270,None
2063,3585,NCT04443673,ClinicalTrials.gov,2020-06-18,2020-06-22,False,Instituto Nacional de Enfermedades Respiratorias,Recruiting,Not Applicable,Interventional,Mexico,Glycine Supplement for Severe COVID-19,Supplement,Glycine,Glycine,82,https://clinicaltrials.gov/show/NCT04443673,None
2064,3587,NCT04443725,ClinicalTrials.gov,2020-06-20,2020-07-01,False,Cairo University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy and Safety of Anti HCV Drugs in the Treatment of COVID-19,Drug,Hydroxychloroquine + Sofosbuvir + Daclatasvir,Hydroxychloroquine; Sofosbuvir; Daclatasvir,100,https://clinicaltrials.gov/show/NCT04443725,None
2065,3590,NCT04443868,ClinicalTrials.gov,2020-06-20,2020-09-01,False,Sanotize Research and Development corp.,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection,Drug,Nitric Oxide,Nitric Oxide,300,https://clinicaltrials.gov/show/NCT04443868,None
2066,3591,NCT04443881,ClinicalTrials.gov,2020-06-18,2020-05-08,True,Fundacin Miguel Servet,Recruiting,Phase 2/Phase 3,Interventional,Spain,Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS),Drug,Anakinra,Anakinra,180,https://clinicaltrials.gov/show/NCT04443881,None
2067,3593,NCT04444271,ClinicalTrials.gov,2020-05-27,2020-05-01,True,"Armed Forces Bone Marrow Transplant Center, Pakistan",Recruiting,Phase 2,Interventional,Pakistan,Mesenchymal Stem Cell Infusion for COVID-19 Infection,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04444271,None
2068,3599,NCT04444596,ClinicalTrials.gov,2020-06-18,2020-06-17,True,Medical University Innsbruck,Recruiting,Not Applicable,Interventional,Austria,Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04444596,None
2069,3602,NCT04444674,ClinicalTrials.gov,2020-06-15,2020-06-01,True,"University of Witwatersrand, South Africa",Not Recruiting,Phase 1/Phase 2,Interventional,South Africa,COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection,ATMP,Vaccine,Vaccine,2000,https://clinicaltrials.gov/show/NCT04444674,None
2070,3604,NCT04444700,ClinicalTrials.gov,2020-06-22,2020-06-25,False,University of So Paulo General Hospital,Recruiting,Phase 3,Interventional,Brazil,A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to COVID-19 Pandemic,Drug,Heparin,Heparin,462,https://clinicaltrials.gov/show/NCT04444700,None
2071,3606,NCT04445194,ClinicalTrials.gov,2020-06-16,2020-06-22,False,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",Not Recruiting,Phase 1,Interventional,No Country Given,Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine,ATMP,Vaccine,Vaccine,50,https://clinicaltrials.gov/show/NCT04445194,None
2072,3608,NCT04445220,ClinicalTrials.gov,2020-06-22,2020-08-01,False,"Sentien Biotechnologies, Inc.",Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy,ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://clinicaltrials.gov/show/NCT04445220,None
2073,3610,NCT04445246,ClinicalTrials.gov,2020-06-09,2020-05-23,True,Hamad Medical Corporation,Recruiting,Phase 2,Interventional,Qatar,Inhaled Iloprost for Suspected COVID-19 Respiratory Failure,Drug,Iloprost,Iloprost,40,https://clinicaltrials.gov/show/NCT04445246,None
2074,3612,NCT04445272,ClinicalTrials.gov,2020-06-13,2020-05-22,True,Fundacin SEIMC-GESIDA,Recruiting,Phase 2,Interventional,Spain,Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia,Drug,Tocilizumab,Tocilizumab,500,https://clinicaltrials.gov/show/NCT04445272,None
2075,3613,NCT04445285,ClinicalTrials.gov,2020-06-22,2020-04-28,True,Jon Simmons,Recruiting,Phase 2,Interventional,United States,Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure,Drug,Dornase alpha,Dornase alpha,44,https://clinicaltrials.gov/show/NCT04445285,None
2076,3614,NCT04445311,ClinicalTrials.gov,2020-06-19,2020-05-31,True,Zagazig University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Ivermectin in Treatment of COVID-19,Drug,Ivermectin,Ivermectin,100,https://clinicaltrials.gov/show/NCT04445311,None
2077,3615,NCT04445324,ClinicalTrials.gov,2020-06-22,2020-07-01,False,Centre de Recherche de l'Institut Universitaire en Sant Mentale de Montral,Not Recruiting,Not Applicable,Interventional,Canada,Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19,Other (psych),Psychological,Psychological,48,https://clinicaltrials.gov/show/NCT04445324,None
2078,3616,NCT04445337,ClinicalTrials.gov,2020-06-09,2020-07-01,False,University of Nebraska,Not Recruiting,Not Applicable,Interventional,No Country Given,Stellate Ganglion Blockade in COVID-19 Positive Patients,Clinical Presentation,No Intervention,No Intervention,10,https://clinicaltrials.gov/show/NCT04445337,None
2079,3617,NCT04445376,ClinicalTrials.gov,2020-06-22,2020-06-25,False,Government College University Faisalabad,Not Recruiting,Not Applicable,Interventional,No Country Given,Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery.,Other (exercise),Exercise,Exercise,150,https://clinicaltrials.gov/show/NCT04445376,None
2080,3618,NCT04445389,ClinicalTrials.gov,2020-06-19,2020-06-17,True,"Genexine, Inc.",Recruiting,Phase 1/Phase 2,Interventional,South Korea,"Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults",ATMP,Vaccine,Vaccine,190,https://clinicaltrials.gov/show/NCT04445389,None
2081,3621,NCT04445428,ClinicalTrials.gov,2020-06-22,2020-07-01,False,Bandim Health Project,Not Recruiting,Phase 4,Interventional,Guinea-Bissau,OPV as Potential Protection Against COVID,ATMP,Vaccine,Vaccine,3400,https://clinicaltrials.gov/show/NCT04445428,None
2082,3623,NCT04445454,ClinicalTrials.gov,2020-06-19,2020-06-12,True,University of Lige,Recruiting,Phase 1/Phase 2,Interventional,Belgium,Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04445454,None
2083,3624,NCT04445467,ClinicalTrials.gov,2020-06-22,2020-07-01,False,Bayside Health,Not Recruiting,Phase 2,Interventional,No Country Given,An Adaptive Randomised Placebo Controlled Phase II Trial of Antivirals for COVID-19 Infection,Drug,Favipiravir,Favipiravir,190,https://clinicaltrials.gov/show/NCT04445467,None
2084,3627,NCT04445597,ClinicalTrials.gov,2020-06-22,2020-05-07,True,UZ Leuven,Recruiting,Not Applicable,Interventional,Belgium,Unraveling the Mechanisms of Olfactory Dysfunction in COVID-19,Clinical Presentation,No Intervention,No Intervention,8,https://clinicaltrials.gov/show/NCT04445597,None
2085,3629,NCT04445623,ClinicalTrials.gov,2020-06-04,2020-07-01,False,AOUI Verona,Not Recruiting,Phase 3,Interventional,Italy,Prasugrel in Severe COVID-19 Pneumonia,Drug,Prasugrel,Prasugrel,128,https://clinicaltrials.gov/show/NCT04445623,None
2086,3631,NCT04445935,ClinicalTrials.gov,2020-06-23,2020-06-28,False,Hamad Medical Corporation,Recruiting,Phase 4,Interventional,Qatar,Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial,Drug,Bivalirudin,Bivalirudin,100,https://clinicaltrials.gov/show/NCT04445935,None
2087,3633,NCT04446065,ClinicalTrials.gov,2020-06-23,2020-07-30,False,MELISA Institute Genomics & Proteomics Research SpA,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Protection of Health Workers Against COVID-19,Drug (Chemoprophylaxis),Epigallocatechin gallate,Epigallocatechin gallate,524,https://clinicaltrials.gov/show/NCT04446065,None
2088,3634,NCT04446104,ClinicalTrials.gov,2020-05-11,2020-05-13,False,"National University Hospital, Singapore",Recruiting,Phase 3,Interventional,Singapore,A Preventive Treatment for Migrant Workers at High-risk of Covid-19,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Ivermectin vs. Zinc + Vitamin C vs. Povidone Iodine vs. Vitamin C,Hydroxychloroquine; Ivermectin; Zinc; Vitamin C; Povidone Iodine,5000,https://clinicaltrials.gov/show/NCT04446104,None
2089,3638,NCT04446377,ClinicalTrials.gov,2020-06-23,2020-06-29,False,"AI Therapeutics, Inc.",Not Recruiting,Phase 2,Interventional,United States,A Study of LAM-002A for the Prevention of Progression of COVID-19,Drug,Apilimod Dimesylate,Apilimod Dimesylate,142,https://clinicaltrials.gov/show/NCT04446377,None
2090,3639,NCT04446429,ClinicalTrials.gov,2020-06-22,2020-06-26,False,"Applied Biology, Inc.",Not Recruiting,Not Applicable,Interventional,Brazil,Anti-Androgen Treatment for COVID-19,Drug,Ivermectin + Azythromycin + Dutasteride vs. Ivermectin + Azythromycin,Ivermectin; Azythromycin; Dutasteride,254,https://clinicaltrials.gov/show/NCT04446429,None
2091,3644,NCT04447235,ClinicalTrials.gov,2020-06-22,2020-07-01,False,Instituto do Cncer do Estado de So Paulo,Not Recruiting,Phase 2,Interventional,No Country Given,Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection,Drug,Ivermectin + Losartan,Ivermectin; Losartan,176,https://clinicaltrials.gov/show/NCT04447235,None
2092,3645,NCT04447469,ClinicalTrials.gov,2020-06-23,2020-06-01,True,"Kiniksa Pharmaceuticals, Ltd.",Not Recruiting,Phase 2/Phase 3,Interventional,United States,Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation,Drug,Mavrilimumab,Mavrilimumab,573,https://clinicaltrials.gov/show/NCT04447469,None
2093,3647,NCT04447534,ClinicalTrials.gov,2020-06-23,2020-06-23,False,Tanta University,Recruiting,Phase 3,Interventional,Egypt,Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19,Drug,Chloroquine + Zinc vs. Chloroquine,Chloroquine; Zinc,200,https://clinicaltrials.gov/show/NCT04447534,None
2094,3650,NCT04448119,ClinicalTrials.gov,2020-06-24,2020-06-01,True,Appili Therapeutics Inc.,Not Recruiting,Phase 2,Interventional,No Country Given,Control of COVID-19 Outbreaks in Long Term Care,Drug,Favipiravir,Favipiravir,760,https://clinicaltrials.gov/show/NCT04448119,None
2095,3657,NCT04448756,ClinicalTrials.gov,2020-06-25,2020-06-27,False,Merck KGaA,Not Recruiting,Phase 2,Interventional,United States,M5049 Study in Participants With Coronavirus Disease 2019 (COVID-19) Pneumonia,Drug,M5049,M5049,150,https://clinicaltrials.gov/show/NCT04448756,None
2096,3658,NCT04448769,ClinicalTrials.gov,2020-06-23,2020-06-01,True,CHU de Nancy,Not Recruiting,Not Applicable,Interventional,No Country Given,Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04448769,None
2097,3663,NCT04449276,ClinicalTrials.gov,2020-06-18,2020-06-17,True,CureVac AG,Recruiting,Phase 1,Interventional,Germany,"A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults",ATMP,Vaccine,Vaccine,168,https://clinicaltrials.gov/show/NCT04449276,None
2098,3664,NCT04449380,ClinicalTrials.gov,2020-06-23,2020-07-01,False,IRCCS Ospedale San Raffaele,Not Recruiting,Phase 2,Interventional,Italy,Clinical Study for the Treatment With Interferon--1a (IFN-1a) of COVID-19 Patients,Drug,Interferon beta,Interferon beta,126,https://clinicaltrials.gov/show/NCT04449380,None
2099,3665,ACTRN12620000688987,ANZCTR,2020-06-19,2020-06-02,True,The Royal Melbourne Hospital,Not Recruiting,Not Applicable,Interventional,Australia,"Comparing the user seal check and fit test between two types of N95 respirators - the Halyard N95 Particulate Filter Respirators and the ProShield N-95 masks
",Other (device),Mask,Mask,80,https://anzctr.org.au/ACTRN12620000688987.aspx,None
2100,3666,ACTRN12620000698976,ANZCTR,2020-06-23,2020-06-10,True,Royal Prince Alfred Hopsital,Recruiting,Not Applicable,Interventional,Australia,Maintaining the health of people with and without COVID-19 during isolation,Other,Other,Other,40,https://anzctr.org.au/ACTRN12620000698976.aspx,None
2101,3668,ACTRN12620000707965,ANZCTR,2020-06-29,2020-06-30,False,Accelagen Pty Ltd,Not Recruiting,Phase 3,Interventional,Australia,"A Placebo-Controlled Study to Evaluate the effect of the recombinant Bacillus CalmetteGurin (BCG) vaccine VPM1002 on the Incidence or Disease Severity of SARS-COV-2/COVID-19 Among High-Risk Participants in Australia
",ATMP,Vaccine,Vaccine,3468,https://anzctr.org.au/ACTRN12620000707965.aspx,None
2102,3674,ISRCTN54917435,ISRCTN,2020-06-15,2020-06-25,False,Uppsala County Council,Recruiting,Not Applicable,Interventional,Sweden,Could prone positioning increase lung function for patients with severe COVID-19 infection?,Procedure,Positioning,Positioning,240,http://isrctn.com/ISRCTN54917435,None
2103,3676,ISRCTN17072692,ISRCTN,2020-06-04,2020-06-08,False,Imperial College London,Recruiting,Phase 1,Interventional,United Kingdom,Clinical trial to assess the safety of a coronavirus vaccine in healthy men and women,ATMP,Vaccine,Vaccine,320,http://isrctn.com/ISRCTN17072692,None
2104,3678,ISRCTN86534580,ISRCTN,2020-03-22,2020-03-25,True,University of Oxford,Recruiting,Phase 3,Interventional,United Kingdom,PRINCIPLE: A trial evaluating treatments for suspected COVID-19 in people aged 50 years and above with pre-existing conditions and those aged 65 years and above,Drug,Hydroxychloroquine,Hydroxychloroquine,3000,http://isrctn.com/ISRCTN86534580,EUCTR2020-001209-22
2105,3679,ISRCTN37530113,ISRCTN,2020-01-31,2017-09-04,True,Central Norway Regional Health Authority,Recruiting,Not Applicable,Interventional,Norway,Enhanced cognitive behavioral therapy for children and adolescents with obsessive compulsive disorder: an open trial,Other (psych),Psychological,Psychological,70,http://isrctn.com/ISRCTN37530113,None
2106,3682,ChiCTR2000034164,ChiCTR,2020-06-27,2020-07-08,False,Chinese Academy of Sciences,Not Recruiting,Not Applicable,Interventional,China,Trauma Healing Project Based on Chinese Mind-Body Wisdom in the novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,340,http://www.chictr.org.cn/showproj.aspx?proj=55154,None
2107,3683,ChiCTR2000034112,ChiCTR,2020-06-24,2020-06-25,False,Shulan (Hangzhou) Hospital; Center for Disease Control and Prevention of Guangxi Zhuang Autonomous Region,Not Recruiting,Phase 1,Prevention,China,"A Phase I clinical trial to evaluate the safety, tolerance and preliminary immunogenicity of different doses of a SARS-CoV-2 mRNA vaccine in population aged 18-59 years and 60 years and above",ATMP,Vaccine,Vaccine,168,http://www.chictr.org.cn/showproj.aspx?proj=55524,None
2108,3684,ChiCTR2000034076,ChiCTR,2020-06-22,2020-05-23,True,Beijing TIL Therapeutics,Recruiting,Not Applicable,Interventional,China,Novel coronavirus pneumonia (COVID-19) loaded autologous dendritic cell trial,ATMP,Cells (dendritic),Cells (dendritic),25,http://www.chictr.org.cn/showproj.aspx?proj=55582,None
2109,3685,ChiCTR2000029589,ChiCTR,2020-02-05,2020-02-06,False,Beijing Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"A prospective, randomized,open, multi-center clinical trial evaluating  the efficiency and safety of Reduning injection  in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=49104,None
2110,3686,EUCTR2020-001767-86-IE,EU Clinical Trials Register,2020-04-15,2020-06-25,False,University College Dublin,Authorised,Phase 2,Interventional,Ireland,trial comparing different doses of single-dose tocilizumab in adults with severe COVID-19 infection,Drug,Tocilizumab,Tocilizumab,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001767-86,None
2111,3687,EUCTR2020-001777-71-GB,EU Clinical Trials Register,2020-04-30,2020-05-06,False,Guy's and St Thomas' NHS Foundation Trust,Authorised,Phase 4,Interventional,United Kingdom,Ruxolitinib therapy to Avoid Ventilation and improve outcome for deteriorating COVID-19 patients,Drug,Ruxolitinib,Ruxolitinib,59,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001777-71,None
2112,3688,EUCTR2020-001745-40-IT,EU Clinical Trials Register,2020-06-24,2020-04-23,True,ASST Fatebenefratelli Sacco,Authorised,Phase 2,Interventional,Italy,PILOT STUDY ON THE USE OF SARILUMAB IN PATIENTS WITH COVID-19 INFECTION,Drug,Sarilumab,Sarilumab,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001745-40,None
2113,3689,EUCTR2020-001501-24-IT,EU Clinical Trials Register,2020-06-24,2020-04-28,True,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori,Authorised,Phase 2,Interventional,Italy,PROTECT: studio randomizzato con idrossiclorochina vs osservazione per la prevenzione e il trattamento precoce della malattia da coronavirus (COVID-19),Drug (+ Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,2300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001501-24,None
2114,3690,EUCTR2020-001390-76-IT,EU Clinical Trials Register,2020-06-24,2020-04-27,True,IRCCS Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani,Authorised,Phase 3,Interventional,Italy,"A phase 3, randomized, open-labeled, multi-center study comparing clinical efficacy and safety of intravenous sarilumab plus standard of care compared to standard of care, in the treatment of patients with severe COVID-19 pneumonia .",Drug,Sarilumab,Sarilumab,171,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001390-76,None
2115,3691,EUCTR2020-001528-32-IT,EU Clinical Trials Register,2020-06-24,2020-05-14,True,IRCCS Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani,Authorised,Phase 3,Interventional,Italy,Adaptive Randomized trial for therapy of COrona virus disease 2019 at home with oral antivirals,Drug,Lopinavir/ritonavir vs. Hydroxychloroquine vs. Darunavir vs. Favipiravir,Lopinavir/ritonavir; Hydroxychloroquine; Darunavir; Favipiravir,435,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001528-32,None
2116,3692,EUCTR2020-001987-28-IT,EU Clinical Trials Register,2020-06-24,2020-05-06,True,IRCCS Ospedale San Raffaele,Authorised,Phase 3,Interventional,Italy,PRECOV: a randomized controlled clinical trial on the effects of hydroxychloroquine in the prevention of COVID-19 in healthcare workers at risk,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001987-28,None
2117,3693,EUCTR2020-001172-15-DE,EU Clinical Trials Register,2020-03-23,2020-04-08,False,Apeiron Biologics,Authorised,Phase 2,Interventional,"Denmark, United States, United Kingdom, Germany, Russian Federation, Austria",Recombinant human angiotensin-converting enzyme 2 (rhACE2) as a treat-ment for patients with COVID-19,Drug,ACE enzyme,ACE enzyme,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001172-15,None
2118,3694,EUCTR2020-001921-30-IT,EU Clinical Trials Register,2020-06-26,2020-05-14,True,AOU di Modena,Authorised,Phase 3,Interventional,Italy,"Steroids and unfractionated heparin in critically-ill patients with pneumonia from COVID-19 infection. A multicenter, interventional, randomized, three arms study design.",Drug,"Corticosteroids, Heparin",Methylprednisolone; Heparin,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001921-30,None
2119,3695,EUCTR2020-001795-15-IT,EU Clinical Trials Register,2020-06-26,2020-05-07,True,IRCCS Ospedale San Raffaele,Authorised,Phase 2,Interventional,Italy,Clinical study aimed to verify the efficacy and safety of mavrilimumab in COVID-19-associated pneumonia in patients who have signs of excessive inflammation,Drug,Mavrilimumab,Mavrilimumab,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001795-15,None
2120,3696,EUCTR2020-001854-23-IT,EU Clinical Trials Register,2020-06-26,2020-04-27,True,Societ Italiana di Malattie Infettive e Tropicali,Authorised,Phase 2/Phase 3,Interventional,Italy,A study with immunotherapy for Moderate COVID-19,Drug,Tocilizumab vs. Hydroxychloroquine vs. Siltuximab vs. Canakinumab vs. Sarilumab vs. Baricitinib vs. Methylprednisolone,Tocilizumab; Hydroxychloroquine; Siltuximab; Canakinumab; Sarilumab; Baricitinib; Methylprednisolone,1400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001854-23,None
2121,3697,EUCTR2020-001558-23-IT,EU Clinical Trials Register,2020-06-26,2020-04-09,True,Azienda Sanitaria Unica Regionale (ASUR),Authorised,Phase 3,Interventional,Italy,Hydroxychloroquine sulfate early administration in symptomatic out of hospital COVID-19 positive patients. Hydro-Stop-COVID19 Trial,Drug,Hydroxychloroquine,Hydroxychloroquine,216,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001558-23,None
2122,3703,NL8523,Netherlands Trial Register,2020-04-13,2020-04-26,False,UMC Utrecht,Not Recruiting,Not Applicable,Interventional,Netherlands,Volatile Anaesthetics in COVID-19  a pilot study,Drug,Isoflurane,Isoflurane,20,https://trialregister.nl/trial/8523,None
2123,3710,NL8521,Netherlands Trial Register,2020-04-13,2020-05-08,False,UMC Amsterdam,Not Recruiting,Not Applicable,Interventional,Netherlands,Continuous positive airway pressure in severe Covid-19 pneumonia,Drug,Oxygen,Oxygen,13,https://trialregister.nl/trial/8521,None
2124,3712,NL8578,Netherlands Trial Register,2020-05-02,2020-07-13,False,Rode Kruis Ziekenhuis Beverwijk,Not Recruiting,Not Applicable,Interventional,Netherlands,Alkaline phosphatase for reducing systemic inflammatory response syndrome (SIRS) in patients with Sars-CoV-2 infection and acute respiratory insufficiency (COVID 19),Drug,Alkaline phosphatase,Alkaline phosphatase,124,https://trialregister.nl/trial/8578,None
2125,3713,NL8577,Netherlands Trial Register,2020-05-06,2020-05-15,False,Academic Hospital Maastricht,Not Recruiting,Not Applicable,Interventional,Netherlands,Digital Cardiac Counseling Trial: DCC Trial,Other (software),eHealth,eHealth,394,https://trialregister.nl/trial/8577,None
2126,3718,NL8538,Netherlands Trial Register,2020-04-17,2020-04-17,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,Netherlands,Sleep position related to hospital length of stay in admitted COVID-19 patients,Procedure,Positioning,Positioning,342,https://trialregister.nl/trial/8538,None
2127,3720,NL8609,Netherlands Trial Register,2020-05-11,2020-05-25,False,Radboud University Medical Centre,Not Recruiting,Not Applicable,Interventional,Netherlands,Enhancing the BCG-induced trained immunity response by addition of bisphosphonate or MMR vaccine: a possible preventive approach against COVID-19 (BCG-PLUS),ATMP,Vaccine,Vaccine,100,https://trialregister.nl/trial/8609,None
2128,3724,NL8547,Netherlands Trial Register,2020-04-22,2020-04-16,True,Radboud University Medical Centre,Recruiting,Not Applicable,Interventional,Netherlands,"REDUCING HOSPITAL ADMISSION OF ELDERLY IN SARS-CoV-2 PANDEMIC VIA THE INDUCTION OF TRAINED IMMUNITY BY BACILLUS CALMETTE-GURIN VACCINATION, A RANDOMIZED CONTROLLED TRIAL",ATMP,Vaccine,Vaccine,1600,https://trialregister.nl/trial/8547,EUCTR2020-001591-15
2129,3726,NL8633,Netherlands Trial Register,2020-05-13,2020-05-13,False,Leiden University Medical Center,Recruiting,Not Applicable,Interventional,Netherlands,"A randomized, double blinded clinical trial of convalescent plasma compared to standard plasma for treatment of hospitalized non-ICU patients with COVID-19 infections",ATMP,Plasma,Plasma,430,https://trialregister.nl/trial/8633,None
2130,3730,NL8490,Netherlands Trial Register,2020-03-31,2020-04-12,False,UMC Utrecht,Recruiting,Not Applicable,Interventional,Netherlands,"An open label randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19
",Drug,Chloroquine vs. hydroxychloroquine,Chloroquine; hydroxychloroquine,950,https://trialregister.nl/trial/8490,None
2131,3740,NL8483,Netherlands Trial Register,2020-03-26,2020-03-16,True,Fred Foundation; Noaber Foundation,Recruiting,Not Applicable,Interventional,Netherlands,A weapon against COVID-19: (Social) media and influencers,Other,Other,Other,17000,https://trialregister.nl/trial/8483,None
2132,3742,NL8491,Netherlands Trial Register,2020-03-31,2020-03-31,False,UMC Amsterdam,Recruiting,Not Applicable,Interventional,Netherlands,Countering Lung Damage in COVID-19 infection (CounterCovid) study,Drug,Imatinib,Imatinib,386,https://trialregister.nl/trial/8491,None
2133,3745,NCT04324606,ClinicalTrials.gov,2020-03-20,2020-04-23,True,University of Oxford,Not Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,A Study of a Candidate COVID-19 Vaccine (COV001),ATMP,Vaccine,Vaccine,1090,https://clinicaltrials.gov/show/NCT04324606,EUCTR2020-001072-15; ISRCTN15281137
2134,3746,NCT04381936,ClinicalTrials.gov,2020-05-07,2020-03-19,True,University of Oxford,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,Randomized Evaluation of COVID-19 Therapy,Drug,Lopinavir/ritonavir vs. corticosteroids vs. hydroxychloroquine vs. azithromycin vs. tocilizumab,Lopinavir/ritonavir; dexamethasone; hydrocortisone;  hydroxychloroquine; azithromycin; tocilizumab,12000,https://clinicaltrials.gov/ct2/show/NCT04381936,EUCTR2020-001113-21; ISRCTN50189673
2135,3747,NCT04348305,ClinicalTrials.gov,2020-04-11,2020-04-17,True,Scandinavian Critical Care Trials Group,Not Recruiting,Phase 3,Interventional,Denmark,Hydrocortisone for COVID-19 and Severe Hypoxia,Drug,Corticosteroids,Hydrocortisone,1000,https://clinicaltrials.gov/ct2/show/NCT04348305,EUCTR2020-001395-15
2136,3748,NCT04327388,ClinicalTrials.gov,2020-03-26,2020-03-28,True,Sanofi,Recruiting,Phase 3,Interventional,"Argentina, Brazil, Russian Federation, Chile, Germany, Spain, Italy, Japan, France, Israel, Canada",Sarilumab COVID-19,Drug,Sarilumab,Sarilumab,400,https://clinicaltrials.gov/ct2/show/NCT04327388,EUCTR2020-001162-12
2137,3749,NCT04451083,ClinicalTrials.gov,2020-06-21,2020-07-01,False,Ono Pharmaceutical Co. Ltd,Recruiting,Phase 1,Interventional,Japan,Multiple-dose Study of FOY-305 in Japanese Healthy Adult Male Subjects,Drug,Camostat Mesilate,Camostat Mesilate,Drug: FOY-305,14,JPRN-JapicCTI-205326
